data_1tq1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1tq1 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 . . . . . 0 N--CA 1.5 2.033 0 CA-C-O 122.16 0.981 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.597 ' H ' ' N ' ' A' ' 109' ' ' GLY . 9.0 t -146.85 101.75 3.92 Favored Pre-proline 0 C--N 1.291 -1.958 0 O-C-N 121.267 -0.896 . . . . 0.0 108.942 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -88.69 124.72 1.61 Allowed 'Trans proline' 0 C--N 1.297 -2.14 0 C-N-CA 121.875 1.716 . . . . 0.0 111.431 177.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.5 p -138.17 152.2 48.45 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 122.021 0.915 . . . . 0.0 109.681 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.419 ' C ' ' CG1' ' A' ' 20' ' ' VAL . 39.6 m -115.96 144.55 43.92 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 122.675 1.226 . . . . 0.0 109.627 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.637 ' CG2' ' N ' ' A' ' 21' ' ' SER . 0.7 OUTLIER -158.81 -179.04 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.196 0 O-C-N 121.025 -1.047 . . . . 0.0 109.402 -178.701 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.637 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 14.3 p -115.58 148.19 39.87 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.48 -1.387 . . . . 0.0 109.395 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.6 p -47.32 -21.24 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.768 0 CA-C-O 122.102 0.953 . . . . 0.0 108.648 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.494 ' OG1' ' N ' ' A' ' 24' ' ' VAL . 0.1 OUTLIER -64.39 -55.7 19.32 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 120.736 -1.227 . . . . 0.0 109.177 179.169 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.494 ' N ' ' OG1' ' A' ' 23' ' ' THR . 0.9 OUTLIER -71.15 -40.5 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.175 -1.578 . . . . 0.0 109.4 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.98 -35.04 70.64 Favored 'General case' 0 C--N 1.286 -2.159 0 O-C-N 120.829 -1.17 . . . . 0.0 108.361 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.431 ' O ' ' CD1' ' A' ' 30' ' ' LEU . 86.4 t60 -52.99 -46.66 68.42 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -55.33 -43.42 74.94 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 120.907 -1.12 . . . . 0.0 108.666 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.4 mp -70.72 -36.8 73.38 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 19.2 tp -56.91 -39.69 74.92 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.431 ' CD1' ' O ' ' A' ' 26' ' ' HIS . 11.0 mp -63.43 -25.8 68.44 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.34 -22.42 66.27 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.77 -1.207 . . . . 0.0 108.385 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.95 48.82 3.5 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -107.41 149.58 27.73 Favored 'General case' 0 C--N 1.292 -1.898 0 O-C-N 121.204 -1.174 . . . . 0.0 109.593 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -58.66 133.68 56.11 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 122.428 1.109 . . . . 0.0 109.827 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.402 ' O ' ' O ' ' A' ' 53' ' ' ILE . 47.3 t80 -112.6 113.61 25.83 Favored 'General case' 0 C--N 1.292 -1.93 0 O-C-N 121.285 -0.884 . . . . 0.0 108.937 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.621 ' CD1' ' N ' ' A' ' 37' ' ' ASP . 0.1 OUTLIER -98.84 130.57 45.27 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.594 -1.317 . . . . 0.0 108.554 179.213 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.621 ' N ' ' CD1' ' A' ' 36' ' ' LEU . 48.2 t0 -138.61 142.5 39.13 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 38' ' ' VAL . 4.5 m -131.04 96.11 2.59 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 CA-C-O 122.433 1.111 . . . . 0.0 108.158 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.754 ' O ' ' OG1' ' A' ' 40' ' ' THR . 0.1 OUTLIER -89.65 -45.32 9.43 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.754 ' OG1' ' O ' ' A' ' 39' ' ' ARG . 3.6 m 177.45 142.32 0.25 Allowed Pre-proline 0 N--CA 1.49 1.573 0 C-N-CA 119.312 -0.955 . . . . 0.0 109.921 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -40.21 -39.96 2.73 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 121.983 1.788 . . . . 0.0 111.074 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.505 ' H ' HG22 ' A' ' 40' ' ' THR . 96.6 mt-10 -61.0 -30.34 70.23 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.951 -1.093 . . . . 0.0 108.567 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 40' ' ' THR . 66.1 tt0 -55.48 -32.01 62.47 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.75 -1.219 . . . . 0.0 109.014 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -67.99 -44.21 77.15 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 122.174 0.988 . . . . 0.0 108.978 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.1 t -56.13 -29.72 61.1 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.191 -0.943 . . . . 0.0 109.048 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -70.16 -36.92 75.04 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.124 -0.985 . . . . 0.0 108.631 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.06 -148.38 17.11 Favored Glycine 0 N--CA 1.499 2.84 0 CA-C-O 122.267 0.926 . . . . 0.0 110.977 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -100.42 -160.2 0.78 Allowed 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 122.684 1.23 . . . . 0.0 109.411 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.62 166.72 24.38 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 122.178 0.99 . . . . 0.0 109.396 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.584 ' O ' ' NE1' ' A' ' 120' ' ' TRP . 4.7 t -83.63 105.33 14.47 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-O 122.541 1.162 . . . . 0.0 107.89 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.56 26.5 65.27 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.0 123.15 5.37 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 120.784 -1.421 . . . . 0.0 109.595 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.56 ' N ' ' CD1' ' A' ' 53' ' ' ILE . 2.7 mp -105.14 104.27 16.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 O-C-N 120.709 -1.245 . . . . 0.0 110.247 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -107.94 118.33 36.46 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-O 121.971 0.891 . . . . 0.0 109.449 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.405 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 2.0 m -142.13 163.34 40.49 Favored Pre-proline 0 C--N 1.274 -2.71 0 CA-C-O 122.171 0.986 . . . . 0.0 109.09 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -84.08 68.2 6.71 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.451 2.101 . . . . 0.0 111.72 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.463 ' CZ ' ' CG2' ' A' ' 38' ' ' VAL . 66.4 m-85 . . . . . 0 C--N 1.298 -1.646 0 CA-C-O 122.229 1.014 . . . . 0.0 109.789 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.509 ' CZ ' ' OD2' ' A' ' 83' ' ' ASP . 22.7 t80 . . . . . 0 N--CA 1.498 1.964 0 CA-C-O 122.142 0.972 . . . . 0.0 110.018 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.456 ' H ' ' HB3' ' A' ' 83' ' ' ASP . . . -116.55 136.24 12.65 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -46.56 -25.92 0.79 Allowed 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.487 -1.007 . . . . 0.0 109.198 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.503 ' O ' ' C ' ' A' ' 83' ' ' ASP . 0.3 OUTLIER -125.09 23.01 7.83 Favored 'General case' 0 C--N 1.292 -1.906 0 O-C-N 120.809 -1.182 . . . . 0.0 107.97 178.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.509 ' OD2' ' CZ ' ' A' ' 79' ' ' PHE . 9.8 p-10 -35.56 116.33 0.36 Allowed 'General case' 0 N--CA 1.507 2.419 0 CA-C-O 121.762 0.792 . . . . 0.0 109.076 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.576 ' N ' ' O ' ' A' ' 109' ' ' GLY . 28.8 t30 63.0 60.88 1.17 Allowed 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.898 0.856 . . . . 0.0 109.426 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.528 ' CG2' ' N ' ' A' ' 86' ' ' ILE . 21.5 mt -145.94 175.24 2.28 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 O-C-N 121.063 -1.023 . . . . 0.0 109.41 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.528 ' N ' ' CG2' ' A' ' 85' ' ' ILE . 28.3 mt -111.26 107.48 23.06 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.294 0 CA-C-O 122.181 0.991 . . . . 0.0 109.407 178.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.485 ' N ' ' O ' ' A' ' 111' ' ' LYS . 38.2 t -109.68 155.11 10.96 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 CA-C-O 121.946 0.879 . . . . 0.0 108.906 -175.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -162.41 138.24 5.27 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.472 ' SG ' ' OG ' ' A' ' 95' ' ' SER . 34.7 t -94.58 144.12 25.86 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 122.059 0.933 . . . . 0.0 109.268 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 9.9 tm0? -44.2 -35.9 2.44 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.985 0.897 . . . . 0.0 110.444 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 69.5 m -102.78 158.25 16.39 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 122.141 0.972 . . . . 0.0 109.51 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' A' ' 94' ' ' ARG . . . -123.16 168.26 15.38 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 65.22 -70.74 0.09 OUTLIER Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 92' ' ' GLY . 89.9 mtt180 -62.59 -36.05 81.48 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.214 -1.168 . . . . 0.0 108.766 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.472 ' OG ' ' SG ' ' A' ' 89' ' ' CYS . 7.0 t -85.5 -24.49 27.32 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.183 -0.948 . . . . 0.0 109.25 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.467 ' O ' ' OG1' ' A' ' 99' ' ' THR . 1.0 OUTLIER -58.8 -47.45 89.21 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 O-C-N 121.044 -1.035 . . . . 0.0 108.895 179.871 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.412 ' N ' ' CG2' ' A' ' 96' ' ' ILE . 49.9 pttt -71.38 -30.87 66.64 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.675 -1.266 . . . . 0.0 108.423 177.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.89 -38.11 89.89 Favored 'General case' 0 C--N 1.289 -2.028 0 O-C-N 120.521 -1.362 . . . . 0.0 109.193 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' A' ' 96' ' ' ILE . 0.0 OUTLIER -63.01 -35.37 79.99 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-O 122.539 1.161 . . . . 0.0 108.679 179.65 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.417 ' H ' ' HG1' ' A' ' 100' ' ' THR . 9.7 m -57.44 -38.25 74.13 Favored 'General case' 0 C--N 1.288 -2.094 0 O-C-N 120.998 -1.064 . . . . 0.0 109.005 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -61.33 -43.32 99.07 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.644 -1.285 . . . . 0.0 108.087 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.2 mt -70.07 -35.03 73.93 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 122.01 0.91 . . . . 0.0 108.848 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 52.0 tp -56.31 -39.77 73.29 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.062 -1.024 . . . . 0.0 108.966 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 30.0 m170 -61.98 -36.48 81.6 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.551 -1.343 . . . . 0.0 108.57 177.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -76.22 -19.22 58.58 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 120.612 -1.305 . . . . 0.0 108.359 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 120.23 83.39 0.78 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -144.55 62.14 1.33 Allowed 'General case' 0 C--N 1.289 -2.032 0 O-C-N 121.09 -1.241 . . . . 0.0 109.35 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.564 ' OG1' ' N ' ' A' ' 109' ' ' GLY . 0.0 OUTLIER -126.47 179.1 5.47 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.642 -1.287 . . . . 0.0 110.136 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.597 ' N ' ' H ' ' A' ' 16' ' ' VAL . . . 85.76 17.76 61.12 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.4 m -147.18 163.06 7.72 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 O-C-N 121.081 -1.247 . . . . 0.0 109.858 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.485 ' O ' ' N ' ' A' ' 87' ' ' VAL . 61.1 mttp -98.57 141.98 30.73 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 122.218 1.009 . . . . 0.0 108.694 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 74.4 m-20 -99.44 108.19 20.59 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.458 ' N ' ' O ' ' A' ' 87' ' ' VAL . 7.4 mm -97.64 155.35 3.67 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 O-C-N 121.241 -0.912 . . . . 0.0 110.218 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 38.0 t -99.12 124.18 52.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 O-C-N 120.783 -1.198 . . . . 0.0 109.638 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.17 -145.67 23.39 Favored Glycine 0 C--N 1.286 -2.235 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 135.59 -90.26 0.23 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.503 ' O ' ' N ' ' A' ' 121' ' ' ALA . 79.6 t80 -51.77 -41.63 61.77 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 121.989 0.899 . . . . 0.0 109.659 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 18.5 t -57.57 -45.03 85.67 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-O 121.923 0.868 . . . . 0.0 109.39 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.22 -52.57 12.0 Favored 'General case' 0 C--N 1.287 -2.152 0 O-C-N 121.134 -0.979 . . . . 0.0 108.901 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . 0.584 ' NE1' ' O ' ' A' ' 50' ' ' CYS . 4.9 t-105 -57.93 -35.54 71.23 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.165 -1.421 . . . . 0.0 107.165 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 117' ' ' TYR . . . -63.69 -30.93 71.97 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 120.912 -1.118 . . . . 0.0 108.79 178.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.4 ttpp -57.45 -36.39 71.36 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -65.86 -65.19 0.71 Allowed 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.645 -1.284 . . . . 0.0 108.354 178.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 105.87 32.89 3.68 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.482 ' O ' ' CB ' ' A' ' 50' ' ' CYS . 18.6 mt -126.43 79.75 70.32 Favored Pre-proline 0 C--N 1.296 -1.736 0 O-C-N 120.933 -1.334 . . . . 0.0 109.376 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo . . . . . 0 C--N 1.301 -1.937 0 C-N-CA 122.255 1.97 . . . . 0.0 113.229 -179.88 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.5 2.045 0 CA-C-O 122.142 0.972 . . . . 0.0 109.781 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.74 177.3 1.9 Allowed Pre-proline 0 C--N 1.291 -1.976 0 O-C-N 121.347 -0.845 . . . . 0.0 108.92 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.459 ' N ' ' OG1' ' A' ' 108' ' ' THR . 29.6 Cg_endo -86.69 135.35 4.13 Favored 'Trans proline' 0 C--N 1.296 -2.194 0 C-N-CA 121.849 1.699 . . . . 0.0 111.426 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 112' ' ' ASP . 32.8 t -140.56 138.99 34.9 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.111 0.958 . . . . 0.0 109.704 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.1 t -99.02 143.91 28.77 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-O 122.742 1.258 . . . . 0.0 109.566 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.713 ' CG2' ' N ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -148.7 178.9 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 O-C-N 121.013 -1.055 . . . . 0.0 109.41 -178.733 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.713 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 62.6 m -119.14 151.34 38.48 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.499 -1.376 . . . . 0.0 109.415 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.5 p -48.62 -27.1 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.273 -2.738 0 CA-C-O 122.159 0.981 . . . . 0.0 108.739 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.509 ' OG1' ' N ' ' A' ' 24' ' ' VAL . 0.1 OUTLIER -65.1 -58.2 6.66 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 120.725 -1.234 . . . . 0.0 109.112 179.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.509 ' N ' ' OG1' ' A' ' 23' ' ' THR . 0.0 OUTLIER -60.31 -35.1 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.158 -1.589 . . . . 0.0 109.436 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -51.11 -37.3 45.13 Favored 'General case' 0 C--N 1.287 -2.144 0 O-C-N 120.799 -1.188 . . . . 0.0 108.394 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -57.66 -44.09 85.43 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -59.9 -43.61 94.72 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 120.904 -1.122 . . . . 0.0 108.697 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.1 mp -66.46 -33.55 75.94 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.431 ' O ' ' CD1' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -53.54 -40.44 65.52 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.733 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.4 mp -63.99 -31.11 72.19 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 120.568 -1.333 . . . . 0.0 107.421 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.9 -28.77 68.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.634 -1.292 . . . . 0.0 108.362 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.31 47.28 8.32 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -96.53 156.45 16.34 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 121.148 -1.207 . . . . 0.0 109.621 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -59.17 144.69 45.13 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 122.365 1.079 . . . . 0.0 109.768 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -123.85 112.16 16.95 Favored 'General case' 0 C--N 1.291 -1.964 0 O-C-N 121.381 -0.824 . . . . 0.0 108.973 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 8.0 tt -122.16 101.22 7.4 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.649 -1.282 . . . . 0.0 108.529 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -98.89 157.3 16.4 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -176.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 38' ' ' VAL . 6.0 m -133.76 89.05 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 CA-C-O 122.396 1.093 . . . . 0.0 108.064 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.565 ' CG ' ' NH1' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -81.71 -45.3 15.89 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -179.394 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.554 ' OG1' ' C ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER 171.58 163.8 0.24 Allowed Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.138 -0.976 . . . . 0.0 109.965 -179.41 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -66.09 -12.97 37.74 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 121.993 1.795 . . . . 0.0 111.125 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -72.81 -37.75 67.42 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.979 -1.076 . . . . 0.0 108.478 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.444 ' OE2' ' O ' ' A' ' 54' ' ' ASN . 2.0 pp20? -58.49 -28.68 65.61 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.726 -1.233 . . . . 0.0 109.04 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -74.08 -42.39 60.22 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 122.148 0.975 . . . . 0.0 108.977 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.9 t -54.83 -37.87 66.7 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.265 -0.897 . . . . 0.0 109.117 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -82.58 -37.27 25.3 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.158 -0.964 . . . . 0.0 108.714 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 43' ' ' GLU . . . 137.93 -139.57 10.49 Favored Glycine 0 N--CA 1.499 2.879 0 CA-C-O 122.298 0.943 . . . . 0.0 110.988 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -101.58 -161.73 0.88 Allowed 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 122.683 1.23 . . . . 0.0 109.396 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.455 ' CB ' ' CZ2' ' A' ' 120' ' ' TRP . . . -146.79 159.94 42.88 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 122.234 1.016 . . . . 0.0 109.374 -178.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.52 ' CB ' ' O ' ' A' ' 125' ' ' LEU . 4.6 t -82.53 162.55 21.96 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-O 122.559 1.171 . . . . 0.0 107.863 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.57 -51.39 4.14 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.23 175.37 14.13 Favored 'General case' 0 C--N 1.29 -1.999 0 O-C-N 120.798 -1.413 . . . . 0.0 109.63 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 73.2 mt -101.41 139.11 23.44 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 O-C-N 120.786 -1.196 . . . . 0.0 110.266 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.444 ' O ' ' OE2' ' A' ' 43' ' ' GLU . 43.5 p-10 -131.44 130.79 42.96 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.982 0.896 . . . . 0.0 109.444 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.477 ' C ' ' H ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -142.99 165.37 26.54 Favored Pre-proline 0 C--N 1.273 -2.719 0 CA-C-O 122.191 0.996 . . . . 0.0 109.146 179.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -76.88 26.45 0.44 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.468 2.112 . . . . 0.0 111.736 -177.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.625 ' CD1' ' NE2' ' A' ' 81' ' ' GLN . 90.7 t80 . . . . . 0 C--N 1.299 -1.61 0 CA-C-O 122.266 1.032 . . . . 0.0 109.887 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 . . . . . 0 N--CA 1.5 2.026 0 CA-C-O 122.205 1.002 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.507 ' H ' ' HB2' ' A' ' 83' ' ' ASP . . . -109.58 138.14 14.64 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.625 ' NE2' ' CD1' ' A' ' 57' ' ' TYR . 10.0 pt20 -45.6 -18.27 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.425 -1.044 . . . . 0.0 109.242 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.49 ' N ' ' O ' ' A' ' 80' ' ' GLY . 19.2 t -123.16 17.57 9.94 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 120.838 -1.164 . . . . 0.0 107.992 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.507 ' HB2' ' H ' ' A' ' 80' ' ' GLY . 11.9 t70 -40.46 107.46 0.07 Allowed 'General case' 0 N--CA 1.508 2.441 0 O-C-N 121.421 -0.799 . . . . 0.0 109.077 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 53.78 70.03 0.65 Allowed 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 121.97 0.89 . . . . 0.0 109.47 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.526 ' CG2' ' N ' ' A' ' 86' ' ' ILE . 17.7 mt -143.1 168.84 12.71 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 O-C-N 121.021 -1.05 . . . . 0.0 109.402 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.526 ' N ' ' CG2' ' A' ' 85' ' ' ILE . 49.0 mt -110.44 109.66 29.3 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.231 0 CA-C-O 122.188 0.994 . . . . 0.0 109.473 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.558 ' O ' ' N ' ' A' ' 113' ' ' ILE . 18.6 t -112.44 166.75 6.26 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 O-C-N 121.219 -0.926 . . . . 0.0 108.898 -177.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -148.97 141.72 9.22 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.502 ' O ' ' C ' ' A' ' 90' ' ' GLN . 0.4 OUTLIER -90.46 140.43 29.73 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 122.127 0.965 . . . . 0.0 109.23 -179.345 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.524 ' H ' ' CD ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -33.46 -89.88 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.992 0.901 . . . . 0.0 110.486 -178.691 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.7 p -149.64 160.36 43.57 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 122.197 0.998 . . . . 0.0 109.521 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.94 119.36 4.31 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.454 ' O ' ' CG2' ' A' ' 96' ' ' ILE . . . -57.43 -37.81 83.81 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.101 -1.599 . . . . 0.0 109.101 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 34.4 mtp180 -62.7 -28.1 69.71 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.317 -1.108 . . . . 0.0 108.807 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.8 m -62.3 -39.48 93.12 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.189 -0.944 . . . . 0.0 109.325 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.454 ' CG2' ' O ' ' A' ' 93' ' ' GLY . 15.7 tt -63.73 -30.9 51.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 O-C-N 121.023 -1.048 . . . . 0.0 108.917 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.412 ' N ' HG23 ' A' ' 96' ' ' ILE . 39.0 mtpt -70.85 -45.31 64.7 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.706 -1.246 . . . . 0.0 108.411 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.0 -33.24 68.71 Favored 'General case' 0 C--N 1.289 -2.041 0 O-C-N 120.578 -1.326 . . . . 0.0 109.207 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.88 -57.84 2.88 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-O 122.546 1.165 . . . . 0.0 108.737 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 96' ' ' ILE . 56.4 m -50.42 -43.44 54.88 Favored 'General case' 0 C--N 1.288 -2.093 0 O-C-N 121.039 -1.038 . . . . 0.0 108.984 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -68.41 -45.91 71.37 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.674 -1.266 . . . . 0.0 108.06 178.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.431 ' CD1' ' C ' ' A' ' 102' ' ' LEU . 3.0 tm? -65.6 -42.87 91.14 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.944 0.878 . . . . 0.0 108.859 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.3 mp -62.96 -36.84 84.8 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 121.088 -1.007 . . . . 0.0 108.915 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -66.62 -17.76 65.01 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.55 -1.344 . . . . 0.0 108.576 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.06 -19.56 63.05 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 120.643 -1.285 . . . . 0.0 108.361 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 135.46 42.18 0.12 Allowed Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -153.35 32.47 0.47 Allowed 'General case' 0 C--N 1.289 -2.063 0 O-C-N 121.079 -1.248 . . . . 0.0 109.391 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.576 ' OG1' ' N ' ' A' ' 109' ' ' GLY . 4.8 t -87.01 -136.73 0.09 Allowed 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.647 -1.283 . . . . 0.0 110.085 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.576 ' N ' ' OG1' ' A' ' 108' ' ' THR . . . 80.08 23.06 62.08 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.425 ' HB ' ' HG ' ' A' ' 82' ' ' SER . 1.8 m -143.63 165.67 14.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 O-C-N 121.021 -1.282 . . . . 0.0 109.901 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -99.27 153.29 19.06 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-O 122.212 1.006 . . . . 0.0 108.729 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.509 ' O ' ' CG1' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -108.31 115.72 30.63 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.558 ' N ' ' O ' ' A' ' 87' ' ' VAL . 1.2 mm -100.88 127.99 53.48 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 O-C-N 121.291 -0.881 . . . . 0.0 110.279 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 71.8 t -99.5 137.09 28.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 O-C-N 120.766 -1.209 . . . . 0.0 109.701 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.6 -154.21 30.87 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 120' ' ' TRP . . . 89.73 -47.33 3.2 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -52.15 -53.64 40.45 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 121.97 0.89 . . . . 0.0 109.637 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 67.8 p -71.52 -34.54 70.17 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.886 0.851 . . . . 0.0 109.33 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.23 -54.72 8.76 Favored 'General case' 0 C--N 1.286 -2.162 0 O-C-N 121.18 -0.95 . . . . 0.0 108.936 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . 0.627 ' O ' ' OD1' ' A' ' 123' ' ' ASN . 28.0 t90 -60.07 -34.87 74.03 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -52.45 -36.74 55.36 Favored 'General case' 0 C--N 1.291 -1.942 0 O-C-N 120.88 -1.138 . . . . 0.0 108.763 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -60.7 -26.87 67.45 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.686 ' ND2' ' H ' ' A' ' 125' ' ' LEU . 6.1 p-10 -54.02 -49.26 69.31 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 120.685 -1.259 . . . . 0.0 108.373 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.681 ' N ' ' OD1' ' A' ' 123' ' ' ASN . . . 71.22 18.8 76.93 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.686 ' H ' ' ND2' ' A' ' 123' ' ' ASN . 15.0 mt -124.34 98.14 38.76 Favored Pre-proline 0 C--N 1.298 -1.667 0 O-C-N 120.859 -1.377 . . . . 0.0 109.405 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo . . . . . 0 C--N 1.301 -1.946 0 C-N-CA 122.339 2.026 . . . . 0.0 113.28 178.802 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.042 0 CA-C-O 122.239 1.019 . . . . 0.0 109.741 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.87 177.46 1.77 Allowed Pre-proline 0 C--N 1.291 -1.951 0 O-C-N 121.193 -0.942 . . . . 0.0 108.965 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.543 ' N ' ' OG1' ' A' ' 108' ' ' THR . 27.4 Cg_endo -86.61 140.76 6.29 Favored 'Trans proline' 0 C--N 1.296 -2.186 0 C-N-CA 121.917 1.744 . . . . 0.0 111.344 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.9 t -144.53 150.1 36.99 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 122.035 0.922 . . . . 0.0 109.779 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 95.2 p -101.02 139.55 36.56 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-O 122.632 1.206 . . . . 0.0 109.661 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.497 HG22 ' N ' ' A' ' 21' ' ' SER . 0.6 OUTLIER -150.17 158.61 5.42 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.185 0 O-C-N 121.023 -1.048 . . . . 0.0 109.318 -178.641 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.497 ' N ' HG22 ' A' ' 20' ' ' VAL . 1.2 m -117.12 160.09 21.56 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.484 -1.385 . . . . 0.0 109.448 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.0 p -49.44 -31.61 5.68 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.81 0 CA-C-O 122.132 0.968 . . . . 0.0 108.669 -178.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.432 HG21 ' H ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -59.7 -56.16 25.38 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 120.718 -1.239 . . . . 0.0 109.144 179.484 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.432 ' H ' HG21 ' A' ' 23' ' ' THR . 0.1 OUTLIER -65.51 -35.66 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.106 -1.622 . . . . 0.0 109.461 178.864 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.54 -36.16 66.47 Favored 'General case' 0 C--N 1.286 -2.157 0 O-C-N 120.85 -1.156 . . . . 0.0 108.354 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -56.18 -47.03 79.09 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -60.9 -42.19 97.54 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.961 -1.087 . . . . 0.0 108.769 178.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 69.5 mt -67.58 -31.69 71.92 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.0 tt -56.86 -39.19 73.83 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.3 mp -62.91 -29.85 71.09 Favored 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.19 -28.87 69.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.705 -1.247 . . . . 0.0 108.448 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.19 49.3 27.45 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.8 t60 -102.56 170.21 8.17 Favored 'General case' 0 C--N 1.292 -1.923 0 O-C-N 121.055 -1.262 . . . . 0.0 109.571 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -59.96 128.05 34.91 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.377 1.084 . . . . 0.0 109.773 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.444 ' CE2' ' OD1' ' A' ' 37' ' ' ASP . 16.0 t80 -109.92 106.64 16.27 Favored 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.307 -0.871 . . . . 0.0 108.945 -178.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.645 ' CD1' ' N ' ' A' ' 37' ' ' ASP . 0.1 OUTLIER -99.92 135.44 41.35 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.541 -1.349 . . . . 0.0 108.611 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.645 ' N ' ' CD1' ' A' ' 36' ' ' LEU . 14.2 m-20 -138.45 138.19 37.91 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.469 ' CG2' ' O ' ' A' ' 38' ' ' VAL . 11.9 m -132.55 75.31 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 CA-C-O 122.358 1.075 . . . . 0.0 108.1 177.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.719 ' H ' HD22 ' A' ' 54' ' ' ASN . 0.4 OUTLIER -82.93 -41.94 18.26 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -179.604 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.522 ' OG1' ' C ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER 176.37 144.42 0.24 Allowed Pre-proline 0 C--N 1.3 -1.577 0 O-C-N 121.131 -0.981 . . . . 0.0 109.981 -179.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -43.14 -27.96 1.22 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.02 1.813 . . . . 0.0 111.102 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -70.02 -30.9 68.31 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.865 -1.147 . . . . 0.0 108.498 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.537 ' CD ' ' HE ' ' A' ' 39' ' ' ARG . 42.1 tp10 -54.42 -33.95 60.43 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.687 -1.258 . . . . 0.0 109.014 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -79.06 -37.12 39.73 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 122.116 0.96 . . . . 0.0 108.854 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.443 ' C ' ' H ' ' A' ' 47' ' ' GLY . 11.2 t -65.95 -40.97 91.82 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.224 -0.922 . . . . 0.0 109.031 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.495 ' NE2' ' O ' ' A' ' 47' ' ' GLY . 5.4 pp0? -75.69 9.5 2.26 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.104 -0.997 . . . . 0.0 108.627 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.495 ' O ' ' NE2' ' A' ' 46' ' ' GLN . . . 89.97 -160.41 28.53 Favored Glycine 0 N--CA 1.5 2.936 0 CA-C-O 122.299 0.944 . . . . 0.0 110.966 178.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -103.05 -159.32 0.72 Allowed 'General case' 0 C--N 1.289 -2.032 0 CA-C-O 122.752 1.263 . . . . 0.0 109.372 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -141.91 169.58 17.32 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 122.207 1.003 . . . . 0.0 109.352 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.58 ' O ' ' NE1' ' A' ' 120' ' ' TRP . 5.2 t -82.67 106.62 14.67 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.79 25.75 55.39 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.29 124.26 9.99 Favored 'General case' 0 C--N 1.29 -1.984 0 O-C-N 120.897 -1.355 . . . . 0.0 109.631 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 29.3 mt -116.99 113.19 42.15 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 O-C-N 120.722 -1.236 . . . . 0.0 110.216 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.719 HD22 ' H ' ' A' ' 39' ' ' ARG . 24.1 t-20 -98.03 135.0 40.36 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 122.01 0.909 . . . . 0.0 109.383 -177.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.9 t -140.24 92.19 9.59 Favored Pre-proline 0 C--N 1.274 -2.706 0 CA-C-O 122.152 0.977 . . . . 0.0 109.093 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -74.12 86.07 1.32 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.473 2.115 . . . . 0.0 111.769 -178.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.3 t80 . . . . . 0 C--N 1.298 -1.645 0 CA-C-O 122.291 1.043 . . . . 0.0 109.818 -179.845 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 N--CA 1.498 1.972 0 CA-C-O 122.19 0.995 . . . . 0.0 110.026 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.447 ' H ' ' HB2' ' A' ' 83' ' ' ASP . . . -114.26 142.89 17.8 Favored Glycine 0 N--CA 1.498 2.768 0 N-CA-C 110.476 -1.049 . . . . 0.0 110.476 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' A' ' 80' ' ' GLY . 0.2 OUTLIER -44.38 -43.48 7.65 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.451 -1.029 . . . . 0.0 109.166 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.501 ' O ' ' C ' ' A' ' 83' ' ' ASP . 0.1 OUTLIER -122.22 24.15 9.54 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 120.837 -1.164 . . . . 0.0 107.972 179.324 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.501 ' C ' ' O ' ' A' ' 82' ' ' SER . 19.4 t0 -34.97 118.07 0.42 Allowed 'General case' 0 N--CA 1.506 2.364 0 CA-C-O 121.715 0.769 . . . . 0.0 109.108 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.612 ' N ' ' O ' ' A' ' 109' ' ' GLY . 6.8 t-20 65.56 60.7 0.72 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.891 0.853 . . . . 0.0 109.418 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.557 ' CG2' ' N ' ' A' ' 86' ' ' ILE . 12.0 mt -150.14 177.67 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 O-C-N 121.064 -1.023 . . . . 0.0 109.496 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.557 ' N ' ' CG2' ' A' ' 85' ' ' ILE . 63.7 mt -111.14 108.33 25.21 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.257 0 CA-C-O 122.195 0.997 . . . . 0.0 109.323 178.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.537 ' O ' ' N ' ' A' ' 113' ' ' ILE . 14.1 t -114.98 166.47 8.74 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-O 121.943 0.878 . . . . 0.0 108.892 -176.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -148.66 142.03 9.57 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 49.7 t -92.64 148.3 22.18 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 122.079 0.942 . . . . 0.0 109.303 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -41.74 -36.3 0.97 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 122.003 0.906 . . . . 0.0 110.402 -178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 96.3 p -132.71 159.02 40.88 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 122.257 1.027 . . . . 0.0 109.444 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -110.58 -178.58 20.65 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 68.39 -72.33 0.33 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -29.59 68.99 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.182 -1.187 . . . . 0.0 108.824 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.49 ' O ' ' CG2' ' A' ' 99' ' ' THR . 54.4 p -84.51 -29.12 26.22 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.187 -0.946 . . . . 0.0 109.27 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.557 ' CG2' ' N ' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -55.53 -48.71 77.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 O-C-N 121.092 -1.005 . . . . 0.0 108.836 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.557 ' N ' ' CG2' ' A' ' 96' ' ' ILE . 4.6 ptmm? -70.67 -40.84 72.74 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.63 -1.294 . . . . 0.0 108.39 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.05 -40.96 95.5 Favored 'General case' 0 C--N 1.289 -2.026 0 O-C-N 120.544 -1.347 . . . . 0.0 109.294 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.49 ' CG2' ' O ' ' A' ' 95' ' ' SER . 35.7 p -64.46 -54.57 30.52 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-O 122.553 1.168 . . . . 0.0 108.683 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.543 ' O ' ' CG ' ' A' ' 104' ' ' HIS . 35.5 m -46.22 -37.35 7.04 Favored 'General case' 0 C--N 1.287 -2.14 0 O-C-N 121.06 -1.025 . . . . 0.0 108.992 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -87.11 -50.65 6.49 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.62 -1.3 . . . . 0.0 108.077 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.451 ' CD1' ' C ' ' A' ' 102' ' ' LEU . 1.9 tm? -61.36 -44.45 97.15 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.982 0.896 . . . . 0.0 108.889 -178.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 99' ' ' THR . 70.5 mt -63.14 -38.58 91.76 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.113 -0.992 . . . . 0.0 108.975 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.543 ' CG ' ' O ' ' A' ' 100' ' ' THR . 24.7 m170 -59.88 -18.58 45.69 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.641 -1.287 . . . . 0.0 108.574 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.01 -19.38 62.77 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 120.629 -1.295 . . . . 0.0 108.326 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 128.78 7.88 4.04 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -103.0 17.65 23.55 Favored 'General case' 0 C--N 1.289 -2.032 0 O-C-N 121.082 -1.246 . . . . 0.0 109.395 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.543 ' OG1' ' N ' ' A' ' 17' ' ' PRO . 8.7 t -78.98 -150.73 0.05 Allowed 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.669 -1.269 . . . . 0.0 110.074 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.612 ' O ' ' N ' ' A' ' 84' ' ' ASN . . . 77.45 19.43 76.37 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.6 m -146.62 166.7 7.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 O-C-N 120.999 -1.295 . . . . 0.0 109.898 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 87' ' ' VAL . 84.9 mttt -97.88 145.48 26.39 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 122.211 1.005 . . . . 0.0 108.71 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.467 ' O ' ' CG1' ' A' ' 20' ' ' VAL . 51.4 t0 -99.95 109.78 22.13 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.537 ' N ' ' O ' ' A' ' 87' ' ' VAL . 1.2 mm -94.88 138.85 19.83 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.39 0 O-C-N 121.229 -0.919 . . . . 0.0 110.291 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 71.5 t -99.48 143.83 12.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 O-C-N 120.838 -1.163 . . . . 0.0 109.684 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 79.41 -117.2 4.47 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.4 -84.78 1.0 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -55.73 -43.98 77.09 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-O 122.031 0.919 . . . . 0.0 109.671 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 36.6 m -59.92 -39.27 84.9 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-O 121.947 0.879 . . . . 0.0 109.376 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 122' ' ' LYS . . . -72.55 -50.22 27.15 Favored 'General case' 0 C--N 1.286 -2.159 0 O-C-N 121.096 -1.003 . . . . 0.0 108.882 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . 0.58 ' NE1' ' O ' ' A' ' 50' ' ' CYS . 1.0 OUTLIER -53.92 -39.25 65.68 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.332 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.63 -25.81 68.39 Favored 'General case' 0 C--N 1.292 -1.924 0 O-C-N 120.834 -1.166 . . . . 0.0 108.838 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.499 ' CB ' ' NZ ' ' A' ' 122' ' ' LYS . 2.4 ttmp? -56.97 -42.66 80.6 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -90.76 -67.68 0.84 Allowed 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.624 -1.298 . . . . 0.0 108.358 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 113.18 48.09 0.62 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.463 ' O ' ' CB ' ' A' ' 50' ' ' CYS . 14.3 mt -126.55 78.67 72.14 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 120.834 -1.392 . . . . 0.0 109.314 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo . . . . . 0 C--N 1.302 -1.897 0 C-N-CA 122.274 1.983 . . . . 0.0 113.212 -179.996 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 . . . . . 0 N--CA 1.5 2.074 0 CA-C-O 122.132 0.967 . . . . 0.0 109.715 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.5 t -143.11 149.0 47.28 Favored Pre-proline 0 C--N 1.29 -1.98 0 O-C-N 121.287 -0.883 . . . . 0.0 108.911 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -90.78 161.91 4.13 Favored 'Trans proline' 0 C--N 1.298 -2.104 0 C-N-CA 121.885 1.723 . . . . 0.0 111.399 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.0 t -161.23 152.55 18.88 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 122.107 0.956 . . . . 0.0 109.721 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 89.0 p -108.5 144.47 36.11 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 122.694 1.235 . . . . 0.0 109.65 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.683 ' CG2' ' N ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -144.76 177.76 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 O-C-N 120.993 -1.067 . . . . 0.0 109.4 -178.495 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.683 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 71.7 m -119.55 151.82 38.0 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.47 -1.394 . . . . 0.0 109.435 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.413 ' CG2' ' CB ' ' A' ' 119' ' ' ALA . 6.5 p -47.53 -33.21 2.99 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.793 0 CA-C-O 122.126 0.965 . . . . 0.0 108.695 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.51 ' OG1' ' N ' ' A' ' 24' ' ' VAL . 0.1 OUTLIER -56.26 -56.77 16.87 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 120.728 -1.233 . . . . 0.0 109.12 179.225 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.51 ' N ' ' OG1' ' A' ' 23' ' ' THR . 0.1 OUTLIER -65.42 -34.74 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.131 -1.605 . . . . 0.0 109.377 179.101 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.41 ' CB ' ' CD1' ' A' ' 113' ' ' ILE . . . -50.92 -37.43 44.0 Favored 'General case' 0 C--N 1.287 -2.132 0 O-C-N 120.825 -1.172 . . . . 0.0 108.39 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -59.55 -47.83 84.03 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -60.25 -44.45 95.25 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 120.885 -1.134 . . . . 0.0 108.675 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.6 mt -68.7 -53.16 23.86 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.465 ' CD2' ' C ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -58.71 -43.1 89.98 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.016 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.448 ' C ' ' CD1' ' A' ' 30' ' ' LEU . 1.4 tm? -58.41 -34.71 71.05 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.09 -19.87 62.41 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.712 -1.243 . . . . 0.0 108.391 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.07 49.6 1.88 Allowed Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -107.4 139.39 41.96 Favored 'General case' 0 C--N 1.291 -1.969 0 O-C-N 121.234 -1.156 . . . . 0.0 109.592 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 36.9 mtt-85 -61.82 141.11 58.13 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 122.331 1.062 . . . . 0.0 109.846 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -125.62 118.06 24.87 Favored 'General case' 0 C--N 1.291 -1.96 0 O-C-N 121.38 -0.825 . . . . 0.0 108.968 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 17.6 mt -92.62 108.2 19.8 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 120.616 -1.303 . . . . 0.0 108.604 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.545 ' OD2' ' NE2' ' A' ' 48' ' ' HIS . 41.0 t0 -90.81 122.97 33.99 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -178.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.518 ' CG1' ' O ' ' A' ' 55' ' ' VAL . 20.2 m -134.17 87.81 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 CA-C-O 122.502 1.144 . . . . 0.0 108.125 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.642 HH12 ' CB ' ' A' ' 117' ' ' TYR . 24.5 mtp180 -83.59 -46.08 12.79 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.535 ' OG1' ' C ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER 172.92 165.64 0.27 Allowed Pre-proline 0 N--CA 1.49 1.564 0 C-N-CA 119.296 -0.962 . . . . 0.0 109.925 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -53.33 -35.43 74.7 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.04 1.827 . . . . 0.0 111.085 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -61.0 -30.43 70.28 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.894 -1.128 . . . . 0.0 108.48 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.593 ' O ' ' N ' ' A' ' 47' ' ' GLY . 83.5 tt0 -55.79 -30.63 61.65 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.755 -1.216 . . . . 0.0 108.968 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -72.6 -38.32 67.85 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 122.176 0.989 . . . . 0.0 108.933 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.6 t -51.49 -48.36 62.92 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.175 -0.953 . . . . 0.0 109.167 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -103.73 -20.75 13.85 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.147 -0.97 . . . . 0.0 108.621 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 43' ' ' GLU . . . 82.37 -172.53 52.47 Favored Glycine 0 N--CA 1.5 2.915 0 CA-C-O 122.289 0.938 . . . . 0.0 110.985 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.545 ' NE2' ' OD2' ' A' ' 37' ' ' ASP . 2.1 t60 176.13 101.71 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.034 0 CA-C-O 122.645 1.212 . . . . 0.0 109.395 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -160.45 147.7 15.94 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 122.26 1.029 . . . . 0.0 109.388 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.4 t -176.32 44.72 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.264 0 CA-C-O 122.548 1.166 . . . . 0.0 107.869 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 117.85 23.81 3.53 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.509 ' CB ' ' CZ2' ' A' ' 120' ' ' TRP . . . -154.11 179.16 9.19 Favored 'General case' 0 C--N 1.289 -2.045 0 O-C-N 120.861 -1.376 . . . . 0.0 109.639 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 77.1 mt -123.47 147.97 27.62 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 O-C-N 120.832 -1.168 . . . . 0.0 110.3 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -131.55 143.57 50.46 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.954 0.883 . . . . 0.0 109.499 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.686 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 1.1 t -140.62 91.89 9.25 Favored Pre-proline 0 C--N 1.274 -2.717 0 CA-C-O 122.205 1.002 . . . . 0.0 109.089 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -78.77 66.26 8.66 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.524 2.149 . . . . 0.0 111.806 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 . . . . . 0 C--N 1.299 -1.6 0 CA-C-O 122.375 1.083 . . . . 0.0 109.826 -179.549 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 . . . . . 0 N--CA 1.499 2.019 0 CA-C-O 122.193 0.997 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.564 ' H ' ' HB3' ' A' ' 83' ' ' ASP . . . -114.19 134.78 11.98 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -48.03 -21.19 0.42 Allowed 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.454 -1.027 . . . . 0.0 109.173 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.402 ' N ' ' C ' ' A' ' 80' ' ' GLY . 54.4 m -123.73 15.54 9.44 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.847 -1.158 . . . . 0.0 107.914 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.564 ' HB3' ' H ' ' A' ' 80' ' ' GLY . 12.6 p30 -45.78 109.91 0.22 Allowed 'General case' 0 N--CA 1.507 2.396 0 O-C-N 121.406 -0.809 . . . . 0.0 109.123 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 58.61 64.07 1.54 Allowed 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.973 0.892 . . . . 0.0 109.4 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.542 ' CG2' ' H ' ' A' ' 86' ' ' ILE . 24.1 mt -142.25 176.32 3.95 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 O-C-N 121.025 -1.047 . . . . 0.0 109.408 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.542 ' H ' ' CG2' ' A' ' 85' ' ' ILE . 6.7 mt -121.78 112.57 35.61 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 O-C-N 121.106 -0.997 . . . . 0.0 109.403 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.674 ' O ' ' N ' ' A' ' 113' ' ' ILE . 92.6 t -100.56 -179.68 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 O-C-N 121.281 -0.887 . . . . 0.0 108.919 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.597 ' H ' ' CG1' ' A' ' 87' ' ' VAL . . . -175.09 140.13 5.13 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 46.3 t -110.61 146.69 35.69 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-O 122.07 0.938 . . . . 0.0 109.283 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.526 ' CD ' HH21 ' A' ' 39' ' ' ARG . 7.8 tt0 -42.57 -70.69 0.1 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.022 0.915 . . . . 0.0 110.464 -178.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.1 t -72.13 160.22 32.82 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 122.238 1.018 . . . . 0.0 109.453 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 94' ' ' ARG . . . -132.25 174.72 20.19 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 61.67 -76.32 0.02 OUTLIER Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.53 ' N ' ' O ' ' A' ' 92' ' ' GLY . 1.1 ttt-85 -65.93 -37.19 85.42 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.216 -1.167 . . . . 0.0 108.778 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.2 t -87.65 -27.6 22.36 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 121.188 -0.945 . . . . 0.0 109.254 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.585 ' CG2' ' N ' ' A' ' 97' ' ' LYS . 2.6 tt -59.07 -48.82 85.47 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 O-C-N 121.084 -1.01 . . . . 0.0 108.879 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.585 ' N ' ' CG2' ' A' ' 96' ' ' ILE . 17.1 pttp -63.99 -35.67 81.47 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.697 -1.252 . . . . 0.0 108.449 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.97 -43.05 79.91 Favored 'General case' 0 C--N 1.288 -2.074 0 O-C-N 120.534 -1.354 . . . . 0.0 109.206 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.458 ' O ' ' N ' ' A' ' 103' ' ' LEU . 30.5 p -77.95 -50.58 11.9 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-O 122.573 1.177 . . . . 0.0 108.697 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.535 ' O ' ' N ' ' A' ' 104' ' ' HIS . 60.3 m -53.91 -49.4 68.7 Favored 'General case' 0 C--N 1.288 -2.102 0 O-C-N 121.012 -1.055 . . . . 0.0 109.033 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -61.94 -46.14 90.63 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.627 -1.296 . . . . 0.0 108.17 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.452 ' CD1' ' C ' ' A' ' 102' ' ' LEU . 2.5 tm? -64.63 -40.79 96.09 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.305 -0.872 . . . . 0.0 108.808 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 107' ' ' PHE . 0.3 OUTLIER -75.19 -30.55 60.69 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.122 -0.986 . . . . 0.0 108.966 178.358 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.535 ' N ' ' O ' ' A' ' 100' ' ' THR . 84.0 t60 -53.39 -34.71 58.77 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.597 -1.315 . . . . 0.0 108.606 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -131.23 35.56 3.89 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 120.573 -1.329 . . . . 0.0 108.301 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -148.13 -37.23 0.04 OUTLIER Glycine 0 N--CA 1.495 2.586 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.478 ' O ' ' O ' ' A' ' 103' ' ' LEU . 66.5 m-85 -134.83 164.18 28.13 Favored 'General case' 0 C--N 1.288 -2.078 0 O-C-N 121.235 -1.156 . . . . 0.0 109.414 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.437 ' HG1' ' N ' ' A' ' 109' ' ' GLY . 9.3 t -176.27 151.03 0.97 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.538 -1.351 . . . . 0.0 110.126 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.437 ' N ' ' HG1' ' A' ' 108' ' ' THR . . . 89.65 21.97 38.39 Favored Glycine 0 N--CA 1.498 2.814 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.9 m -148.03 155.86 9.59 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 O-C-N 121.064 -1.257 . . . . 0.0 109.932 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.453 ' O ' ' N ' ' A' ' 87' ' ' VAL . 52.8 mttp -98.87 158.81 15.39 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 122.252 1.025 . . . . 0.0 108.726 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.92 125.57 53.79 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.674 ' N ' ' O ' ' A' ' 87' ' ' VAL . 3.7 mt -102.7 152.72 5.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.401 0 O-C-N 121.301 -0.874 . . . . 0.0 110.261 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 44.0 t -97.74 135.83 30.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 O-C-N 120.821 -1.174 . . . . 0.0 109.664 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.13 -145.2 17.55 Favored Glycine 0 C--N 1.285 -2.302 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 160.6 -95.26 0.14 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.642 ' CB ' HH12 ' A' ' 39' ' ' ARG . 66.1 t80 -52.85 -38.33 61.36 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-O 122.084 0.945 . . . . 0.0 109.711 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 29.3 t -57.27 -33.07 67.25 Favored 'General case' 0 C--N 1.291 -1.939 0 O-C-N 121.286 -0.883 . . . . 0.0 109.301 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.413 ' CB ' ' CG2' ' A' ' 22' ' ' VAL . . . -69.81 -52.4 25.45 Favored 'General case' 0 C--N 1.286 -2.171 0 O-C-N 121.103 -0.998 . . . . 0.0 108.873 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . 0.509 ' CZ2' ' CB ' ' A' ' 52' ' ' ALA . 0.6 OUTLIER -61.57 -37.35 83.52 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.886 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.25 -27.86 64.78 Favored 'General case' 0 C--N 1.292 -1.92 0 O-C-N 120.848 -1.157 . . . . 0.0 108.789 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.8 ttmm -56.06 -42.78 77.16 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -85.52 -64.59 1.13 Allowed 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.643 -1.286 . . . . 0.0 108.375 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 137.4 39.1 0.13 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.662 ' O ' ' O ' ' A' ' 126' ' ' PRO . 2.7 mt -102.74 127.95 29.01 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 120.848 -1.383 . . . . 0.0 109.362 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.662 ' O ' ' O ' ' A' ' 125' ' ' LEU . 51.3 Cg_exo . . . . . 0 C--N 1.302 -1.89 0 C-N-CA 122.269 1.979 . . . . 0.0 113.2 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.679 ' HE ' ' ND2' ' A' ' 84' ' ' ASN . 4.5 mpt_? . . . . . 0 N--CA 1.5 2.042 0 CA-C-O 122.211 1.005 . . . . 0.0 109.754 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -131.44 173.96 5.26 Favored Pre-proline 0 C--N 1.291 -1.949 0 O-C-N 121.277 -0.89 . . . . 0.0 108.872 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -88.91 78.64 1.09 Allowed 'Trans proline' 0 C--N 1.297 -2.16 0 C-N-CA 121.831 1.687 . . . . 0.0 111.42 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 112' ' ' ASP . 33.0 t -75.19 144.52 42.65 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 122.029 0.918 . . . . 0.0 109.705 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 82.7 p -100.36 151.51 21.42 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 122.703 1.239 . . . . 0.0 109.63 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.663 ' CG2' ' N ' ' A' ' 21' ' ' SER . 0.1 OUTLIER -150.6 173.92 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 O-C-N 121.002 -1.061 . . . . 0.0 109.431 -178.653 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.663 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 1.5 m -108.82 166.12 11.05 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.516 -1.365 . . . . 0.0 109.46 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.1 t -62.86 -29.98 48.42 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.808 0 CA-C-O 122.106 0.955 . . . . 0.0 108.707 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.429 ' CG2' ' N ' ' A' ' 24' ' ' VAL . 6.5 t -55.38 -47.78 75.3 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 120.82 -1.175 . . . . 0.0 109.106 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.429 ' N ' ' CG2' ' A' ' 23' ' ' THR . 1.4 t -69.68 -39.74 78.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.157 -1.589 . . . . 0.0 109.42 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 29' ' ' LEU . . . -51.3 -36.27 41.72 Favored 'General case' 0 C--N 1.288 -2.103 0 O-C-N 120.804 -1.185 . . . . 0.0 108.39 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -60.29 -48.63 80.93 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -59.81 -36.15 76.18 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 120.878 -1.139 . . . . 0.0 108.699 178.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.2 mt -80.86 -25.03 37.96 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 25' ' ' ALA . 8.9 tt -62.22 -43.38 98.95 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.48 ' C ' ' CD1' ' A' ' 30' ' ' LEU . 3.4 pp -80.21 -14.39 58.48 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.509 -1.369 . . . . 0.0 107.477 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.27 -27.67 67.39 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.736 -1.228 . . . . 0.0 108.398 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.24 47.68 6.0 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.526 ' O ' ' CZ ' ' A' ' 35' ' ' TYR . 14.1 m-70 -115.37 163.61 15.47 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.204 -1.174 . . . . 0.0 109.589 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.549 HH12 ' CD1' ' A' ' 53' ' ' ILE . 20.0 mmm180 -59.8 132.04 52.75 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 122.359 1.076 . . . . 0.0 109.793 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.526 ' CZ ' ' O ' ' A' ' 33' ' ' HIS . 21.6 m-85 -118.2 108.14 14.8 Favored 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.314 -0.866 . . . . 0.0 108.95 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.582 ' CD1' ' N ' ' A' ' 37' ' ' ASP . 0.1 OUTLIER -102.35 133.16 47.73 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 120.582 -1.324 . . . . 0.0 108.587 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.582 ' N ' ' CD1' ' A' ' 36' ' ' LEU . 22.1 t70 -147.75 111.39 5.01 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 -178.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -83.1 103.97 11.09 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 O-C-N 120.959 -1.088 . . . . 0.0 108.093 177.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.665 ' NH2' HE22 ' A' ' 46' ' ' GLN . 25.7 ttp180 -84.34 -43.45 14.74 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.481 ' OG1' ' C ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -179.01 170.39 0.73 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.182 -0.949 . . . . 0.0 109.95 -179.026 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 40' ' ' THR . 24.7 Cg_exo -55.47 -145.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 121.92 1.746 . . . . 0.0 111.125 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -58.28 -23.44 56.24 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.85 -1.156 . . . . 0.0 108.543 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.473 ' O ' ' OE1' ' A' ' 46' ' ' GLN . 96.7 mt-10 -50.66 -30.0 12.52 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.802 -1.186 . . . . 0.0 108.997 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.662 ' CD1' ' N ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -78.06 -32.22 50.73 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 122.217 1.008 . . . . 0.0 108.91 177.446 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.662 ' N ' ' CD1' ' A' ' 44' ' ' PHE . 16.0 t -49.01 -19.1 0.36 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.153 -0.967 . . . . 0.0 109.052 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.665 HE22 ' NH2' ' A' ' 39' ' ' ARG . 0.4 OUTLIER -69.8 -9.57 55.14 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.089 -1.007 . . . . 0.0 108.619 179.46 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.515 ' O ' ' O ' ' A' ' 44' ' ' PHE . . . 161.78 -164.76 35.41 Favored Glycine 0 N--CA 1.499 2.875 0 CA-C-O 122.245 0.914 . . . . 0.0 111.051 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.635 ' O ' ' O ' ' A' ' 49' ' ' ALA . 3.9 p80 -176.0 106.01 0.08 Allowed 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 122.732 1.254 . . . . 0.0 109.38 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.635 ' O ' ' O ' ' A' ' 48' ' ' HIS . . . -30.87 157.44 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 122.159 0.981 . . . . 0.0 109.421 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.694 ' SG ' ' N ' ' A' ' 51' ' ' GLY . 0.5 OUTLIER -93.53 162.17 14.07 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.648 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.694 ' N ' ' SG ' ' A' ' 50' ' ' CYS . . . 105.79 -8.13 42.66 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -170.46 157.78 6.13 Favored 'General case' 0 C--N 1.29 -2.009 0 O-C-N 120.784 -1.421 . . . . 0.0 109.615 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.549 ' CD1' HH12 ' A' ' 34' ' ' ARG . 38.6 mt -99.6 134.83 37.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 O-C-N 120.762 -1.211 . . . . 0.0 110.262 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.477 ' ND2' ' OD2' ' A' ' 37' ' ' ASP . 6.7 m120 -113.3 134.2 54.73 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 121.937 0.875 . . . . 0.0 109.472 -178.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.588 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 1.1 t -142.6 95.77 6.37 Favored Pre-proline 0 C--N 1.273 -2.754 0 CA-C-O 122.221 1.01 . . . . 0.0 109.133 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.407 ' HG3' ' CD1' ' A' ' 44' ' ' PHE . 28.3 Cg_endo -77.94 54.37 4.83 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.5 2.134 . . . . 0.0 111.693 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.518 ' CE1' ' NE2' ' A' ' 81' ' ' GLN . 61.8 m-85 . . . . . 0 C--N 1.298 -1.661 0 CA-C-O 122.31 1.052 . . . . 0.0 109.848 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 . . . . . 0 N--CA 1.499 2.01 0 CA-C-O 122.211 1.005 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.488 ' H ' ' HB2' ' A' ' 83' ' ' ASP . . . -112.26 137.79 14.51 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.518 ' NE2' ' CE1' ' A' ' 57' ' ' TYR . 10.5 pt20 -45.71 -19.56 0.06 Allowed 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.491 -1.005 . . . . 0.0 109.17 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 80' ' ' GLY . 16.3 m -122.84 20.92 10.04 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.793 -1.192 . . . . 0.0 107.969 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.488 ' HB2' ' H ' ' A' ' 80' ' ' GLY . 42.2 t0 -42.42 113.8 0.49 Allowed 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.408 -0.808 . . . . 0.0 109.11 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.679 ' ND2' ' HE ' ' A' ' 15' ' ' ARG . 5.4 m120 59.6 63.36 1.53 Allowed 'General case' 0 C--N 1.291 -1.936 0 O-C-N 121.308 -0.87 . . . . 0.0 109.451 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.579 ' CG2' ' N ' ' A' ' 86' ' ' ILE . 17.8 mt -145.93 176.66 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 O-C-N 121.076 -1.015 . . . . 0.0 109.421 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.579 ' N ' ' CG2' ' A' ' 85' ' ' ILE . 64.1 mt -111.01 112.43 40.55 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 O-C-N 121.078 -1.014 . . . . 0.0 109.422 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.607 ' N ' ' O ' ' A' ' 111' ' ' LYS . 60.4 t -110.94 175.0 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 O-C-N 121.261 -0.899 . . . . 0.0 108.887 -176.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.459 ' H ' ' CG1' ' A' ' 87' ' ' VAL . . . -172.02 175.63 45.28 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 19.7 t -128.46 120.31 26.61 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 122.029 0.919 . . . . 0.0 109.319 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.439 ' O ' ' OE1' ' A' ' 90' ' ' GLN . 1.0 OUTLIER -65.63 -38.63 89.95 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.039 0.923 . . . . 0.0 110.422 -178.492 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 92' ' ' GLY . 4.1 m -61.52 160.98 10.26 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 122.171 0.986 . . . . 0.0 109.473 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 91' ' ' SER . . . -43.17 161.95 0.05 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -54.83 -28.06 46.02 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -55.05 -28.32 51.38 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.221 -1.164 . . . . 0.0 108.72 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 43.7 t -85.24 -32.44 22.6 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.15 -0.969 . . . . 0.0 109.237 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.432 ' O ' ' CD1' ' A' ' 96' ' ' ILE . 0.3 OUTLIER -60.3 -30.56 46.42 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 O-C-N 121.03 -1.044 . . . . 0.0 108.881 -179.289 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.1 mtpp -62.56 -47.68 82.78 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.707 -1.246 . . . . 0.0 108.402 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.34 -50.09 72.49 Favored 'General case' 0 C--N 1.289 -2.029 0 O-C-N 120.557 -1.339 . . . . 0.0 109.266 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.483 ' O ' ' CD1' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -57.86 -47.84 81.55 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-O 122.525 1.155 . . . . 0.0 108.705 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 57.9 m -56.39 -48.81 76.13 Favored 'General case' 0 C--N 1.287 -2.134 0 O-C-N 120.943 -1.098 . . . . 0.0 108.989 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -65.43 -40.34 93.2 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.654 -1.279 . . . . 0.0 108.153 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.7 tt -68.48 -40.54 80.94 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.968 0.89 . . . . 0.0 108.818 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.59 ' HA ' ' H ' ' A' ' 107' ' ' PHE . 10.8 mp -69.86 -28.93 66.07 Favored 'General case' 0 C--N 1.292 -1.914 0 O-C-N 121.088 -1.007 . . . . 0.0 109.017 178.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -64.02 -32.54 74.12 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.519 -1.363 . . . . 0.0 108.527 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -130.93 37.2 3.8 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.623 -1.298 . . . . 0.0 108.393 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -151.34 -67.64 0.01 OUTLIER Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.59 ' H ' ' HA ' ' A' ' 103' ' ' LEU . 96.7 m-85 -138.48 156.24 47.71 Favored 'General case' 0 C--N 1.289 -2.048 0 O-C-N 121.175 -1.191 . . . . 0.0 109.38 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.705 ' HG1' ' H ' ' A' ' 109' ' ' GLY . 11.0 t -166.42 -161.93 0.49 Allowed 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.667 -1.271 . . . . 0.0 110.104 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.705 ' H ' ' HG1' ' A' ' 108' ' ' THR . . . 79.05 21.13 68.6 Favored Glycine 0 N--CA 1.499 2.836 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.489 ' CG2' ' CG2' ' A' ' 87' ' ' VAL . 1.7 m -142.29 167.93 14.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 O-C-N 121.07 -1.253 . . . . 0.0 109.874 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.607 ' O ' ' N ' ' A' ' 87' ' ' VAL . 85.6 mttt -97.88 148.94 22.92 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 122.198 0.999 . . . . 0.0 108.739 -179.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -111.74 108.08 17.38 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -178.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.504 ' CD1' ' CB ' ' A' ' 25' ' ' ALA . 69.7 mt -83.08 125.1 40.04 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 O-C-N 121.265 -0.897 . . . . 0.0 110.261 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.427 ' N ' ' O ' ' A' ' 20' ' ' VAL . 67.2 t -100.78 138.22 25.75 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 O-C-N 120.825 -1.172 . . . . 0.0 109.63 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 167.67 -147.48 11.72 Favored Glycine 0 C--N 1.285 -2.268 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -154.22 -176.99 27.17 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -59.06 -33.02 70.3 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-O 122.011 0.91 . . . . 0.0 109.647 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 32.1 t -56.47 -32.26 64.8 Favored 'General case' 0 C--N 1.292 -1.905 0 O-C-N 121.332 -0.855 . . . . 0.0 109.331 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.21 -40.91 97.66 Favored 'General case' 0 C--N 1.286 -2.159 0 O-C-N 121.185 -0.947 . . . . 0.0 108.892 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -60.34 -33.77 72.88 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.84 -37.63 71.53 Favored 'General case' 0 C--N 1.292 -1.911 0 O-C-N 120.795 -1.19 . . . . 0.0 108.812 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -56.44 -39.19 72.71 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -63.36 -65.29 0.71 Allowed 'General case' 0 N--CA 1.503 2.184 0 O-C-N 120.649 -1.282 . . . . 0.0 108.371 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.06 16.53 35.19 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 50' ' ' CYS . 12.6 mt -126.83 71.98 74.9 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 120.827 -1.396 . . . . 0.0 109.369 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo . . . . . 0 C--N 1.302 -1.911 0 C-N-CA 122.29 1.993 . . . . 0.0 113.16 -179.356 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 122.16 0.981 . . . . 0.0 109.225 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -105.6 145.29 31.18 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-O 122.018 0.913 . . . . 0.0 109.233 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -147.26 25.01 1.12 Allowed 'General case' 0 C--N 1.29 -1.989 0 CA-C-O 122.219 1.009 . . . . 0.0 109.657 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.2 p -83.57 0.58 46.02 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -139.39 99.34 3.71 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 122.16 0.981 . . . . 0.0 109.735 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.597 ' H ' ' N ' ' A' ' 109' ' ' GLY . 9.0 t -146.85 101.75 3.92 Favored Pre-proline 0 C--N 1.291 -1.958 0 O-C-N 121.267 -0.896 . . . . 0.0 108.942 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -88.69 124.72 1.61 Allowed 'Trans proline' 0 C--N 1.297 -2.14 0 C-N-CA 121.875 1.716 . . . . 0.0 111.431 177.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.5 p -138.17 152.2 48.45 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 122.021 0.915 . . . . 0.0 109.681 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.419 ' C ' ' CG1' ' A' ' 20' ' ' VAL . 39.6 m -115.96 144.55 43.92 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 122.675 1.226 . . . . 0.0 109.627 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.637 ' CG2' ' N ' ' A' ' 21' ' ' SER . 0.7 OUTLIER -158.81 -179.04 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.196 0 O-C-N 121.025 -1.047 . . . . 0.0 109.402 -178.701 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.637 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 14.3 p -115.58 148.19 39.87 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.48 -1.387 . . . . 0.0 109.395 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.6 p -47.32 -21.24 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.768 0 CA-C-O 122.102 0.953 . . . . 0.0 108.648 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.494 ' OG1' ' N ' ' A' ' 24' ' ' VAL . 0.1 OUTLIER -64.39 -55.7 19.32 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 120.736 -1.227 . . . . 0.0 109.177 179.169 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.494 ' N ' ' OG1' ' A' ' 23' ' ' THR . 0.9 OUTLIER -71.15 -40.5 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.175 -1.578 . . . . 0.0 109.4 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.98 -35.04 70.64 Favored 'General case' 0 C--N 1.286 -2.159 0 O-C-N 120.829 -1.17 . . . . 0.0 108.361 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.431 ' O ' ' CD1' ' A' ' 30' ' ' LEU . 86.4 t60 -52.99 -46.66 68.42 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -55.33 -43.42 74.94 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 120.907 -1.12 . . . . 0.0 108.666 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.4 mp -70.72 -36.8 73.38 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 19.2 tp -56.91 -39.69 74.92 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.431 ' CD1' ' O ' ' A' ' 26' ' ' HIS . 11.0 mp -63.43 -25.8 68.44 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.34 -22.42 66.27 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.77 -1.207 . . . . 0.0 108.385 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.95 48.82 3.5 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -107.41 149.58 27.73 Favored 'General case' 0 C--N 1.292 -1.898 0 O-C-N 121.204 -1.174 . . . . 0.0 109.593 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -58.66 133.68 56.11 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 122.428 1.109 . . . . 0.0 109.827 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.402 ' O ' ' O ' ' A' ' 53' ' ' ILE . 47.3 t80 -112.6 113.61 25.83 Favored 'General case' 0 C--N 1.292 -1.93 0 O-C-N 121.285 -0.884 . . . . 0.0 108.937 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.621 ' CD1' ' N ' ' A' ' 37' ' ' ASP . 0.1 OUTLIER -98.84 130.57 45.27 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.594 -1.317 . . . . 0.0 108.554 179.213 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.621 ' N ' ' CD1' ' A' ' 36' ' ' LEU . 48.2 t0 -138.61 142.5 39.13 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 38' ' ' VAL . 4.5 m -131.04 96.11 2.59 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 CA-C-O 122.433 1.111 . . . . 0.0 108.158 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.754 ' O ' ' OG1' ' A' ' 40' ' ' THR . 0.1 OUTLIER -89.65 -45.32 9.43 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.754 ' OG1' ' O ' ' A' ' 39' ' ' ARG . 3.6 m 177.45 142.32 0.25 Allowed Pre-proline 0 N--CA 1.49 1.573 0 C-N-CA 119.312 -0.955 . . . . 0.0 109.921 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -40.21 -39.96 2.73 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 121.983 1.788 . . . . 0.0 111.074 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.505 ' H ' HG22 ' A' ' 40' ' ' THR . 96.6 mt-10 -61.0 -30.34 70.23 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.951 -1.093 . . . . 0.0 108.567 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 40' ' ' THR . 66.1 tt0 -55.48 -32.01 62.47 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.75 -1.219 . . . . 0.0 109.014 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -67.99 -44.21 77.15 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 122.174 0.988 . . . . 0.0 108.978 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.1 t -56.13 -29.72 61.1 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.191 -0.943 . . . . 0.0 109.048 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -70.16 -36.92 75.04 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.124 -0.985 . . . . 0.0 108.631 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.06 -148.38 17.11 Favored Glycine 0 N--CA 1.499 2.84 0 CA-C-O 122.267 0.926 . . . . 0.0 110.977 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.702 ' H ' ' CB ' ' A' ' 128' ' ' LYS . 96.6 m-70 -100.42 -160.2 0.78 Allowed 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 122.684 1.23 . . . . 0.0 109.411 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.598 ' C ' ' H ' ' A' ' 127' ' ' THR . . . -144.62 166.72 24.38 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 122.178 0.99 . . . . 0.0 109.396 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.883 ' N ' ' H ' ' A' ' 127' ' ' THR . 4.7 t -83.63 105.33 14.47 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-O 122.541 1.162 . . . . 0.0 107.89 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.56 26.5 65.27 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.0 123.15 5.37 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 120.784 -1.421 . . . . 0.0 109.595 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.56 ' N ' ' CD1' ' A' ' 53' ' ' ILE . 2.7 mp -105.14 104.27 16.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 O-C-N 120.709 -1.245 . . . . 0.0 110.247 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -107.94 118.33 36.46 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-O 121.971 0.891 . . . . 0.0 109.449 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.405 ' O ' ' CG1' ' A' ' 38' ' ' VAL . 2.0 m -142.13 163.34 40.49 Favored Pre-proline 0 C--N 1.274 -2.71 0 CA-C-O 122.171 0.986 . . . . 0.0 109.09 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.638 ' O ' ' N ' ' A' ' 58' ' ' MET . 36.8 Cg_endo -84.08 68.2 6.71 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.451 2.101 . . . . 0.0 111.72 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.463 ' CZ ' ' CG2' ' A' ' 38' ' ' VAL . 66.4 m-85 54.83 -78.64 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 122.229 1.014 . . . . 0.0 109.789 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.781 ' HB2' ' H ' ' A' ' 68' ' ' ASN . 28.8 mmm -109.45 142.86 39.84 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-O 122.123 0.964 . . . . 0.0 110.071 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -148.26 133.27 18.19 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.2 ttt-85 -78.12 132.73 37.8 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.138 -0.976 . . . . 0.0 108.629 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.57 ' C ' ' H ' ' A' ' 63' ' ' SER . . . -175.83 -171.8 40.03 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.425 ' C ' ' H ' ' A' ' 64' ' ' GLY . . . -63.06 -1.5 0.98 Allowed 'General case' 0 C--N 1.28 -2.44 0 O-C-N 121.166 -1.196 . . . . 0.0 108.315 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.57 ' H ' ' C ' ' A' ' 61' ' ' GLY . 26.4 t -63.21 -8.59 8.55 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 65' ' ' MET . . . 106.95 29.81 4.47 Favored Glycine 0 N--CA 1.5 2.933 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.438 ' O ' ' O ' ' A' ' 64' ' ' GLY . 72.2 mtm 55.66 115.61 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 122.284 1.04 . . . . 0.0 110.316 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.0 t -161.47 97.63 1.1 Allowed 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 69' ' ' THR . 16.5 tptm -127.54 121.29 30.26 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.03 -1.044 . . . . 0.0 108.544 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.781 ' H ' ' HB2' ' A' ' 58' ' ' MET . 19.5 t30 -40.14 94.14 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 122.208 1.004 . . . . 0.0 110.041 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.505 ' N ' ' O ' ' A' ' 67' ' ' LYS . 4.9 m -159.35 -48.54 0.06 Allowed 'General case' 0 C--N 1.281 -2.396 0 O-C-N 121.465 -0.772 . . . . 0.0 109.915 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' A' ' 71' ' ' PHE . 44.1 p30 -154.06 -27.9 0.13 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.323 -1.486 . . . . 0.0 108.332 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.558 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 97.5 m-85 -51.03 -24.23 3.63 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 122.126 0.965 . . . . 0.0 108.849 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 76' ' ' SER . 3.0 mt -52.51 -42.47 64.34 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.973 0.892 . . . . 0.0 108.656 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.47 ' CG ' ' N ' ' A' ' 74' ' ' GLN . 13.5 pt-20 -60.88 -40.85 94.54 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.907 -1.121 . . . . 0.0 108.933 177.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.47 ' N ' ' CG ' ' A' ' 73' ' ' GLU . 84.7 mt-30 -75.53 -45.12 39.93 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.795 -1.191 . . . . 0.0 108.682 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.488 ' O ' ' O ' ' A' ' 79' ' ' PHE . 24.3 t -70.88 -54.0 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.781 -1.2 . . . . 0.0 108.752 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 72' ' ' LEU . 9.0 t -58.24 -14.49 7.3 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.598 ' O ' ' CG ' ' A' ' 78' ' ' HIS . 54.8 p -51.21 -37.56 47.45 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.91 -1.119 . . . . 0.0 109.229 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.598 ' CG ' ' O ' ' A' ' 77' ' ' SER . 5.1 m80 -174.41 14.02 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.509 ' CZ ' ' OD2' ' A' ' 83' ' ' ASP . 22.7 t80 -142.42 151.24 41.6 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.91 -1.119 . . . . 0.0 110.018 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.456 ' H ' ' HB3' ' A' ' 83' ' ' ASP . . . -116.55 136.24 12.65 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -46.56 -25.92 0.79 Allowed 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.487 -1.007 . . . . 0.0 109.198 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.503 ' O ' ' C ' ' A' ' 83' ' ' ASP . 0.3 OUTLIER -125.09 23.01 7.83 Favored 'General case' 0 C--N 1.292 -1.906 0 O-C-N 120.809 -1.182 . . . . 0.0 107.97 178.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.509 ' OD2' ' CZ ' ' A' ' 79' ' ' PHE . 9.8 p-10 -35.56 116.33 0.36 Allowed 'General case' 0 N--CA 1.507 2.419 0 CA-C-O 121.762 0.792 . . . . 0.0 109.076 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.576 ' N ' ' O ' ' A' ' 109' ' ' GLY . 28.8 t30 63.0 60.88 1.17 Allowed 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.898 0.856 . . . . 0.0 109.426 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.528 ' CG2' ' N ' ' A' ' 86' ' ' ILE . 21.5 mt -145.94 175.24 2.28 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 O-C-N 121.063 -1.023 . . . . 0.0 109.41 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.528 ' N ' ' CG2' ' A' ' 85' ' ' ILE . 28.3 mt -111.26 107.48 23.06 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.294 0 CA-C-O 122.181 0.991 . . . . 0.0 109.407 178.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.485 ' N ' ' O ' ' A' ' 111' ' ' LYS . 38.2 t -109.68 155.11 10.96 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 CA-C-O 121.946 0.879 . . . . 0.0 108.906 -175.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -162.41 138.24 5.27 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.472 ' SG ' ' OG ' ' A' ' 95' ' ' SER . 34.7 t -94.58 144.12 25.86 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 122.059 0.933 . . . . 0.0 109.268 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 9.9 tm0? -44.2 -35.9 2.44 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.985 0.897 . . . . 0.0 110.444 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 69.5 m -102.78 158.25 16.39 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 122.141 0.972 . . . . 0.0 109.51 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' A' ' 94' ' ' ARG . . . -123.16 168.26 15.38 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 65.22 -70.74 0.09 OUTLIER Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 92' ' ' GLY . 89.9 mtt180 -62.59 -36.05 81.48 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.214 -1.168 . . . . 0.0 108.766 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.472 ' OG ' ' SG ' ' A' ' 89' ' ' CYS . 7.0 t -85.5 -24.49 27.32 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.183 -0.948 . . . . 0.0 109.25 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.467 ' O ' ' OG1' ' A' ' 99' ' ' THR . 1.0 OUTLIER -58.8 -47.45 89.21 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 O-C-N 121.044 -1.035 . . . . 0.0 108.895 179.871 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.412 ' N ' ' CG2' ' A' ' 96' ' ' ILE . 49.9 pttt -71.38 -30.87 66.64 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.675 -1.266 . . . . 0.0 108.423 177.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.89 -38.11 89.89 Favored 'General case' 0 C--N 1.289 -2.028 0 O-C-N 120.521 -1.362 . . . . 0.0 109.193 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' A' ' 96' ' ' ILE . 0.0 OUTLIER -63.01 -35.37 79.99 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-O 122.539 1.161 . . . . 0.0 108.679 179.65 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.417 ' H ' ' HG1' ' A' ' 100' ' ' THR . 9.7 m -57.44 -38.25 74.13 Favored 'General case' 0 C--N 1.288 -2.094 0 O-C-N 120.998 -1.064 . . . . 0.0 109.005 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -61.33 -43.32 99.07 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.644 -1.285 . . . . 0.0 108.087 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.2 mt -70.07 -35.03 73.93 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 122.01 0.91 . . . . 0.0 108.848 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 52.0 tp -56.31 -39.77 73.29 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.062 -1.024 . . . . 0.0 108.966 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 30.0 m170 -61.98 -36.48 81.6 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.551 -1.343 . . . . 0.0 108.57 177.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -76.22 -19.22 58.58 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 120.612 -1.305 . . . . 0.0 108.359 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 120.23 83.39 0.78 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -144.55 62.14 1.33 Allowed 'General case' 0 C--N 1.289 -2.032 0 O-C-N 121.09 -1.241 . . . . 0.0 109.35 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.564 ' OG1' ' N ' ' A' ' 109' ' ' GLY . 0.0 OUTLIER -126.47 179.1 5.47 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.642 -1.287 . . . . 0.0 110.136 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.597 ' N ' ' H ' ' A' ' 16' ' ' VAL . . . 85.76 17.76 61.12 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.4 m -147.18 163.06 7.72 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 O-C-N 121.081 -1.247 . . . . 0.0 109.858 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.485 ' O ' ' N ' ' A' ' 87' ' ' VAL . 61.1 mttp -98.57 141.98 30.73 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 122.218 1.009 . . . . 0.0 108.694 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 74.4 m-20 -99.44 108.19 20.59 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.458 ' N ' ' O ' ' A' ' 87' ' ' VAL . 7.4 mm -97.64 155.35 3.67 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 O-C-N 121.241 -0.912 . . . . 0.0 110.218 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 38.0 t -99.12 124.18 52.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 O-C-N 120.783 -1.198 . . . . 0.0 109.638 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.17 -145.67 23.39 Favored Glycine 0 C--N 1.286 -2.235 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 135.59 -90.26 0.23 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.503 ' O ' ' N ' ' A' ' 121' ' ' ALA . 79.6 t80 -51.77 -41.63 61.77 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 121.989 0.899 . . . . 0.0 109.659 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 18.5 t -57.57 -45.03 85.67 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-O 121.923 0.868 . . . . 0.0 109.39 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.22 -52.57 12.0 Favored 'General case' 0 C--N 1.287 -2.152 0 O-C-N 121.134 -0.979 . . . . 0.0 108.901 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . 0.584 ' NE1' ' O ' ' A' ' 50' ' ' CYS . 4.9 t-105 -57.93 -35.54 71.23 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.165 -1.421 . . . . 0.0 107.165 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 117' ' ' TYR . . . -63.69 -30.93 71.97 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 120.912 -1.118 . . . . 0.0 108.79 178.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.4 ttpp -57.45 -36.39 71.36 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -65.86 -65.19 0.71 Allowed 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.645 -1.284 . . . . 0.0 108.354 178.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 105.87 32.89 3.68 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.482 ' O ' ' CB ' ' A' ' 50' ' ' CYS . 18.6 mt -126.43 79.75 70.32 Favored Pre-proline 0 C--N 1.296 -1.736 0 O-C-N 120.933 -1.334 . . . . 0.0 109.376 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -95.65 115.79 0.17 Allowed 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 122.255 1.97 . . . . 0.0 113.229 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.883 ' H ' ' N ' ' A' ' 50' ' ' CYS . 93.8 m -93.08 132.42 37.21 Favored 'General case' 0 C--N 1.285 -2.212 0 O-C-N 120.733 -1.229 . . . . 0.0 108.996 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.702 ' CB ' ' H ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -175.69 167.21 3.18 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-O 122.178 0.99 . . . . 0.0 108.914 -178.224 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.28 -2.424 0 O-C-N 120.79 -1.193 . . . . 0.0 110.04 -178.424 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 122.188 0.994 . . . . 0.0 109.282 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -94.85 21.35 7.64 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-O 122.002 0.906 . . . . 0.0 109.238 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -52.72 142.33 18.9 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 122.323 1.059 . . . . 0.0 109.63 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.9 m -150.42 83.66 1.36 Allowed 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -164.24 61.95 0.15 Allowed 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.142 0.972 . . . . 0.0 109.781 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.74 177.3 1.9 Allowed Pre-proline 0 C--N 1.291 -1.976 0 O-C-N 121.347 -0.845 . . . . 0.0 108.92 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.459 ' N ' ' OG1' ' A' ' 108' ' ' THR . 29.6 Cg_endo -86.69 135.35 4.13 Favored 'Trans proline' 0 C--N 1.296 -2.194 0 C-N-CA 121.849 1.699 . . . . 0.0 111.426 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 112' ' ' ASP . 32.8 t -140.56 138.99 34.9 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.111 0.958 . . . . 0.0 109.704 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.1 t -99.02 143.91 28.77 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-O 122.742 1.258 . . . . 0.0 109.566 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.713 ' CG2' ' N ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -148.7 178.9 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 O-C-N 121.013 -1.055 . . . . 0.0 109.41 -178.733 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.713 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 62.6 m -119.14 151.34 38.48 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.499 -1.376 . . . . 0.0 109.415 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.5 p -48.62 -27.1 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.273 -2.738 0 CA-C-O 122.159 0.981 . . . . 0.0 108.739 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.509 ' OG1' ' N ' ' A' ' 24' ' ' VAL . 0.1 OUTLIER -65.1 -58.2 6.66 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 120.725 -1.234 . . . . 0.0 109.112 179.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.509 ' N ' ' OG1' ' A' ' 23' ' ' THR . 0.0 OUTLIER -60.31 -35.1 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.158 -1.589 . . . . 0.0 109.436 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -51.11 -37.3 45.13 Favored 'General case' 0 C--N 1.287 -2.144 0 O-C-N 120.799 -1.188 . . . . 0.0 108.394 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -57.66 -44.09 85.43 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -59.9 -43.61 94.72 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 120.904 -1.122 . . . . 0.0 108.697 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.1 mp -66.46 -33.55 75.94 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.431 ' O ' ' CD1' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -53.54 -40.44 65.52 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.733 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.4 mp -63.99 -31.11 72.19 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 120.568 -1.333 . . . . 0.0 107.421 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.9 -28.77 68.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.634 -1.292 . . . . 0.0 108.362 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.31 47.28 8.32 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -96.53 156.45 16.34 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 121.148 -1.207 . . . . 0.0 109.621 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -59.17 144.69 45.13 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 122.365 1.079 . . . . 0.0 109.768 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -123.85 112.16 16.95 Favored 'General case' 0 C--N 1.291 -1.964 0 O-C-N 121.381 -0.824 . . . . 0.0 108.973 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 8.0 tt -122.16 101.22 7.4 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.649 -1.282 . . . . 0.0 108.529 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -98.89 157.3 16.4 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -176.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 38' ' ' VAL . 6.0 m -133.76 89.05 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 CA-C-O 122.396 1.093 . . . . 0.0 108.064 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.565 ' CG ' ' NH1' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -81.71 -45.3 15.89 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -179.394 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.554 ' OG1' ' C ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER 171.58 163.8 0.24 Allowed Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.138 -0.976 . . . . 0.0 109.965 -179.41 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -66.09 -12.97 37.74 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 121.993 1.795 . . . . 0.0 111.125 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -72.81 -37.75 67.42 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.979 -1.076 . . . . 0.0 108.478 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.444 ' OE2' ' O ' ' A' ' 54' ' ' ASN . 2.0 pp20? -58.49 -28.68 65.61 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.726 -1.233 . . . . 0.0 109.04 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -74.08 -42.39 60.22 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 122.148 0.975 . . . . 0.0 108.977 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.9 t -54.83 -37.87 66.7 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.265 -0.897 . . . . 0.0 109.117 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -82.58 -37.27 25.3 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.158 -0.964 . . . . 0.0 108.714 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 43' ' ' GLU . . . 137.93 -139.57 10.49 Favored Glycine 0 N--CA 1.499 2.879 0 CA-C-O 122.298 0.943 . . . . 0.0 110.988 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.754 ' H ' ' CB ' ' A' ' 128' ' ' LYS . 94.7 m-70 -101.58 -161.73 0.88 Allowed 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 122.683 1.23 . . . . 0.0 109.396 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.588 ' C ' ' H ' ' A' ' 127' ' ' THR . . . -146.79 159.94 42.88 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 122.234 1.016 . . . . 0.0 109.374 -178.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.888 ' N ' ' H ' ' A' ' 127' ' ' THR . 4.6 t -82.53 162.55 21.96 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-O 122.559 1.171 . . . . 0.0 107.863 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.57 -51.39 4.14 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.23 175.37 14.13 Favored 'General case' 0 C--N 1.29 -1.999 0 O-C-N 120.798 -1.413 . . . . 0.0 109.63 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 73.2 mt -101.41 139.11 23.44 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 O-C-N 120.786 -1.196 . . . . 0.0 110.266 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.444 ' O ' ' OE2' ' A' ' 43' ' ' GLU . 43.5 p-10 -131.44 130.79 42.96 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.982 0.896 . . . . 0.0 109.444 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.477 ' C ' ' H ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -142.99 165.37 26.54 Favored Pre-proline 0 C--N 1.273 -2.719 0 CA-C-O 122.191 0.996 . . . . 0.0 109.146 179.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.53 ' O ' ' N ' ' A' ' 58' ' ' MET . 35.7 Cg_endo -76.88 26.45 0.44 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.468 2.112 . . . . 0.0 111.736 -177.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.625 ' CD1' ' NE2' ' A' ' 81' ' ' GLN . 90.7 t80 48.0 -91.21 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 122.266 1.032 . . . . 0.0 109.887 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.53 ' N ' ' O ' ' A' ' 56' ' ' PRO . 24.2 ttt -154.18 127.67 8.6 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-O 122.123 0.963 . . . . 0.0 110.023 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.424 ' OD1' ' CB ' ' A' ' 62' ' ' ALA . 50.3 t-20 -154.83 123.98 6.32 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.456 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 0.2 OUTLIER -120.56 122.16 39.97 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.094 -1.004 . . . . 0.0 108.598 179.376 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 64' ' ' GLY . . . 76.42 -55.22 3.27 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.424 ' CB ' ' OD1' ' A' ' 59' ' ' ASN . . . -54.06 -29.8 45.52 Favored 'General case' 0 C--N 1.28 -2.448 0 O-C-N 121.16 -1.2 . . . . 0.0 108.227 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.9 t -96.11 16.12 18.93 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 61' ' ' GLY . . . 80.49 42.47 10.24 Favored Glycine 0 N--CA 1.501 3.003 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.421 ' H ' ' HA2' ' A' ' 61' ' ' GLY . 72.2 mtm 57.98 59.81 2.98 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 122.305 1.05 . . . . 0.0 110.337 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.7 t -151.5 91.96 1.72 Allowed 'General case' 0 C--N 1.289 -2.037 0 O-C-N 121.14 -0.975 . . . . 0.0 108.431 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.569 ' O ' ' N ' ' A' ' 69' ' ' THR . 1.1 ttmp? -102.61 147.26 27.01 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 122.244 1.021 . . . . 0.0 108.523 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.709 HD21 ' H ' ' A' ' 68' ' ' ASN . 1.3 m-80 -39.08 90.8 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 122.176 0.988 . . . . 0.0 110.043 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.622 ' CG2' ' N ' ' A' ' 70' ' ' ASP . 3.0 m 44.64 -101.9 0.05 Allowed 'General case' 0 C--N 1.281 -2.397 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.888 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.622 ' N ' ' CG2' ' A' ' 69' ' ' THR . 58.7 t0 -173.68 8.23 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.278 -1.514 . . . . 0.0 108.35 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -52.21 -23.63 5.9 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 122.128 0.966 . . . . 0.0 108.858 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.571 ' O ' ' N ' ' A' ' 76' ' ' SER . 3.2 mm? -48.9 -52.34 25.03 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -56.84 -34.93 68.25 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.988 -1.07 . . . . 0.0 108.881 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -73.62 -51.66 16.06 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.812 -1.18 . . . . 0.0 108.661 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.621 ' CG2' ' N ' ' A' ' 76' ' ' SER . 1.0 OUTLIER -76.83 -48.57 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.738 -1.226 . . . . 0.0 108.779 -179.315 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.621 ' N ' ' CG2' ' A' ' 75' ' ' VAL . 63.0 p -52.42 -19.96 2.52 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 t -53.58 -32.31 50.39 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.834 -1.166 . . . . 0.0 109.251 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -162.55 -19.09 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.572 ' N ' ' O ' ' A' ' 75' ' ' VAL . 99.1 m-85 -117.19 169.77 9.2 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.003 -1.061 . . . . 0.0 110.014 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.507 ' H ' ' HB2' ' A' ' 83' ' ' ASP . . . -109.58 138.14 14.64 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.625 ' NE2' ' CD1' ' A' ' 57' ' ' TYR . 10.0 pt20 -45.6 -18.27 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.425 -1.044 . . . . 0.0 109.242 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.49 ' N ' ' O ' ' A' ' 80' ' ' GLY . 19.2 t -123.16 17.57 9.94 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 120.838 -1.164 . . . . 0.0 107.992 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.507 ' HB2' ' H ' ' A' ' 80' ' ' GLY . 11.9 t70 -40.46 107.46 0.07 Allowed 'General case' 0 N--CA 1.508 2.441 0 O-C-N 121.421 -0.799 . . . . 0.0 109.077 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 53.78 70.03 0.65 Allowed 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 121.97 0.89 . . . . 0.0 109.47 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.526 ' CG2' ' N ' ' A' ' 86' ' ' ILE . 17.7 mt -143.1 168.84 12.71 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 O-C-N 121.021 -1.05 . . . . 0.0 109.402 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.526 ' N ' ' CG2' ' A' ' 85' ' ' ILE . 49.0 mt -110.44 109.66 29.3 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.231 0 CA-C-O 122.188 0.994 . . . . 0.0 109.473 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.558 ' O ' ' N ' ' A' ' 113' ' ' ILE . 18.6 t -112.44 166.75 6.26 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 O-C-N 121.219 -0.926 . . . . 0.0 108.898 -177.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -148.97 141.72 9.22 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.502 ' O ' ' C ' ' A' ' 90' ' ' GLN . 0.4 OUTLIER -90.46 140.43 29.73 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 122.127 0.965 . . . . 0.0 109.23 -179.345 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.524 ' H ' ' CD ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -33.46 -89.88 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.992 0.901 . . . . 0.0 110.486 -178.691 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.7 p -149.64 160.36 43.57 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 122.197 0.998 . . . . 0.0 109.521 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.94 119.36 4.31 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.454 ' O ' ' CG2' ' A' ' 96' ' ' ILE . . . -57.43 -37.81 83.81 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.101 -1.599 . . . . 0.0 109.101 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 34.4 mtp180 -62.7 -28.1 69.71 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.317 -1.108 . . . . 0.0 108.807 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.8 m -62.3 -39.48 93.12 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.189 -0.944 . . . . 0.0 109.325 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.454 ' CG2' ' O ' ' A' ' 93' ' ' GLY . 15.7 tt -63.73 -30.9 51.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 O-C-N 121.023 -1.048 . . . . 0.0 108.917 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.412 ' N ' HG23 ' A' ' 96' ' ' ILE . 39.0 mtpt -70.85 -45.31 64.7 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.706 -1.246 . . . . 0.0 108.411 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.0 -33.24 68.71 Favored 'General case' 0 C--N 1.289 -2.041 0 O-C-N 120.578 -1.326 . . . . 0.0 109.207 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.88 -57.84 2.88 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-O 122.546 1.165 . . . . 0.0 108.737 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 96' ' ' ILE . 56.4 m -50.42 -43.44 54.88 Favored 'General case' 0 C--N 1.288 -2.093 0 O-C-N 121.039 -1.038 . . . . 0.0 108.984 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -68.41 -45.91 71.37 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.674 -1.266 . . . . 0.0 108.06 178.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.431 ' CD1' ' C ' ' A' ' 102' ' ' LEU . 3.0 tm? -65.6 -42.87 91.14 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.944 0.878 . . . . 0.0 108.859 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.3 mp -62.96 -36.84 84.8 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 121.088 -1.007 . . . . 0.0 108.915 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -66.62 -17.76 65.01 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.55 -1.344 . . . . 0.0 108.576 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.06 -19.56 63.05 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 120.643 -1.285 . . . . 0.0 108.361 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 135.46 42.18 0.12 Allowed Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -153.35 32.47 0.47 Allowed 'General case' 0 C--N 1.289 -2.063 0 O-C-N 121.079 -1.248 . . . . 0.0 109.391 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.576 ' OG1' ' N ' ' A' ' 109' ' ' GLY . 4.8 t -87.01 -136.73 0.09 Allowed 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.647 -1.283 . . . . 0.0 110.085 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.576 ' N ' ' OG1' ' A' ' 108' ' ' THR . . . 80.08 23.06 62.08 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.425 ' HB ' ' HG ' ' A' ' 82' ' ' SER . 1.8 m -143.63 165.67 14.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 O-C-N 121.021 -1.282 . . . . 0.0 109.901 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -99.27 153.29 19.06 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-O 122.212 1.006 . . . . 0.0 108.729 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.509 ' O ' ' CG1' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -108.31 115.72 30.63 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.558 ' N ' ' O ' ' A' ' 87' ' ' VAL . 1.2 mm -100.88 127.99 53.48 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 O-C-N 121.291 -0.881 . . . . 0.0 110.279 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 71.8 t -99.5 137.09 28.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 O-C-N 120.766 -1.209 . . . . 0.0 109.701 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.6 -154.21 30.87 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 120' ' ' TRP . . . 89.73 -47.33 3.2 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -52.15 -53.64 40.45 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 121.97 0.89 . . . . 0.0 109.637 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 67.8 p -71.52 -34.54 70.17 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.886 0.851 . . . . 0.0 109.33 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.23 -54.72 8.76 Favored 'General case' 0 C--N 1.286 -2.162 0 O-C-N 121.18 -0.95 . . . . 0.0 108.936 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . 0.627 ' O ' ' OD1' ' A' ' 123' ' ' ASN . 28.0 t90 -60.07 -34.87 74.03 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -52.45 -36.74 55.36 Favored 'General case' 0 C--N 1.291 -1.942 0 O-C-N 120.88 -1.138 . . . . 0.0 108.763 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -60.7 -26.87 67.45 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.686 ' ND2' ' H ' ' A' ' 125' ' ' LEU . 6.1 p-10 -54.02 -49.26 69.31 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 120.685 -1.259 . . . . 0.0 108.373 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.681 ' N ' ' OD1' ' A' ' 123' ' ' ASN . . . 71.22 18.8 76.93 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.686 ' H ' ' ND2' ' A' ' 123' ' ' ASN . 15.0 mt -124.34 98.14 38.76 Favored Pre-proline 0 C--N 1.298 -1.667 0 O-C-N 120.859 -1.377 . . . . 0.0 109.405 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.526 ' O ' ' NZ ' ' A' ' 128' ' ' LYS . 45.9 Cg_endo -93.29 117.96 0.34 Allowed 'Trans proline' 0 C--N 1.301 -1.946 0 C-N-CA 122.339 2.026 . . . . 0.0 113.28 178.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.888 ' H ' ' N ' ' A' ' 50' ' ' CYS . 53.2 m -92.96 126.19 37.92 Favored 'General case' 0 C--N 1.286 -2.186 0 O-C-N 120.713 -1.242 . . . . 0.0 108.964 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.754 ' CB ' ' H ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -175.46 148.38 0.92 Allowed 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 122.204 1.002 . . . . 0.0 108.933 -178.224 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.281 -2.399 0 O-C-N 120.762 -1.211 . . . . 0.0 109.992 -178.633 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.206 -1.19 0 CA-C-O 122.147 0.975 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -140.93 65.64 1.39 Allowed 'General case' 0 C--N 1.283 -2.292 0 CA-C-O 121.996 0.903 . . . . 0.0 109.198 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -142.09 142.52 32.82 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-O 122.245 1.021 . . . . 0.0 109.69 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 60.1 p -84.42 160.82 20.53 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.65 105.21 3.27 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 122.239 1.019 . . . . 0.0 109.741 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.87 177.46 1.77 Allowed Pre-proline 0 C--N 1.291 -1.951 0 O-C-N 121.193 -0.942 . . . . 0.0 108.965 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.543 ' N ' ' OG1' ' A' ' 108' ' ' THR . 27.4 Cg_endo -86.61 140.76 6.29 Favored 'Trans proline' 0 C--N 1.296 -2.186 0 C-N-CA 121.917 1.744 . . . . 0.0 111.344 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.9 t -144.53 150.1 36.99 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 122.035 0.922 . . . . 0.0 109.779 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 95.2 p -101.02 139.55 36.56 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-O 122.632 1.206 . . . . 0.0 109.661 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.497 HG22 ' N ' ' A' ' 21' ' ' SER . 0.6 OUTLIER -150.17 158.61 5.42 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.185 0 O-C-N 121.023 -1.048 . . . . 0.0 109.318 -178.641 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.497 ' N ' HG22 ' A' ' 20' ' ' VAL . 1.2 m -117.12 160.09 21.56 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.484 -1.385 . . . . 0.0 109.448 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.0 p -49.44 -31.61 5.68 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.81 0 CA-C-O 122.132 0.968 . . . . 0.0 108.669 -178.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.432 HG21 ' H ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -59.7 -56.16 25.38 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 120.718 -1.239 . . . . 0.0 109.144 179.484 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.432 ' H ' HG21 ' A' ' 23' ' ' THR . 0.1 OUTLIER -65.51 -35.66 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.106 -1.622 . . . . 0.0 109.461 178.864 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.54 -36.16 66.47 Favored 'General case' 0 C--N 1.286 -2.157 0 O-C-N 120.85 -1.156 . . . . 0.0 108.354 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -56.18 -47.03 79.09 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -60.9 -42.19 97.54 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.961 -1.087 . . . . 0.0 108.769 178.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 69.5 mt -67.58 -31.69 71.92 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.0 tt -56.86 -39.19 73.83 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.3 mp -62.91 -29.85 71.09 Favored 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.19 -28.87 69.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.705 -1.247 . . . . 0.0 108.448 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.19 49.3 27.45 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.8 t60 -102.56 170.21 8.17 Favored 'General case' 0 C--N 1.292 -1.923 0 O-C-N 121.055 -1.262 . . . . 0.0 109.571 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -59.96 128.05 34.91 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.377 1.084 . . . . 0.0 109.773 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.444 ' CE2' ' OD1' ' A' ' 37' ' ' ASP . 16.0 t80 -109.92 106.64 16.27 Favored 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.307 -0.871 . . . . 0.0 108.945 -178.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.645 ' CD1' ' N ' ' A' ' 37' ' ' ASP . 0.1 OUTLIER -99.92 135.44 41.35 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.541 -1.349 . . . . 0.0 108.611 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.645 ' N ' ' CD1' ' A' ' 36' ' ' LEU . 14.2 m-20 -138.45 138.19 37.91 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.469 ' CG2' ' O ' ' A' ' 38' ' ' VAL . 11.9 m -132.55 75.31 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 CA-C-O 122.358 1.075 . . . . 0.0 108.1 177.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.719 ' H ' HD22 ' A' ' 54' ' ' ASN . 0.4 OUTLIER -82.93 -41.94 18.26 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -179.604 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.522 ' OG1' ' C ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER 176.37 144.42 0.24 Allowed Pre-proline 0 C--N 1.3 -1.577 0 O-C-N 121.131 -0.981 . . . . 0.0 109.981 -179.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -43.14 -27.96 1.22 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.02 1.813 . . . . 0.0 111.102 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -70.02 -30.9 68.31 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.865 -1.147 . . . . 0.0 108.498 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.537 ' CD ' ' HE ' ' A' ' 39' ' ' ARG . 42.1 tp10 -54.42 -33.95 60.43 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.687 -1.258 . . . . 0.0 109.014 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -79.06 -37.12 39.73 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 122.116 0.96 . . . . 0.0 108.854 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.443 ' C ' ' H ' ' A' ' 47' ' ' GLY . 11.2 t -65.95 -40.97 91.82 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.224 -0.922 . . . . 0.0 109.031 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.495 ' NE2' ' O ' ' A' ' 47' ' ' GLY . 5.4 pp0? -75.69 9.5 2.26 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.104 -0.997 . . . . 0.0 108.627 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.495 ' O ' ' NE2' ' A' ' 46' ' ' GLN . . . 89.97 -160.41 28.53 Favored Glycine 0 N--CA 1.5 2.936 0 CA-C-O 122.299 0.944 . . . . 0.0 110.966 178.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.669 ' H ' ' CB ' ' A' ' 128' ' ' LYS . 34.5 m170 -103.05 -159.32 0.72 Allowed 'General case' 0 C--N 1.289 -2.032 0 CA-C-O 122.752 1.263 . . . . 0.0 109.372 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.629 ' C ' ' H ' ' A' ' 127' ' ' THR . . . -141.91 169.58 17.32 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 122.207 1.003 . . . . 0.0 109.352 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.916 ' N ' ' H ' ' A' ' 127' ' ' THR . 5.2 t -82.67 106.62 14.67 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.79 25.75 55.39 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.29 124.26 9.99 Favored 'General case' 0 C--N 1.29 -1.984 0 O-C-N 120.897 -1.355 . . . . 0.0 109.631 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 29.3 mt -116.99 113.19 42.15 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 O-C-N 120.722 -1.236 . . . . 0.0 110.216 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.719 HD22 ' H ' ' A' ' 39' ' ' ARG . 24.1 t-20 -98.03 135.0 40.36 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 122.01 0.909 . . . . 0.0 109.383 -177.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.9 t -140.24 92.19 9.59 Favored Pre-proline 0 C--N 1.274 -2.706 0 CA-C-O 122.152 0.977 . . . . 0.0 109.093 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -74.12 86.07 1.32 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.473 2.115 . . . . 0.0 111.769 -178.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.52 ' O ' ' SD ' ' A' ' 58' ' ' MET . 11.3 t80 -64.14 -61.27 2.37 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 122.291 1.043 . . . . 0.0 109.818 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.52 ' SD ' ' O ' ' A' ' 57' ' ' TYR . 16.2 mmt -143.02 149.71 38.64 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-O 122.105 0.955 . . . . 0.0 110.082 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -149.69 120.51 7.6 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.434 ' O ' ' CG ' ' A' ' 60' ' ' ARG . 22.2 ptt180 -94.89 124.11 38.75 Favored 'General case' 0 N--CA 1.504 2.272 0 CA-C-O 122.244 1.021 . . . . 0.0 108.567 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.547 ' C ' ' H ' ' A' ' 63' ' ' SER . . . 75.97 -52.47 2.89 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.62 -7.58 0.69 Allowed 'General case' 0 C--N 1.28 -2.417 0 O-C-N 121.068 -1.254 . . . . 0.0 108.246 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.547 ' H ' ' C ' ' A' ' 61' ' ' GLY . 4.8 t -127.35 14.46 7.17 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 107.545 -1.279 . . . . 0.0 107.545 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.41 46.25 9.11 Favored Glycine 0 N--CA 1.503 3.101 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 71.6 mtm 55.95 87.61 0.05 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 122.34 1.067 . . . . 0.0 110.306 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.9 m -168.51 92.48 0.31 Allowed 'General case' 0 C--N 1.29 -1.991 0 O-C-N 121.136 -0.977 . . . . 0.0 108.459 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -128.39 121.91 30.18 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.094 -1.004 . . . . 0.0 108.545 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.467 ' CB ' ' SD ' ' A' ' 58' ' ' MET . 8.5 t-20 -61.03 168.5 2.42 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 122.234 1.016 . . . . 0.0 109.997 -178.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 69' ' ' THR . 0.6 OUTLIER -160.63 51.4 0.28 Allowed 'General case' 0 C--N 1.28 -2.415 0 O-C-N 121.493 -0.754 . . . . 0.0 109.873 -179.441 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -127.3 -44.81 1.55 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.381 -1.45 . . . . 0.0 108.272 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.487 ' O ' ' N ' ' A' ' 74' ' ' GLN . 97.6 m-85 -57.77 -22.02 44.74 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 122.073 0.94 . . . . 0.0 108.837 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 76' ' ' SER . 2.2 mt -46.66 -45.47 19.3 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 122.03 0.919 . . . . 0.0 108.679 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -58.27 -36.61 73.53 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.89 -1.131 . . . . 0.0 108.88 176.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 71' ' ' PHE . 43.3 mt-30 -81.76 -49.26 10.62 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.832 -1.168 . . . . 0.0 108.67 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.8 t -64.76 -43.85 96.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.758 -1.213 . . . . 0.0 108.735 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 72' ' ' LEU . 18.4 t -66.21 -19.93 65.97 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.572 ' O ' ' CG ' ' A' ' 78' ' ' HIS . 8.0 t -52.9 -49.77 65.24 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.858 -1.151 . . . . 0.0 109.252 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.572 ' CG ' ' O ' ' A' ' 77' ' ' SER . 0.3 OUTLIER 168.7 -10.81 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.014 -1.054 . . . . 0.0 108.223 179.613 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -101.2 150.11 23.3 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.921 -1.112 . . . . 0.0 110.026 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.447 ' H ' ' HB2' ' A' ' 83' ' ' ASP . . . -114.26 142.89 17.8 Favored Glycine 0 N--CA 1.498 2.768 0 N-CA-C 110.476 -1.049 . . . . 0.0 110.476 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' A' ' 80' ' ' GLY . 0.2 OUTLIER -44.38 -43.48 7.65 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.451 -1.029 . . . . 0.0 109.166 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.501 ' O ' ' C ' ' A' ' 83' ' ' ASP . 0.1 OUTLIER -122.22 24.15 9.54 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 120.837 -1.164 . . . . 0.0 107.972 179.324 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.501 ' C ' ' O ' ' A' ' 82' ' ' SER . 19.4 t0 -34.97 118.07 0.42 Allowed 'General case' 0 N--CA 1.506 2.364 0 CA-C-O 121.715 0.769 . . . . 0.0 109.108 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.612 ' N ' ' O ' ' A' ' 109' ' ' GLY . 6.8 t-20 65.56 60.7 0.72 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.891 0.853 . . . . 0.0 109.418 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.557 ' CG2' ' N ' ' A' ' 86' ' ' ILE . 12.0 mt -150.14 177.67 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 O-C-N 121.064 -1.023 . . . . 0.0 109.496 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.557 ' N ' ' CG2' ' A' ' 85' ' ' ILE . 63.7 mt -111.14 108.33 25.21 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.257 0 CA-C-O 122.195 0.997 . . . . 0.0 109.323 178.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.537 ' O ' ' N ' ' A' ' 113' ' ' ILE . 14.1 t -114.98 166.47 8.74 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-O 121.943 0.878 . . . . 0.0 108.892 -176.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -148.66 142.03 9.57 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 49.7 t -92.64 148.3 22.18 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 122.079 0.942 . . . . 0.0 109.303 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -41.74 -36.3 0.97 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 122.003 0.906 . . . . 0.0 110.402 -178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 96.3 p -132.71 159.02 40.88 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 122.257 1.027 . . . . 0.0 109.444 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -110.58 -178.58 20.65 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 68.39 -72.33 0.33 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -29.59 68.99 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.182 -1.187 . . . . 0.0 108.824 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.49 ' O ' ' CG2' ' A' ' 99' ' ' THR . 54.4 p -84.51 -29.12 26.22 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.187 -0.946 . . . . 0.0 109.27 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.557 ' CG2' ' N ' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -55.53 -48.71 77.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 O-C-N 121.092 -1.005 . . . . 0.0 108.836 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.557 ' N ' ' CG2' ' A' ' 96' ' ' ILE . 4.6 ptmm? -70.67 -40.84 72.74 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.63 -1.294 . . . . 0.0 108.39 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.05 -40.96 95.5 Favored 'General case' 0 C--N 1.289 -2.026 0 O-C-N 120.544 -1.347 . . . . 0.0 109.294 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.49 ' CG2' ' O ' ' A' ' 95' ' ' SER . 35.7 p -64.46 -54.57 30.52 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-O 122.553 1.168 . . . . 0.0 108.683 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.543 ' O ' ' CG ' ' A' ' 104' ' ' HIS . 35.5 m -46.22 -37.35 7.04 Favored 'General case' 0 C--N 1.287 -2.14 0 O-C-N 121.06 -1.025 . . . . 0.0 108.992 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -87.11 -50.65 6.49 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.62 -1.3 . . . . 0.0 108.077 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.451 ' CD1' ' C ' ' A' ' 102' ' ' LEU . 1.9 tm? -61.36 -44.45 97.15 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.982 0.896 . . . . 0.0 108.889 -178.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 99' ' ' THR . 70.5 mt -63.14 -38.58 91.76 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.113 -0.992 . . . . 0.0 108.975 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.543 ' CG ' ' O ' ' A' ' 100' ' ' THR . 24.7 m170 -59.88 -18.58 45.69 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.641 -1.287 . . . . 0.0 108.574 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.01 -19.38 62.77 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 120.629 -1.295 . . . . 0.0 108.326 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 128.78 7.88 4.04 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -103.0 17.65 23.55 Favored 'General case' 0 C--N 1.289 -2.032 0 O-C-N 121.082 -1.246 . . . . 0.0 109.395 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.543 ' OG1' ' N ' ' A' ' 17' ' ' PRO . 8.7 t -78.98 -150.73 0.05 Allowed 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.669 -1.269 . . . . 0.0 110.074 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.612 ' O ' ' N ' ' A' ' 84' ' ' ASN . . . 77.45 19.43 76.37 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.6 m -146.62 166.7 7.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 O-C-N 120.999 -1.295 . . . . 0.0 109.898 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 87' ' ' VAL . 84.9 mttt -97.88 145.48 26.39 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 122.211 1.005 . . . . 0.0 108.71 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.467 ' O ' ' CG1' ' A' ' 20' ' ' VAL . 51.4 t0 -99.95 109.78 22.13 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.537 ' N ' ' O ' ' A' ' 87' ' ' VAL . 1.2 mm -94.88 138.85 19.83 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.39 0 O-C-N 121.229 -0.919 . . . . 0.0 110.291 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 71.5 t -99.48 143.83 12.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 O-C-N 120.838 -1.163 . . . . 0.0 109.684 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 79.41 -117.2 4.47 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.4 -84.78 1.0 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -55.73 -43.98 77.09 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-O 122.031 0.919 . . . . 0.0 109.671 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 36.6 m -59.92 -39.27 84.9 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-O 121.947 0.879 . . . . 0.0 109.376 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 122' ' ' LYS . . . -72.55 -50.22 27.15 Favored 'General case' 0 C--N 1.286 -2.159 0 O-C-N 121.096 -1.003 . . . . 0.0 108.882 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . 0.58 ' NE1' ' O ' ' A' ' 50' ' ' CYS . 1.0 OUTLIER -53.92 -39.25 65.68 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.332 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.63 -25.81 68.39 Favored 'General case' 0 C--N 1.292 -1.924 0 O-C-N 120.834 -1.166 . . . . 0.0 108.838 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.499 ' CB ' ' NZ ' ' A' ' 122' ' ' LYS . 2.4 ttmp? -56.97 -42.66 80.6 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -90.76 -67.68 0.84 Allowed 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.624 -1.298 . . . . 0.0 108.358 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 113.18 48.09 0.62 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.463 ' O ' ' CB ' ' A' ' 50' ' ' CYS . 14.3 mt -126.55 78.67 72.14 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 120.834 -1.392 . . . . 0.0 109.314 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -95.09 118.17 0.23 Allowed 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 122.274 1.983 . . . . 0.0 113.212 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.916 ' H ' ' N ' ' A' ' 50' ' ' CYS . 93.7 m -93.8 136.07 34.46 Favored 'General case' 0 C--N 1.286 -2.174 0 O-C-N 120.668 -1.27 . . . . 0.0 109.039 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.669 ' CB ' ' H ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -175.48 146.78 0.81 Allowed 'General case' 0 C--N 1.289 -2.038 0 CA-C-O 122.213 1.006 . . . . 0.0 108.943 -178.202 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.28 -2.414 0 O-C-N 120.794 -1.191 . . . . 0.0 110.019 -178.399 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 122.158 0.98 . . . . 0.0 109.175 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -82.14 9.6 8.31 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-O 121.97 0.89 . . . . 0.0 109.172 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.539 ' O ' ' CB ' ' A' ' 14' ' ' SER . 71.5 mm-40 -62.71 -147.99 0.0 OUTLIER 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 122.247 1.022 . . . . 0.0 109.696 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.539 ' CB ' ' O ' ' A' ' 13' ' ' GLU . 1.8 p 81.39 142.79 0.07 Allowed 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 -125.05 125.65 44.15 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.132 0.967 . . . . 0.0 109.715 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.5 t -143.11 149.0 47.28 Favored Pre-proline 0 C--N 1.29 -1.98 0 O-C-N 121.287 -0.883 . . . . 0.0 108.911 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -90.78 161.91 4.13 Favored 'Trans proline' 0 C--N 1.298 -2.104 0 C-N-CA 121.885 1.723 . . . . 0.0 111.399 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.0 t -161.23 152.55 18.88 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 122.107 0.956 . . . . 0.0 109.721 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 89.0 p -108.5 144.47 36.11 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 122.694 1.235 . . . . 0.0 109.65 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.683 ' CG2' ' N ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -144.76 177.76 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 O-C-N 120.993 -1.067 . . . . 0.0 109.4 -178.495 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.683 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 71.7 m -119.55 151.82 38.0 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.47 -1.394 . . . . 0.0 109.435 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.413 ' CG2' ' CB ' ' A' ' 119' ' ' ALA . 6.5 p -47.53 -33.21 2.99 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.793 0 CA-C-O 122.126 0.965 . . . . 0.0 108.695 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.51 ' OG1' ' N ' ' A' ' 24' ' ' VAL . 0.1 OUTLIER -56.26 -56.77 16.87 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 120.728 -1.233 . . . . 0.0 109.12 179.225 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.51 ' N ' ' OG1' ' A' ' 23' ' ' THR . 0.1 OUTLIER -65.42 -34.74 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.131 -1.605 . . . . 0.0 109.377 179.101 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.41 ' CB ' ' CD1' ' A' ' 113' ' ' ILE . . . -50.92 -37.43 44.0 Favored 'General case' 0 C--N 1.287 -2.132 0 O-C-N 120.825 -1.172 . . . . 0.0 108.39 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -59.55 -47.83 84.03 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -60.25 -44.45 95.25 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 120.885 -1.134 . . . . 0.0 108.675 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.6 mt -68.7 -53.16 23.86 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.465 ' CD2' ' C ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -58.71 -43.1 89.98 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.016 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.448 ' C ' ' CD1' ' A' ' 30' ' ' LEU . 1.4 tm? -58.41 -34.71 71.05 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.09 -19.87 62.41 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.712 -1.243 . . . . 0.0 108.391 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.07 49.6 1.88 Allowed Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -107.4 139.39 41.96 Favored 'General case' 0 C--N 1.291 -1.969 0 O-C-N 121.234 -1.156 . . . . 0.0 109.592 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 36.9 mtt-85 -61.82 141.11 58.13 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 122.331 1.062 . . . . 0.0 109.846 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -125.62 118.06 24.87 Favored 'General case' 0 C--N 1.291 -1.96 0 O-C-N 121.38 -0.825 . . . . 0.0 108.968 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 17.6 mt -92.62 108.2 19.8 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 120.616 -1.303 . . . . 0.0 108.604 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.545 ' OD2' ' NE2' ' A' ' 48' ' ' HIS . 41.0 t0 -90.81 122.97 33.99 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -178.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.518 ' CG1' ' O ' ' A' ' 55' ' ' VAL . 20.2 m -134.17 87.81 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 CA-C-O 122.502 1.144 . . . . 0.0 108.125 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.642 HH12 ' CB ' ' A' ' 117' ' ' TYR . 24.5 mtp180 -83.59 -46.08 12.79 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.535 ' OG1' ' C ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER 172.92 165.64 0.27 Allowed Pre-proline 0 N--CA 1.49 1.564 0 C-N-CA 119.296 -0.962 . . . . 0.0 109.925 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -53.33 -35.43 74.7 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.04 1.827 . . . . 0.0 111.085 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -61.0 -30.43 70.28 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.894 -1.128 . . . . 0.0 108.48 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.593 ' O ' ' N ' ' A' ' 47' ' ' GLY . 83.5 tt0 -55.79 -30.63 61.65 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.755 -1.216 . . . . 0.0 108.968 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -72.6 -38.32 67.85 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 122.176 0.989 . . . . 0.0 108.933 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.6 t -51.49 -48.36 62.92 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.175 -0.953 . . . . 0.0 109.167 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -103.73 -20.75 13.85 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.147 -0.97 . . . . 0.0 108.621 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 43' ' ' GLU . . . 82.37 -172.53 52.47 Favored Glycine 0 N--CA 1.5 2.915 0 CA-C-O 122.289 0.938 . . . . 0.0 110.985 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.654 ' H ' ' C ' ' A' ' 129' ' ' ALA . 2.1 t60 176.13 101.71 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.034 0 CA-C-O 122.645 1.212 . . . . 0.0 109.395 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 1.033 ' H ' ' N ' ' A' ' 128' ' ' LYS . . . -160.45 147.7 15.94 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 122.26 1.029 . . . . 0.0 109.388 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.4 t -176.32 44.72 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.264 0 CA-C-O 122.548 1.166 . . . . 0.0 107.869 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 117.85 23.81 3.53 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.509 ' CB ' ' CZ2' ' A' ' 120' ' ' TRP . . . -154.11 179.16 9.19 Favored 'General case' 0 C--N 1.289 -2.045 0 O-C-N 120.861 -1.376 . . . . 0.0 109.639 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 77.1 mt -123.47 147.97 27.62 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 O-C-N 120.832 -1.168 . . . . 0.0 110.3 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -131.55 143.57 50.46 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.954 0.883 . . . . 0.0 109.499 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.686 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 1.1 t -140.62 91.89 9.25 Favored Pre-proline 0 C--N 1.274 -2.717 0 CA-C-O 122.205 1.002 . . . . 0.0 109.089 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.566 ' O ' ' N ' ' A' ' 58' ' ' MET . 36.9 Cg_endo -78.77 66.26 8.66 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.524 2.149 . . . . 0.0 111.806 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 52.39 -85.85 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 122.375 1.083 . . . . 0.0 109.826 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.566 ' N ' ' O ' ' A' ' 56' ' ' PRO . 73.9 mtm -86.79 131.17 34.2 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-O 122.158 0.98 . . . . 0.0 110.051 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.445 ' ND2' ' OG ' ' A' ' 63' ' ' SER . 47.3 t-20 -142.43 116.83 9.61 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.424 ' O ' ' CG ' ' A' ' 60' ' ' ARG . 22.1 ptt180 -111.48 124.75 52.91 Favored 'General case' 0 N--CA 1.504 2.25 0 CA-C-O 122.255 1.026 . . . . 0.0 108.627 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' A' ' 64' ' ' GLY . . . 77.52 -58.36 3.75 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 178.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.43 -28.97 32.83 Favored 'General case' 0 C--N 1.281 -2.41 0 O-C-N 121.161 -1.199 . . . . 0.0 108.254 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.445 ' OG ' ' ND2' ' A' ' 59' ' ' ASN . 2.1 m -97.56 6.35 48.2 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 61' ' ' GLY . . . 85.66 47.47 5.09 Favored Glycine 0 N--CA 1.501 3.0 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 72.7 mtm 56.64 61.19 2.74 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 122.332 1.063 . . . . 0.0 110.31 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.5 m -165.92 94.08 0.56 Allowed 'General case' 0 C--N 1.29 -2.012 0 O-C-N 121.17 -0.956 . . . . 0.0 108.422 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.7 ptpp? -98.13 142.98 29.14 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 122.24 1.019 . . . . 0.0 108.535 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.419 ' O ' ' OG1' ' A' ' 69' ' ' THR . 3.2 m120 -50.64 128.91 21.61 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 122.219 1.009 . . . . 0.0 109.999 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 68' ' ' ASN . 4.7 m -167.01 -29.17 0.02 OUTLIER 'General case' 0 C--N 1.282 -2.363 0 O-C-N 121.507 -0.746 . . . . 0.0 109.943 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.428 ' OD2' ' OE1' ' A' ' 73' ' ' GLU . 16.0 p30 -150.74 68.07 0.95 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.37 -1.456 . . . . 0.0 108.32 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -48.34 -26.56 2.09 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 122.106 0.955 . . . . 0.0 108.85 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 76' ' ' SER . 3.0 mt -54.44 -46.7 73.3 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.916 0.865 . . . . 0.0 108.712 -178.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.432 ' CG ' ' N ' ' A' ' 74' ' ' GLN . 10.9 pt-20 -54.86 -37.75 66.63 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.911 -1.118 . . . . 0.0 108.941 177.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.432 ' N ' ' CG ' ' A' ' 73' ' ' GLU . 23.7 mt-30 -82.52 -48.25 11.24 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.761 -1.212 . . . . 0.0 108.682 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 78' ' ' HIS . 19.8 t -66.84 -44.18 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.783 -1.198 . . . . 0.0 108.74 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.583 ' N ' ' O ' ' A' ' 72' ' ' LEU . 44.6 t -51.68 -36.99 48.67 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.544 ' O ' ' CB ' ' A' ' 78' ' ' HIS . 53.0 p -71.35 1.39 6.3 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.896 -1.127 . . . . 0.0 109.168 178.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.544 ' CB ' ' O ' ' A' ' 77' ' ' SER . 5.1 t-80 78.44 45.14 0.06 Allowed 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.05 -1.032 . . . . 0.0 108.252 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.536 ' CG ' ' O ' ' A' ' 78' ' ' HIS . 65.8 m-85 -162.08 133.06 5.08 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.015 -1.053 . . . . 0.0 109.969 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.564 ' H ' ' HB3' ' A' ' 83' ' ' ASP . . . -114.19 134.78 11.98 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -48.03 -21.19 0.42 Allowed 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.454 -1.027 . . . . 0.0 109.173 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.402 ' N ' ' C ' ' A' ' 80' ' ' GLY . 54.4 m -123.73 15.54 9.44 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.847 -1.158 . . . . 0.0 107.914 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.564 ' HB3' ' H ' ' A' ' 80' ' ' GLY . 12.6 p30 -45.78 109.91 0.22 Allowed 'General case' 0 N--CA 1.507 2.396 0 O-C-N 121.406 -0.809 . . . . 0.0 109.123 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 58.61 64.07 1.54 Allowed 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.973 0.892 . . . . 0.0 109.4 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.542 ' CG2' ' H ' ' A' ' 86' ' ' ILE . 24.1 mt -142.25 176.32 3.95 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 O-C-N 121.025 -1.047 . . . . 0.0 109.408 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.542 ' H ' ' CG2' ' A' ' 85' ' ' ILE . 6.7 mt -121.78 112.57 35.61 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 O-C-N 121.106 -0.997 . . . . 0.0 109.403 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.674 ' O ' ' N ' ' A' ' 113' ' ' ILE . 92.6 t -100.56 -179.68 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 O-C-N 121.281 -0.887 . . . . 0.0 108.919 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.597 ' H ' ' CG1' ' A' ' 87' ' ' VAL . . . -175.09 140.13 5.13 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 46.3 t -110.61 146.69 35.69 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-O 122.07 0.938 . . . . 0.0 109.283 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.526 ' CD ' HH21 ' A' ' 39' ' ' ARG . 7.8 tt0 -42.57 -70.69 0.1 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.022 0.915 . . . . 0.0 110.464 -178.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.1 t -72.13 160.22 32.82 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 122.238 1.018 . . . . 0.0 109.453 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 94' ' ' ARG . . . -132.25 174.72 20.19 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 61.67 -76.32 0.02 OUTLIER Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.53 ' N ' ' O ' ' A' ' 92' ' ' GLY . 1.1 ttt-85 -65.93 -37.19 85.42 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.216 -1.167 . . . . 0.0 108.778 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.2 t -87.65 -27.6 22.36 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 121.188 -0.945 . . . . 0.0 109.254 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.585 ' CG2' ' N ' ' A' ' 97' ' ' LYS . 2.6 tt -59.07 -48.82 85.47 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 O-C-N 121.084 -1.01 . . . . 0.0 108.879 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.585 ' N ' ' CG2' ' A' ' 96' ' ' ILE . 17.1 pttp -63.99 -35.67 81.47 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.697 -1.252 . . . . 0.0 108.449 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.97 -43.05 79.91 Favored 'General case' 0 C--N 1.288 -2.074 0 O-C-N 120.534 -1.354 . . . . 0.0 109.206 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.458 ' O ' ' N ' ' A' ' 103' ' ' LEU . 30.5 p -77.95 -50.58 11.9 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-O 122.573 1.177 . . . . 0.0 108.697 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.535 ' O ' ' N ' ' A' ' 104' ' ' HIS . 60.3 m -53.91 -49.4 68.7 Favored 'General case' 0 C--N 1.288 -2.102 0 O-C-N 121.012 -1.055 . . . . 0.0 109.033 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -61.94 -46.14 90.63 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.627 -1.296 . . . . 0.0 108.17 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.452 ' CD1' ' C ' ' A' ' 102' ' ' LEU . 2.5 tm? -64.63 -40.79 96.09 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.305 -0.872 . . . . 0.0 108.808 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 107' ' ' PHE . 0.3 OUTLIER -75.19 -30.55 60.69 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.122 -0.986 . . . . 0.0 108.966 178.358 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.535 ' N ' ' O ' ' A' ' 100' ' ' THR . 84.0 t60 -53.39 -34.71 58.77 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.597 -1.315 . . . . 0.0 108.606 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -131.23 35.56 3.89 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 120.573 -1.329 . . . . 0.0 108.301 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -148.13 -37.23 0.04 OUTLIER Glycine 0 N--CA 1.495 2.586 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.478 ' O ' ' O ' ' A' ' 103' ' ' LEU . 66.5 m-85 -134.83 164.18 28.13 Favored 'General case' 0 C--N 1.288 -2.078 0 O-C-N 121.235 -1.156 . . . . 0.0 109.414 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.437 ' HG1' ' N ' ' A' ' 109' ' ' GLY . 9.3 t -176.27 151.03 0.97 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.538 -1.351 . . . . 0.0 110.126 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.437 ' N ' ' HG1' ' A' ' 108' ' ' THR . . . 89.65 21.97 38.39 Favored Glycine 0 N--CA 1.498 2.814 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.9 m -148.03 155.86 9.59 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 O-C-N 121.064 -1.257 . . . . 0.0 109.932 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.453 ' O ' ' N ' ' A' ' 87' ' ' VAL . 52.8 mttp -98.87 158.81 15.39 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 122.252 1.025 . . . . 0.0 108.726 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.92 125.57 53.79 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.674 ' N ' ' O ' ' A' ' 87' ' ' VAL . 3.7 mt -102.7 152.72 5.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.401 0 O-C-N 121.301 -0.874 . . . . 0.0 110.261 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 44.0 t -97.74 135.83 30.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 O-C-N 120.821 -1.174 . . . . 0.0 109.664 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.13 -145.2 17.55 Favored Glycine 0 C--N 1.285 -2.302 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 160.6 -95.26 0.14 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.642 ' CB ' HH12 ' A' ' 39' ' ' ARG . 66.1 t80 -52.85 -38.33 61.36 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-O 122.084 0.945 . . . . 0.0 109.711 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 29.3 t -57.27 -33.07 67.25 Favored 'General case' 0 C--N 1.291 -1.939 0 O-C-N 121.286 -0.883 . . . . 0.0 109.301 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.413 ' CB ' ' CG2' ' A' ' 22' ' ' VAL . . . -69.81 -52.4 25.45 Favored 'General case' 0 C--N 1.286 -2.171 0 O-C-N 121.103 -0.998 . . . . 0.0 108.873 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . 0.509 ' CZ2' ' CB ' ' A' ' 52' ' ' ALA . 0.6 OUTLIER -61.57 -37.35 83.52 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.886 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.25 -27.86 64.78 Favored 'General case' 0 C--N 1.292 -1.92 0 O-C-N 120.848 -1.157 . . . . 0.0 108.789 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.8 ttmm -56.06 -42.78 77.16 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -85.52 -64.59 1.13 Allowed 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.643 -1.286 . . . . 0.0 108.375 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 137.4 39.1 0.13 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.662 ' O ' ' O ' ' A' ' 126' ' ' PRO . 2.7 mt -102.74 127.95 29.01 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 120.848 -1.383 . . . . 0.0 109.362 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.662 ' O ' ' O ' ' A' ' 125' ' ' LEU . 51.3 Cg_exo -43.57 -154.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 122.269 1.979 . . . . 0.0 113.2 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.612 ' CG2' ' ND1' ' A' ' 48' ' ' HIS . 0.0 OUTLIER 178.14 109.45 0.03 OUTLIER 'General case' 0 C--N 1.286 -2.163 0 O-C-N 120.778 -1.201 . . . . 0.0 109.001 -178.386 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 1.033 ' N ' ' H ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -138.16 168.41 19.79 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-O 122.204 1.002 . . . . 0.0 108.966 -178.417 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.654 ' C ' ' H ' ' A' ' 48' ' ' HIS . . . . . . . . 0 C--N 1.281 -2.395 0 O-C-N 120.789 -1.194 . . . . 0.0 110.073 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 122.112 0.958 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 61.07 24.58 14.67 Favored 'General case' 0 C--N 1.282 -2.362 0 CA-C-O 122.054 0.931 . . . . 0.0 109.222 178.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.564 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.7 OUTLIER -84.12 25.79 0.8 Allowed 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 122.299 1.047 . . . . 0.0 109.714 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.564 ' CB ' ' O ' ' A' ' 13' ' ' GLU . 0.9 OUTLIER 83.1 172.69 0.09 Allowed 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.679 ' HE ' ' ND2' ' A' ' 84' ' ' ASN . 4.5 mpt_? -111.68 102.59 10.89 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 122.211 1.005 . . . . 0.0 109.754 -179.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -131.44 173.96 5.26 Favored Pre-proline 0 C--N 1.291 -1.949 0 O-C-N 121.277 -0.89 . . . . 0.0 108.872 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -88.91 78.64 1.09 Allowed 'Trans proline' 0 C--N 1.297 -2.16 0 C-N-CA 121.831 1.687 . . . . 0.0 111.42 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 112' ' ' ASP . 33.0 t -75.19 144.52 42.65 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 122.029 0.918 . . . . 0.0 109.705 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 82.7 p -100.36 151.51 21.42 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 122.703 1.239 . . . . 0.0 109.63 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.663 ' CG2' ' N ' ' A' ' 21' ' ' SER . 0.1 OUTLIER -150.6 173.92 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 O-C-N 121.002 -1.061 . . . . 0.0 109.431 -178.653 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.663 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 1.5 m -108.82 166.12 11.05 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.516 -1.365 . . . . 0.0 109.46 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.1 t -62.86 -29.98 48.42 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.808 0 CA-C-O 122.106 0.955 . . . . 0.0 108.707 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.429 ' CG2' ' N ' ' A' ' 24' ' ' VAL . 6.5 t -55.38 -47.78 75.3 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 120.82 -1.175 . . . . 0.0 109.106 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.429 ' N ' ' CG2' ' A' ' 23' ' ' THR . 1.4 t -69.68 -39.74 78.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.157 -1.589 . . . . 0.0 109.42 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 29' ' ' LEU . . . -51.3 -36.27 41.72 Favored 'General case' 0 C--N 1.288 -2.103 0 O-C-N 120.804 -1.185 . . . . 0.0 108.39 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -60.29 -48.63 80.93 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -59.81 -36.15 76.18 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 120.878 -1.139 . . . . 0.0 108.699 178.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.2 mt -80.86 -25.03 37.96 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 25' ' ' ALA . 8.9 tt -62.22 -43.38 98.95 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.48 ' C ' ' CD1' ' A' ' 30' ' ' LEU . 3.4 pp -80.21 -14.39 58.48 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.509 -1.369 . . . . 0.0 107.477 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.27 -27.67 67.39 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.736 -1.228 . . . . 0.0 108.398 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.24 47.68 6.0 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.526 ' O ' ' CZ ' ' A' ' 35' ' ' TYR . 14.1 m-70 -115.37 163.61 15.47 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.204 -1.174 . . . . 0.0 109.589 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.549 HH12 ' CD1' ' A' ' 53' ' ' ILE . 20.0 mmm180 -59.8 132.04 52.75 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 122.359 1.076 . . . . 0.0 109.793 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.526 ' CZ ' ' O ' ' A' ' 33' ' ' HIS . 21.6 m-85 -118.2 108.14 14.8 Favored 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.314 -0.866 . . . . 0.0 108.95 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.582 ' CD1' ' N ' ' A' ' 37' ' ' ASP . 0.1 OUTLIER -102.35 133.16 47.73 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 120.582 -1.324 . . . . 0.0 108.587 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.582 ' N ' ' CD1' ' A' ' 36' ' ' LEU . 22.1 t70 -147.75 111.39 5.01 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 -178.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -83.1 103.97 11.09 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 O-C-N 120.959 -1.088 . . . . 0.0 108.093 177.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.665 ' NH2' HE22 ' A' ' 46' ' ' GLN . 25.7 ttp180 -84.34 -43.45 14.74 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.481 ' OG1' ' C ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -179.01 170.39 0.73 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.182 -0.949 . . . . 0.0 109.95 -179.026 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 40' ' ' THR . 24.7 Cg_exo -55.47 -145.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 121.92 1.746 . . . . 0.0 111.125 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.527 ' OE1' ' NH2' ' A' ' 60' ' ' ARG . 22.2 pt-20 -58.28 -23.44 56.24 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.85 -1.156 . . . . 0.0 108.543 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.473 ' O ' ' OE1' ' A' ' 46' ' ' GLN . 96.7 mt-10 -50.66 -30.0 12.52 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.802 -1.186 . . . . 0.0 108.997 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.662 ' CD1' ' N ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -78.06 -32.22 50.73 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 122.217 1.008 . . . . 0.0 108.91 177.446 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.662 ' N ' ' CD1' ' A' ' 44' ' ' PHE . 16.0 t -49.01 -19.1 0.36 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.153 -0.967 . . . . 0.0 109.052 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.665 HE22 ' NH2' ' A' ' 39' ' ' ARG . 0.4 OUTLIER -69.8 -9.57 55.14 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.089 -1.007 . . . . 0.0 108.619 179.46 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.515 ' O ' ' O ' ' A' ' 44' ' ' PHE . . . 161.78 -164.76 35.41 Favored Glycine 0 N--CA 1.499 2.875 0 CA-C-O 122.245 0.914 . . . . 0.0 111.051 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.635 ' O ' ' O ' ' A' ' 49' ' ' ALA . 3.9 p80 -176.0 106.01 0.08 Allowed 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 122.732 1.254 . . . . 0.0 109.38 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.635 ' O ' ' O ' ' A' ' 48' ' ' HIS . . . -30.87 157.44 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 122.159 0.981 . . . . 0.0 109.421 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.819 ' H ' ' H ' ' A' ' 127' ' ' THR . 0.5 OUTLIER -93.53 162.17 14.07 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.648 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.694 ' N ' ' SG ' ' A' ' 50' ' ' CYS . . . 105.79 -8.13 42.66 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -170.46 157.78 6.13 Favored 'General case' 0 C--N 1.29 -2.009 0 O-C-N 120.784 -1.421 . . . . 0.0 109.615 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.549 ' CD1' HH12 ' A' ' 34' ' ' ARG . 38.6 mt -99.6 134.83 37.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 O-C-N 120.762 -1.211 . . . . 0.0 110.262 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.477 ' ND2' ' OD2' ' A' ' 37' ' ' ASP . 6.7 m120 -113.3 134.2 54.73 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 121.937 0.875 . . . . 0.0 109.472 -178.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.588 ' O ' ' CG1' ' A' ' 55' ' ' VAL . 1.1 t -142.6 95.77 6.37 Favored Pre-proline 0 C--N 1.273 -2.754 0 CA-C-O 122.221 1.01 . . . . 0.0 109.133 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.527 ' C ' ' H ' ' A' ' 58' ' ' MET . 28.3 Cg_endo -77.94 54.37 4.83 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.5 2.134 . . . . 0.0 111.693 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.518 ' CE1' ' NE2' ' A' ' 81' ' ' GLN . 61.8 m-85 50.37 12.08 0.09 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 122.31 1.052 . . . . 0.0 109.848 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.527 ' H ' ' C ' ' A' ' 56' ' ' PRO . 77.8 mtm -151.09 147.16 26.74 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-O 122.137 0.97 . . . . 0.0 110.072 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.416 ' OD1' ' O ' ' A' ' 58' ' ' MET . 79.5 m-20 -146.52 98.58 3.09 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.527 ' NH2' ' OE1' ' A' ' 42' ' ' GLU . 28.4 ttp180 -116.62 137.31 52.28 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.034 -1.042 . . . . 0.0 108.594 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.536 ' C ' ' H ' ' A' ' 63' ' ' SER . . . -174.33 -165.88 31.52 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.23 1.89 1.89 Allowed 'General case' 0 C--N 1.28 -2.419 0 O-C-N 121.191 -1.182 . . . . 0.0 108.338 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.536 ' H ' ' C ' ' A' ' 61' ' ' GLY . 48.3 t -62.45 -11.4 15.77 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 111.15 25.67 4.95 Favored Glycine 0 N--CA 1.5 2.956 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 92.8 mtp 50.84 101.1 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 122.337 1.065 . . . . 0.0 110.326 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.7 m -165.83 93.06 0.54 Allowed 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.4 ptpp? -103.58 144.94 30.77 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.077 -1.014 . . . . 0.0 108.572 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -45.08 132.97 6.85 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 122.244 1.021 . . . . 0.0 110.037 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.0 m -146.57 155.62 42.63 Favored 'General case' 0 C--N 1.282 -2.367 0 O-C-N 121.437 -0.79 . . . . 0.0 109.869 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 52.34 47.76 24.04 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.309 -1.494 . . . . 0.0 108.306 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -48.24 -25.49 1.55 Allowed 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 122.127 0.965 . . . . 0.0 108.8 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 76' ' ' SER . 0.5 OUTLIER -50.79 -45.96 59.43 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.026 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -55.81 -35.99 66.93 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.94 -1.1 . . . . 0.0 108.889 176.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.431 ' O ' ' OG ' ' A' ' 77' ' ' SER . 73.3 mm-40 -83.03 -47.91 11.19 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.83 -1.169 . . . . 0.0 108.703 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.418 ' O ' ' N ' ' A' ' 78' ' ' HIS . 25.8 t -67.45 -47.06 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.835 -1.165 . . . . 0.0 108.717 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 72' ' ' LEU . 30.7 t -52.78 -33.12 47.29 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.546 ' O ' ' CB ' ' A' ' 78' ' ' HIS . 43.9 p -72.35 -0.05 11.34 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.956 -1.09 . . . . 0.0 109.116 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.546 ' CB ' ' O ' ' A' ' 77' ' ' SER . 4.0 t-80 77.18 57.26 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.526 ' CG ' ' O ' ' A' ' 78' ' ' HIS . 47.2 m-85 -163.53 139.05 6.5 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.921 -1.112 . . . . 0.0 110.035 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.488 ' H ' ' HB2' ' A' ' 83' ' ' ASP . . . -112.26 137.79 14.51 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.518 ' NE2' ' CE1' ' A' ' 57' ' ' TYR . 10.5 pt20 -45.71 -19.56 0.06 Allowed 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.491 -1.005 . . . . 0.0 109.17 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 80' ' ' GLY . 16.3 m -122.84 20.92 10.04 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.793 -1.192 . . . . 0.0 107.969 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.488 ' HB2' ' H ' ' A' ' 80' ' ' GLY . 42.2 t0 -42.42 113.8 0.49 Allowed 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.408 -0.808 . . . . 0.0 109.11 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.679 ' ND2' ' HE ' ' A' ' 15' ' ' ARG . 5.4 m120 59.6 63.36 1.53 Allowed 'General case' 0 C--N 1.291 -1.936 0 O-C-N 121.308 -0.87 . . . . 0.0 109.451 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.579 ' CG2' ' N ' ' A' ' 86' ' ' ILE . 17.8 mt -145.93 176.66 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 O-C-N 121.076 -1.015 . . . . 0.0 109.421 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.579 ' N ' ' CG2' ' A' ' 85' ' ' ILE . 64.1 mt -111.01 112.43 40.55 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 O-C-N 121.078 -1.014 . . . . 0.0 109.422 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.607 ' N ' ' O ' ' A' ' 111' ' ' LYS . 60.4 t -110.94 175.0 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 O-C-N 121.261 -0.899 . . . . 0.0 108.887 -176.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.459 ' H ' ' CG1' ' A' ' 87' ' ' VAL . . . -172.02 175.63 45.28 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 19.7 t -128.46 120.31 26.61 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 122.029 0.919 . . . . 0.0 109.319 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.439 ' O ' ' OE1' ' A' ' 90' ' ' GLN . 1.0 OUTLIER -65.63 -38.63 89.95 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.039 0.923 . . . . 0.0 110.422 -178.492 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 92' ' ' GLY . 4.1 m -61.52 160.98 10.26 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 122.171 0.986 . . . . 0.0 109.473 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 91' ' ' SER . . . -43.17 161.95 0.05 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -54.83 -28.06 46.02 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -55.05 -28.32 51.38 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.221 -1.164 . . . . 0.0 108.72 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 43.7 t -85.24 -32.44 22.6 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.15 -0.969 . . . . 0.0 109.237 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.432 ' O ' ' CD1' ' A' ' 96' ' ' ILE . 0.3 OUTLIER -60.3 -30.56 46.42 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 O-C-N 121.03 -1.044 . . . . 0.0 108.881 -179.289 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.1 mtpp -62.56 -47.68 82.78 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.707 -1.246 . . . . 0.0 108.402 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.34 -50.09 72.49 Favored 'General case' 0 C--N 1.289 -2.029 0 O-C-N 120.557 -1.339 . . . . 0.0 109.266 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.483 ' O ' ' CD1' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -57.86 -47.84 81.55 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-O 122.525 1.155 . . . . 0.0 108.705 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 57.9 m -56.39 -48.81 76.13 Favored 'General case' 0 C--N 1.287 -2.134 0 O-C-N 120.943 -1.098 . . . . 0.0 108.989 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -65.43 -40.34 93.2 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.654 -1.279 . . . . 0.0 108.153 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.7 tt -68.48 -40.54 80.94 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.968 0.89 . . . . 0.0 108.818 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.59 ' HA ' ' H ' ' A' ' 107' ' ' PHE . 10.8 mp -69.86 -28.93 66.07 Favored 'General case' 0 C--N 1.292 -1.914 0 O-C-N 121.088 -1.007 . . . . 0.0 109.017 178.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -64.02 -32.54 74.12 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.519 -1.363 . . . . 0.0 108.527 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -130.93 37.2 3.8 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.623 -1.298 . . . . 0.0 108.393 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -151.34 -67.64 0.01 OUTLIER Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.59 ' H ' ' HA ' ' A' ' 103' ' ' LEU . 96.7 m-85 -138.48 156.24 47.71 Favored 'General case' 0 C--N 1.289 -2.048 0 O-C-N 121.175 -1.191 . . . . 0.0 109.38 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.705 ' HG1' ' H ' ' A' ' 109' ' ' GLY . 11.0 t -166.42 -161.93 0.49 Allowed 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.667 -1.271 . . . . 0.0 110.104 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.705 ' H ' ' HG1' ' A' ' 108' ' ' THR . . . 79.05 21.13 68.6 Favored Glycine 0 N--CA 1.499 2.836 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.489 ' CG2' ' CG2' ' A' ' 87' ' ' VAL . 1.7 m -142.29 167.93 14.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 O-C-N 121.07 -1.253 . . . . 0.0 109.874 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.607 ' O ' ' N ' ' A' ' 87' ' ' VAL . 85.6 mttt -97.88 148.94 22.92 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 122.198 0.999 . . . . 0.0 108.739 -179.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -111.74 108.08 17.38 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -178.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.504 ' CD1' ' CB ' ' A' ' 25' ' ' ALA . 69.7 mt -83.08 125.1 40.04 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 O-C-N 121.265 -0.897 . . . . 0.0 110.261 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.427 ' N ' ' O ' ' A' ' 20' ' ' VAL . 67.2 t -100.78 138.22 25.75 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 O-C-N 120.825 -1.172 . . . . 0.0 109.63 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 167.67 -147.48 11.72 Favored Glycine 0 C--N 1.285 -2.268 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -154.22 -176.99 27.17 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -59.06 -33.02 70.3 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-O 122.011 0.91 . . . . 0.0 109.647 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 32.1 t -56.47 -32.26 64.8 Favored 'General case' 0 C--N 1.292 -1.905 0 O-C-N 121.332 -0.855 . . . . 0.0 109.331 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.21 -40.91 97.66 Favored 'General case' 0 C--N 1.286 -2.159 0 O-C-N 121.185 -0.947 . . . . 0.0 108.892 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -60.34 -33.77 72.88 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.84 -37.63 71.53 Favored 'General case' 0 C--N 1.292 -1.911 0 O-C-N 120.795 -1.19 . . . . 0.0 108.812 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -56.44 -39.19 72.71 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -63.36 -65.29 0.71 Allowed 'General case' 0 N--CA 1.503 2.184 0 O-C-N 120.649 -1.282 . . . . 0.0 108.371 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.06 16.53 35.19 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 50' ' ' CYS . 12.6 mt -126.83 71.98 74.9 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 120.827 -1.396 . . . . 0.0 109.369 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.45 ' CB ' ' HZ3' ' A' ' 128' ' ' LYS . 32.9 Cg_endo -96.54 115.86 0.14 Allowed 'Trans proline' 0 C--N 1.302 -1.911 0 C-N-CA 122.29 1.993 . . . . 0.0 113.16 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.819 ' H ' ' H ' ' A' ' 50' ' ' CYS . 82.0 p -125.08 130.39 52.16 Favored 'General case' 0 C--N 1.287 -2.151 0 O-C-N 120.743 -1.223 . . . . 0.0 109.027 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.45 ' HZ3' ' CB ' ' A' ' 126' ' ' PRO . 0.0 OUTLIER -179.63 141.02 0.15 Allowed 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 122.126 0.965 . . . . 0.0 108.953 -179.121 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.438 ' H ' ' HA3' ' A' ' 47' ' ' GLY . . . . . . . . 0 C--N 1.281 -2.401 0 O-C-N 120.859 -1.151 . . . . 0.0 110.086 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 . . . . . 0 N--CA 1.5 2.033 0 CA-C-O 122.16 0.981 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.625 ' H ' ' N ' ' A' ' 109' ' ' GLY . 9.0 t -146.85 101.75 3.92 Favored Pre-proline 0 C--N 1.291 -1.958 0 O-C-N 121.267 -0.896 . . . . 0.0 108.942 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -88.69 124.72 1.61 Allowed 'Trans proline' 0 C--N 1.297 -2.14 0 C-N-CA 121.875 1.716 . . . . 0.0 111.431 177.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.5 p -138.17 152.2 48.45 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 122.021 0.915 . . . . 0.0 109.681 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.534 ' C ' HG12 ' A' ' 20' ' ' VAL . 39.6 m -115.96 144.55 43.92 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 122.675 1.226 . . . . 0.0 109.627 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.761 HG23 ' N ' ' A' ' 21' ' ' SER . 0.7 OUTLIER -158.81 -179.04 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.196 0 O-C-N 121.025 -1.047 . . . . 0.0 109.402 -178.701 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.761 ' N ' HG23 ' A' ' 20' ' ' VAL . 14.3 p -115.58 148.19 39.87 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.48 -1.387 . . . . 0.0 109.395 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.6 p -47.32 -21.24 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.768 0 CA-C-O 122.102 0.953 . . . . 0.0 108.648 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.597 HG23 ' HB2' ' A' ' 21' ' ' SER . 0.1 OUTLIER -64.39 -55.7 19.32 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 120.736 -1.227 . . . . 0.0 109.177 179.169 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.494 ' N ' ' OG1' ' A' ' 23' ' ' THR . 0.9 OUTLIER -71.15 -40.5 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.175 -1.578 . . . . 0.0 109.4 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.634 ' HB2' HD12 ' A' ' 113' ' ' ILE . . . -57.98 -35.04 70.64 Favored 'General case' 0 C--N 1.286 -2.159 0 O-C-N 120.829 -1.17 . . . . 0.0 108.361 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.612 ' O ' HD13 ' A' ' 30' ' ' LEU . 86.4 t60 -52.99 -46.66 68.42 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -55.33 -43.42 74.94 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 120.907 -1.12 . . . . 0.0 108.666 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.505 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 10.4 mp -70.72 -36.8 73.38 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 19.2 tp -56.91 -39.69 74.92 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.612 HD13 ' O ' ' A' ' 26' ' ' HIS . 11.0 mp -63.43 -25.8 68.44 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 28' ' ' LEU . . . -66.34 -22.42 66.27 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.77 -1.207 . . . . 0.0 108.385 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.95 48.82 3.5 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -107.41 149.58 27.73 Favored 'General case' 0 C--N 1.292 -1.898 0 O-C-N 121.204 -1.174 . . . . 0.0 109.593 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.429 ' NH2' HD11 ' A' ' 85' ' ' ILE . 75.5 mtm180 -58.66 133.68 56.11 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 122.428 1.109 . . . . 0.0 109.827 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.402 ' O ' ' O ' ' A' ' 53' ' ' ILE . 47.3 t80 -112.6 113.61 25.83 Favored 'General case' 0 C--N 1.292 -1.93 0 O-C-N 121.285 -0.884 . . . . 0.0 108.937 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.756 ' HB3' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -98.84 130.57 45.27 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.594 -1.317 . . . . 0.0 108.554 179.213 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.621 ' N ' ' CD1' ' A' ' 36' ' ' LEU . 48.2 t0 -138.61 142.5 39.13 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.988 HG21 ' CZ ' ' A' ' 57' ' ' TYR . 4.5 m -131.04 96.11 2.59 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 CA-C-O 122.433 1.111 . . . . 0.0 108.158 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.754 ' O ' ' OG1' ' A' ' 40' ' ' THR . 0.1 OUTLIER -89.65 -45.32 9.43 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.862 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.754 ' OG1' ' O ' ' A' ' 39' ' ' ARG . 3.6 m 177.45 142.32 0.25 Allowed Pre-proline 0 N--CA 1.49 1.573 0 C-N-CA 119.312 -0.955 . . . . 0.0 109.921 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.559 ' HD2' HG23 ' A' ' 40' ' ' THR . 50.8 Cg_exo -40.21 -39.96 2.73 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 121.983 1.788 . . . . 0.0 111.074 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.663 ' H ' HG22 ' A' ' 40' ' ' THR . 96.6 mt-10 -61.0 -30.34 70.23 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.951 -1.093 . . . . 0.0 108.567 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 40' ' ' THR . 66.1 tt0 -55.48 -32.01 62.47 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.75 -1.219 . . . . 0.0 109.014 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -67.99 -44.21 77.15 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 122.174 0.988 . . . . 0.0 108.978 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.1 t -56.13 -29.72 61.1 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.191 -0.943 . . . . 0.0 109.048 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -70.16 -36.92 75.04 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.124 -0.985 . . . . 0.0 108.631 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.06 -148.38 17.11 Favored Glycine 0 N--CA 1.499 2.84 0 CA-C-O 122.267 0.926 . . . . 0.0 110.977 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -100.42 -160.2 0.78 Allowed 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 122.684 1.23 . . . . 0.0 109.411 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.563 ' HB3' ' HB3' ' A' ' 52' ' ' ALA . . . -144.62 166.72 24.38 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 122.178 0.99 . . . . 0.0 109.396 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.584 ' O ' ' NE1' ' A' ' 120' ' ' TRP . 4.7 t -83.63 105.33 14.47 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-O 122.541 1.162 . . . . 0.0 107.89 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.56 26.5 65.27 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.609 ' C ' HD12 ' A' ' 53' ' ' ILE . . . -156.0 123.15 5.37 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 120.784 -1.421 . . . . 0.0 109.595 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.777 ' N ' HD12 ' A' ' 53' ' ' ILE . 2.7 mp -105.14 104.27 16.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 O-C-N 120.709 -1.245 . . . . 0.0 110.247 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -107.94 118.33 36.46 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-O 121.971 0.891 . . . . 0.0 109.449 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.904 ' O ' HG12 ' A' ' 38' ' ' VAL . 2.0 m -142.13 163.34 40.49 Favored Pre-proline 0 C--N 1.274 -2.71 0 CA-C-O 122.171 0.986 . . . . 0.0 109.09 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -84.08 68.2 6.71 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.451 2.101 . . . . 0.0 111.72 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.988 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 66.4 m-85 . . . . . 0 C--N 1.298 -1.646 0 CA-C-O 122.229 1.014 . . . . 0.0 109.789 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.509 ' CZ ' ' OD2' ' A' ' 83' ' ' ASP . 22.7 t80 . . . . . 0 N--CA 1.498 1.964 0 CA-C-O 122.142 0.972 . . . . 0.0 110.018 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.568 ' H ' ' HB3' ' A' ' 83' ' ' ASP . . . -116.55 136.24 12.65 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -46.56 -25.92 0.79 Allowed 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.487 -1.007 . . . . 0.0 109.198 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.796 ' HA ' HD12 ' A' ' 85' ' ' ILE . 0.3 OUTLIER -125.09 23.01 7.83 Favored 'General case' 0 C--N 1.292 -1.906 0 O-C-N 120.809 -1.182 . . . . 0.0 107.97 178.866 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.568 ' HB3' ' H ' ' A' ' 80' ' ' GLY . 9.8 p-10 -35.56 116.33 0.36 Allowed 'General case' 0 N--CA 1.507 2.419 0 CA-C-O 121.762 0.792 . . . . 0.0 109.076 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.576 ' N ' ' O ' ' A' ' 109' ' ' GLY . 28.8 t30 63.0 60.88 1.17 Allowed 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.898 0.856 . . . . 0.0 109.426 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.796 HD12 ' HA ' ' A' ' 82' ' ' SER . 21.5 mt -145.94 175.24 2.28 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 O-C-N 121.063 -1.023 . . . . 0.0 109.41 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.637 ' N ' HG22 ' A' ' 85' ' ' ILE . 28.3 mt -111.26 107.48 23.06 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.294 0 CA-C-O 122.181 0.991 . . . . 0.0 109.407 178.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.756 HG22 ' HB3' ' A' ' 36' ' ' LEU . 38.2 t -109.68 155.11 10.96 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 CA-C-O 121.946 0.879 . . . . 0.0 108.906 -175.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -162.41 138.24 5.27 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 34.7 t -94.58 144.12 25.86 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 122.059 0.933 . . . . 0.0 109.268 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 9.9 tm0? -44.2 -35.9 2.44 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.985 0.897 . . . . 0.0 110.444 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 69.5 m -102.78 158.25 16.39 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 122.141 0.972 . . . . 0.0 109.51 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' A' ' 94' ' ' ARG . . . -123.16 168.26 15.38 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 65.22 -70.74 0.09 OUTLIER Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 92' ' ' GLY . 89.9 mtt180 -62.59 -36.05 81.48 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.214 -1.168 . . . . 0.0 108.766 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.404 ' O ' ' OG1' ' A' ' 99' ' ' THR . 7.0 t -85.5 -24.49 27.32 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.183 -0.948 . . . . 0.0 109.25 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.533 HG22 ' N ' ' A' ' 97' ' ' LYS . 1.0 OUTLIER -58.8 -47.45 89.21 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 O-C-N 121.044 -1.035 . . . . 0.0 108.895 179.871 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.533 ' N ' HG22 ' A' ' 96' ' ' ILE . 49.9 pttt -71.38 -30.87 66.64 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.675 -1.266 . . . . 0.0 108.423 177.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.89 -38.11 89.89 Favored 'General case' 0 C--N 1.289 -2.028 0 O-C-N 120.521 -1.362 . . . . 0.0 109.193 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 95' ' ' SER . 0.0 OUTLIER -63.01 -35.37 79.99 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-O 122.539 1.161 . . . . 0.0 108.679 179.65 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.7 m -57.44 -38.25 74.13 Favored 'General case' 0 C--N 1.288 -2.094 0 O-C-N 120.998 -1.064 . . . . 0.0 109.005 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -61.33 -43.32 99.07 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.644 -1.285 . . . . 0.0 108.087 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.2 mt -70.07 -35.03 73.93 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 122.01 0.91 . . . . 0.0 108.848 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 52.0 tp -56.31 -39.77 73.29 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.062 -1.024 . . . . 0.0 108.966 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 30.0 m170 -61.98 -36.48 81.6 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.551 -1.343 . . . . 0.0 108.57 177.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -76.22 -19.22 58.58 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 120.612 -1.305 . . . . 0.0 108.359 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 120.23 83.39 0.78 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -144.55 62.14 1.33 Allowed 'General case' 0 C--N 1.289 -2.032 0 O-C-N 121.09 -1.241 . . . . 0.0 109.35 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.564 ' OG1' ' N ' ' A' ' 109' ' ' GLY . 0.0 OUTLIER -126.47 179.1 5.47 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.642 -1.287 . . . . 0.0 110.136 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.625 ' N ' ' H ' ' A' ' 16' ' ' VAL . . . 85.76 17.76 61.12 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.563 HG21 ' CG2' ' A' ' 87' ' ' VAL . 1.4 m -147.18 163.06 7.72 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 O-C-N 121.081 -1.247 . . . . 0.0 109.858 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.508 ' N ' HG23 ' A' ' 110' ' ' VAL . 61.1 mttp -98.57 141.98 30.73 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 122.218 1.009 . . . . 0.0 108.694 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.463 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 74.4 m-20 -99.44 108.19 20.59 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.634 HD12 ' HB2' ' A' ' 25' ' ' ALA . 7.4 mm -97.64 155.35 3.67 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 O-C-N 121.241 -0.912 . . . . 0.0 110.218 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.439 HG13 ' HA3' ' A' ' 92' ' ' GLY . 38.0 t -99.12 124.18 52.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 O-C-N 120.783 -1.198 . . . . 0.0 109.638 178.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.17 -145.67 23.39 Favored Glycine 0 C--N 1.286 -2.235 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 135.59 -90.26 0.23 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.503 ' O ' ' N ' ' A' ' 121' ' ' ALA . 79.6 t80 -51.77 -41.63 61.77 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 121.989 0.899 . . . . 0.0 109.659 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 18.5 t -57.57 -45.03 85.67 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-O 121.923 0.868 . . . . 0.0 109.39 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.22 -52.57 12.0 Favored 'General case' 0 C--N 1.287 -2.152 0 O-C-N 121.134 -0.979 . . . . 0.0 108.901 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' TRP . . . . . 0.584 ' NE1' ' O ' ' A' ' 50' ' ' CYS . 4.9 t-105 -57.93 -35.54 71.23 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.165 -1.421 . . . . 0.0 107.165 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 117' ' ' TYR . . . -63.69 -30.93 71.97 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 120.912 -1.118 . . . . 0.0 108.79 178.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.446 ' HB3' ' HZ2' ' A' ' 122' ' ' LYS . 14.4 ttpp -57.45 -36.39 71.36 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -65.86 -65.19 0.71 Allowed 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.645 -1.284 . . . . 0.0 108.354 178.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 105.87 32.89 3.68 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.482 ' O ' ' CB ' ' A' ' 50' ' ' CYS . 18.6 mt -126.43 79.75 70.32 Favored Pre-proline 0 C--N 1.296 -1.736 0 O-C-N 120.933 -1.334 . . . . 0.0 109.376 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.404 ' HA ' ' H ' ' A' ' 50' ' ' CYS . 30.9 Cg_endo . . . . . 0 C--N 1.301 -1.937 0 C-N-CA 122.255 1.97 . . . . 0.0 113.229 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.5 2.045 0 CA-C-O 122.142 0.972 . . . . 0.0 109.781 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.541 HG12 ' HD3' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -142.74 177.3 1.9 Allowed Pre-proline 0 C--N 1.291 -1.976 0 O-C-N 121.347 -0.845 . . . . 0.0 108.92 -179.161 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.541 ' HD3' HG12 ' A' ' 16' ' ' VAL . 29.6 Cg_endo -86.69 135.35 4.13 Favored 'Trans proline' 0 C--N 1.296 -2.194 0 C-N-CA 121.849 1.699 . . . . 0.0 111.426 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 112' ' ' ASP . 32.8 t -140.56 138.99 34.9 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.111 0.958 . . . . 0.0 109.704 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.42 ' OG ' HD11 ' A' ' 96' ' ' ILE . 18.1 t -99.02 143.91 28.77 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-O 122.742 1.258 . . . . 0.0 109.566 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.831 HG13 ' O ' ' A' ' 112' ' ' ASP . 0.2 OUTLIER -148.7 178.9 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 O-C-N 121.013 -1.055 . . . . 0.0 109.41 -178.733 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.713 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 62.6 m -119.14 151.34 38.48 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.499 -1.376 . . . . 0.0 109.415 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.458 HG21 ' HA2' ' A' ' 116' ' ' GLY . 12.5 p -48.62 -27.1 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.273 -2.738 0 CA-C-O 122.159 0.981 . . . . 0.0 108.739 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.509 ' OG1' ' N ' ' A' ' 24' ' ' VAL . 0.1 OUTLIER -65.1 -58.2 6.66 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 120.725 -1.234 . . . . 0.0 109.112 179.853 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.509 ' N ' ' OG1' ' A' ' 23' ' ' THR . 0.0 OUTLIER -60.31 -35.1 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.158 -1.589 . . . . 0.0 109.436 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.54 ' HB2' HD12 ' A' ' 113' ' ' ILE . . . -51.11 -37.3 45.13 Favored 'General case' 0 C--N 1.287 -2.144 0 O-C-N 120.799 -1.188 . . . . 0.0 108.394 178.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -57.66 -44.09 85.43 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -59.9 -43.61 94.72 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 120.904 -1.122 . . . . 0.0 108.697 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.5 ' N ' HD12 ' A' ' 28' ' ' LEU . 9.1 mp -66.46 -33.55 75.94 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.504 ' O ' HD13 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -53.54 -40.44 65.52 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.733 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.429 ' N ' HD12 ' A' ' 30' ' ' LEU . 9.4 mp -63.99 -31.11 72.19 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 120.568 -1.333 . . . . 0.0 107.421 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 28' ' ' LEU . . . -66.9 -28.77 68.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.634 -1.292 . . . . 0.0 108.362 179.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.31 47.28 8.32 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -96.53 156.45 16.34 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 121.148 -1.207 . . . . 0.0 109.621 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -59.17 144.69 45.13 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 122.365 1.079 . . . . 0.0 109.768 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.707 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 1.4 t80 -123.85 112.16 16.95 Favored 'General case' 0 C--N 1.291 -1.964 0 O-C-N 121.381 -0.824 . . . . 0.0 108.973 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.657 ' O ' HG13 ' A' ' 87' ' ' VAL . 8.0 tt -122.16 101.22 7.4 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.649 -1.282 . . . . 0.0 108.529 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.501 ' OD2' ' NH2' ' A' ' 39' ' ' ARG . 80.6 m-20 -98.89 157.3 16.4 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -176.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 38' ' ' VAL . 6.0 m -133.76 89.05 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 CA-C-O 122.396 1.093 . . . . 0.0 108.064 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.779 ' O ' HG23 ' A' ' 40' ' ' THR . 0.0 OUTLIER -81.71 -45.3 15.89 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -179.394 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.779 HG23 ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER 171.58 163.8 0.24 Allowed Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.138 -0.976 . . . . 0.0 109.965 -179.41 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -66.09 -12.97 37.74 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 121.993 1.795 . . . . 0.0 111.125 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -72.81 -37.75 67.42 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.979 -1.076 . . . . 0.0 108.478 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.444 ' OE2' ' O ' ' A' ' 54' ' ' ASN . 2.0 pp20? -58.49 -28.68 65.61 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.726 -1.233 . . . . 0.0 109.04 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -74.08 -42.39 60.22 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 122.148 0.975 . . . . 0.0 108.977 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.9 t -54.83 -37.87 66.7 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.265 -0.897 . . . . 0.0 109.117 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -82.58 -37.27 25.3 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.158 -0.964 . . . . 0.0 108.714 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 43' ' ' GLU . . . 137.93 -139.57 10.49 Favored Glycine 0 N--CA 1.499 2.879 0 CA-C-O 122.298 0.943 . . . . 0.0 110.988 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -101.58 -161.73 0.88 Allowed 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 122.683 1.23 . . . . 0.0 109.396 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.944 ' HB1' ' CZ2' ' A' ' 120' ' ' TRP . . . -146.79 159.94 42.88 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 122.234 1.016 . . . . 0.0 109.374 -178.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.522 ' HB3' ' O ' ' A' ' 125' ' ' LEU . 4.6 t -82.53 162.55 21.96 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-O 122.559 1.171 . . . . 0.0 107.863 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.57 -51.39 4.14 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.707 ' HB1' ' HB3' ' A' ' 35' ' ' TYR . . . -157.23 175.37 14.13 Favored 'General case' 0 C--N 1.29 -1.999 0 O-C-N 120.798 -1.413 . . . . 0.0 109.63 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 73.2 mt -101.41 139.11 23.44 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 O-C-N 120.786 -1.196 . . . . 0.0 110.266 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.444 ' O ' ' OE2' ' A' ' 43' ' ' GLU . 43.5 p-10 -131.44 130.79 42.96 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.982 0.896 . . . . 0.0 109.444 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.557 HG12 ' HD2' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -142.99 165.37 26.54 Favored Pre-proline 0 C--N 1.273 -2.719 0 CA-C-O 122.191 0.996 . . . . 0.0 109.146 179.82 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.557 ' HD2' HG12 ' A' ' 55' ' ' VAL . 35.7 Cg_endo -76.88 26.45 0.44 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.468 2.112 . . . . 0.0 111.736 -177.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.542 ' CZ ' ' NE2' ' A' ' 81' ' ' GLN . 90.7 t80 . . . . . 0 C--N 1.299 -1.61 0 CA-C-O 122.266 1.032 . . . . 0.0 109.887 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 . . . . . 0 N--CA 1.5 2.026 0 CA-C-O 122.205 1.002 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.589 ' H ' ' HB2' ' A' ' 83' ' ' ASP . . . -109.58 138.14 14.64 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.542 ' NE2' ' CZ ' ' A' ' 57' ' ' TYR . 4.6 pt20 -45.6 -18.27 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.425 -1.044 . . . . 0.0 109.242 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.845 ' HA ' HD12 ' A' ' 85' ' ' ILE . 19.2 t -123.16 17.57 9.94 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 120.838 -1.164 . . . . 0.0 107.992 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.589 ' HB2' ' H ' ' A' ' 80' ' ' GLY . 11.9 t70 -40.46 107.46 0.07 Allowed 'General case' 0 N--CA 1.508 2.441 0 O-C-N 121.421 -0.799 . . . . 0.0 109.077 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 53.78 70.03 0.65 Allowed 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 121.97 0.89 . . . . 0.0 109.47 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.845 HD12 ' HA ' ' A' ' 82' ' ' SER . 17.7 mt -143.1 168.84 12.71 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 O-C-N 121.021 -1.05 . . . . 0.0 109.402 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.706 HG22 HG13 ' A' ' 113' ' ' ILE . 49.0 mt -110.44 109.66 29.3 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.231 0 CA-C-O 122.188 0.994 . . . . 0.0 109.473 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.657 HG13 ' O ' ' A' ' 36' ' ' LEU . 18.6 t -112.44 166.75 6.26 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 O-C-N 121.219 -0.926 . . . . 0.0 108.898 -177.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.407 ' HA2' ' H ' ' A' ' 113' ' ' ILE . . . -148.97 141.72 9.22 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.502 ' O ' ' C ' ' A' ' 90' ' ' GLN . 0.4 OUTLIER -90.46 140.43 29.73 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 122.127 0.965 . . . . 0.0 109.23 -179.345 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.537 ' H ' ' CD ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -33.46 -89.88 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.992 0.901 . . . . 0.0 110.486 -178.691 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.7 p -149.64 160.36 43.57 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 122.197 0.998 . . . . 0.0 109.521 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.94 119.36 4.31 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.998 ' O ' HG22 ' A' ' 96' ' ' ILE . . . -57.43 -37.81 83.81 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.101 -1.599 . . . . 0.0 109.101 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 34.4 mtp180 -62.7 -28.1 69.71 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.317 -1.108 . . . . 0.0 108.807 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.8 m -62.3 -39.48 93.12 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.189 -0.944 . . . . 0.0 109.325 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.998 HG22 ' O ' ' A' ' 93' ' ' GLY . 15.7 tt -63.73 -30.9 51.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 O-C-N 121.023 -1.048 . . . . 0.0 108.917 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.0 mtpt -70.85 -45.31 64.7 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.706 -1.246 . . . . 0.0 108.411 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.0 -33.24 68.71 Favored 'General case' 0 C--N 1.289 -2.041 0 O-C-N 120.578 -1.326 . . . . 0.0 109.207 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.88 -57.84 2.88 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-O 122.546 1.165 . . . . 0.0 108.737 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 56.4 m -50.42 -43.44 54.88 Favored 'General case' 0 C--N 1.288 -2.093 0 O-C-N 121.039 -1.038 . . . . 0.0 108.984 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -68.41 -45.91 71.37 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.674 -1.266 . . . . 0.0 108.06 178.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.678 HD13 ' C ' ' A' ' 102' ' ' LEU . 3.0 tm? -65.6 -42.87 91.14 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.944 0.878 . . . . 0.0 108.859 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.3 mp -62.96 -36.84 84.8 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 121.088 -1.007 . . . . 0.0 108.915 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -66.62 -17.76 65.01 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.55 -1.344 . . . . 0.0 108.576 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 102' ' ' LEU . . . -62.06 -19.56 63.05 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 120.643 -1.285 . . . . 0.0 108.361 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 135.46 42.18 0.12 Allowed Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -153.35 32.47 0.47 Allowed 'General case' 0 C--N 1.289 -2.063 0 O-C-N 121.079 -1.248 . . . . 0.0 109.391 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.576 ' OG1' ' N ' ' A' ' 109' ' ' GLY . 4.8 t -87.01 -136.73 0.09 Allowed 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.647 -1.283 . . . . 0.0 110.085 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.576 ' N ' ' OG1' ' A' ' 108' ' ' THR . . . 80.08 23.06 62.08 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.61 HG11 ' HB3' ' A' ' 82' ' ' SER . 1.8 m -143.63 165.67 14.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 O-C-N 121.021 -1.282 . . . . 0.0 109.901 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.519 ' N ' HG23 ' A' ' 110' ' ' VAL . 63.0 mttm -99.27 153.29 19.06 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-O 122.212 1.006 . . . . 0.0 108.729 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.831 ' O ' HG13 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -108.31 115.72 30.63 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.706 HG13 HG22 ' A' ' 86' ' ' ILE . 1.2 mm -100.88 127.99 53.48 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 O-C-N 121.291 -0.881 . . . . 0.0 110.279 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 71.8 t -99.5 137.09 28.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 O-C-N 120.766 -1.209 . . . . 0.0 109.701 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.6 -154.21 30.87 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.458 ' HA2' HG21 ' A' ' 22' ' ' VAL . . . 89.73 -47.33 3.2 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.496 ' O ' ' HB2' ' A' ' 121' ' ' ALA . 46.4 t80 -52.15 -53.64 40.45 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 121.97 0.89 . . . . 0.0 109.637 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 67.8 p -71.52 -34.54 70.17 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.886 0.851 . . . . 0.0 109.33 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.23 -54.72 8.76 Favored 'General case' 0 C--N 1.286 -2.162 0 O-C-N 121.18 -0.95 . . . . 0.0 108.936 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' TRP . . . . . 0.944 ' CZ2' ' HB1' ' A' ' 49' ' ' ALA . 28.0 t90 -60.07 -34.87 74.03 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' A' ' 117' ' ' TYR . . . -52.45 -36.74 55.36 Favored 'General case' 0 C--N 1.291 -1.942 0 O-C-N 120.88 -1.138 . . . . 0.0 108.763 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -60.7 -26.87 67.45 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.776 ' ND2' ' H ' ' A' ' 125' ' ' LEU . 6.1 p-10 -54.02 -49.26 69.31 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 120.685 -1.259 . . . . 0.0 108.373 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.681 ' N ' ' OD1' ' A' ' 123' ' ' ASN . . . 71.22 18.8 76.93 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.776 ' H ' ' ND2' ' A' ' 123' ' ' ASN . 15.0 mt -124.34 98.14 38.76 Favored Pre-proline 0 C--N 1.298 -1.667 0 O-C-N 120.859 -1.377 . . . . 0.0 109.405 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.45 ' HA ' ' H ' ' A' ' 50' ' ' CYS . 45.9 Cg_endo . . . . . 0 C--N 1.301 -1.946 0 C-N-CA 122.339 2.026 . . . . 0.0 113.28 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.042 0 CA-C-O 122.239 1.019 . . . . 0.0 109.741 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.559 HG12 ' HD3' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -144.87 177.46 1.77 Allowed Pre-proline 0 C--N 1.291 -1.951 0 O-C-N 121.193 -0.942 . . . . 0.0 108.965 -179.624 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.559 ' HD3' HG12 ' A' ' 16' ' ' VAL . 27.4 Cg_endo -86.61 140.76 6.29 Favored 'Trans proline' 0 C--N 1.296 -2.186 0 C-N-CA 121.917 1.744 . . . . 0.0 111.344 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.9 t -144.53 150.1 36.99 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 122.035 0.922 . . . . 0.0 109.779 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.713 ' HB3' HD11 ' A' ' 96' ' ' ILE . 95.2 p -101.02 139.55 36.56 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-O 122.632 1.206 . . . . 0.0 109.661 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.596 HG13 ' O ' ' A' ' 112' ' ' ASP . 0.6 OUTLIER -150.17 158.61 5.42 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.185 0 O-C-N 121.023 -1.048 . . . . 0.0 109.318 -178.641 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.645 ' HB3' HG22 ' A' ' 23' ' ' THR . 1.2 m -117.12 160.09 21.56 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.484 -1.385 . . . . 0.0 109.448 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.564 HG21 ' CB ' ' A' ' 119' ' ' ALA . 9.0 p -49.44 -31.61 5.68 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.81 0 CA-C-O 122.132 0.968 . . . . 0.0 108.669 -178.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.645 HG22 ' HB3' ' A' ' 21' ' ' SER . 0.0 OUTLIER -59.7 -56.16 25.38 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 120.718 -1.239 . . . . 0.0 109.144 179.484 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.614 ' H ' HG23 ' A' ' 23' ' ' THR . 0.1 OUTLIER -65.51 -35.66 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.106 -1.622 . . . . 0.0 109.461 178.864 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.57 ' HB2' HD12 ' A' ' 113' ' ' ILE . . . -55.54 -36.16 66.47 Favored 'General case' 0 C--N 1.286 -2.157 0 O-C-N 120.85 -1.156 . . . . 0.0 108.354 178.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -56.18 -47.03 79.09 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -60.9 -42.19 97.54 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.961 -1.087 . . . . 0.0 108.769 178.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.444 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 69.5 mt -67.58 -31.69 71.92 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.0 tt -56.86 -39.19 73.83 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.3 mp -62.91 -29.85 71.09 Favored 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 28' ' ' LEU . . . -66.19 -28.87 69.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.705 -1.247 . . . . 0.0 108.448 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.19 49.3 27.45 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.8 t60 -102.56 170.21 8.17 Favored 'General case' 0 C--N 1.292 -1.923 0 O-C-N 121.055 -1.262 . . . . 0.0 109.571 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -59.96 128.05 34.91 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.377 1.084 . . . . 0.0 109.773 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.444 ' CE2' ' OD1' ' A' ' 37' ' ' ASP . 16.0 t80 -109.92 106.64 16.27 Favored 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.307 -0.871 . . . . 0.0 108.945 -178.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.813 ' HB3' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -99.92 135.44 41.35 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.541 -1.349 . . . . 0.0 108.611 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.734 ' H ' HD13 ' A' ' 36' ' ' LEU . 14.2 m-20 -138.45 138.19 37.91 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 38' ' ' VAL . 11.9 m -132.55 75.31 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 CA-C-O 122.358 1.075 . . . . 0.0 108.1 177.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.655 ' O ' HG23 ' A' ' 40' ' ' THR . 0.4 OUTLIER -82.93 -41.94 18.26 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -179.604 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.655 HG23 ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER 176.37 144.42 0.24 Allowed Pre-proline 0 C--N 1.3 -1.577 0 O-C-N 121.131 -0.981 . . . . 0.0 109.981 -179.658 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -43.14 -27.96 1.22 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.02 1.813 . . . . 0.0 111.102 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -70.02 -30.9 68.31 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.865 -1.147 . . . . 0.0 108.498 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.563 ' CD ' ' HE ' ' A' ' 39' ' ' ARG . 42.1 tp10 -54.42 -33.95 60.43 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.687 -1.258 . . . . 0.0 109.014 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -79.06 -37.12 39.73 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 122.116 0.96 . . . . 0.0 108.854 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.413 ' C ' ' H ' ' A' ' 47' ' ' GLY . 11.2 t -65.95 -40.97 91.82 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.224 -0.922 . . . . 0.0 109.031 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.495 ' NE2' ' O ' ' A' ' 47' ' ' GLY . 5.4 pp0? -75.69 9.5 2.26 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.104 -0.997 . . . . 0.0 108.627 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.495 ' O ' ' NE2' ' A' ' 46' ' ' GLN . . . 89.97 -160.41 28.53 Favored Glycine 0 N--CA 1.5 2.936 0 CA-C-O 122.299 0.944 . . . . 0.0 110.966 178.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -103.05 -159.32 0.72 Allowed 'General case' 0 C--N 1.289 -2.032 0 CA-C-O 122.752 1.263 . . . . 0.0 109.372 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 1.049 ' HB3' ' HB3' ' A' ' 52' ' ' ALA . . . -141.91 169.58 17.32 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 122.207 1.003 . . . . 0.0 109.352 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.595 ' O ' ' NE1' ' A' ' 120' ' ' TRP . 5.2 t -82.67 106.62 14.67 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.79 25.75 55.39 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 1.049 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . . . -149.29 124.26 9.99 Favored 'General case' 0 C--N 1.29 -1.984 0 O-C-N 120.897 -1.355 . . . . 0.0 109.631 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 29.3 mt -116.99 113.19 42.15 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 O-C-N 120.722 -1.236 . . . . 0.0 110.216 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.566 HD21 ' HD3' ' A' ' 56' ' ' PRO . 3.9 t30 -98.03 135.0 40.36 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 122.01 0.909 . . . . 0.0 109.383 -177.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.42 ' O ' HG12 ' A' ' 55' ' ' VAL . 8.9 t -140.24 92.19 9.59 Favored Pre-proline 0 C--N 1.274 -2.706 0 CA-C-O 122.152 0.977 . . . . 0.0 109.093 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.566 ' HD3' HD21 ' A' ' 54' ' ' ASN . 30.0 Cg_endo -74.12 86.07 1.32 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.473 2.115 . . . . 0.0 111.769 -178.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.3 t80 . . . . . 0 C--N 1.298 -1.645 0 CA-C-O 122.291 1.043 . . . . 0.0 109.818 -179.845 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 N--CA 1.498 1.972 0 CA-C-O 122.19 0.995 . . . . 0.0 110.026 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.552 ' H ' ' HB2' ' A' ' 83' ' ' ASP . . . -114.26 142.89 17.8 Favored Glycine 0 N--CA 1.498 2.768 0 N-CA-C 110.476 -1.049 . . . . 0.0 110.476 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' A' ' 80' ' ' GLY . 9.6 tp60 -44.38 -43.48 7.65 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.451 -1.029 . . . . 0.0 109.166 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.563 ' HA ' HD12 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -122.22 24.15 9.54 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 120.837 -1.164 . . . . 0.0 107.972 179.324 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.552 ' HB2' ' H ' ' A' ' 80' ' ' GLY . 19.4 t0 -34.97 118.07 0.42 Allowed 'General case' 0 N--CA 1.506 2.364 0 CA-C-O 121.715 0.769 . . . . 0.0 109.108 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.612 ' N ' ' O ' ' A' ' 109' ' ' GLY . 6.8 t-20 65.56 60.7 0.72 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.891 0.853 . . . . 0.0 109.418 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.669 HG22 ' N ' ' A' ' 86' ' ' ILE . 12.0 mt -150.14 177.67 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 O-C-N 121.064 -1.023 . . . . 0.0 109.496 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.669 ' N ' HG22 ' A' ' 85' ' ' ILE . 63.7 mt -111.14 108.33 25.21 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.257 0 CA-C-O 122.195 0.997 . . . . 0.0 109.323 178.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.813 HG22 ' HB3' ' A' ' 36' ' ' LEU . 14.1 t -114.98 166.47 8.74 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-O 121.943 0.878 . . . . 0.0 108.892 -176.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -148.66 142.03 9.57 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 49.7 t -92.64 148.3 22.18 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 122.079 0.942 . . . . 0.0 109.303 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -41.74 -36.3 0.97 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 122.003 0.906 . . . . 0.0 110.402 -178.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 96.3 p -132.71 159.02 40.88 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 122.257 1.027 . . . . 0.0 109.444 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 94' ' ' ARG . . . -110.58 -178.58 20.65 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 68.39 -72.33 0.33 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 92' ' ' GLY . 0.0 OUTLIER -67.57 -29.59 68.99 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.182 -1.187 . . . . 0.0 108.824 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.755 ' O ' HG23 ' A' ' 99' ' ' THR . 54.4 p -84.51 -29.12 26.22 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.187 -0.946 . . . . 0.0 109.27 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.713 HD11 ' HB3' ' A' ' 19' ' ' SER . 0.4 OUTLIER -55.53 -48.71 77.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 O-C-N 121.092 -1.005 . . . . 0.0 108.836 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.557 ' N ' ' CG2' ' A' ' 96' ' ' ILE . 4.6 ptmm? -70.67 -40.84 72.74 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.63 -1.294 . . . . 0.0 108.39 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.05 -40.96 95.5 Favored 'General case' 0 C--N 1.289 -2.026 0 O-C-N 120.544 -1.347 . . . . 0.0 109.294 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.755 HG23 ' O ' ' A' ' 95' ' ' SER . 35.7 p -64.46 -54.57 30.52 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-O 122.553 1.168 . . . . 0.0 108.683 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.543 ' O ' ' CG ' ' A' ' 104' ' ' HIS . 35.5 m -46.22 -37.35 7.04 Favored 'General case' 0 C--N 1.287 -2.14 0 O-C-N 121.06 -1.025 . . . . 0.0 108.992 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -87.11 -50.65 6.49 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.62 -1.3 . . . . 0.0 108.077 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.714 HD13 ' C ' ' A' ' 102' ' ' LEU . 1.9 tm? -61.36 -44.45 97.15 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.982 0.896 . . . . 0.0 108.889 -178.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 99' ' ' THR . 70.5 mt -63.14 -38.58 91.76 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.113 -0.992 . . . . 0.0 108.975 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.543 ' CG ' ' O ' ' A' ' 100' ' ' THR . 1.2 m-70 -59.88 -18.58 45.69 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.641 -1.287 . . . . 0.0 108.574 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 102' ' ' LEU . . . -62.01 -19.38 62.77 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 120.629 -1.295 . . . . 0.0 108.326 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 128.78 7.88 4.04 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -103.0 17.65 23.55 Favored 'General case' 0 C--N 1.289 -2.032 0 O-C-N 121.082 -1.246 . . . . 0.0 109.395 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.543 ' OG1' ' N ' ' A' ' 17' ' ' PRO . 8.7 t -78.98 -150.73 0.05 Allowed 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.669 -1.269 . . . . 0.0 110.074 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.612 ' O ' ' N ' ' A' ' 84' ' ' ASN . . . 77.45 19.43 76.37 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.48 HG23 ' N ' ' A' ' 111' ' ' LYS . 1.6 m -146.62 166.7 7.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 O-C-N 120.999 -1.295 . . . . 0.0 109.898 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.48 ' N ' HG23 ' A' ' 110' ' ' VAL . 84.9 mttt -97.88 145.48 26.39 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 122.211 1.005 . . . . 0.0 108.71 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.596 ' O ' HG13 ' A' ' 20' ' ' VAL . 51.4 t0 -99.95 109.78 22.13 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.639 HD11 ' CG2' ' A' ' 86' ' ' ILE . 1.2 mm -94.88 138.85 19.83 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.39 0 O-C-N 121.229 -0.919 . . . . 0.0 110.291 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 71.5 t -99.48 143.83 12.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 O-C-N 120.838 -1.163 . . . . 0.0 109.684 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 79.41 -117.2 4.47 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.4 -84.78 1.0 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -55.73 -43.98 77.09 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-O 122.031 0.919 . . . . 0.0 109.671 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 36.6 m -59.92 -39.27 84.9 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-O 121.947 0.879 . . . . 0.0 109.376 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.564 ' CB ' HG21 ' A' ' 22' ' ' VAL . . . -72.55 -50.22 27.15 Favored 'General case' 0 C--N 1.286 -2.159 0 O-C-N 121.096 -1.003 . . . . 0.0 108.882 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' TRP . . . . . 0.595 ' NE1' ' O ' ' A' ' 50' ' ' CYS . 1.0 OUTLIER -53.92 -39.25 65.68 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.332 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.63 -25.81 68.39 Favored 'General case' 0 C--N 1.292 -1.924 0 O-C-N 120.834 -1.166 . . . . 0.0 108.838 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.578 ' CB ' ' HZ2' ' A' ' 122' ' ' LYS . 2.4 ttmp? -56.97 -42.66 80.6 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -90.76 -67.68 0.84 Allowed 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.624 -1.298 . . . . 0.0 108.358 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 113.18 48.09 0.62 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.463 ' O ' ' CB ' ' A' ' 50' ' ' CYS . 14.3 mt -126.55 78.67 72.14 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 120.834 -1.392 . . . . 0.0 109.314 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.463 ' HA ' ' H ' ' A' ' 50' ' ' CYS . 31.7 Cg_endo . . . . . 0 C--N 1.302 -1.897 0 C-N-CA 122.274 1.983 . . . . 0.0 113.212 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 . . . . . 0 N--CA 1.5 2.074 0 CA-C-O 122.132 0.967 . . . . 0.0 109.715 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.512 HG12 ' HD2' ' A' ' 17' ' ' PRO . 3.5 t -143.11 149.0 47.28 Favored Pre-proline 0 C--N 1.29 -1.98 0 O-C-N 121.287 -0.883 . . . . 0.0 108.911 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.921 ' CB ' HD21 ' A' ' 103' ' ' LEU . 39.9 Cg_endo -90.78 161.91 4.13 Favored 'Trans proline' 0 C--N 1.298 -2.104 0 C-N-CA 121.885 1.723 . . . . 0.0 111.399 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.0 t -161.23 152.55 18.88 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 122.107 0.956 . . . . 0.0 109.721 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 89.0 p -108.5 144.47 36.11 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 122.694 1.235 . . . . 0.0 109.65 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.687 HG23 ' N ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -144.76 177.76 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 O-C-N 120.993 -1.067 . . . . 0.0 109.4 -178.495 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.687 ' N ' HG23 ' A' ' 20' ' ' VAL . 71.7 m -119.55 151.82 38.0 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.47 -1.394 . . . . 0.0 109.435 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.758 ' CG2' ' HB2' ' A' ' 119' ' ' ALA . 6.5 p -47.53 -33.21 2.99 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.793 0 CA-C-O 122.126 0.965 . . . . 0.0 108.695 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.51 ' OG1' ' N ' ' A' ' 24' ' ' VAL . 0.1 OUTLIER -56.26 -56.77 16.87 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 120.728 -1.233 . . . . 0.0 109.12 179.225 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.51 ' N ' ' OG1' ' A' ' 23' ' ' THR . 0.1 OUTLIER -65.42 -34.74 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.131 -1.605 . . . . 0.0 109.377 179.101 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.947 ' HB2' HD13 ' A' ' 113' ' ' ILE . . . -50.92 -37.43 44.0 Favored 'General case' 0 C--N 1.287 -2.132 0 O-C-N 120.825 -1.172 . . . . 0.0 108.39 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -59.55 -47.83 84.03 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -60.25 -44.45 95.25 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 120.885 -1.134 . . . . 0.0 108.675 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.6 mt -68.7 -53.16 23.86 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.465 ' CD2' ' C ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -58.71 -43.1 89.98 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.016 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.707 HD13 ' C ' ' A' ' 30' ' ' LEU . 1.4 tm? -58.41 -34.71 71.05 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.466 ' HB3' ' CE1' ' A' ' 33' ' ' HIS . . . -71.09 -19.87 62.41 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.712 -1.243 . . . . 0.0 108.391 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.07 49.6 1.88 Allowed Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.466 ' CE1' ' HB3' ' A' ' 31' ' ' ALA . 39.3 m80 -107.4 139.39 41.96 Favored 'General case' 0 C--N 1.291 -1.969 0 O-C-N 121.234 -1.156 . . . . 0.0 109.592 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 36.9 mtt-85 -61.82 141.11 58.13 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 122.331 1.062 . . . . 0.0 109.846 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -125.62 118.06 24.87 Favored 'General case' 0 C--N 1.291 -1.96 0 O-C-N 121.38 -0.825 . . . . 0.0 108.968 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.815 ' HB2' HG22 ' A' ' 87' ' ' VAL . 17.6 mt -92.62 108.2 19.8 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 120.616 -1.303 . . . . 0.0 108.604 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.743 ' OD2' ' CE1' ' A' ' 48' ' ' HIS . 41.0 t0 -90.81 122.97 33.99 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -178.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.756 HG12 ' O ' ' A' ' 55' ' ' VAL . 20.2 m -134.17 87.81 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 CA-C-O 122.502 1.144 . . . . 0.0 108.125 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.744 ' O ' HG23 ' A' ' 40' ' ' THR . 24.5 mtp180 -83.59 -46.08 12.79 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.744 HG23 ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER 172.92 165.64 0.27 Allowed Pre-proline 0 N--CA 1.49 1.564 0 C-N-CA 119.296 -0.962 . . . . 0.0 109.925 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -53.33 -35.43 74.7 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.04 1.827 . . . . 0.0 111.085 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -61.0 -30.43 70.28 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.894 -1.128 . . . . 0.0 108.48 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.593 ' O ' ' N ' ' A' ' 47' ' ' GLY . 83.5 tt0 -55.79 -30.63 61.65 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.755 -1.216 . . . . 0.0 108.968 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -72.6 -38.32 67.85 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 122.176 0.989 . . . . 0.0 108.933 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.6 t -51.49 -48.36 62.92 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.175 -0.953 . . . . 0.0 109.167 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -103.73 -20.75 13.85 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.147 -0.97 . . . . 0.0 108.621 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 43' ' ' GLU . . . 82.37 -172.53 52.47 Favored Glycine 0 N--CA 1.5 2.915 0 CA-C-O 122.289 0.938 . . . . 0.0 110.985 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.743 ' CE1' ' OD2' ' A' ' 37' ' ' ASP . 0.3 OUTLIER 176.13 101.71 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.034 0 CA-C-O 122.645 1.212 . . . . 0.0 109.395 179.215 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -160.45 147.7 15.94 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 122.26 1.029 . . . . 0.0 109.388 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.4 t -176.32 44.72 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.264 0 CA-C-O 122.548 1.166 . . . . 0.0 107.869 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 117.85 23.81 3.53 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.984 ' HB2' ' CZ2' ' A' ' 120' ' ' TRP . . . -154.11 179.16 9.19 Favored 'General case' 0 C--N 1.289 -2.045 0 O-C-N 120.861 -1.376 . . . . 0.0 109.639 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 77.1 mt -123.47 147.97 27.62 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 O-C-N 120.832 -1.168 . . . . 0.0 110.3 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -131.55 143.57 50.46 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.954 0.883 . . . . 0.0 109.499 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.765 ' O ' HG12 ' A' ' 55' ' ' VAL . 1.1 t -140.62 91.89 9.25 Favored Pre-proline 0 C--N 1.274 -2.717 0 CA-C-O 122.205 1.002 . . . . 0.0 109.089 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -78.77 66.26 8.66 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.524 2.149 . . . . 0.0 111.806 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 . . . . . 0 C--N 1.299 -1.6 0 CA-C-O 122.375 1.083 . . . . 0.0 109.826 -179.549 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 . . . . . 0 N--CA 1.499 2.019 0 CA-C-O 122.193 0.997 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.66 ' H ' ' HB3' ' A' ' 83' ' ' ASP . . . -114.19 134.78 11.98 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -48.03 -21.19 0.42 Allowed 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.454 -1.027 . . . . 0.0 109.173 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.812 ' HA ' HD12 ' A' ' 85' ' ' ILE . 54.4 m -123.73 15.54 9.44 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.847 -1.158 . . . . 0.0 107.914 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.66 ' HB3' ' H ' ' A' ' 80' ' ' GLY . 12.6 p30 -45.78 109.91 0.22 Allowed 'General case' 0 N--CA 1.507 2.396 0 O-C-N 121.406 -0.809 . . . . 0.0 109.123 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 58.61 64.07 1.54 Allowed 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.973 0.892 . . . . 0.0 109.4 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.812 HD12 ' HA ' ' A' ' 82' ' ' SER . 24.1 mt -142.25 176.32 3.95 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 O-C-N 121.025 -1.047 . . . . 0.0 109.408 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.889 HG23 ' HB2' ' A' ' 111' ' ' LYS . 6.7 mt -121.78 112.57 35.61 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 O-C-N 121.106 -0.997 . . . . 0.0 109.403 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.815 HG22 ' HB2' ' A' ' 36' ' ' LEU . 92.6 t -100.56 -179.68 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 O-C-N 121.281 -0.887 . . . . 0.0 108.919 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.67 ' H ' HG12 ' A' ' 87' ' ' VAL . . . -175.09 140.13 5.13 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 46.3 t -110.61 146.69 35.69 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-O 122.07 0.938 . . . . 0.0 109.283 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.45 ' CD ' HH21 ' A' ' 39' ' ' ARG . 65.0 tt0 -42.57 -70.69 0.1 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.022 0.915 . . . . 0.0 110.464 -178.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.1 t -72.13 160.22 32.82 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 122.238 1.018 . . . . 0.0 109.453 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 94' ' ' ARG . . . -132.25 174.72 20.19 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.415 ' O ' HG22 ' A' ' 96' ' ' ILE . . . 61.67 -76.32 0.02 OUTLIER Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.53 ' N ' ' O ' ' A' ' 92' ' ' GLY . 1.1 ttt-85 -65.93 -37.19 85.42 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.216 -1.167 . . . . 0.0 108.778 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.2 t -87.65 -27.6 22.36 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 121.188 -0.945 . . . . 0.0 109.254 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.585 ' CG2' ' N ' ' A' ' 97' ' ' LYS . 2.6 tt -59.07 -48.82 85.47 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 O-C-N 121.084 -1.01 . . . . 0.0 108.879 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.585 ' N ' ' CG2' ' A' ' 96' ' ' ILE . 17.1 pttp -63.99 -35.67 81.47 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.697 -1.252 . . . . 0.0 108.449 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.97 -43.05 79.91 Favored 'General case' 0 C--N 1.288 -2.074 0 O-C-N 120.534 -1.354 . . . . 0.0 109.206 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 103' ' ' LEU . 30.5 p -77.95 -50.58 11.9 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-O 122.573 1.177 . . . . 0.0 108.697 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.535 ' O ' ' N ' ' A' ' 104' ' ' HIS . 60.3 m -53.91 -49.4 68.7 Favored 'General case' 0 C--N 1.288 -2.102 0 O-C-N 121.012 -1.055 . . . . 0.0 109.033 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -61.94 -46.14 90.63 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.627 -1.296 . . . . 0.0 108.17 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.776 ' O ' HD13 ' A' ' 102' ' ' LEU . 2.5 tm? -64.63 -40.79 96.09 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.305 -0.872 . . . . 0.0 108.808 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.921 HD21 ' CB ' ' A' ' 17' ' ' PRO . 0.3 OUTLIER -75.19 -30.55 60.69 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.122 -0.986 . . . . 0.0 108.966 178.358 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.535 ' N ' ' O ' ' A' ' 100' ' ' THR . 84.0 t60 -53.39 -34.71 58.77 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.597 -1.315 . . . . 0.0 108.606 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -131.23 35.56 3.89 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 120.573 -1.329 . . . . 0.0 108.301 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -148.13 -37.23 0.04 OUTLIER Glycine 0 N--CA 1.495 2.586 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.478 ' O ' ' O ' ' A' ' 103' ' ' LEU . 66.5 m-85 -134.83 164.18 28.13 Favored 'General case' 0 C--N 1.288 -2.078 0 O-C-N 121.235 -1.156 . . . . 0.0 109.414 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.3 t -176.27 151.03 0.97 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.538 -1.351 . . . . 0.0 110.126 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.65 21.97 38.39 Favored Glycine 0 N--CA 1.498 2.814 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.412 HG11 ' CB ' ' A' ' 82' ' ' SER . 1.9 m -148.03 155.86 9.59 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 O-C-N 121.064 -1.257 . . . . 0.0 109.932 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.889 ' HB2' HG23 ' A' ' 86' ' ' ILE . 52.8 mttp -98.87 158.81 15.39 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 122.252 1.025 . . . . 0.0 108.726 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.609 ' O ' HG13 ' A' ' 20' ' ' VAL . 85.2 m-20 -114.92 125.57 53.79 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.947 HD13 ' HB2' ' A' ' 25' ' ' ALA . 3.7 mt -102.7 152.72 5.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.401 0 O-C-N 121.301 -0.874 . . . . 0.0 110.261 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 44.0 t -97.74 135.83 30.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 O-C-N 120.821 -1.174 . . . . 0.0 109.664 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.13 -145.2 17.55 Favored Glycine 0 C--N 1.285 -2.302 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 160.6 -95.26 0.14 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -52.85 -38.33 61.36 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-O 122.084 0.945 . . . . 0.0 109.711 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 29.3 t -57.27 -33.07 67.25 Favored 'General case' 0 C--N 1.291 -1.939 0 O-C-N 121.286 -0.883 . . . . 0.0 109.301 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.758 ' HB2' ' CG2' ' A' ' 22' ' ' VAL . . . -69.81 -52.4 25.45 Favored 'General case' 0 C--N 1.286 -2.171 0 O-C-N 121.103 -0.998 . . . . 0.0 108.873 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' TRP . . . . . 0.984 ' CZ2' ' HB2' ' A' ' 52' ' ' ALA . 0.6 OUTLIER -61.57 -37.35 83.52 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.886 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.25 -27.86 64.78 Favored 'General case' 0 C--N 1.292 -1.92 0 O-C-N 120.848 -1.157 . . . . 0.0 108.789 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.8 ttmm -56.06 -42.78 77.16 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -85.52 -64.59 1.13 Allowed 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.643 -1.286 . . . . 0.0 108.375 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 137.4 39.1 0.13 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.662 ' O ' ' O ' ' A' ' 126' ' ' PRO . 2.7 mt -102.74 127.95 29.01 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 120.848 -1.383 . . . . 0.0 109.362 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.662 ' O ' ' O ' ' A' ' 125' ' ' LEU . 51.3 Cg_exo . . . . . 0 C--N 1.302 -1.89 0 C-N-CA 122.269 1.979 . . . . 0.0 113.2 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? . . . . . 0 N--CA 1.5 2.042 0 CA-C-O 122.211 1.005 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -131.44 173.96 5.26 Favored Pre-proline 0 C--N 1.291 -1.949 0 O-C-N 121.277 -0.89 . . . . 0.0 108.872 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.406 ' N ' ' HG1' ' A' ' 108' ' ' THR . 20.8 Cg_endo -88.91 78.64 1.09 Allowed 'Trans proline' 0 C--N 1.297 -2.16 0 C-N-CA 121.831 1.687 . . . . 0.0 111.42 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 112' ' ' ASP . 33.0 t -75.19 144.52 42.65 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 122.029 0.918 . . . . 0.0 109.705 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 82.7 p -100.36 151.51 21.42 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 122.703 1.239 . . . . 0.0 109.63 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.663 ' CG2' ' N ' ' A' ' 21' ' ' SER . 0.1 OUTLIER -150.6 173.92 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 O-C-N 121.002 -1.061 . . . . 0.0 109.431 -178.653 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.663 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 1.5 m -108.82 166.12 11.05 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.516 -1.365 . . . . 0.0 109.46 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 1.052 HG11 ' HB1' ' A' ' 119' ' ' ALA . 37.1 t -62.86 -29.98 48.42 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.808 0 CA-C-O 122.106 0.955 . . . . 0.0 108.707 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.608 HG23 ' N ' ' A' ' 24' ' ' VAL . 6.5 t -55.38 -47.78 75.3 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 120.82 -1.175 . . . . 0.0 109.106 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.608 ' N ' HG23 ' A' ' 23' ' ' THR . 1.4 t -69.68 -39.74 78.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.157 -1.589 . . . . 0.0 109.42 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.996 ' HB2' HD13 ' A' ' 113' ' ' ILE . . . -51.3 -36.27 41.72 Favored 'General case' 0 C--N 1.288 -2.103 0 O-C-N 120.804 -1.185 . . . . 0.0 108.39 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -60.29 -48.63 80.93 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -59.81 -36.15 76.18 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 120.878 -1.139 . . . . 0.0 108.699 178.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.539 HD13 HD13 ' A' ' 86' ' ' ILE . 51.2 mt -80.86 -25.03 37.96 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 25' ' ' ALA . 8.9 tt -62.22 -43.38 98.95 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.8 HD12 ' N ' ' A' ' 31' ' ' ALA . 3.4 pp -80.21 -14.39 58.48 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.509 -1.369 . . . . 0.0 107.477 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.8 ' N ' HD12 ' A' ' 30' ' ' LEU . . . -67.27 -27.67 67.39 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.736 -1.228 . . . . 0.0 108.398 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.24 47.68 6.0 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.526 ' O ' ' CZ ' ' A' ' 35' ' ' TYR . 14.1 m-70 -115.37 163.61 15.47 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.204 -1.174 . . . . 0.0 109.589 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.636 HH12 HD13 ' A' ' 53' ' ' ILE . 20.0 mmm180 -59.8 132.04 52.75 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 122.359 1.076 . . . . 0.0 109.793 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.526 ' CZ ' ' O ' ' A' ' 33' ' ' HIS . 21.6 m-85 -118.2 108.14 14.8 Favored 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.314 -0.866 . . . . 0.0 108.95 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.788 ' HB3' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -102.35 133.16 47.73 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 120.582 -1.324 . . . . 0.0 108.587 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.62 ' H ' HD13 ' A' ' 36' ' ' LEU . 22.1 t70 -147.75 111.39 5.01 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 -178.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.427 ' O ' HG22 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -83.1 103.97 11.09 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 O-C-N 120.959 -1.088 . . . . 0.0 108.093 177.44 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.705 HH22 ' NE2' ' A' ' 46' ' ' GLN . 25.7 ttp180 -84.34 -43.45 14.74 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -179.01 170.39 0.73 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.182 -0.949 . . . . 0.0 109.95 -179.026 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 40' ' ' THR . 24.7 Cg_exo -55.47 -145.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 121.92 1.746 . . . . 0.0 111.125 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -58.28 -23.44 56.24 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.85 -1.156 . . . . 0.0 108.543 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.473 ' O ' ' OE1' ' A' ' 46' ' ' GLN . 96.7 mt-10 -50.66 -30.0 12.52 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.802 -1.186 . . . . 0.0 108.997 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.662 ' CD1' ' N ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -78.06 -32.22 50.73 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 122.217 1.008 . . . . 0.0 108.91 177.446 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.662 ' N ' ' CD1' ' A' ' 44' ' ' PHE . 16.0 t -49.01 -19.1 0.36 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.153 -0.967 . . . . 0.0 109.052 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.705 ' NE2' HH22 ' A' ' 39' ' ' ARG . 0.4 OUTLIER -69.8 -9.57 55.14 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.089 -1.007 . . . . 0.0 108.619 179.46 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.515 ' O ' ' O ' ' A' ' 44' ' ' PHE . . . 161.78 -164.76 35.41 Favored Glycine 0 N--CA 1.499 2.875 0 CA-C-O 122.245 0.914 . . . . 0.0 111.051 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.635 ' O ' ' O ' ' A' ' 49' ' ' ALA . 6.4 p-80 -176.0 106.01 0.08 Allowed 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 122.732 1.254 . . . . 0.0 109.38 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.635 ' O ' ' O ' ' A' ' 48' ' ' HIS . . . -30.87 157.44 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 122.159 0.981 . . . . 0.0 109.421 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.694 ' SG ' ' N ' ' A' ' 51' ' ' GLY . 0.5 OUTLIER -93.53 162.17 14.07 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.648 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.694 ' N ' ' SG ' ' A' ' 50' ' ' CYS . . . 105.79 -8.13 42.66 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.771 ' HB3' ' CZ2' ' A' ' 120' ' ' TRP . . . -170.46 157.78 6.13 Favored 'General case' 0 C--N 1.29 -2.009 0 O-C-N 120.784 -1.421 . . . . 0.0 109.615 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.636 HD13 HH12 ' A' ' 34' ' ' ARG . 38.6 mt -99.6 134.83 37.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 O-C-N 120.762 -1.211 . . . . 0.0 110.262 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.518 HD22 ' HH2' ' A' ' 120' ' ' TRP . 2.5 m-80 -113.3 134.2 54.73 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 121.937 0.875 . . . . 0.0 109.472 -178.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.734 ' O ' HG12 ' A' ' 55' ' ' VAL . 1.1 t -142.6 95.77 6.37 Favored Pre-proline 0 C--N 1.273 -2.754 0 CA-C-O 122.221 1.01 . . . . 0.0 109.133 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.433 ' HG3' ' CD1' ' A' ' 44' ' ' PHE . 28.3 Cg_endo -77.94 54.37 4.83 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.5 2.134 . . . . 0.0 111.693 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.518 ' CE1' ' NE2' ' A' ' 81' ' ' GLN . 61.8 m-85 . . . . . 0 C--N 1.298 -1.661 0 CA-C-O 122.31 1.052 . . . . 0.0 109.848 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 . . . . . 0 N--CA 1.499 2.01 0 CA-C-O 122.211 1.005 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.548 ' H ' ' HB2' ' A' ' 83' ' ' ASP . . . -112.26 137.79 14.51 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.518 ' NE2' ' CE1' ' A' ' 57' ' ' TYR . 10.5 pt20 -45.71 -19.56 0.06 Allowed 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.491 -1.005 . . . . 0.0 109.17 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.819 ' HA ' HD12 ' A' ' 85' ' ' ILE . 16.3 m -122.84 20.92 10.04 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.793 -1.192 . . . . 0.0 107.969 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.548 ' HB2' ' H ' ' A' ' 80' ' ' GLY . 42.2 t0 -42.42 113.8 0.49 Allowed 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.408 -0.808 . . . . 0.0 109.11 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 17.4 m-20 59.6 63.36 1.53 Allowed 'General case' 0 C--N 1.291 -1.936 0 O-C-N 121.308 -0.87 . . . . 0.0 109.451 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.819 HD12 ' HA ' ' A' ' 82' ' ' SER . 17.8 mt -145.93 176.66 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 O-C-N 121.076 -1.015 . . . . 0.0 109.421 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.66 ' N ' HG22 ' A' ' 85' ' ' ILE . 64.1 mt -111.01 112.43 40.55 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 O-C-N 121.078 -1.014 . . . . 0.0 109.422 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.926 ' CG2' HG21 ' A' ' 110' ' ' VAL . 60.4 t -110.94 175.0 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 O-C-N 121.261 -0.899 . . . . 0.0 108.887 -176.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.561 ' N ' HG12 ' A' ' 87' ' ' VAL . . . -172.02 175.63 45.28 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 19.7 t -128.46 120.31 26.61 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 122.029 0.919 . . . . 0.0 109.319 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.439 ' O ' ' OE1' ' A' ' 90' ' ' GLN . 1.0 OUTLIER -65.63 -38.63 89.95 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.039 0.923 . . . . 0.0 110.422 -178.492 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 92' ' ' GLY . 4.1 m -61.52 160.98 10.26 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 122.171 0.986 . . . . 0.0 109.473 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 91' ' ' SER . . . -43.17 161.95 0.05 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.668 ' O ' HG22 ' A' ' 96' ' ' ILE . . . -54.83 -28.06 46.02 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -55.05 -28.32 51.38 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.221 -1.164 . . . . 0.0 108.72 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 43.7 t -85.24 -32.44 22.6 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.15 -0.969 . . . . 0.0 109.237 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.748 HG13 HG22 ' A' ' 114' ' ' VAL . 0.3 OUTLIER -60.3 -30.56 46.42 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 O-C-N 121.03 -1.044 . . . . 0.0 108.881 -179.289 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.413 ' HB3' ' HZ2' ' A' ' 97' ' ' LYS . 16.1 mtpp -62.56 -47.68 82.78 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.707 -1.246 . . . . 0.0 108.402 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.34 -50.09 72.49 Favored 'General case' 0 C--N 1.289 -2.029 0 O-C-N 120.557 -1.339 . . . . 0.0 109.266 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.733 ' O ' HD13 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -57.86 -47.84 81.55 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-O 122.525 1.155 . . . . 0.0 108.705 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 57.9 m -56.39 -48.81 76.13 Favored 'General case' 0 C--N 1.287 -2.134 0 O-C-N 120.943 -1.098 . . . . 0.0 108.989 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -65.43 -40.34 93.2 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.654 -1.279 . . . . 0.0 108.153 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 102' ' ' LEU . 3.7 tt -68.48 -40.54 80.94 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.968 0.89 . . . . 0.0 108.818 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.733 HD13 ' O ' ' A' ' 99' ' ' THR . 10.8 mp -69.86 -28.93 66.07 Favored 'General case' 0 C--N 1.292 -1.914 0 O-C-N 121.088 -1.007 . . . . 0.0 109.017 178.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -64.02 -32.54 74.12 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.519 -1.363 . . . . 0.0 108.527 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -130.93 37.2 3.8 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.623 -1.298 . . . . 0.0 108.393 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -151.34 -67.64 0.01 OUTLIER Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.666 ' H ' ' HA ' ' A' ' 103' ' ' LEU . 96.7 m-85 -138.48 156.24 47.71 Favored 'General case' 0 C--N 1.289 -2.048 0 O-C-N 121.175 -1.191 . . . . 0.0 109.38 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.426 ' OG1' ' N ' ' A' ' 109' ' ' GLY . 11.0 t -166.42 -161.93 0.49 Allowed 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.667 -1.271 . . . . 0.0 110.104 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.426 ' N ' ' OG1' ' A' ' 108' ' ' THR . . . 79.05 21.13 68.6 Favored Glycine 0 N--CA 1.499 2.836 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.926 HG21 ' CG2' ' A' ' 87' ' ' VAL . 1.7 m -142.29 167.93 14.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 O-C-N 121.07 -1.253 . . . . 0.0 109.874 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.607 ' O ' ' N ' ' A' ' 87' ' ' VAL . 85.6 mttt -97.88 148.94 22.92 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 122.198 0.999 . . . . 0.0 108.739 -179.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -111.74 108.08 17.38 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -178.836 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.996 HD13 ' HB2' ' A' ' 25' ' ' ALA . 69.7 mt -83.08 125.1 40.04 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 O-C-N 121.265 -0.897 . . . . 0.0 110.261 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.748 HG22 HG13 ' A' ' 96' ' ' ILE . 67.2 t -100.78 138.22 25.75 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 O-C-N 120.825 -1.172 . . . . 0.0 109.63 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 167.67 -147.48 11.72 Favored Glycine 0 C--N 1.285 -2.268 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -154.22 -176.99 27.17 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -59.06 -33.02 70.3 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-O 122.011 0.91 . . . . 0.0 109.647 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.499 ' O ' ' HB3' ' A' ' 121' ' ' ALA . 32.1 t -56.47 -32.26 64.8 Favored 'General case' 0 C--N 1.292 -1.905 0 O-C-N 121.332 -0.855 . . . . 0.0 109.331 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 1.052 ' HB1' HG11 ' A' ' 22' ' ' VAL . . . -62.21 -40.91 97.66 Favored 'General case' 0 C--N 1.286 -2.159 0 O-C-N 121.185 -0.947 . . . . 0.0 108.892 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' TRP . . . . . 0.771 ' CZ2' ' HB3' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -60.34 -33.77 72.88 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 179.294 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 118' ' ' SER . . . -56.84 -37.63 71.53 Favored 'General case' 0 C--N 1.292 -1.911 0 O-C-N 120.795 -1.19 . . . . 0.0 108.812 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -56.44 -39.19 72.71 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -63.36 -65.29 0.71 Allowed 'General case' 0 N--CA 1.503 2.184 0 O-C-N 120.649 -1.282 . . . . 0.0 108.371 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.06 16.53 35.19 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 50' ' ' CYS . 12.6 mt -126.83 71.98 74.9 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 120.827 -1.396 . . . . 0.0 109.369 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.49 ' HA ' ' H ' ' A' ' 50' ' ' CYS . 32.9 Cg_endo . . . . . 0 C--N 1.302 -1.911 0 C-N-CA 122.29 1.993 . . . . 0.0 113.16 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 122.16 0.981 . . . . 0.0 109.225 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -105.6 145.29 31.18 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-O 122.018 0.913 . . . . 0.0 109.233 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -147.26 25.01 1.12 Allowed 'General case' 0 C--N 1.29 -1.989 0 CA-C-O 122.219 1.009 . . . . 0.0 109.657 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.2 p -83.57 0.58 46.02 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -139.39 99.34 3.71 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 122.16 0.981 . . . . 0.0 109.735 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.625 ' H ' ' N ' ' A' ' 109' ' ' GLY . 9.0 t -146.85 101.75 3.92 Favored Pre-proline 0 C--N 1.291 -1.958 0 O-C-N 121.267 -0.896 . . . . 0.0 108.942 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -88.69 124.72 1.61 Allowed 'Trans proline' 0 C--N 1.297 -2.14 0 C-N-CA 121.875 1.716 . . . . 0.0 111.431 177.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.5 p -138.17 152.2 48.45 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 122.021 0.915 . . . . 0.0 109.681 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.534 ' C ' HG12 ' A' ' 20' ' ' VAL . 39.6 m -115.96 144.55 43.92 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 122.675 1.226 . . . . 0.0 109.627 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.761 HG23 ' N ' ' A' ' 21' ' ' SER . 0.7 OUTLIER -158.81 -179.04 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.196 0 O-C-N 121.025 -1.047 . . . . 0.0 109.402 -178.701 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.761 ' N ' HG23 ' A' ' 20' ' ' VAL . 14.3 p -115.58 148.19 39.87 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.48 -1.387 . . . . 0.0 109.395 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.6 p -47.32 -21.24 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.768 0 CA-C-O 122.102 0.953 . . . . 0.0 108.648 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.597 HG23 ' HB2' ' A' ' 21' ' ' SER . 0.1 OUTLIER -64.39 -55.7 19.32 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 120.736 -1.227 . . . . 0.0 109.177 179.169 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.494 ' N ' ' OG1' ' A' ' 23' ' ' THR . 0.9 OUTLIER -71.15 -40.5 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.175 -1.578 . . . . 0.0 109.4 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.634 ' HB2' HD12 ' A' ' 113' ' ' ILE . . . -57.98 -35.04 70.64 Favored 'General case' 0 C--N 1.286 -2.159 0 O-C-N 120.829 -1.17 . . . . 0.0 108.361 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.612 ' O ' HD13 ' A' ' 30' ' ' LEU . 86.4 t60 -52.99 -46.66 68.42 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -55.33 -43.42 74.94 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 120.907 -1.12 . . . . 0.0 108.666 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.505 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 10.4 mp -70.72 -36.8 73.38 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 19.2 tp -56.91 -39.69 74.92 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.612 HD13 ' O ' ' A' ' 26' ' ' HIS . 11.0 mp -63.43 -25.8 68.44 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 28' ' ' LEU . . . -66.34 -22.42 66.27 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.77 -1.207 . . . . 0.0 108.385 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.95 48.82 3.5 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -107.41 149.58 27.73 Favored 'General case' 0 C--N 1.292 -1.898 0 O-C-N 121.204 -1.174 . . . . 0.0 109.593 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.429 ' NH2' HD11 ' A' ' 85' ' ' ILE . 75.5 mtm180 -58.66 133.68 56.11 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 122.428 1.109 . . . . 0.0 109.827 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.402 ' O ' ' O ' ' A' ' 53' ' ' ILE . 47.3 t80 -112.6 113.61 25.83 Favored 'General case' 0 C--N 1.292 -1.93 0 O-C-N 121.285 -0.884 . . . . 0.0 108.937 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.756 ' HB3' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -98.84 130.57 45.27 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.594 -1.317 . . . . 0.0 108.554 179.213 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.621 ' N ' ' CD1' ' A' ' 36' ' ' LEU . 48.2 t0 -138.61 142.5 39.13 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.988 HG21 ' CZ ' ' A' ' 57' ' ' TYR . 4.5 m -131.04 96.11 2.59 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 CA-C-O 122.433 1.111 . . . . 0.0 108.158 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.754 ' O ' ' OG1' ' A' ' 40' ' ' THR . 0.1 OUTLIER -89.65 -45.32 9.43 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.862 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.754 ' OG1' ' O ' ' A' ' 39' ' ' ARG . 3.6 m 177.45 142.32 0.25 Allowed Pre-proline 0 N--CA 1.49 1.573 0 C-N-CA 119.312 -0.955 . . . . 0.0 109.921 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.559 ' HD2' HG23 ' A' ' 40' ' ' THR . 50.8 Cg_exo -40.21 -39.96 2.73 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 121.983 1.788 . . . . 0.0 111.074 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.663 ' H ' HG22 ' A' ' 40' ' ' THR . 96.6 mt-10 -61.0 -30.34 70.23 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.951 -1.093 . . . . 0.0 108.567 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 40' ' ' THR . 66.1 tt0 -55.48 -32.01 62.47 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.75 -1.219 . . . . 0.0 109.014 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.484 ' CZ ' ' ND2' ' A' ' 59' ' ' ASN . 74.4 t80 -67.99 -44.21 77.15 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 122.174 0.988 . . . . 0.0 108.978 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.1 t -56.13 -29.72 61.1 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.191 -0.943 . . . . 0.0 109.048 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -70.16 -36.92 75.04 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.124 -0.985 . . . . 0.0 108.631 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.06 -148.38 17.11 Favored Glycine 0 N--CA 1.499 2.84 0 CA-C-O 122.267 0.926 . . . . 0.0 110.977 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.742 ' H ' ' CB ' ' A' ' 128' ' ' LYS . 96.6 m-70 -100.42 -160.2 0.78 Allowed 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 122.684 1.23 . . . . 0.0 109.411 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.69 ' C ' ' H ' ' A' ' 127' ' ' THR . . . -144.62 166.72 24.38 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 122.178 0.99 . . . . 0.0 109.396 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.902 ' N ' ' H ' ' A' ' 127' ' ' THR . 4.7 t -83.63 105.33 14.47 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-O 122.541 1.162 . . . . 0.0 107.89 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.56 26.5 65.27 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.609 ' C ' HD12 ' A' ' 53' ' ' ILE . . . -156.0 123.15 5.37 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 120.784 -1.421 . . . . 0.0 109.595 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.777 ' N ' HD12 ' A' ' 53' ' ' ILE . 2.7 mp -105.14 104.27 16.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 O-C-N 120.709 -1.245 . . . . 0.0 110.247 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -107.94 118.33 36.46 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-O 121.971 0.891 . . . . 0.0 109.449 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.904 ' O ' HG12 ' A' ' 38' ' ' VAL . 2.0 m -142.13 163.34 40.49 Favored Pre-proline 0 C--N 1.274 -2.71 0 CA-C-O 122.171 0.986 . . . . 0.0 109.09 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.638 ' O ' ' N ' ' A' ' 58' ' ' MET . 36.8 Cg_endo -84.08 68.2 6.71 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.451 2.101 . . . . 0.0 111.72 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.988 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 66.4 m-85 54.83 -78.64 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 122.229 1.014 . . . . 0.0 109.789 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.83 ' HB2' ' H ' ' A' ' 68' ' ' ASN . 28.8 mmm -109.45 142.86 39.84 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-O 122.123 0.964 . . . . 0.0 110.071 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.484 ' ND2' ' CZ ' ' A' ' 44' ' ' PHE . 31.1 t30 -148.26 133.27 18.19 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.2 ttt-85 -78.12 132.73 37.8 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.138 -0.976 . . . . 0.0 108.629 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 63' ' ' SER . . . -175.83 -171.8 40.03 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.06 -1.5 0.98 Allowed 'General case' 0 C--N 1.28 -2.44 0 O-C-N 121.166 -1.196 . . . . 0.0 108.315 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.51 ' H ' ' C ' ' A' ' 61' ' ' GLY . 26.4 t -63.21 -8.59 8.55 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 65' ' ' MET . . . 106.95 29.81 4.47 Favored Glycine 0 N--CA 1.5 2.933 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.438 ' O ' ' O ' ' A' ' 64' ' ' GLY . 72.2 mtm 55.66 115.61 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 122.284 1.04 . . . . 0.0 110.316 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.0 t -161.47 97.63 1.1 Allowed 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 69' ' ' THR . 16.5 tptm -127.54 121.29 30.26 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.03 -1.044 . . . . 0.0 108.544 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.922 ' OD1' HD11 ' A' ' 72' ' ' LEU . 19.5 t30 -40.14 94.14 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 122.208 1.004 . . . . 0.0 110.041 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.505 ' N ' ' O ' ' A' ' 67' ' ' LYS . 4.9 m -159.35 -48.54 0.06 Allowed 'General case' 0 C--N 1.281 -2.396 0 O-C-N 121.465 -0.772 . . . . 0.0 109.915 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' A' ' 71' ' ' PHE . 44.1 p30 -154.06 -27.9 0.13 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.323 -1.486 . . . . 0.0 108.332 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.558 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 97.5 m-85 -51.03 -24.23 3.63 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 122.126 0.965 . . . . 0.0 108.849 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.922 HD11 ' OD1' ' A' ' 68' ' ' ASN . 3.0 mt -52.51 -42.47 64.34 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.973 0.892 . . . . 0.0 108.656 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.47 ' CG ' ' N ' ' A' ' 74' ' ' GLN . 13.5 pt-20 -60.88 -40.85 94.54 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.907 -1.121 . . . . 0.0 108.933 177.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.47 ' N ' ' CG ' ' A' ' 73' ' ' GLU . 84.7 mt-30 -75.53 -45.12 39.93 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.795 -1.191 . . . . 0.0 108.682 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.611 HG12 ' O ' ' A' ' 79' ' ' PHE . 24.3 t -70.88 -54.0 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.781 -1.2 . . . . 0.0 108.752 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 72' ' ' LEU . 9.0 t -58.24 -14.49 7.3 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.598 ' O ' ' CG ' ' A' ' 78' ' ' HIS . 54.8 p -51.21 -37.56 47.45 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.91 -1.119 . . . . 0.0 109.229 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.598 ' CG ' ' O ' ' A' ' 77' ' ' SER . 5.1 m80 -174.41 14.02 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.611 ' O ' HG12 ' A' ' 75' ' ' VAL . 22.7 t80 -142.42 151.24 41.6 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.91 -1.119 . . . . 0.0 110.018 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.568 ' H ' ' HB3' ' A' ' 83' ' ' ASP . . . -116.55 136.24 12.65 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -46.56 -25.92 0.79 Allowed 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.487 -1.007 . . . . 0.0 109.198 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.796 ' HA ' HD12 ' A' ' 85' ' ' ILE . 0.3 OUTLIER -125.09 23.01 7.83 Favored 'General case' 0 C--N 1.292 -1.906 0 O-C-N 120.809 -1.182 . . . . 0.0 107.97 178.866 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.568 ' HB3' ' H ' ' A' ' 80' ' ' GLY . 9.8 p-10 -35.56 116.33 0.36 Allowed 'General case' 0 N--CA 1.507 2.419 0 CA-C-O 121.762 0.792 . . . . 0.0 109.076 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.576 ' N ' ' O ' ' A' ' 109' ' ' GLY . 28.8 t30 63.0 60.88 1.17 Allowed 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.898 0.856 . . . . 0.0 109.426 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.796 HD12 ' HA ' ' A' ' 82' ' ' SER . 21.5 mt -145.94 175.24 2.28 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 O-C-N 121.063 -1.023 . . . . 0.0 109.41 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.637 ' N ' HG22 ' A' ' 85' ' ' ILE . 28.3 mt -111.26 107.48 23.06 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.294 0 CA-C-O 122.181 0.991 . . . . 0.0 109.407 178.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.756 HG22 ' HB3' ' A' ' 36' ' ' LEU . 38.2 t -109.68 155.11 10.96 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 CA-C-O 121.946 0.879 . . . . 0.0 108.906 -175.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -162.41 138.24 5.27 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 34.7 t -94.58 144.12 25.86 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 122.059 0.933 . . . . 0.0 109.268 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 9.9 tm0? -44.2 -35.9 2.44 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.985 0.897 . . . . 0.0 110.444 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 69.5 m -102.78 158.25 16.39 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 122.141 0.972 . . . . 0.0 109.51 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' A' ' 94' ' ' ARG . . . -123.16 168.26 15.38 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 65.22 -70.74 0.09 OUTLIER Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 92' ' ' GLY . 89.9 mtt180 -62.59 -36.05 81.48 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.214 -1.168 . . . . 0.0 108.766 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.404 ' O ' ' OG1' ' A' ' 99' ' ' THR . 7.0 t -85.5 -24.49 27.32 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.183 -0.948 . . . . 0.0 109.25 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.533 HG22 ' N ' ' A' ' 97' ' ' LYS . 1.0 OUTLIER -58.8 -47.45 89.21 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 O-C-N 121.044 -1.035 . . . . 0.0 108.895 179.871 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.533 ' N ' HG22 ' A' ' 96' ' ' ILE . 49.9 pttt -71.38 -30.87 66.64 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.675 -1.266 . . . . 0.0 108.423 177.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.89 -38.11 89.89 Favored 'General case' 0 C--N 1.289 -2.028 0 O-C-N 120.521 -1.362 . . . . 0.0 109.193 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 95' ' ' SER . 0.0 OUTLIER -63.01 -35.37 79.99 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-O 122.539 1.161 . . . . 0.0 108.679 179.65 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.7 m -57.44 -38.25 74.13 Favored 'General case' 0 C--N 1.288 -2.094 0 O-C-N 120.998 -1.064 . . . . 0.0 109.005 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -61.33 -43.32 99.07 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.644 -1.285 . . . . 0.0 108.087 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.2 mt -70.07 -35.03 73.93 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 122.01 0.91 . . . . 0.0 108.848 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 52.0 tp -56.31 -39.77 73.29 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.062 -1.024 . . . . 0.0 108.966 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 30.0 m170 -61.98 -36.48 81.6 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.551 -1.343 . . . . 0.0 108.57 177.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -76.22 -19.22 58.58 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 120.612 -1.305 . . . . 0.0 108.359 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 120.23 83.39 0.78 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -144.55 62.14 1.33 Allowed 'General case' 0 C--N 1.289 -2.032 0 O-C-N 121.09 -1.241 . . . . 0.0 109.35 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.564 ' OG1' ' N ' ' A' ' 109' ' ' GLY . 0.0 OUTLIER -126.47 179.1 5.47 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.642 -1.287 . . . . 0.0 110.136 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.625 ' N ' ' H ' ' A' ' 16' ' ' VAL . . . 85.76 17.76 61.12 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.563 HG21 ' CG2' ' A' ' 87' ' ' VAL . 1.4 m -147.18 163.06 7.72 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 O-C-N 121.081 -1.247 . . . . 0.0 109.858 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.508 ' N ' HG23 ' A' ' 110' ' ' VAL . 61.1 mttp -98.57 141.98 30.73 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 122.218 1.009 . . . . 0.0 108.694 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.463 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 74.4 m-20 -99.44 108.19 20.59 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.634 HD12 ' HB2' ' A' ' 25' ' ' ALA . 7.4 mm -97.64 155.35 3.67 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 O-C-N 121.241 -0.912 . . . . 0.0 110.218 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.439 HG13 ' HA3' ' A' ' 92' ' ' GLY . 38.0 t -99.12 124.18 52.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 O-C-N 120.783 -1.198 . . . . 0.0 109.638 178.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.17 -145.67 23.39 Favored Glycine 0 C--N 1.286 -2.235 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 135.59 -90.26 0.23 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.503 ' O ' ' N ' ' A' ' 121' ' ' ALA . 79.6 t80 -51.77 -41.63 61.77 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 121.989 0.899 . . . . 0.0 109.659 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 18.5 t -57.57 -45.03 85.67 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-O 121.923 0.868 . . . . 0.0 109.39 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.22 -52.57 12.0 Favored 'General case' 0 C--N 1.287 -2.152 0 O-C-N 121.134 -0.979 . . . . 0.0 108.901 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TRP . . . . . 0.584 ' NE1' ' O ' ' A' ' 50' ' ' CYS . 4.9 t-105 -57.93 -35.54 71.23 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.165 -1.421 . . . . 0.0 107.165 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 117' ' ' TYR . . . -63.69 -30.93 71.97 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 120.912 -1.118 . . . . 0.0 108.79 178.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.446 ' HB3' ' HZ2' ' A' ' 122' ' ' LYS . 14.4 ttpp -57.45 -36.39 71.36 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -65.86 -65.19 0.71 Allowed 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.645 -1.284 . . . . 0.0 108.354 178.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 105.87 32.89 3.68 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.482 ' O ' ' CB ' ' A' ' 50' ' ' CYS . 18.6 mt -126.43 79.75 70.32 Favored Pre-proline 0 C--N 1.296 -1.736 0 O-C-N 120.933 -1.334 . . . . 0.0 109.376 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.404 ' HA ' ' H ' ' A' ' 50' ' ' CYS . 30.9 Cg_endo -95.65 115.79 0.17 Allowed 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 122.255 1.97 . . . . 0.0 113.229 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.902 ' H ' ' N ' ' A' ' 50' ' ' CYS . 93.8 m -93.08 132.42 37.21 Favored 'General case' 0 C--N 1.285 -2.212 0 O-C-N 120.733 -1.229 . . . . 0.0 108.996 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.742 ' CB ' ' H ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -175.69 167.21 3.18 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-O 122.178 0.99 . . . . 0.0 108.914 -178.224 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.28 -2.424 0 O-C-N 120.79 -1.193 . . . . 0.0 110.04 -178.424 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 122.188 0.994 . . . . 0.0 109.282 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -94.85 21.35 7.64 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-O 122.002 0.906 . . . . 0.0 109.238 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -52.72 142.33 18.9 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 122.323 1.059 . . . . 0.0 109.63 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.9 m -150.42 83.66 1.36 Allowed 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -164.24 61.95 0.15 Allowed 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.142 0.972 . . . . 0.0 109.781 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.541 HG12 ' HD3' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -142.74 177.3 1.9 Allowed Pre-proline 0 C--N 1.291 -1.976 0 O-C-N 121.347 -0.845 . . . . 0.0 108.92 -179.161 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.541 ' HD3' HG12 ' A' ' 16' ' ' VAL . 29.6 Cg_endo -86.69 135.35 4.13 Favored 'Trans proline' 0 C--N 1.296 -2.194 0 C-N-CA 121.849 1.699 . . . . 0.0 111.426 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 112' ' ' ASP . 32.8 t -140.56 138.99 34.9 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.111 0.958 . . . . 0.0 109.704 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.42 ' OG ' HD11 ' A' ' 96' ' ' ILE . 18.1 t -99.02 143.91 28.77 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-O 122.742 1.258 . . . . 0.0 109.566 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.831 HG13 ' O ' ' A' ' 112' ' ' ASP . 0.2 OUTLIER -148.7 178.9 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 O-C-N 121.013 -1.055 . . . . 0.0 109.41 -178.733 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.713 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 62.6 m -119.14 151.34 38.48 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.499 -1.376 . . . . 0.0 109.415 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.458 HG21 ' HA2' ' A' ' 116' ' ' GLY . 12.5 p -48.62 -27.1 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.273 -2.738 0 CA-C-O 122.159 0.981 . . . . 0.0 108.739 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.509 ' OG1' ' N ' ' A' ' 24' ' ' VAL . 0.1 OUTLIER -65.1 -58.2 6.66 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 120.725 -1.234 . . . . 0.0 109.112 179.853 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.509 ' N ' ' OG1' ' A' ' 23' ' ' THR . 0.0 OUTLIER -60.31 -35.1 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.158 -1.589 . . . . 0.0 109.436 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.54 ' HB2' HD12 ' A' ' 113' ' ' ILE . . . -51.11 -37.3 45.13 Favored 'General case' 0 C--N 1.287 -2.144 0 O-C-N 120.799 -1.188 . . . . 0.0 108.394 178.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -57.66 -44.09 85.43 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -59.9 -43.61 94.72 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 120.904 -1.122 . . . . 0.0 108.697 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.5 ' N ' HD12 ' A' ' 28' ' ' LEU . 9.1 mp -66.46 -33.55 75.94 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.504 ' O ' HD13 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -53.54 -40.44 65.52 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.733 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.429 ' N ' HD12 ' A' ' 30' ' ' LEU . 9.4 mp -63.99 -31.11 72.19 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 120.568 -1.333 . . . . 0.0 107.421 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 28' ' ' LEU . . . -66.9 -28.77 68.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.634 -1.292 . . . . 0.0 108.362 179.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.31 47.28 8.32 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -96.53 156.45 16.34 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 121.148 -1.207 . . . . 0.0 109.621 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -59.17 144.69 45.13 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 122.365 1.079 . . . . 0.0 109.768 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.707 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 1.4 t80 -123.85 112.16 16.95 Favored 'General case' 0 C--N 1.291 -1.964 0 O-C-N 121.381 -0.824 . . . . 0.0 108.973 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.657 ' O ' HG13 ' A' ' 87' ' ' VAL . 8.0 tt -122.16 101.22 7.4 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.649 -1.282 . . . . 0.0 108.529 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.501 ' OD2' ' NH2' ' A' ' 39' ' ' ARG . 80.6 m-20 -98.89 157.3 16.4 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -176.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 38' ' ' VAL . 6.0 m -133.76 89.05 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 CA-C-O 122.396 1.093 . . . . 0.0 108.064 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.779 ' O ' HG23 ' A' ' 40' ' ' THR . 0.0 OUTLIER -81.71 -45.3 15.89 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -179.394 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.779 HG23 ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER 171.58 163.8 0.24 Allowed Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.138 -0.976 . . . . 0.0 109.965 -179.41 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -66.09 -12.97 37.74 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 121.993 1.795 . . . . 0.0 111.125 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -72.81 -37.75 67.42 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.979 -1.076 . . . . 0.0 108.478 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.444 ' OE2' ' O ' ' A' ' 54' ' ' ASN . 2.0 pp20? -58.49 -28.68 65.61 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.726 -1.233 . . . . 0.0 109.04 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -74.08 -42.39 60.22 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 122.148 0.975 . . . . 0.0 108.977 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.9 t -54.83 -37.87 66.7 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.265 -0.897 . . . . 0.0 109.117 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -82.58 -37.27 25.3 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.158 -0.964 . . . . 0.0 108.714 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 43' ' ' GLU . . . 137.93 -139.57 10.49 Favored Glycine 0 N--CA 1.499 2.879 0 CA-C-O 122.298 0.943 . . . . 0.0 110.988 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.791 ' H ' ' CB ' ' A' ' 128' ' ' LYS . 94.7 m-70 -101.58 -161.73 0.88 Allowed 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 122.683 1.23 . . . . 0.0 109.396 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.944 ' HB1' ' CZ2' ' A' ' 120' ' ' TRP . . . -146.79 159.94 42.88 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 122.234 1.016 . . . . 0.0 109.374 -178.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.916 ' N ' ' H ' ' A' ' 127' ' ' THR . 4.6 t -82.53 162.55 21.96 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-O 122.559 1.171 . . . . 0.0 107.863 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.57 -51.39 4.14 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.707 ' HB1' ' HB3' ' A' ' 35' ' ' TYR . . . -157.23 175.37 14.13 Favored 'General case' 0 C--N 1.29 -1.999 0 O-C-N 120.798 -1.413 . . . . 0.0 109.63 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 73.2 mt -101.41 139.11 23.44 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 O-C-N 120.786 -1.196 . . . . 0.0 110.266 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.444 ' O ' ' OE2' ' A' ' 43' ' ' GLU . 43.5 p-10 -131.44 130.79 42.96 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.982 0.896 . . . . 0.0 109.444 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.557 HG12 ' HD2' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -142.99 165.37 26.54 Favored Pre-proline 0 C--N 1.273 -2.719 0 CA-C-O 122.191 0.996 . . . . 0.0 109.146 179.82 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.557 ' HD2' HG12 ' A' ' 55' ' ' VAL . 35.7 Cg_endo -76.88 26.45 0.44 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.468 2.112 . . . . 0.0 111.736 -177.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.542 ' CZ ' ' NE2' ' A' ' 81' ' ' GLN . 90.7 t80 48.0 -91.21 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 122.266 1.032 . . . . 0.0 109.887 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.53 ' N ' ' O ' ' A' ' 56' ' ' PRO . 24.2 ttt -154.18 127.67 8.6 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-O 122.123 0.963 . . . . 0.0 110.023 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.942 ' OD1' ' HB3' ' A' ' 62' ' ' ALA . 50.3 t-20 -154.83 123.98 6.32 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.456 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 0.2 OUTLIER -120.56 122.16 39.97 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.094 -1.004 . . . . 0.0 108.598 179.376 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.476 ' CA ' ' H ' ' A' ' 65' ' ' MET . . . 76.42 -55.22 3.27 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.942 ' HB3' ' OD1' ' A' ' 59' ' ' ASN . . . -54.06 -29.8 45.52 Favored 'General case' 0 C--N 1.28 -2.448 0 O-C-N 121.16 -1.2 . . . . 0.0 108.227 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.9 t -96.11 16.12 18.93 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 61' ' ' GLY . . . 80.49 42.47 10.24 Favored Glycine 0 N--CA 1.501 3.003 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.476 ' H ' ' CA ' ' A' ' 61' ' ' GLY . 72.2 mtm 57.98 59.81 2.98 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 122.305 1.05 . . . . 0.0 110.337 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.7 t -151.5 91.96 1.72 Allowed 'General case' 0 C--N 1.289 -2.037 0 O-C-N 121.14 -0.975 . . . . 0.0 108.431 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.569 ' O ' ' N ' ' A' ' 69' ' ' THR . 1.1 ttmp? -102.61 147.26 27.01 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 122.244 1.021 . . . . 0.0 108.523 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 67' ' ' LYS . 3.4 m120 -39.08 90.8 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 122.176 0.988 . . . . 0.0 110.043 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.866 HG22 ' N ' ' A' ' 70' ' ' ASP . 3.0 m 44.64 -101.9 0.05 Allowed 'General case' 0 C--N 1.281 -2.397 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.888 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.866 ' N ' HG22 ' A' ' 69' ' ' THR . 58.7 t0 -173.68 8.23 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.278 -1.514 . . . . 0.0 108.35 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.549 ' O ' HG13 ' A' ' 75' ' ' VAL . 69.2 m-85 -52.21 -23.63 5.9 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 122.128 0.966 . . . . 0.0 108.858 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.571 ' O ' ' N ' ' A' ' 76' ' ' SER . 3.2 mm? -48.9 -52.34 25.03 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -56.84 -34.93 68.25 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.988 -1.07 . . . . 0.0 108.881 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -73.62 -51.66 16.06 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.812 -1.18 . . . . 0.0 108.661 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.621 ' CG2' ' N ' ' A' ' 76' ' ' SER . 1.0 OUTLIER -76.83 -48.57 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.738 -1.226 . . . . 0.0 108.779 -179.315 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.621 ' N ' ' CG2' ' A' ' 75' ' ' VAL . 63.0 p -52.42 -19.96 2.52 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 t -53.58 -32.31 50.39 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.834 -1.166 . . . . 0.0 109.251 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.413 ' H ' ' H ' ' A' ' 79' ' ' PHE . 81.8 t60 -162.55 -19.09 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.572 ' N ' ' O ' ' A' ' 75' ' ' VAL . 99.1 m-85 -117.19 169.77 9.2 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.003 -1.061 . . . . 0.0 110.014 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.589 ' H ' ' HB2' ' A' ' 83' ' ' ASP . . . -109.58 138.14 14.64 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.542 ' NE2' ' CZ ' ' A' ' 57' ' ' TYR . 4.6 pt20 -45.6 -18.27 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.425 -1.044 . . . . 0.0 109.242 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.845 ' HA ' HD12 ' A' ' 85' ' ' ILE . 19.2 t -123.16 17.57 9.94 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 120.838 -1.164 . . . . 0.0 107.992 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.589 ' HB2' ' H ' ' A' ' 80' ' ' GLY . 11.9 t70 -40.46 107.46 0.07 Allowed 'General case' 0 N--CA 1.508 2.441 0 O-C-N 121.421 -0.799 . . . . 0.0 109.077 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 53.78 70.03 0.65 Allowed 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 121.97 0.89 . . . . 0.0 109.47 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.845 HD12 ' HA ' ' A' ' 82' ' ' SER . 17.7 mt -143.1 168.84 12.71 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 O-C-N 121.021 -1.05 . . . . 0.0 109.402 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.706 HG22 HG13 ' A' ' 113' ' ' ILE . 49.0 mt -110.44 109.66 29.3 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.231 0 CA-C-O 122.188 0.994 . . . . 0.0 109.473 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.657 HG13 ' O ' ' A' ' 36' ' ' LEU . 18.6 t -112.44 166.75 6.26 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 O-C-N 121.219 -0.926 . . . . 0.0 108.898 -177.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.407 ' HA2' ' H ' ' A' ' 113' ' ' ILE . . . -148.97 141.72 9.22 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.502 ' O ' ' C ' ' A' ' 90' ' ' GLN . 0.4 OUTLIER -90.46 140.43 29.73 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 122.127 0.965 . . . . 0.0 109.23 -179.345 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.537 ' H ' ' CD ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -33.46 -89.88 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.992 0.901 . . . . 0.0 110.486 -178.691 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.7 p -149.64 160.36 43.57 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 122.197 0.998 . . . . 0.0 109.521 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.94 119.36 4.31 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.998 ' O ' HG22 ' A' ' 96' ' ' ILE . . . -57.43 -37.81 83.81 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.101 -1.599 . . . . 0.0 109.101 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 34.4 mtp180 -62.7 -28.1 69.71 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.317 -1.108 . . . . 0.0 108.807 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.8 m -62.3 -39.48 93.12 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.189 -0.944 . . . . 0.0 109.325 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.998 HG22 ' O ' ' A' ' 93' ' ' GLY . 15.7 tt -63.73 -30.9 51.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 O-C-N 121.023 -1.048 . . . . 0.0 108.917 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.0 mtpt -70.85 -45.31 64.7 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.706 -1.246 . . . . 0.0 108.411 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.0 -33.24 68.71 Favored 'General case' 0 C--N 1.289 -2.041 0 O-C-N 120.578 -1.326 . . . . 0.0 109.207 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.88 -57.84 2.88 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-O 122.546 1.165 . . . . 0.0 108.737 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 56.4 m -50.42 -43.44 54.88 Favored 'General case' 0 C--N 1.288 -2.093 0 O-C-N 121.039 -1.038 . . . . 0.0 108.984 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -68.41 -45.91 71.37 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.674 -1.266 . . . . 0.0 108.06 178.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.678 HD13 ' C ' ' A' ' 102' ' ' LEU . 3.0 tm? -65.6 -42.87 91.14 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.944 0.878 . . . . 0.0 108.859 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.3 mp -62.96 -36.84 84.8 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 121.088 -1.007 . . . . 0.0 108.915 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -66.62 -17.76 65.01 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.55 -1.344 . . . . 0.0 108.576 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 102' ' ' LEU . . . -62.06 -19.56 63.05 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 120.643 -1.285 . . . . 0.0 108.361 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 135.46 42.18 0.12 Allowed Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -153.35 32.47 0.47 Allowed 'General case' 0 C--N 1.289 -2.063 0 O-C-N 121.079 -1.248 . . . . 0.0 109.391 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.576 ' OG1' ' N ' ' A' ' 109' ' ' GLY . 4.8 t -87.01 -136.73 0.09 Allowed 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.647 -1.283 . . . . 0.0 110.085 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.576 ' N ' ' OG1' ' A' ' 108' ' ' THR . . . 80.08 23.06 62.08 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.61 HG11 ' HB3' ' A' ' 82' ' ' SER . 1.8 m -143.63 165.67 14.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 O-C-N 121.021 -1.282 . . . . 0.0 109.901 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.519 ' N ' HG23 ' A' ' 110' ' ' VAL . 63.0 mttm -99.27 153.29 19.06 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-O 122.212 1.006 . . . . 0.0 108.729 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.831 ' O ' HG13 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -108.31 115.72 30.63 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.706 HG13 HG22 ' A' ' 86' ' ' ILE . 1.2 mm -100.88 127.99 53.48 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 O-C-N 121.291 -0.881 . . . . 0.0 110.279 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 71.8 t -99.5 137.09 28.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 O-C-N 120.766 -1.209 . . . . 0.0 109.701 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.6 -154.21 30.87 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.458 ' HA2' HG21 ' A' ' 22' ' ' VAL . . . 89.73 -47.33 3.2 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.496 ' O ' ' HB2' ' A' ' 121' ' ' ALA . 46.4 t80 -52.15 -53.64 40.45 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 121.97 0.89 . . . . 0.0 109.637 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 67.8 p -71.52 -34.54 70.17 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.886 0.851 . . . . 0.0 109.33 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.23 -54.72 8.76 Favored 'General case' 0 C--N 1.286 -2.162 0 O-C-N 121.18 -0.95 . . . . 0.0 108.936 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TRP . . . . . 0.944 ' CZ2' ' HB1' ' A' ' 49' ' ' ALA . 28.0 t90 -60.07 -34.87 74.03 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' A' ' 117' ' ' TYR . . . -52.45 -36.74 55.36 Favored 'General case' 0 C--N 1.291 -1.942 0 O-C-N 120.88 -1.138 . . . . 0.0 108.763 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -60.7 -26.87 67.45 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.776 ' ND2' ' H ' ' A' ' 125' ' ' LEU . 6.1 p-10 -54.02 -49.26 69.31 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 120.685 -1.259 . . . . 0.0 108.373 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.681 ' N ' ' OD1' ' A' ' 123' ' ' ASN . . . 71.22 18.8 76.93 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.776 ' H ' ' ND2' ' A' ' 123' ' ' ASN . 15.0 mt -124.34 98.14 38.76 Favored Pre-proline 0 C--N 1.298 -1.667 0 O-C-N 120.859 -1.377 . . . . 0.0 109.405 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.48 ' O ' ' NZ ' ' A' ' 128' ' ' LYS . 45.9 Cg_endo -93.29 117.96 0.34 Allowed 'Trans proline' 0 C--N 1.301 -1.946 0 C-N-CA 122.339 2.026 . . . . 0.0 113.28 178.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.916 ' H ' ' N ' ' A' ' 50' ' ' CYS . 53.2 m -92.96 126.19 37.92 Favored 'General case' 0 C--N 1.286 -2.186 0 O-C-N 120.713 -1.242 . . . . 0.0 108.964 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.791 ' CB ' ' H ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -175.46 148.38 0.92 Allowed 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 122.204 1.002 . . . . 0.0 108.933 -178.224 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.281 -2.399 0 O-C-N 120.762 -1.211 . . . . 0.0 109.992 -178.633 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.206 -1.19 0 CA-C-O 122.147 0.975 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -140.93 65.64 1.39 Allowed 'General case' 0 C--N 1.283 -2.292 0 CA-C-O 121.996 0.903 . . . . 0.0 109.198 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -142.09 142.52 32.82 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-O 122.245 1.021 . . . . 0.0 109.69 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 60.1 p -84.42 160.82 20.53 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.65 105.21 3.27 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 122.239 1.019 . . . . 0.0 109.741 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.559 HG12 ' HD3' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -144.87 177.46 1.77 Allowed Pre-proline 0 C--N 1.291 -1.951 0 O-C-N 121.193 -0.942 . . . . 0.0 108.965 -179.624 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.559 ' HD3' HG12 ' A' ' 16' ' ' VAL . 27.4 Cg_endo -86.61 140.76 6.29 Favored 'Trans proline' 0 C--N 1.296 -2.186 0 C-N-CA 121.917 1.744 . . . . 0.0 111.344 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.9 t -144.53 150.1 36.99 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 122.035 0.922 . . . . 0.0 109.779 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.713 ' HB3' HD11 ' A' ' 96' ' ' ILE . 95.2 p -101.02 139.55 36.56 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-O 122.632 1.206 . . . . 0.0 109.661 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.596 HG13 ' O ' ' A' ' 112' ' ' ASP . 0.6 OUTLIER -150.17 158.61 5.42 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.185 0 O-C-N 121.023 -1.048 . . . . 0.0 109.318 -178.641 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.645 ' HB3' HG22 ' A' ' 23' ' ' THR . 1.2 m -117.12 160.09 21.56 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.484 -1.385 . . . . 0.0 109.448 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.564 HG21 ' CB ' ' A' ' 119' ' ' ALA . 9.0 p -49.44 -31.61 5.68 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.81 0 CA-C-O 122.132 0.968 . . . . 0.0 108.669 -178.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.645 HG22 ' HB3' ' A' ' 21' ' ' SER . 0.0 OUTLIER -59.7 -56.16 25.38 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 120.718 -1.239 . . . . 0.0 109.144 179.484 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.614 ' H ' HG23 ' A' ' 23' ' ' THR . 0.1 OUTLIER -65.51 -35.66 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.106 -1.622 . . . . 0.0 109.461 178.864 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.57 ' HB2' HD12 ' A' ' 113' ' ' ILE . . . -55.54 -36.16 66.47 Favored 'General case' 0 C--N 1.286 -2.157 0 O-C-N 120.85 -1.156 . . . . 0.0 108.354 178.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -56.18 -47.03 79.09 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -60.9 -42.19 97.54 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.961 -1.087 . . . . 0.0 108.769 178.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.444 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 69.5 mt -67.58 -31.69 71.92 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.0 tt -56.86 -39.19 73.83 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.3 mp -62.91 -29.85 71.09 Favored 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 28' ' ' LEU . . . -66.19 -28.87 69.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.705 -1.247 . . . . 0.0 108.448 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.19 49.3 27.45 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.8 t60 -102.56 170.21 8.17 Favored 'General case' 0 C--N 1.292 -1.923 0 O-C-N 121.055 -1.262 . . . . 0.0 109.571 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -59.96 128.05 34.91 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.377 1.084 . . . . 0.0 109.773 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.444 ' CE2' ' OD1' ' A' ' 37' ' ' ASP . 16.0 t80 -109.92 106.64 16.27 Favored 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.307 -0.871 . . . . 0.0 108.945 -178.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.813 ' HB3' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -99.92 135.44 41.35 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.541 -1.349 . . . . 0.0 108.611 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.734 ' H ' HD13 ' A' ' 36' ' ' LEU . 14.2 m-20 -138.45 138.19 37.91 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 38' ' ' VAL . 11.9 m -132.55 75.31 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 CA-C-O 122.358 1.075 . . . . 0.0 108.1 177.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.655 ' O ' HG23 ' A' ' 40' ' ' THR . 0.4 OUTLIER -82.93 -41.94 18.26 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -179.604 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.655 HG23 ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER 176.37 144.42 0.24 Allowed Pre-proline 0 C--N 1.3 -1.577 0 O-C-N 121.131 -0.981 . . . . 0.0 109.981 -179.658 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -43.14 -27.96 1.22 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.02 1.813 . . . . 0.0 111.102 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -70.02 -30.9 68.31 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.865 -1.147 . . . . 0.0 108.498 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.563 ' CD ' ' HE ' ' A' ' 39' ' ' ARG . 42.1 tp10 -54.42 -33.95 60.43 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.687 -1.258 . . . . 0.0 109.014 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -79.06 -37.12 39.73 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 122.116 0.96 . . . . 0.0 108.854 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.413 ' C ' ' H ' ' A' ' 47' ' ' GLY . 11.2 t -65.95 -40.97 91.82 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.224 -0.922 . . . . 0.0 109.031 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.495 ' NE2' ' O ' ' A' ' 47' ' ' GLY . 5.4 pp0? -75.69 9.5 2.26 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.104 -0.997 . . . . 0.0 108.627 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.495 ' O ' ' NE2' ' A' ' 46' ' ' GLN . . . 89.97 -160.41 28.53 Favored Glycine 0 N--CA 1.5 2.936 0 CA-C-O 122.299 0.944 . . . . 0.0 110.966 178.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.68 ' H ' ' CB ' ' A' ' 128' ' ' LYS . 34.5 m170 -103.05 -159.32 0.72 Allowed 'General case' 0 C--N 1.289 -2.032 0 CA-C-O 122.752 1.263 . . . . 0.0 109.372 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 1.049 ' HB3' ' HB3' ' A' ' 52' ' ' ALA . . . -141.91 169.58 17.32 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 122.207 1.003 . . . . 0.0 109.352 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.942 ' N ' ' H ' ' A' ' 127' ' ' THR . 5.2 t -82.67 106.62 14.67 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.79 25.75 55.39 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 1.049 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . . . -149.29 124.26 9.99 Favored 'General case' 0 C--N 1.29 -1.984 0 O-C-N 120.897 -1.355 . . . . 0.0 109.631 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 29.3 mt -116.99 113.19 42.15 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 O-C-N 120.722 -1.236 . . . . 0.0 110.216 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.566 HD21 ' HD3' ' A' ' 56' ' ' PRO . 3.9 t30 -98.03 135.0 40.36 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 122.01 0.909 . . . . 0.0 109.383 -177.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.42 ' O ' HG12 ' A' ' 55' ' ' VAL . 8.9 t -140.24 92.19 9.59 Favored Pre-proline 0 C--N 1.274 -2.706 0 CA-C-O 122.152 0.977 . . . . 0.0 109.093 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.566 ' HD3' HD21 ' A' ' 54' ' ' ASN . 30.0 Cg_endo -74.12 86.07 1.32 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.473 2.115 . . . . 0.0 111.769 -178.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.52 ' O ' ' SD ' ' A' ' 58' ' ' MET . 11.3 t80 -64.14 -61.27 2.37 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 122.291 1.043 . . . . 0.0 109.818 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.52 ' SD ' ' O ' ' A' ' 57' ' ' TYR . 16.2 mmt -143.02 149.71 38.64 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-O 122.105 0.955 . . . . 0.0 110.082 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -149.69 120.51 7.6 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.434 ' O ' ' CG ' ' A' ' 60' ' ' ARG . 22.2 ptt180 -94.89 124.11 38.75 Favored 'General case' 0 N--CA 1.504 2.272 0 CA-C-O 122.244 1.021 . . . . 0.0 108.567 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 63' ' ' SER . . . 75.97 -52.47 2.89 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.62 -7.58 0.69 Allowed 'General case' 0 C--N 1.28 -2.417 0 O-C-N 121.068 -1.254 . . . . 0.0 108.246 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.496 ' H ' ' C ' ' A' ' 61' ' ' GLY . 4.8 t -127.35 14.46 7.17 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 107.545 -1.279 . . . . 0.0 107.545 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.41 46.25 9.11 Favored Glycine 0 N--CA 1.503 3.101 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 71.6 mtm 55.95 87.61 0.05 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 122.34 1.067 . . . . 0.0 110.306 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.9 m -168.51 92.48 0.31 Allowed 'General case' 0 C--N 1.29 -1.991 0 O-C-N 121.136 -0.977 . . . . 0.0 108.459 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -128.39 121.91 30.18 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.094 -1.004 . . . . 0.0 108.545 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.467 ' CB ' ' SD ' ' A' ' 58' ' ' MET . 8.5 t-20 -61.03 168.5 2.42 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 122.234 1.016 . . . . 0.0 109.997 -178.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -160.63 51.4 0.28 Allowed 'General case' 0 C--N 1.28 -2.415 0 O-C-N 121.493 -0.754 . . . . 0.0 109.873 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -127.3 -44.81 1.55 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.381 -1.45 . . . . 0.0 108.272 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.487 ' O ' ' N ' ' A' ' 74' ' ' GLN . 97.6 m-85 -57.77 -22.02 44.74 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 122.073 0.94 . . . . 0.0 108.837 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.655 HD23 ' N ' ' A' ' 72' ' ' LEU . 2.2 mt -46.66 -45.47 19.3 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 122.03 0.919 . . . . 0.0 108.679 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -58.27 -36.61 73.53 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.89 -1.131 . . . . 0.0 108.88 176.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 71' ' ' PHE . 43.3 mt-30 -81.76 -49.26 10.62 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.832 -1.168 . . . . 0.0 108.67 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.403 ' N ' ' O ' ' A' ' 71' ' ' PHE . 50.8 t -64.76 -43.85 96.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.758 -1.213 . . . . 0.0 108.735 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 72' ' ' LEU . 18.4 t -66.21 -19.93 65.97 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.572 ' O ' ' CG ' ' A' ' 78' ' ' HIS . 8.0 t -52.9 -49.77 65.24 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.858 -1.151 . . . . 0.0 109.252 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.572 ' CG ' ' O ' ' A' ' 77' ' ' SER . 0.3 OUTLIER 168.7 -10.81 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.014 -1.054 . . . . 0.0 108.223 179.613 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -101.2 150.11 23.3 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.921 -1.112 . . . . 0.0 110.026 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.552 ' H ' ' HB2' ' A' ' 83' ' ' ASP . . . -114.26 142.89 17.8 Favored Glycine 0 N--CA 1.498 2.768 0 N-CA-C 110.476 -1.049 . . . . 0.0 110.476 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' A' ' 80' ' ' GLY . 9.6 tp60 -44.38 -43.48 7.65 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.451 -1.029 . . . . 0.0 109.166 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.563 ' HA ' HD12 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -122.22 24.15 9.54 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 120.837 -1.164 . . . . 0.0 107.972 179.324 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.552 ' HB2' ' H ' ' A' ' 80' ' ' GLY . 19.4 t0 -34.97 118.07 0.42 Allowed 'General case' 0 N--CA 1.506 2.364 0 CA-C-O 121.715 0.769 . . . . 0.0 109.108 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.612 ' N ' ' O ' ' A' ' 109' ' ' GLY . 6.8 t-20 65.56 60.7 0.72 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.891 0.853 . . . . 0.0 109.418 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.669 HG22 ' N ' ' A' ' 86' ' ' ILE . 12.0 mt -150.14 177.67 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 O-C-N 121.064 -1.023 . . . . 0.0 109.496 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.669 ' N ' HG22 ' A' ' 85' ' ' ILE . 63.7 mt -111.14 108.33 25.21 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.257 0 CA-C-O 122.195 0.997 . . . . 0.0 109.323 178.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.813 HG22 ' HB3' ' A' ' 36' ' ' LEU . 14.1 t -114.98 166.47 8.74 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-O 121.943 0.878 . . . . 0.0 108.892 -176.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -148.66 142.03 9.57 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 49.7 t -92.64 148.3 22.18 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 122.079 0.942 . . . . 0.0 109.303 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -41.74 -36.3 0.97 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 122.003 0.906 . . . . 0.0 110.402 -178.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 96.3 p -132.71 159.02 40.88 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 122.257 1.027 . . . . 0.0 109.444 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 94' ' ' ARG . . . -110.58 -178.58 20.65 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 68.39 -72.33 0.33 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 92' ' ' GLY . 0.0 OUTLIER -67.57 -29.59 68.99 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.182 -1.187 . . . . 0.0 108.824 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.755 ' O ' HG23 ' A' ' 99' ' ' THR . 54.4 p -84.51 -29.12 26.22 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.187 -0.946 . . . . 0.0 109.27 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.713 HD11 ' HB3' ' A' ' 19' ' ' SER . 0.4 OUTLIER -55.53 -48.71 77.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 O-C-N 121.092 -1.005 . . . . 0.0 108.836 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.557 ' N ' ' CG2' ' A' ' 96' ' ' ILE . 4.6 ptmm? -70.67 -40.84 72.74 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.63 -1.294 . . . . 0.0 108.39 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.05 -40.96 95.5 Favored 'General case' 0 C--N 1.289 -2.026 0 O-C-N 120.544 -1.347 . . . . 0.0 109.294 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.755 HG23 ' O ' ' A' ' 95' ' ' SER . 35.7 p -64.46 -54.57 30.52 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-O 122.553 1.168 . . . . 0.0 108.683 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.543 ' O ' ' CG ' ' A' ' 104' ' ' HIS . 35.5 m -46.22 -37.35 7.04 Favored 'General case' 0 C--N 1.287 -2.14 0 O-C-N 121.06 -1.025 . . . . 0.0 108.992 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -87.11 -50.65 6.49 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.62 -1.3 . . . . 0.0 108.077 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.714 HD13 ' C ' ' A' ' 102' ' ' LEU . 1.9 tm? -61.36 -44.45 97.15 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.982 0.896 . . . . 0.0 108.889 -178.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 99' ' ' THR . 70.5 mt -63.14 -38.58 91.76 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.113 -0.992 . . . . 0.0 108.975 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.543 ' CG ' ' O ' ' A' ' 100' ' ' THR . 1.2 m-70 -59.88 -18.58 45.69 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.641 -1.287 . . . . 0.0 108.574 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 102' ' ' LEU . . . -62.01 -19.38 62.77 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 120.629 -1.295 . . . . 0.0 108.326 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 128.78 7.88 4.04 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -103.0 17.65 23.55 Favored 'General case' 0 C--N 1.289 -2.032 0 O-C-N 121.082 -1.246 . . . . 0.0 109.395 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.543 ' OG1' ' N ' ' A' ' 17' ' ' PRO . 8.7 t -78.98 -150.73 0.05 Allowed 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.669 -1.269 . . . . 0.0 110.074 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.612 ' O ' ' N ' ' A' ' 84' ' ' ASN . . . 77.45 19.43 76.37 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.48 HG23 ' N ' ' A' ' 111' ' ' LYS . 1.6 m -146.62 166.7 7.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 O-C-N 120.999 -1.295 . . . . 0.0 109.898 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.48 ' N ' HG23 ' A' ' 110' ' ' VAL . 84.9 mttt -97.88 145.48 26.39 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 122.211 1.005 . . . . 0.0 108.71 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.596 ' O ' HG13 ' A' ' 20' ' ' VAL . 51.4 t0 -99.95 109.78 22.13 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.639 HD11 ' CG2' ' A' ' 86' ' ' ILE . 1.2 mm -94.88 138.85 19.83 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.39 0 O-C-N 121.229 -0.919 . . . . 0.0 110.291 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 71.5 t -99.48 143.83 12.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 O-C-N 120.838 -1.163 . . . . 0.0 109.684 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 79.41 -117.2 4.47 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.4 -84.78 1.0 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -55.73 -43.98 77.09 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-O 122.031 0.919 . . . . 0.0 109.671 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 36.6 m -59.92 -39.27 84.9 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-O 121.947 0.879 . . . . 0.0 109.376 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.564 ' CB ' HG21 ' A' ' 22' ' ' VAL . . . -72.55 -50.22 27.15 Favored 'General case' 0 C--N 1.286 -2.159 0 O-C-N 121.096 -1.003 . . . . 0.0 108.882 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TRP . . . . . 0.595 ' NE1' ' O ' ' A' ' 50' ' ' CYS . 1.0 OUTLIER -53.92 -39.25 65.68 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.332 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.63 -25.81 68.39 Favored 'General case' 0 C--N 1.292 -1.924 0 O-C-N 120.834 -1.166 . . . . 0.0 108.838 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.578 ' CB ' ' HZ2' ' A' ' 122' ' ' LYS . 2.4 ttmp? -56.97 -42.66 80.6 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -90.76 -67.68 0.84 Allowed 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.624 -1.298 . . . . 0.0 108.358 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 113.18 48.09 0.62 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.463 ' O ' ' CB ' ' A' ' 50' ' ' CYS . 14.3 mt -126.55 78.67 72.14 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 120.834 -1.392 . . . . 0.0 109.314 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.564 ' HB2' ' HZ3' ' A' ' 128' ' ' LYS . 31.7 Cg_endo -95.09 118.17 0.23 Allowed 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 122.274 1.983 . . . . 0.0 113.212 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.942 ' H ' ' N ' ' A' ' 50' ' ' CYS . 93.7 m -93.8 136.07 34.46 Favored 'General case' 0 C--N 1.286 -2.174 0 O-C-N 120.668 -1.27 . . . . 0.0 109.039 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.68 ' CB ' ' H ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -175.48 146.78 0.81 Allowed 'General case' 0 C--N 1.289 -2.038 0 CA-C-O 122.213 1.006 . . . . 0.0 108.943 -178.202 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.28 -2.414 0 O-C-N 120.794 -1.191 . . . . 0.0 110.019 -178.399 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 122.158 0.98 . . . . 0.0 109.175 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -82.14 9.6 8.31 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-O 121.97 0.89 . . . . 0.0 109.172 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.539 ' O ' ' CB ' ' A' ' 14' ' ' SER . 71.5 mm-40 -62.71 -147.99 0.0 OUTLIER 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 122.247 1.022 . . . . 0.0 109.696 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.539 ' CB ' ' O ' ' A' ' 13' ' ' GLU . 1.8 p 81.39 142.79 0.07 Allowed 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 -125.05 125.65 44.15 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.132 0.967 . . . . 0.0 109.715 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.512 HG12 ' HD2' ' A' ' 17' ' ' PRO . 3.5 t -143.11 149.0 47.28 Favored Pre-proline 0 C--N 1.29 -1.98 0 O-C-N 121.287 -0.883 . . . . 0.0 108.911 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.921 ' CB ' HD21 ' A' ' 103' ' ' LEU . 39.9 Cg_endo -90.78 161.91 4.13 Favored 'Trans proline' 0 C--N 1.298 -2.104 0 C-N-CA 121.885 1.723 . . . . 0.0 111.399 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.0 t -161.23 152.55 18.88 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 122.107 0.956 . . . . 0.0 109.721 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 89.0 p -108.5 144.47 36.11 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 122.694 1.235 . . . . 0.0 109.65 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.687 HG23 ' N ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -144.76 177.76 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 O-C-N 120.993 -1.067 . . . . 0.0 109.4 -178.495 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.687 ' N ' HG23 ' A' ' 20' ' ' VAL . 71.7 m -119.55 151.82 38.0 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.47 -1.394 . . . . 0.0 109.435 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.758 ' CG2' ' HB2' ' A' ' 119' ' ' ALA . 6.5 p -47.53 -33.21 2.99 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.793 0 CA-C-O 122.126 0.965 . . . . 0.0 108.695 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.51 ' OG1' ' N ' ' A' ' 24' ' ' VAL . 0.1 OUTLIER -56.26 -56.77 16.87 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 120.728 -1.233 . . . . 0.0 109.12 179.225 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.51 ' N ' ' OG1' ' A' ' 23' ' ' THR . 0.1 OUTLIER -65.42 -34.74 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.131 -1.605 . . . . 0.0 109.377 179.101 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.947 ' HB2' HD13 ' A' ' 113' ' ' ILE . . . -50.92 -37.43 44.0 Favored 'General case' 0 C--N 1.287 -2.132 0 O-C-N 120.825 -1.172 . . . . 0.0 108.39 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -59.55 -47.83 84.03 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -60.25 -44.45 95.25 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 120.885 -1.134 . . . . 0.0 108.675 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.6 mt -68.7 -53.16 23.86 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.465 ' CD2' ' C ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -58.71 -43.1 89.98 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.016 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.707 HD13 ' C ' ' A' ' 30' ' ' LEU . 1.4 tm? -58.41 -34.71 71.05 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.466 ' HB3' ' CE1' ' A' ' 33' ' ' HIS . . . -71.09 -19.87 62.41 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.712 -1.243 . . . . 0.0 108.391 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.07 49.6 1.88 Allowed Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.466 ' CE1' ' HB3' ' A' ' 31' ' ' ALA . 39.3 m80 -107.4 139.39 41.96 Favored 'General case' 0 C--N 1.291 -1.969 0 O-C-N 121.234 -1.156 . . . . 0.0 109.592 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 36.9 mtt-85 -61.82 141.11 58.13 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 122.331 1.062 . . . . 0.0 109.846 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -125.62 118.06 24.87 Favored 'General case' 0 C--N 1.291 -1.96 0 O-C-N 121.38 -0.825 . . . . 0.0 108.968 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.815 ' HB2' HG22 ' A' ' 87' ' ' VAL . 17.6 mt -92.62 108.2 19.8 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 120.616 -1.303 . . . . 0.0 108.604 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.545 ' OD2' ' NE2' ' A' ' 48' ' ' HIS . 41.0 t0 -90.81 122.97 33.99 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -178.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.756 HG12 ' O ' ' A' ' 55' ' ' VAL . 20.2 m -134.17 87.81 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 CA-C-O 122.502 1.144 . . . . 0.0 108.125 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.744 ' O ' HG23 ' A' ' 40' ' ' THR . 24.5 mtp180 -83.59 -46.08 12.79 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.744 HG23 ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER 172.92 165.64 0.27 Allowed Pre-proline 0 N--CA 1.49 1.564 0 C-N-CA 119.296 -0.962 . . . . 0.0 109.925 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -53.33 -35.43 74.7 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.04 1.827 . . . . 0.0 111.085 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -61.0 -30.43 70.28 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.894 -1.128 . . . . 0.0 108.48 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.593 ' O ' ' N ' ' A' ' 47' ' ' GLY . 83.5 tt0 -55.79 -30.63 61.65 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.755 -1.216 . . . . 0.0 108.968 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -72.6 -38.32 67.85 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 122.176 0.989 . . . . 0.0 108.933 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.6 t -51.49 -48.36 62.92 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.175 -0.953 . . . . 0.0 109.167 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -103.73 -20.75 13.85 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.147 -0.97 . . . . 0.0 108.621 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 43' ' ' GLU . . . 82.37 -172.53 52.47 Favored Glycine 0 N--CA 1.5 2.915 0 CA-C-O 122.289 0.938 . . . . 0.0 110.985 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.674 ' H ' ' C ' ' A' ' 129' ' ' ALA . 2.1 t60 176.13 101.71 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.034 0 CA-C-O 122.645 1.212 . . . . 0.0 109.395 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 1.059 ' H ' ' N ' ' A' ' 128' ' ' LYS . . . -160.45 147.7 15.94 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 122.26 1.029 . . . . 0.0 109.388 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.4 t -176.32 44.72 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.264 0 CA-C-O 122.548 1.166 . . . . 0.0 107.869 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 117.85 23.81 3.53 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.984 ' HB2' ' CZ2' ' A' ' 120' ' ' TRP . . . -154.11 179.16 9.19 Favored 'General case' 0 C--N 1.289 -2.045 0 O-C-N 120.861 -1.376 . . . . 0.0 109.639 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 77.1 mt -123.47 147.97 27.62 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 O-C-N 120.832 -1.168 . . . . 0.0 110.3 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -131.55 143.57 50.46 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.954 0.883 . . . . 0.0 109.499 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.765 ' O ' HG12 ' A' ' 55' ' ' VAL . 1.1 t -140.62 91.89 9.25 Favored Pre-proline 0 C--N 1.274 -2.717 0 CA-C-O 122.205 1.002 . . . . 0.0 109.089 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.566 ' O ' ' N ' ' A' ' 58' ' ' MET . 36.9 Cg_endo -78.77 66.26 8.66 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.524 2.149 . . . . 0.0 111.806 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 52.39 -85.85 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 122.375 1.083 . . . . 0.0 109.826 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.566 ' N ' ' O ' ' A' ' 56' ' ' PRO . 73.9 mtm -86.79 131.17 34.2 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-O 122.158 0.98 . . . . 0.0 110.051 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.747 ' OD1' ' HB3' ' A' ' 62' ' ' ALA . 47.3 t-20 -142.43 116.83 9.61 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.424 ' O ' ' CG ' ' A' ' 60' ' ' ARG . 22.1 ptt180 -111.48 124.75 52.91 Favored 'General case' 0 N--CA 1.504 2.25 0 CA-C-O 122.255 1.026 . . . . 0.0 108.627 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.405 ' HA2' ' H ' ' A' ' 65' ' ' MET . . . 77.52 -58.36 3.75 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 178.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.747 ' HB3' ' OD1' ' A' ' 59' ' ' ASN . . . -53.43 -28.97 32.83 Favored 'General case' 0 C--N 1.281 -2.41 0 O-C-N 121.161 -1.199 . . . . 0.0 108.254 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.445 ' OG ' ' ND2' ' A' ' 59' ' ' ASN . 2.1 m -97.56 6.35 48.2 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 61' ' ' GLY . . . 85.66 47.47 5.09 Favored Glycine 0 N--CA 1.501 3.0 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.405 ' H ' ' HA2' ' A' ' 61' ' ' GLY . 72.7 mtm 56.64 61.19 2.74 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 122.332 1.063 . . . . 0.0 110.31 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.5 m -165.92 94.08 0.56 Allowed 'General case' 0 C--N 1.29 -2.012 0 O-C-N 121.17 -0.956 . . . . 0.0 108.422 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.7 ptpp? -98.13 142.98 29.14 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 122.24 1.019 . . . . 0.0 108.535 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.417 ' O ' ' OG1' ' A' ' 69' ' ' THR . 42.7 m-20 -50.64 128.91 21.61 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 122.219 1.009 . . . . 0.0 109.999 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 68' ' ' ASN . 4.7 m -167.01 -29.17 0.02 OUTLIER 'General case' 0 C--N 1.282 -2.363 0 O-C-N 121.507 -0.746 . . . . 0.0 109.943 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.428 ' OD2' ' OE1' ' A' ' 73' ' ' GLU . 16.0 p30 -150.74 68.07 0.95 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.37 -1.456 . . . . 0.0 108.32 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.659 ' HE1' HE22 ' A' ' 81' ' ' GLN . 34.2 m-85 -48.34 -26.56 2.09 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 122.106 0.955 . . . . 0.0 108.85 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 76' ' ' SER . 3.0 mt -54.44 -46.7 73.3 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.916 0.865 . . . . 0.0 108.712 -178.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.432 ' CG ' ' N ' ' A' ' 74' ' ' GLN . 10.9 pt-20 -54.86 -37.75 66.63 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.911 -1.118 . . . . 0.0 108.941 177.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.432 ' N ' ' CG ' ' A' ' 73' ' ' GLU . 77.1 mt-30 -82.52 -48.25 11.24 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.761 -1.212 . . . . 0.0 108.682 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 71' ' ' PHE . 19.8 t -66.84 -44.18 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.783 -1.198 . . . . 0.0 108.74 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.583 ' N ' ' O ' ' A' ' 72' ' ' LEU . 44.6 t -51.68 -36.99 48.67 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.544 ' O ' ' CB ' ' A' ' 78' ' ' HIS . 53.0 p -71.35 1.39 6.3 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.896 -1.127 . . . . 0.0 109.168 178.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.544 ' CB ' ' O ' ' A' ' 77' ' ' SER . 5.1 t-80 78.44 45.14 0.06 Allowed 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.05 -1.032 . . . . 0.0 108.252 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.536 ' CG ' ' O ' ' A' ' 78' ' ' HIS . 65.8 m-85 -162.08 133.06 5.08 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.015 -1.053 . . . . 0.0 109.969 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.66 ' H ' ' HB3' ' A' ' 83' ' ' ASP . . . -114.19 134.78 11.98 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.659 HE22 ' HE1' ' A' ' 71' ' ' PHE . 2.8 pt20 -48.03 -21.19 0.42 Allowed 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.454 -1.027 . . . . 0.0 109.173 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.812 ' HA ' HD12 ' A' ' 85' ' ' ILE . 54.4 m -123.73 15.54 9.44 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.847 -1.158 . . . . 0.0 107.914 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.66 ' HB3' ' H ' ' A' ' 80' ' ' GLY . 12.6 p30 -45.78 109.91 0.22 Allowed 'General case' 0 N--CA 1.507 2.396 0 O-C-N 121.406 -0.809 . . . . 0.0 109.123 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 58.61 64.07 1.54 Allowed 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.973 0.892 . . . . 0.0 109.4 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.812 HD12 ' HA ' ' A' ' 82' ' ' SER . 24.1 mt -142.25 176.32 3.95 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 O-C-N 121.025 -1.047 . . . . 0.0 109.408 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.889 HG23 ' HB2' ' A' ' 111' ' ' LYS . 6.7 mt -121.78 112.57 35.61 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 O-C-N 121.106 -0.997 . . . . 0.0 109.403 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.815 HG22 ' HB2' ' A' ' 36' ' ' LEU . 92.6 t -100.56 -179.68 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 O-C-N 121.281 -0.887 . . . . 0.0 108.919 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.67 ' H ' HG12 ' A' ' 87' ' ' VAL . . . -175.09 140.13 5.13 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 46.3 t -110.61 146.69 35.69 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-O 122.07 0.938 . . . . 0.0 109.283 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.45 ' CD ' HH21 ' A' ' 39' ' ' ARG . 65.0 tt0 -42.57 -70.69 0.1 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.022 0.915 . . . . 0.0 110.464 -178.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.1 t -72.13 160.22 32.82 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 122.238 1.018 . . . . 0.0 109.453 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 94' ' ' ARG . . . -132.25 174.72 20.19 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.415 ' O ' HG22 ' A' ' 96' ' ' ILE . . . 61.67 -76.32 0.02 OUTLIER Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.53 ' N ' ' O ' ' A' ' 92' ' ' GLY . 1.1 ttt-85 -65.93 -37.19 85.42 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.216 -1.167 . . . . 0.0 108.778 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.2 t -87.65 -27.6 22.36 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 121.188 -0.945 . . . . 0.0 109.254 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.585 ' CG2' ' N ' ' A' ' 97' ' ' LYS . 2.6 tt -59.07 -48.82 85.47 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 O-C-N 121.084 -1.01 . . . . 0.0 108.879 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.585 ' N ' ' CG2' ' A' ' 96' ' ' ILE . 17.1 pttp -63.99 -35.67 81.47 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.697 -1.252 . . . . 0.0 108.449 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.97 -43.05 79.91 Favored 'General case' 0 C--N 1.288 -2.074 0 O-C-N 120.534 -1.354 . . . . 0.0 109.206 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 103' ' ' LEU . 30.5 p -77.95 -50.58 11.9 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-O 122.573 1.177 . . . . 0.0 108.697 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.535 ' O ' ' N ' ' A' ' 104' ' ' HIS . 60.3 m -53.91 -49.4 68.7 Favored 'General case' 0 C--N 1.288 -2.102 0 O-C-N 121.012 -1.055 . . . . 0.0 109.033 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -61.94 -46.14 90.63 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.627 -1.296 . . . . 0.0 108.17 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.776 ' O ' HD13 ' A' ' 102' ' ' LEU . 2.5 tm? -64.63 -40.79 96.09 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.305 -0.872 . . . . 0.0 108.808 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.921 HD21 ' CB ' ' A' ' 17' ' ' PRO . 0.3 OUTLIER -75.19 -30.55 60.69 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.122 -0.986 . . . . 0.0 108.966 178.358 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.535 ' N ' ' O ' ' A' ' 100' ' ' THR . 84.0 t60 -53.39 -34.71 58.77 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.597 -1.315 . . . . 0.0 108.606 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -131.23 35.56 3.89 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 120.573 -1.329 . . . . 0.0 108.301 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -148.13 -37.23 0.04 OUTLIER Glycine 0 N--CA 1.495 2.586 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.478 ' O ' ' O ' ' A' ' 103' ' ' LEU . 66.5 m-85 -134.83 164.18 28.13 Favored 'General case' 0 C--N 1.288 -2.078 0 O-C-N 121.235 -1.156 . . . . 0.0 109.414 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.3 t -176.27 151.03 0.97 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.538 -1.351 . . . . 0.0 110.126 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.65 21.97 38.39 Favored Glycine 0 N--CA 1.498 2.814 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.412 HG11 ' CB ' ' A' ' 82' ' ' SER . 1.9 m -148.03 155.86 9.59 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 O-C-N 121.064 -1.257 . . . . 0.0 109.932 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.889 ' HB2' HG23 ' A' ' 86' ' ' ILE . 52.8 mttp -98.87 158.81 15.39 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 122.252 1.025 . . . . 0.0 108.726 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.609 ' O ' HG13 ' A' ' 20' ' ' VAL . 85.2 m-20 -114.92 125.57 53.79 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.947 HD13 ' HB2' ' A' ' 25' ' ' ALA . 3.7 mt -102.7 152.72 5.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.401 0 O-C-N 121.301 -0.874 . . . . 0.0 110.261 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 44.0 t -97.74 135.83 30.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 O-C-N 120.821 -1.174 . . . . 0.0 109.664 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.13 -145.2 17.55 Favored Glycine 0 C--N 1.285 -2.302 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 160.6 -95.26 0.14 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -52.85 -38.33 61.36 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-O 122.084 0.945 . . . . 0.0 109.711 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 29.3 t -57.27 -33.07 67.25 Favored 'General case' 0 C--N 1.291 -1.939 0 O-C-N 121.286 -0.883 . . . . 0.0 109.301 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.758 ' HB2' ' CG2' ' A' ' 22' ' ' VAL . . . -69.81 -52.4 25.45 Favored 'General case' 0 C--N 1.286 -2.171 0 O-C-N 121.103 -0.998 . . . . 0.0 108.873 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TRP . . . . . 0.984 ' CZ2' ' HB2' ' A' ' 52' ' ' ALA . 0.6 OUTLIER -61.57 -37.35 83.52 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.886 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.25 -27.86 64.78 Favored 'General case' 0 C--N 1.292 -1.92 0 O-C-N 120.848 -1.157 . . . . 0.0 108.789 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.8 ttmm -56.06 -42.78 77.16 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -85.52 -64.59 1.13 Allowed 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.643 -1.286 . . . . 0.0 108.375 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 137.4 39.1 0.13 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.662 ' O ' ' O ' ' A' ' 126' ' ' PRO . 2.7 mt -102.74 127.95 29.01 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 120.848 -1.383 . . . . 0.0 109.362 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.775 ' O ' HG23 ' A' ' 127' ' ' THR . 51.3 Cg_exo -43.57 -154.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 122.269 1.979 . . . . 0.0 113.2 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.775 HG23 ' O ' ' A' ' 126' ' ' PRO . 0.0 OUTLIER 178.14 109.45 0.03 OUTLIER 'General case' 0 C--N 1.286 -2.163 0 O-C-N 120.778 -1.201 . . . . 0.0 109.001 -178.386 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 1.059 ' N ' ' H ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -138.16 168.41 19.79 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-O 122.204 1.002 . . . . 0.0 108.966 -178.417 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.674 ' C ' ' H ' ' A' ' 48' ' ' HIS . . . . . . . . 0 C--N 1.281 -2.395 0 O-C-N 120.789 -1.194 . . . . 0.0 110.073 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 122.112 0.958 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 61.07 24.58 14.67 Favored 'General case' 0 C--N 1.282 -2.362 0 CA-C-O 122.054 0.931 . . . . 0.0 109.222 178.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.564 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.7 OUTLIER -84.12 25.79 0.8 Allowed 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 122.299 1.047 . . . . 0.0 109.714 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.564 ' CB ' ' O ' ' A' ' 13' ' ' GLU . 0.9 OUTLIER 83.1 172.69 0.09 Allowed 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -111.68 102.59 10.89 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 122.211 1.005 . . . . 0.0 109.754 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -131.44 173.96 5.26 Favored Pre-proline 0 C--N 1.291 -1.949 0 O-C-N 121.277 -0.89 . . . . 0.0 108.872 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.406 ' N ' ' HG1' ' A' ' 108' ' ' THR . 20.8 Cg_endo -88.91 78.64 1.09 Allowed 'Trans proline' 0 C--N 1.297 -2.16 0 C-N-CA 121.831 1.687 . . . . 0.0 111.42 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 112' ' ' ASP . 33.0 t -75.19 144.52 42.65 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 122.029 0.918 . . . . 0.0 109.705 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 82.7 p -100.36 151.51 21.42 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 122.703 1.239 . . . . 0.0 109.63 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.663 ' CG2' ' N ' ' A' ' 21' ' ' SER . 0.1 OUTLIER -150.6 173.92 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 O-C-N 121.002 -1.061 . . . . 0.0 109.431 -178.653 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.663 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 1.5 m -108.82 166.12 11.05 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.516 -1.365 . . . . 0.0 109.46 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 1.052 HG11 ' HB1' ' A' ' 119' ' ' ALA . 37.1 t -62.86 -29.98 48.42 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.808 0 CA-C-O 122.106 0.955 . . . . 0.0 108.707 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.608 HG23 ' N ' ' A' ' 24' ' ' VAL . 6.5 t -55.38 -47.78 75.3 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 120.82 -1.175 . . . . 0.0 109.106 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.608 ' N ' HG23 ' A' ' 23' ' ' THR . 1.4 t -69.68 -39.74 78.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.157 -1.589 . . . . 0.0 109.42 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.996 ' HB2' HD13 ' A' ' 113' ' ' ILE . . . -51.3 -36.27 41.72 Favored 'General case' 0 C--N 1.288 -2.103 0 O-C-N 120.804 -1.185 . . . . 0.0 108.39 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -60.29 -48.63 80.93 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -59.81 -36.15 76.18 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 120.878 -1.139 . . . . 0.0 108.699 178.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.539 HD13 HD13 ' A' ' 86' ' ' ILE . 51.2 mt -80.86 -25.03 37.96 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 25' ' ' ALA . 8.9 tt -62.22 -43.38 98.95 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.8 HD12 ' N ' ' A' ' 31' ' ' ALA . 3.4 pp -80.21 -14.39 58.48 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.509 -1.369 . . . . 0.0 107.477 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.8 ' N ' HD12 ' A' ' 30' ' ' LEU . . . -67.27 -27.67 67.39 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.736 -1.228 . . . . 0.0 108.398 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.24 47.68 6.0 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.526 ' O ' ' CZ ' ' A' ' 35' ' ' TYR . 14.1 m-70 -115.37 163.61 15.47 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.204 -1.174 . . . . 0.0 109.589 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.636 HH12 HD13 ' A' ' 53' ' ' ILE . 20.0 mmm180 -59.8 132.04 52.75 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 122.359 1.076 . . . . 0.0 109.793 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.526 ' CZ ' ' O ' ' A' ' 33' ' ' HIS . 21.6 m-85 -118.2 108.14 14.8 Favored 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.314 -0.866 . . . . 0.0 108.95 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.788 ' HB3' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -102.35 133.16 47.73 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 120.582 -1.324 . . . . 0.0 108.587 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.62 ' H ' HD13 ' A' ' 36' ' ' LEU . 22.1 t70 -147.75 111.39 5.01 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 -178.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.427 ' O ' HG22 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -83.1 103.97 11.09 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 O-C-N 120.959 -1.088 . . . . 0.0 108.093 177.44 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.705 HH22 ' NE2' ' A' ' 46' ' ' GLN . 25.7 ttp180 -84.34 -43.45 14.74 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -179.01 170.39 0.73 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.182 -0.949 . . . . 0.0 109.95 -179.026 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 40' ' ' THR . 24.7 Cg_exo -55.47 -145.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 121.92 1.746 . . . . 0.0 111.125 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.527 ' OE1' ' NH2' ' A' ' 60' ' ' ARG . 22.2 pt-20 -58.28 -23.44 56.24 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.85 -1.156 . . . . 0.0 108.543 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.473 ' O ' ' OE1' ' A' ' 46' ' ' GLN . 96.7 mt-10 -50.66 -30.0 12.52 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.802 -1.186 . . . . 0.0 108.997 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.662 ' CD1' ' N ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -78.06 -32.22 50.73 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 122.217 1.008 . . . . 0.0 108.91 177.446 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.662 ' N ' ' CD1' ' A' ' 44' ' ' PHE . 16.0 t -49.01 -19.1 0.36 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.153 -0.967 . . . . 0.0 109.052 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.705 ' NE2' HH22 ' A' ' 39' ' ' ARG . 0.4 OUTLIER -69.8 -9.57 55.14 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.089 -1.007 . . . . 0.0 108.619 179.46 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.515 ' O ' ' O ' ' A' ' 44' ' ' PHE . . . 161.78 -164.76 35.41 Favored Glycine 0 N--CA 1.499 2.875 0 CA-C-O 122.245 0.914 . . . . 0.0 111.051 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.635 ' O ' ' O ' ' A' ' 49' ' ' ALA . 6.4 p-80 -176.0 106.01 0.08 Allowed 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 122.732 1.254 . . . . 0.0 109.38 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.635 ' O ' ' O ' ' A' ' 48' ' ' HIS . . . -30.87 157.44 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 122.159 0.981 . . . . 0.0 109.421 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.797 ' N ' ' H ' ' A' ' 127' ' ' THR . 0.5 OUTLIER -93.53 162.17 14.07 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.648 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.694 ' N ' ' SG ' ' A' ' 50' ' ' CYS . . . 105.79 -8.13 42.66 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.771 ' HB3' ' CZ2' ' A' ' 120' ' ' TRP . . . -170.46 157.78 6.13 Favored 'General case' 0 C--N 1.29 -2.009 0 O-C-N 120.784 -1.421 . . . . 0.0 109.615 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.636 HD13 HH12 ' A' ' 34' ' ' ARG . 38.6 mt -99.6 134.83 37.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 O-C-N 120.762 -1.211 . . . . 0.0 110.262 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.518 HD22 ' HH2' ' A' ' 120' ' ' TRP . 2.5 m-80 -113.3 134.2 54.73 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 121.937 0.875 . . . . 0.0 109.472 -178.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.734 ' O ' HG12 ' A' ' 55' ' ' VAL . 1.1 t -142.6 95.77 6.37 Favored Pre-proline 0 C--N 1.273 -2.754 0 CA-C-O 122.221 1.01 . . . . 0.0 109.133 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.476 ' C ' ' H ' ' A' ' 58' ' ' MET . 28.3 Cg_endo -77.94 54.37 4.83 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.5 2.134 . . . . 0.0 111.693 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.518 ' CE1' ' NE2' ' A' ' 81' ' ' GLN . 61.8 m-85 50.37 12.08 0.09 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 122.31 1.052 . . . . 0.0 109.848 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.476 ' H ' ' C ' ' A' ' 56' ' ' PRO . 77.8 mtm -151.09 147.16 26.74 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-O 122.137 0.97 . . . . 0.0 110.072 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.416 ' OD1' ' O ' ' A' ' 58' ' ' MET . 79.5 m-20 -146.52 98.58 3.09 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.527 ' NH2' ' OE1' ' A' ' 42' ' ' GLU . 28.4 ttp180 -116.62 137.31 52.28 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.034 -1.042 . . . . 0.0 108.594 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 63' ' ' SER . . . -174.33 -165.88 31.52 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.23 1.89 1.89 Allowed 'General case' 0 C--N 1.28 -2.419 0 O-C-N 121.191 -1.182 . . . . 0.0 108.338 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.483 ' H ' ' C ' ' A' ' 61' ' ' GLY . 48.3 t -62.45 -11.4 15.77 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 111.15 25.67 4.95 Favored Glycine 0 N--CA 1.5 2.956 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 92.8 mtp 50.84 101.1 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 122.337 1.065 . . . . 0.0 110.326 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.7 m -165.83 93.06 0.54 Allowed 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.4 ptpp? -103.58 144.94 30.77 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.077 -1.014 . . . . 0.0 108.572 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -45.08 132.97 6.85 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 122.244 1.021 . . . . 0.0 110.037 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.0 m -146.57 155.62 42.63 Favored 'General case' 0 C--N 1.282 -2.367 0 O-C-N 121.437 -0.79 . . . . 0.0 109.869 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 52.34 47.76 24.04 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.309 -1.494 . . . . 0.0 108.306 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -48.24 -25.49 1.55 Allowed 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 122.127 0.965 . . . . 0.0 108.8 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 76' ' ' SER . 0.5 OUTLIER -50.79 -45.96 59.43 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.026 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -55.81 -35.99 66.93 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.94 -1.1 . . . . 0.0 108.889 176.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -83.03 -47.91 11.19 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.83 -1.169 . . . . 0.0 108.703 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.8 t -67.45 -47.06 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.835 -1.165 . . . . 0.0 108.717 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 72' ' ' LEU . 30.7 t -52.78 -33.12 47.29 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.546 ' O ' ' CB ' ' A' ' 78' ' ' HIS . 43.9 p -72.35 -0.05 11.34 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.956 -1.09 . . . . 0.0 109.116 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.546 ' CB ' ' O ' ' A' ' 77' ' ' SER . 4.0 t-80 77.18 57.26 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.526 ' CG ' ' O ' ' A' ' 78' ' ' HIS . 47.2 m-85 -163.53 139.05 6.5 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.921 -1.112 . . . . 0.0 110.035 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.548 ' H ' ' HB2' ' A' ' 83' ' ' ASP . . . -112.26 137.79 14.51 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.518 ' NE2' ' CE1' ' A' ' 57' ' ' TYR . 10.5 pt20 -45.71 -19.56 0.06 Allowed 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.491 -1.005 . . . . 0.0 109.17 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.819 ' HA ' HD12 ' A' ' 85' ' ' ILE . 16.3 m -122.84 20.92 10.04 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.793 -1.192 . . . . 0.0 107.969 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.548 ' HB2' ' H ' ' A' ' 80' ' ' GLY . 42.2 t0 -42.42 113.8 0.49 Allowed 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.408 -0.808 . . . . 0.0 109.11 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 17.4 m-20 59.6 63.36 1.53 Allowed 'General case' 0 C--N 1.291 -1.936 0 O-C-N 121.308 -0.87 . . . . 0.0 109.451 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.819 HD12 ' HA ' ' A' ' 82' ' ' SER . 17.8 mt -145.93 176.66 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 O-C-N 121.076 -1.015 . . . . 0.0 109.421 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.66 ' N ' HG22 ' A' ' 85' ' ' ILE . 64.1 mt -111.01 112.43 40.55 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 O-C-N 121.078 -1.014 . . . . 0.0 109.422 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.926 ' CG2' HG21 ' A' ' 110' ' ' VAL . 60.4 t -110.94 175.0 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 O-C-N 121.261 -0.899 . . . . 0.0 108.887 -176.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.561 ' N ' HG12 ' A' ' 87' ' ' VAL . . . -172.02 175.63 45.28 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 19.7 t -128.46 120.31 26.61 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 122.029 0.919 . . . . 0.0 109.319 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.439 ' O ' ' OE1' ' A' ' 90' ' ' GLN . 1.0 OUTLIER -65.63 -38.63 89.95 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.039 0.923 . . . . 0.0 110.422 -178.492 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 92' ' ' GLY . 4.1 m -61.52 160.98 10.26 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 122.171 0.986 . . . . 0.0 109.473 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 91' ' ' SER . . . -43.17 161.95 0.05 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.668 ' O ' HG22 ' A' ' 96' ' ' ILE . . . -54.83 -28.06 46.02 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -55.05 -28.32 51.38 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.221 -1.164 . . . . 0.0 108.72 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 43.7 t -85.24 -32.44 22.6 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.15 -0.969 . . . . 0.0 109.237 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.748 HG13 HG22 ' A' ' 114' ' ' VAL . 0.3 OUTLIER -60.3 -30.56 46.42 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 O-C-N 121.03 -1.044 . . . . 0.0 108.881 -179.289 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.413 ' HB3' ' HZ2' ' A' ' 97' ' ' LYS . 16.1 mtpp -62.56 -47.68 82.78 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.707 -1.246 . . . . 0.0 108.402 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.34 -50.09 72.49 Favored 'General case' 0 C--N 1.289 -2.029 0 O-C-N 120.557 -1.339 . . . . 0.0 109.266 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.733 ' O ' HD13 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -57.86 -47.84 81.55 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-O 122.525 1.155 . . . . 0.0 108.705 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 57.9 m -56.39 -48.81 76.13 Favored 'General case' 0 C--N 1.287 -2.134 0 O-C-N 120.943 -1.098 . . . . 0.0 108.989 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -65.43 -40.34 93.2 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.654 -1.279 . . . . 0.0 108.153 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 102' ' ' LEU . 3.7 tt -68.48 -40.54 80.94 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.968 0.89 . . . . 0.0 108.818 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.733 HD13 ' O ' ' A' ' 99' ' ' THR . 10.8 mp -69.86 -28.93 66.07 Favored 'General case' 0 C--N 1.292 -1.914 0 O-C-N 121.088 -1.007 . . . . 0.0 109.017 178.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -64.02 -32.54 74.12 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.519 -1.363 . . . . 0.0 108.527 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -130.93 37.2 3.8 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.623 -1.298 . . . . 0.0 108.393 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -151.34 -67.64 0.01 OUTLIER Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.666 ' H ' ' HA ' ' A' ' 103' ' ' LEU . 96.7 m-85 -138.48 156.24 47.71 Favored 'General case' 0 C--N 1.289 -2.048 0 O-C-N 121.175 -1.191 . . . . 0.0 109.38 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.426 ' OG1' ' N ' ' A' ' 109' ' ' GLY . 11.0 t -166.42 -161.93 0.49 Allowed 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.667 -1.271 . . . . 0.0 110.104 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.426 ' N ' ' OG1' ' A' ' 108' ' ' THR . . . 79.05 21.13 68.6 Favored Glycine 0 N--CA 1.499 2.836 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.926 HG21 ' CG2' ' A' ' 87' ' ' VAL . 1.7 m -142.29 167.93 14.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 O-C-N 121.07 -1.253 . . . . 0.0 109.874 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.607 ' O ' ' N ' ' A' ' 87' ' ' VAL . 85.6 mttt -97.88 148.94 22.92 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 122.198 0.999 . . . . 0.0 108.739 -179.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -111.74 108.08 17.38 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -178.836 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.996 HD13 ' HB2' ' A' ' 25' ' ' ALA . 69.7 mt -83.08 125.1 40.04 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 O-C-N 121.265 -0.897 . . . . 0.0 110.261 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.748 HG22 HG13 ' A' ' 96' ' ' ILE . 67.2 t -100.78 138.22 25.75 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 O-C-N 120.825 -1.172 . . . . 0.0 109.63 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 167.67 -147.48 11.72 Favored Glycine 0 C--N 1.285 -2.268 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -154.22 -176.99 27.17 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -59.06 -33.02 70.3 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-O 122.011 0.91 . . . . 0.0 109.647 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.499 ' O ' ' HB3' ' A' ' 121' ' ' ALA . 32.1 t -56.47 -32.26 64.8 Favored 'General case' 0 C--N 1.292 -1.905 0 O-C-N 121.332 -0.855 . . . . 0.0 109.331 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 1.052 ' HB1' HG11 ' A' ' 22' ' ' VAL . . . -62.21 -40.91 97.66 Favored 'General case' 0 C--N 1.286 -2.159 0 O-C-N 121.185 -0.947 . . . . 0.0 108.892 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TRP . . . . . 0.771 ' CZ2' ' HB3' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -60.34 -33.77 72.88 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 179.294 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 118' ' ' SER . . . -56.84 -37.63 71.53 Favored 'General case' 0 C--N 1.292 -1.911 0 O-C-N 120.795 -1.19 . . . . 0.0 108.812 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -56.44 -39.19 72.71 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -63.36 -65.29 0.71 Allowed 'General case' 0 N--CA 1.503 2.184 0 O-C-N 120.649 -1.282 . . . . 0.0 108.371 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.06 16.53 35.19 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 50' ' ' CYS . 12.6 mt -126.83 71.98 74.9 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 120.827 -1.396 . . . . 0.0 109.369 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.49 ' HA ' ' H ' ' A' ' 50' ' ' CYS . 32.9 Cg_endo -96.54 115.86 0.14 Allowed 'Trans proline' 0 C--N 1.302 -1.911 0 C-N-CA 122.29 1.993 . . . . 0.0 113.16 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.797 ' H ' ' N ' ' A' ' 50' ' ' CYS . 82.0 p -125.08 130.39 52.16 Favored 'General case' 0 C--N 1.287 -2.151 0 O-C-N 120.743 -1.223 . . . . 0.0 109.027 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.524 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -179.63 141.02 0.15 Allowed 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 122.126 0.965 . . . . 0.0 108.953 -179.121 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 128' ' ' LYS . . . . . . . . 0 C--N 1.281 -2.401 0 O-C-N 120.859 -1.151 . . . . 0.0 110.086 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 . . . . . 0 N--CA 1.5 2.033 0 CA-C-O 122.16 0.981 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.625 ' H ' ' N ' ' A' ' 109' ' ' GLY . 9.0 t -146.85 101.75 3.92 Favored Pre-proline 0 C--N 1.291 -1.958 0 O-C-N 121.267 -0.896 . . . . 0.0 108.942 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -88.69 124.72 1.61 Allowed 'Trans proline' 0 C--N 1.297 -2.14 0 C-N-CA 121.875 1.716 . . . . 0.0 111.431 177.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.5 p -138.17 152.2 48.45 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 122.021 0.915 . . . . 0.0 109.681 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.534 ' C ' HG12 ' A' ' 20' ' ' VAL . 39.6 m -115.96 144.55 43.92 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 122.675 1.226 . . . . 0.0 109.627 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.761 HG23 ' N ' ' A' ' 21' ' ' SER . 0.7 OUTLIER -158.81 -179.04 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.196 0 O-C-N 121.025 -1.047 . . . . 0.0 109.402 -178.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.761 ' N ' HG23 ' A' ' 20' ' ' VAL . 14.3 p -115.58 148.19 39.87 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.48 -1.387 . . . . 0.0 109.395 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.6 p -47.32 -21.24 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.768 0 CA-C-O 122.102 0.953 . . . . 0.0 108.648 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.597 HG23 ' HB2' ' A' ' 21' ' ' SER . 0.1 OUTLIER -64.39 -55.7 19.32 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 120.736 -1.227 . . . . 0.0 109.177 179.169 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.494 ' N ' ' OG1' ' A' ' 23' ' ' THR . 0.9 OUTLIER -71.15 -40.5 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.175 -1.578 . . . . 0.0 109.4 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.634 ' HB2' HD12 ' A' ' 113' ' ' ILE . . . -57.98 -35.04 70.64 Favored 'General case' 0 C--N 1.286 -2.159 0 O-C-N 120.829 -1.17 . . . . 0.0 108.361 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.612 ' O ' HD13 ' A' ' 30' ' ' LEU . 86.4 t60 -52.99 -46.66 68.42 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -55.33 -43.42 74.94 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 120.907 -1.12 . . . . 0.0 108.666 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.505 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 10.4 mp -70.72 -36.8 73.38 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 19.2 tp -56.91 -39.69 74.92 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.612 HD13 ' O ' ' A' ' 26' ' ' HIS . 11.0 mp -63.43 -25.8 68.44 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 28' ' ' LEU . . . -66.34 -22.42 66.27 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.77 -1.207 . . . . 0.0 108.385 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.95 48.82 3.5 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -107.41 149.58 27.73 Favored 'General case' 0 C--N 1.292 -1.898 0 O-C-N 121.204 -1.174 . . . . 0.0 109.593 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.429 ' NH2' HD11 ' A' ' 85' ' ' ILE . 75.5 mtm180 -58.66 133.68 56.11 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 122.428 1.109 . . . . 0.0 109.827 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.402 ' O ' ' O ' ' A' ' 53' ' ' ILE . 47.3 t80 -112.6 113.61 25.83 Favored 'General case' 0 C--N 1.292 -1.93 0 O-C-N 121.285 -0.884 . . . . 0.0 108.937 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.756 ' HB3' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -98.84 130.57 45.27 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.594 -1.317 . . . . 0.0 108.554 179.213 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.621 ' N ' ' CD1' ' A' ' 36' ' ' LEU . 48.2 t0 -138.61 142.5 39.13 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.988 HG21 ' CZ ' ' A' ' 57' ' ' TYR . 4.5 m -131.04 96.11 2.59 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 CA-C-O 122.433 1.111 . . . . 0.0 108.158 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.754 ' O ' ' OG1' ' A' ' 40' ' ' THR . 0.1 OUTLIER -89.65 -45.32 9.43 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.754 ' OG1' ' O ' ' A' ' 39' ' ' ARG . 3.6 m 177.45 142.32 0.25 Allowed Pre-proline 0 N--CA 1.49 1.573 0 C-N-CA 119.312 -0.955 . . . . 0.0 109.921 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.559 ' HD2' HG23 ' A' ' 40' ' ' THR . 50.8 Cg_exo -40.21 -39.96 2.73 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 121.983 1.788 . . . . 0.0 111.074 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.663 ' H ' HG22 ' A' ' 40' ' ' THR . 96.6 mt-10 -61.0 -30.34 70.23 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.951 -1.093 . . . . 0.0 108.567 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 40' ' ' THR . 66.1 tt0 -55.48 -32.01 62.47 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.75 -1.219 . . . . 0.0 109.014 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -67.99 -44.21 77.15 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 122.174 0.988 . . . . 0.0 108.978 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.1 t -56.13 -29.72 61.1 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.191 -0.943 . . . . 0.0 109.048 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -70.16 -36.92 75.04 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.124 -0.985 . . . . 0.0 108.631 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.06 -148.38 17.11 Favored Glycine 0 N--CA 1.499 2.84 0 CA-C-O 122.267 0.926 . . . . 0.0 110.977 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -100.42 -160.2 0.78 Allowed 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 122.684 1.23 . . . . 0.0 109.411 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.563 ' HB3' ' HB3' ' A' ' 52' ' ' ALA . . . -144.62 166.72 24.38 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 122.178 0.99 . . . . 0.0 109.396 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.584 ' O ' ' NE1' ' A' ' 120' ' ' TRP . 4.7 t -83.63 105.33 14.47 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-O 122.541 1.162 . . . . 0.0 107.89 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.56 26.5 65.27 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.609 ' C ' HD12 ' A' ' 53' ' ' ILE . . . -156.0 123.15 5.37 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 120.784 -1.421 . . . . 0.0 109.595 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.777 ' N ' HD12 ' A' ' 53' ' ' ILE . 2.7 mp -105.14 104.27 16.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 O-C-N 120.709 -1.245 . . . . 0.0 110.247 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -107.94 118.33 36.46 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-O 121.971 0.891 . . . . 0.0 109.449 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.904 ' O ' HG12 ' A' ' 38' ' ' VAL . 2.0 m -142.13 163.34 40.49 Favored Pre-proline 0 C--N 1.274 -2.71 0 CA-C-O 122.171 0.986 . . . . 0.0 109.09 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -84.08 68.2 6.71 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.451 2.101 . . . . 0.0 111.72 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.988 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 66.4 m-85 . . . . . 0 C--N 1.298 -1.646 0 CA-C-O 122.229 1.014 . . . . 0.0 109.789 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.509 ' CZ ' ' OD2' ' A' ' 83' ' ' ASP . 22.7 t80 . . . . . 0 N--CA 1.498 1.964 0 CA-C-O 122.142 0.972 . . . . 0.0 110.018 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.568 ' H ' ' HB3' ' A' ' 83' ' ' ASP . . . -116.55 136.24 12.65 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -46.56 -25.92 0.79 Allowed 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.487 -1.007 . . . . 0.0 109.198 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.796 ' HA ' HD12 ' A' ' 85' ' ' ILE . 0.3 OUTLIER -125.09 23.01 7.83 Favored 'General case' 0 C--N 1.292 -1.906 0 O-C-N 120.809 -1.182 . . . . 0.0 107.97 178.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.568 ' HB3' ' H ' ' A' ' 80' ' ' GLY . 9.8 p-10 -35.56 116.33 0.36 Allowed 'General case' 0 N--CA 1.507 2.419 0 CA-C-O 121.762 0.792 . . . . 0.0 109.076 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.576 ' N ' ' O ' ' A' ' 109' ' ' GLY . 28.8 t30 63.0 60.88 1.17 Allowed 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.898 0.856 . . . . 0.0 109.426 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.796 HD12 ' HA ' ' A' ' 82' ' ' SER . 21.5 mt -145.94 175.24 2.28 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 O-C-N 121.063 -1.023 . . . . 0.0 109.41 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.637 ' N ' HG22 ' A' ' 85' ' ' ILE . 28.3 mt -111.26 107.48 23.06 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.294 0 CA-C-O 122.181 0.991 . . . . 0.0 109.407 178.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.756 HG22 ' HB3' ' A' ' 36' ' ' LEU . 38.2 t -109.68 155.11 10.96 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 CA-C-O 121.946 0.879 . . . . 0.0 108.906 -175.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -162.41 138.24 5.27 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 34.7 t -94.58 144.12 25.86 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 122.059 0.933 . . . . 0.0 109.268 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 9.9 tm0? -44.2 -35.9 2.44 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.985 0.897 . . . . 0.0 110.444 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 69.5 m -102.78 158.25 16.39 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 122.141 0.972 . . . . 0.0 109.51 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' A' ' 94' ' ' ARG . . . -123.16 168.26 15.38 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 65.22 -70.74 0.09 OUTLIER Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 92' ' ' GLY . 89.9 mtt180 -62.59 -36.05 81.48 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.214 -1.168 . . . . 0.0 108.766 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.404 ' O ' ' OG1' ' A' ' 99' ' ' THR . 7.0 t -85.5 -24.49 27.32 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.183 -0.948 . . . . 0.0 109.25 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.533 HG22 ' N ' ' A' ' 97' ' ' LYS . 1.0 OUTLIER -58.8 -47.45 89.21 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 O-C-N 121.044 -1.035 . . . . 0.0 108.895 179.871 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.533 ' N ' HG22 ' A' ' 96' ' ' ILE . 49.9 pttt -71.38 -30.87 66.64 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.675 -1.266 . . . . 0.0 108.423 177.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.89 -38.11 89.89 Favored 'General case' 0 C--N 1.289 -2.028 0 O-C-N 120.521 -1.362 . . . . 0.0 109.193 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 95' ' ' SER . 0.0 OUTLIER -63.01 -35.37 79.99 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-O 122.539 1.161 . . . . 0.0 108.679 179.65 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.7 m -57.44 -38.25 74.13 Favored 'General case' 0 C--N 1.288 -2.094 0 O-C-N 120.998 -1.064 . . . . 0.0 109.005 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -61.33 -43.32 99.07 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.644 -1.285 . . . . 0.0 108.087 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.2 mt -70.07 -35.03 73.93 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 122.01 0.91 . . . . 0.0 108.848 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 52.0 tp -56.31 -39.77 73.29 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.062 -1.024 . . . . 0.0 108.966 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 30.0 m170 -61.98 -36.48 81.6 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.551 -1.343 . . . . 0.0 108.57 177.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -76.22 -19.22 58.58 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 120.612 -1.305 . . . . 0.0 108.359 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 120.23 83.39 0.78 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -144.55 62.14 1.33 Allowed 'General case' 0 C--N 1.289 -2.032 0 O-C-N 121.09 -1.241 . . . . 0.0 109.35 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.564 ' OG1' ' N ' ' A' ' 109' ' ' GLY . 0.0 OUTLIER -126.47 179.1 5.47 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.642 -1.287 . . . . 0.0 110.136 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.625 ' N ' ' H ' ' A' ' 16' ' ' VAL . . . 85.76 17.76 61.12 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.563 HG21 ' CG2' ' A' ' 87' ' ' VAL . 1.4 m -147.18 163.06 7.72 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 O-C-N 121.081 -1.247 . . . . 0.0 109.858 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.508 ' N ' HG23 ' A' ' 110' ' ' VAL . 61.1 mttp -98.57 141.98 30.73 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 122.218 1.009 . . . . 0.0 108.694 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.463 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 74.4 m-20 -99.44 108.19 20.59 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.634 HD12 ' HB2' ' A' ' 25' ' ' ALA . 7.4 mm -97.64 155.35 3.67 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 O-C-N 121.241 -0.912 . . . . 0.0 110.218 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.439 HG13 ' HA3' ' A' ' 92' ' ' GLY . 38.0 t -99.12 124.18 52.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 O-C-N 120.783 -1.198 . . . . 0.0 109.638 178.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.17 -145.67 23.39 Favored Glycine 0 C--N 1.286 -2.235 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 135.59 -90.26 0.23 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.503 ' O ' ' N ' ' A' ' 121' ' ' ALA . 79.6 t80 -51.77 -41.63 61.77 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 121.989 0.899 . . . . 0.0 109.659 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 18.5 t -57.57 -45.03 85.67 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-O 121.923 0.868 . . . . 0.0 109.39 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.22 -52.57 12.0 Favored 'General case' 0 C--N 1.287 -2.152 0 O-C-N 121.134 -0.979 . . . . 0.0 108.901 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . 0.584 ' NE1' ' O ' ' A' ' 50' ' ' CYS . 4.9 t-105 -57.93 -35.54 71.23 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.165 -1.421 . . . . 0.0 107.165 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 117' ' ' TYR . . . -63.69 -30.93 71.97 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 120.912 -1.118 . . . . 0.0 108.79 178.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.446 ' HB3' ' HZ2' ' A' ' 122' ' ' LYS . 14.4 ttpp -57.45 -36.39 71.36 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -65.86 -65.19 0.71 Allowed 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.645 -1.284 . . . . 0.0 108.354 178.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 105.87 32.89 3.68 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.482 ' O ' ' CB ' ' A' ' 50' ' ' CYS . 18.6 mt -126.43 79.75 70.32 Favored Pre-proline 0 C--N 1.296 -1.736 0 O-C-N 120.933 -1.334 . . . . 0.0 109.376 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.404 ' HA ' ' H ' ' A' ' 50' ' ' CYS . 30.9 Cg_endo . . . . . 0 C--N 1.301 -1.937 0 C-N-CA 122.255 1.97 . . . . 0.0 113.229 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.5 2.045 0 CA-C-O 122.142 0.972 . . . . 0.0 109.781 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.541 HG12 ' HD3' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -142.74 177.3 1.9 Allowed Pre-proline 0 C--N 1.291 -1.976 0 O-C-N 121.347 -0.845 . . . . 0.0 108.92 -179.161 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.541 ' HD3' HG12 ' A' ' 16' ' ' VAL . 29.6 Cg_endo -86.69 135.35 4.13 Favored 'Trans proline' 0 C--N 1.296 -2.194 0 C-N-CA 121.849 1.699 . . . . 0.0 111.426 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 112' ' ' ASP . 32.8 t -140.56 138.99 34.9 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.111 0.958 . . . . 0.0 109.704 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.42 ' OG ' HD11 ' A' ' 96' ' ' ILE . 18.1 t -99.02 143.91 28.77 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-O 122.742 1.258 . . . . 0.0 109.566 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.831 HG13 ' O ' ' A' ' 112' ' ' ASP . 0.2 OUTLIER -148.7 178.9 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 O-C-N 121.013 -1.055 . . . . 0.0 109.41 -178.733 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.713 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 62.6 m -119.14 151.34 38.48 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.499 -1.376 . . . . 0.0 109.415 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.458 HG21 ' HA2' ' A' ' 116' ' ' GLY . 12.5 p -48.62 -27.1 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.273 -2.738 0 CA-C-O 122.159 0.981 . . . . 0.0 108.739 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.509 ' OG1' ' N ' ' A' ' 24' ' ' VAL . 0.1 OUTLIER -65.1 -58.2 6.66 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 120.725 -1.234 . . . . 0.0 109.112 179.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.509 ' N ' ' OG1' ' A' ' 23' ' ' THR . 0.0 OUTLIER -60.31 -35.1 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.158 -1.589 . . . . 0.0 109.436 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.54 ' HB2' HD12 ' A' ' 113' ' ' ILE . . . -51.11 -37.3 45.13 Favored 'General case' 0 C--N 1.287 -2.144 0 O-C-N 120.799 -1.188 . . . . 0.0 108.394 178.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -57.66 -44.09 85.43 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -59.9 -43.61 94.72 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 120.904 -1.122 . . . . 0.0 108.697 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.5 ' N ' HD12 ' A' ' 28' ' ' LEU . 9.1 mp -66.46 -33.55 75.94 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.504 ' O ' HD13 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -53.54 -40.44 65.52 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.733 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.429 ' N ' HD12 ' A' ' 30' ' ' LEU . 9.4 mp -63.99 -31.11 72.19 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 120.568 -1.333 . . . . 0.0 107.421 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 28' ' ' LEU . . . -66.9 -28.77 68.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.634 -1.292 . . . . 0.0 108.362 179.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.31 47.28 8.32 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -96.53 156.45 16.34 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 121.148 -1.207 . . . . 0.0 109.621 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -59.17 144.69 45.13 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 122.365 1.079 . . . . 0.0 109.768 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.707 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 1.4 t80 -123.85 112.16 16.95 Favored 'General case' 0 C--N 1.291 -1.964 0 O-C-N 121.381 -0.824 . . . . 0.0 108.973 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.657 ' O ' HG13 ' A' ' 87' ' ' VAL . 8.0 tt -122.16 101.22 7.4 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.649 -1.282 . . . . 0.0 108.529 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.501 ' OD2' ' NH2' ' A' ' 39' ' ' ARG . 80.6 m-20 -98.89 157.3 16.4 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -176.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 38' ' ' VAL . 6.0 m -133.76 89.05 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 CA-C-O 122.396 1.093 . . . . 0.0 108.064 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.779 ' O ' HG23 ' A' ' 40' ' ' THR . 0.0 OUTLIER -81.71 -45.3 15.89 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -179.394 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.779 HG23 ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER 171.58 163.8 0.24 Allowed Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.138 -0.976 . . . . 0.0 109.965 -179.41 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -66.09 -12.97 37.74 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 121.993 1.795 . . . . 0.0 111.125 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -72.81 -37.75 67.42 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.979 -1.076 . . . . 0.0 108.478 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.444 ' OE2' ' O ' ' A' ' 54' ' ' ASN . 2.0 pp20? -58.49 -28.68 65.61 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.726 -1.233 . . . . 0.0 109.04 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -74.08 -42.39 60.22 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 122.148 0.975 . . . . 0.0 108.977 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.9 t -54.83 -37.87 66.7 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.265 -0.897 . . . . 0.0 109.117 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -82.58 -37.27 25.3 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.158 -0.964 . . . . 0.0 108.714 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 43' ' ' GLU . . . 137.93 -139.57 10.49 Favored Glycine 0 N--CA 1.499 2.879 0 CA-C-O 122.298 0.943 . . . . 0.0 110.988 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -101.58 -161.73 0.88 Allowed 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 122.683 1.23 . . . . 0.0 109.396 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.944 ' HB1' ' CZ2' ' A' ' 120' ' ' TRP . . . -146.79 159.94 42.88 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 122.234 1.016 . . . . 0.0 109.374 -178.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.522 ' HB3' ' O ' ' A' ' 125' ' ' LEU . 4.6 t -82.53 162.55 21.96 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-O 122.559 1.171 . . . . 0.0 107.863 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.57 -51.39 4.14 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.707 ' HB1' ' HB3' ' A' ' 35' ' ' TYR . . . -157.23 175.37 14.13 Favored 'General case' 0 C--N 1.29 -1.999 0 O-C-N 120.798 -1.413 . . . . 0.0 109.63 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 73.2 mt -101.41 139.11 23.44 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 O-C-N 120.786 -1.196 . . . . 0.0 110.266 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.444 ' O ' ' OE2' ' A' ' 43' ' ' GLU . 43.5 p-10 -131.44 130.79 42.96 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.982 0.896 . . . . 0.0 109.444 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.557 HG12 ' HD2' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -142.99 165.37 26.54 Favored Pre-proline 0 C--N 1.273 -2.719 0 CA-C-O 122.191 0.996 . . . . 0.0 109.146 179.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.557 ' HD2' HG12 ' A' ' 55' ' ' VAL . 35.7 Cg_endo -76.88 26.45 0.44 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.468 2.112 . . . . 0.0 111.736 -177.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.625 ' CD1' ' NE2' ' A' ' 81' ' ' GLN . 90.7 t80 . . . . . 0 C--N 1.299 -1.61 0 CA-C-O 122.266 1.032 . . . . 0.0 109.887 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 . . . . . 0 N--CA 1.5 2.026 0 CA-C-O 122.205 1.002 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.589 ' H ' ' HB2' ' A' ' 83' ' ' ASP . . . -109.58 138.14 14.64 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.625 ' NE2' ' CD1' ' A' ' 57' ' ' TYR . 10.0 pt20 -45.6 -18.27 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.425 -1.044 . . . . 0.0 109.242 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.845 ' HA ' HD12 ' A' ' 85' ' ' ILE . 19.2 t -123.16 17.57 9.94 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 120.838 -1.164 . . . . 0.0 107.992 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.589 ' HB2' ' H ' ' A' ' 80' ' ' GLY . 11.9 t70 -40.46 107.46 0.07 Allowed 'General case' 0 N--CA 1.508 2.441 0 O-C-N 121.421 -0.799 . . . . 0.0 109.077 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 53.78 70.03 0.65 Allowed 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 121.97 0.89 . . . . 0.0 109.47 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.845 HD12 ' HA ' ' A' ' 82' ' ' SER . 17.7 mt -143.1 168.84 12.71 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 O-C-N 121.021 -1.05 . . . . 0.0 109.402 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.706 HG22 HG13 ' A' ' 113' ' ' ILE . 49.0 mt -110.44 109.66 29.3 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.231 0 CA-C-O 122.188 0.994 . . . . 0.0 109.473 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.657 HG13 ' O ' ' A' ' 36' ' ' LEU . 18.6 t -112.44 166.75 6.26 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 O-C-N 121.219 -0.926 . . . . 0.0 108.898 -177.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.407 ' HA2' ' H ' ' A' ' 113' ' ' ILE . . . -148.97 141.72 9.22 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.502 ' O ' ' C ' ' A' ' 90' ' ' GLN . 0.4 OUTLIER -90.46 140.43 29.73 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 122.127 0.965 . . . . 0.0 109.23 -179.345 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.537 ' H ' ' CD ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -33.46 -89.88 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.992 0.901 . . . . 0.0 110.486 -178.691 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.7 p -149.64 160.36 43.57 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 122.197 0.998 . . . . 0.0 109.521 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.94 119.36 4.31 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.998 ' O ' HG22 ' A' ' 96' ' ' ILE . . . -57.43 -37.81 83.81 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.101 -1.599 . . . . 0.0 109.101 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 34.4 mtp180 -62.7 -28.1 69.71 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.317 -1.108 . . . . 0.0 108.807 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.8 m -62.3 -39.48 93.12 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.189 -0.944 . . . . 0.0 109.325 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.998 HG22 ' O ' ' A' ' 93' ' ' GLY . 15.7 tt -63.73 -30.9 51.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 O-C-N 121.023 -1.048 . . . . 0.0 108.917 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.0 mtpt -70.85 -45.31 64.7 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.706 -1.246 . . . . 0.0 108.411 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.0 -33.24 68.71 Favored 'General case' 0 C--N 1.289 -2.041 0 O-C-N 120.578 -1.326 . . . . 0.0 109.207 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.88 -57.84 2.88 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-O 122.546 1.165 . . . . 0.0 108.737 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 56.4 m -50.42 -43.44 54.88 Favored 'General case' 0 C--N 1.288 -2.093 0 O-C-N 121.039 -1.038 . . . . 0.0 108.984 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -68.41 -45.91 71.37 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.674 -1.266 . . . . 0.0 108.06 178.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.678 HD13 ' C ' ' A' ' 102' ' ' LEU . 3.0 tm? -65.6 -42.87 91.14 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.944 0.878 . . . . 0.0 108.859 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.3 mp -62.96 -36.84 84.8 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 121.088 -1.007 . . . . 0.0 108.915 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -66.62 -17.76 65.01 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.55 -1.344 . . . . 0.0 108.576 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 102' ' ' LEU . . . -62.06 -19.56 63.05 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 120.643 -1.285 . . . . 0.0 108.361 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 135.46 42.18 0.12 Allowed Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -153.35 32.47 0.47 Allowed 'General case' 0 C--N 1.289 -2.063 0 O-C-N 121.079 -1.248 . . . . 0.0 109.391 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.576 ' OG1' ' N ' ' A' ' 109' ' ' GLY . 4.8 t -87.01 -136.73 0.09 Allowed 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.647 -1.283 . . . . 0.0 110.085 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.576 ' N ' ' OG1' ' A' ' 108' ' ' THR . . . 80.08 23.06 62.08 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.61 HG11 ' HB3' ' A' ' 82' ' ' SER . 1.8 m -143.63 165.67 14.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 O-C-N 121.021 -1.282 . . . . 0.0 109.901 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.519 ' N ' HG23 ' A' ' 110' ' ' VAL . 63.0 mttm -99.27 153.29 19.06 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-O 122.212 1.006 . . . . 0.0 108.729 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.831 ' O ' HG13 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -108.31 115.72 30.63 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.706 HG13 HG22 ' A' ' 86' ' ' ILE . 1.2 mm -100.88 127.99 53.48 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 O-C-N 121.291 -0.881 . . . . 0.0 110.279 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 71.8 t -99.5 137.09 28.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 O-C-N 120.766 -1.209 . . . . 0.0 109.701 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.6 -154.21 30.87 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.458 ' HA2' HG21 ' A' ' 22' ' ' VAL . . . 89.73 -47.33 3.2 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.496 ' O ' ' HB2' ' A' ' 121' ' ' ALA . 46.4 t80 -52.15 -53.64 40.45 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 121.97 0.89 . . . . 0.0 109.637 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 67.8 p -71.52 -34.54 70.17 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.886 0.851 . . . . 0.0 109.33 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.23 -54.72 8.76 Favored 'General case' 0 C--N 1.286 -2.162 0 O-C-N 121.18 -0.95 . . . . 0.0 108.936 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . 0.944 ' CZ2' ' HB1' ' A' ' 49' ' ' ALA . 28.0 t90 -60.07 -34.87 74.03 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' A' ' 117' ' ' TYR . . . -52.45 -36.74 55.36 Favored 'General case' 0 C--N 1.291 -1.942 0 O-C-N 120.88 -1.138 . . . . 0.0 108.763 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -60.7 -26.87 67.45 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.776 ' ND2' ' H ' ' A' ' 125' ' ' LEU . 6.1 p-10 -54.02 -49.26 69.31 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 120.685 -1.259 . . . . 0.0 108.373 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.681 ' N ' ' OD1' ' A' ' 123' ' ' ASN . . . 71.22 18.8 76.93 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.776 ' H ' ' ND2' ' A' ' 123' ' ' ASN . 15.0 mt -124.34 98.14 38.76 Favored Pre-proline 0 C--N 1.298 -1.667 0 O-C-N 120.859 -1.377 . . . . 0.0 109.405 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.45 ' HA ' ' H ' ' A' ' 50' ' ' CYS . 45.9 Cg_endo . . . . . 0 C--N 1.301 -1.946 0 C-N-CA 122.339 2.026 . . . . 0.0 113.28 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.042 0 CA-C-O 122.239 1.019 . . . . 0.0 109.741 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.559 HG12 ' HD3' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -144.87 177.46 1.77 Allowed Pre-proline 0 C--N 1.291 -1.951 0 O-C-N 121.193 -0.942 . . . . 0.0 108.965 -179.624 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.559 ' HD3' HG12 ' A' ' 16' ' ' VAL . 27.4 Cg_endo -86.61 140.76 6.29 Favored 'Trans proline' 0 C--N 1.296 -2.186 0 C-N-CA 121.917 1.744 . . . . 0.0 111.344 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.9 t -144.53 150.1 36.99 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 122.035 0.922 . . . . 0.0 109.779 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.713 ' HB3' HD11 ' A' ' 96' ' ' ILE . 95.2 p -101.02 139.55 36.56 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-O 122.632 1.206 . . . . 0.0 109.661 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.596 HG13 ' O ' ' A' ' 112' ' ' ASP . 0.6 OUTLIER -150.17 158.61 5.42 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.185 0 O-C-N 121.023 -1.048 . . . . 0.0 109.318 -178.641 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.645 ' HB3' HG22 ' A' ' 23' ' ' THR . 1.2 m -117.12 160.09 21.56 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.484 -1.385 . . . . 0.0 109.448 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.564 HG21 ' CB ' ' A' ' 119' ' ' ALA . 9.0 p -49.44 -31.61 5.68 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.81 0 CA-C-O 122.132 0.968 . . . . 0.0 108.669 -178.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.645 HG22 ' HB3' ' A' ' 21' ' ' SER . 0.0 OUTLIER -59.7 -56.16 25.38 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 120.718 -1.239 . . . . 0.0 109.144 179.484 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.614 ' H ' HG23 ' A' ' 23' ' ' THR . 0.1 OUTLIER -65.51 -35.66 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.106 -1.622 . . . . 0.0 109.461 178.864 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.57 ' HB2' HD12 ' A' ' 113' ' ' ILE . . . -55.54 -36.16 66.47 Favored 'General case' 0 C--N 1.286 -2.157 0 O-C-N 120.85 -1.156 . . . . 0.0 108.354 178.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -56.18 -47.03 79.09 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -60.9 -42.19 97.54 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.961 -1.087 . . . . 0.0 108.769 178.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.444 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 69.5 mt -67.58 -31.69 71.92 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.0 tt -56.86 -39.19 73.83 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.3 mp -62.91 -29.85 71.09 Favored 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 28' ' ' LEU . . . -66.19 -28.87 69.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.705 -1.247 . . . . 0.0 108.448 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.19 49.3 27.45 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.8 t60 -102.56 170.21 8.17 Favored 'General case' 0 C--N 1.292 -1.923 0 O-C-N 121.055 -1.262 . . . . 0.0 109.571 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -59.96 128.05 34.91 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.377 1.084 . . . . 0.0 109.773 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.444 ' CE2' ' OD1' ' A' ' 37' ' ' ASP . 16.0 t80 -109.92 106.64 16.27 Favored 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.307 -0.871 . . . . 0.0 108.945 -178.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.813 ' HB3' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -99.92 135.44 41.35 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.541 -1.349 . . . . 0.0 108.611 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.734 ' H ' HD13 ' A' ' 36' ' ' LEU . 14.2 m-20 -138.45 138.19 37.91 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 38' ' ' VAL . 11.9 m -132.55 75.31 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 CA-C-O 122.358 1.075 . . . . 0.0 108.1 177.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.719 ' H ' HD21 ' A' ' 54' ' ' ASN . 0.4 OUTLIER -82.93 -41.94 18.26 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -179.604 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.655 HG23 ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER 176.37 144.42 0.24 Allowed Pre-proline 0 C--N 1.3 -1.577 0 O-C-N 121.131 -0.981 . . . . 0.0 109.981 -179.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -43.14 -27.96 1.22 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.02 1.813 . . . . 0.0 111.102 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -70.02 -30.9 68.31 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.865 -1.147 . . . . 0.0 108.498 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.563 ' CD ' ' HE ' ' A' ' 39' ' ' ARG . 42.1 tp10 -54.42 -33.95 60.43 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.687 -1.258 . . . . 0.0 109.014 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -79.06 -37.12 39.73 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 122.116 0.96 . . . . 0.0 108.854 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.413 ' C ' ' H ' ' A' ' 47' ' ' GLY . 11.2 t -65.95 -40.97 91.82 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.224 -0.922 . . . . 0.0 109.031 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.495 ' NE2' ' O ' ' A' ' 47' ' ' GLY . 5.4 pp0? -75.69 9.5 2.26 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.104 -0.997 . . . . 0.0 108.627 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.495 ' O ' ' NE2' ' A' ' 46' ' ' GLN . . . 89.97 -160.41 28.53 Favored Glycine 0 N--CA 1.5 2.936 0 CA-C-O 122.299 0.944 . . . . 0.0 110.966 178.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -103.05 -159.32 0.72 Allowed 'General case' 0 C--N 1.289 -2.032 0 CA-C-O 122.752 1.263 . . . . 0.0 109.372 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 1.049 ' HB3' ' HB3' ' A' ' 52' ' ' ALA . . . -141.91 169.58 17.32 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 122.207 1.003 . . . . 0.0 109.352 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.595 ' O ' ' NE1' ' A' ' 120' ' ' TRP . 5.2 t -82.67 106.62 14.67 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.79 25.75 55.39 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 1.049 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . . . -149.29 124.26 9.99 Favored 'General case' 0 C--N 1.29 -1.984 0 O-C-N 120.897 -1.355 . . . . 0.0 109.631 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 29.3 mt -116.99 113.19 42.15 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 O-C-N 120.722 -1.236 . . . . 0.0 110.216 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.719 HD21 ' H ' ' A' ' 39' ' ' ARG . 24.1 t-20 -98.03 135.0 40.36 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 122.01 0.909 . . . . 0.0 109.383 -177.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.42 ' O ' HG12 ' A' ' 55' ' ' VAL . 8.9 t -140.24 92.19 9.59 Favored Pre-proline 0 C--N 1.274 -2.706 0 CA-C-O 122.152 0.977 . . . . 0.0 109.093 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -74.12 86.07 1.32 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.473 2.115 . . . . 0.0 111.769 -178.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.3 t80 . . . . . 0 C--N 1.298 -1.645 0 CA-C-O 122.291 1.043 . . . . 0.0 109.818 -179.845 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 N--CA 1.498 1.972 0 CA-C-O 122.19 0.995 . . . . 0.0 110.026 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.552 ' H ' ' HB2' ' A' ' 83' ' ' ASP . . . -114.26 142.89 17.8 Favored Glycine 0 N--CA 1.498 2.768 0 N-CA-C 110.476 -1.049 . . . . 0.0 110.476 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' A' ' 80' ' ' GLY . 0.2 OUTLIER -44.38 -43.48 7.65 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.451 -1.029 . . . . 0.0 109.166 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.563 ' HA ' HD12 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -122.22 24.15 9.54 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 120.837 -1.164 . . . . 0.0 107.972 179.324 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.552 ' HB2' ' H ' ' A' ' 80' ' ' GLY . 19.4 t0 -34.97 118.07 0.42 Allowed 'General case' 0 N--CA 1.506 2.364 0 CA-C-O 121.715 0.769 . . . . 0.0 109.108 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.612 ' N ' ' O ' ' A' ' 109' ' ' GLY . 6.8 t-20 65.56 60.7 0.72 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.891 0.853 . . . . 0.0 109.418 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.669 HG22 ' N ' ' A' ' 86' ' ' ILE . 12.0 mt -150.14 177.67 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 O-C-N 121.064 -1.023 . . . . 0.0 109.496 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.669 ' N ' HG22 ' A' ' 85' ' ' ILE . 63.7 mt -111.14 108.33 25.21 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.257 0 CA-C-O 122.195 0.997 . . . . 0.0 109.323 178.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.813 HG22 ' HB3' ' A' ' 36' ' ' LEU . 14.1 t -114.98 166.47 8.74 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-O 121.943 0.878 . . . . 0.0 108.892 -176.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -148.66 142.03 9.57 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 49.7 t -92.64 148.3 22.18 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 122.079 0.942 . . . . 0.0 109.303 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -41.74 -36.3 0.97 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 122.003 0.906 . . . . 0.0 110.402 -178.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 96.3 p -132.71 159.02 40.88 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 122.257 1.027 . . . . 0.0 109.444 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 94' ' ' ARG . . . -110.58 -178.58 20.65 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 68.39 -72.33 0.33 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 92' ' ' GLY . 0.0 OUTLIER -67.57 -29.59 68.99 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.182 -1.187 . . . . 0.0 108.824 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.755 ' O ' HG23 ' A' ' 99' ' ' THR . 54.4 p -84.51 -29.12 26.22 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.187 -0.946 . . . . 0.0 109.27 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.713 HD11 ' HB3' ' A' ' 19' ' ' SER . 0.4 OUTLIER -55.53 -48.71 77.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 O-C-N 121.092 -1.005 . . . . 0.0 108.836 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.557 ' N ' ' CG2' ' A' ' 96' ' ' ILE . 4.6 ptmm? -70.67 -40.84 72.74 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.63 -1.294 . . . . 0.0 108.39 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.05 -40.96 95.5 Favored 'General case' 0 C--N 1.289 -2.026 0 O-C-N 120.544 -1.347 . . . . 0.0 109.294 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.755 HG23 ' O ' ' A' ' 95' ' ' SER . 35.7 p -64.46 -54.57 30.52 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-O 122.553 1.168 . . . . 0.0 108.683 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.543 ' O ' ' CG ' ' A' ' 104' ' ' HIS . 35.5 m -46.22 -37.35 7.04 Favored 'General case' 0 C--N 1.287 -2.14 0 O-C-N 121.06 -1.025 . . . . 0.0 108.992 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -87.11 -50.65 6.49 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.62 -1.3 . . . . 0.0 108.077 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.714 HD13 ' C ' ' A' ' 102' ' ' LEU . 1.9 tm? -61.36 -44.45 97.15 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.982 0.896 . . . . 0.0 108.889 -178.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 99' ' ' THR . 70.5 mt -63.14 -38.58 91.76 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.113 -0.992 . . . . 0.0 108.975 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.543 ' CG ' ' O ' ' A' ' 100' ' ' THR . 24.7 m170 -59.88 -18.58 45.69 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.641 -1.287 . . . . 0.0 108.574 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 102' ' ' LEU . . . -62.01 -19.38 62.77 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 120.629 -1.295 . . . . 0.0 108.326 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 128.78 7.88 4.04 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -103.0 17.65 23.55 Favored 'General case' 0 C--N 1.289 -2.032 0 O-C-N 121.082 -1.246 . . . . 0.0 109.395 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.543 ' OG1' ' N ' ' A' ' 17' ' ' PRO . 8.7 t -78.98 -150.73 0.05 Allowed 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.669 -1.269 . . . . 0.0 110.074 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.612 ' O ' ' N ' ' A' ' 84' ' ' ASN . . . 77.45 19.43 76.37 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.48 HG23 ' N ' ' A' ' 111' ' ' LYS . 1.6 m -146.62 166.7 7.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 O-C-N 120.999 -1.295 . . . . 0.0 109.898 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.48 ' N ' HG23 ' A' ' 110' ' ' VAL . 84.9 mttt -97.88 145.48 26.39 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 122.211 1.005 . . . . 0.0 108.71 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.596 ' O ' HG13 ' A' ' 20' ' ' VAL . 51.4 t0 -99.95 109.78 22.13 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.639 HD11 ' CG2' ' A' ' 86' ' ' ILE . 1.2 mm -94.88 138.85 19.83 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.39 0 O-C-N 121.229 -0.919 . . . . 0.0 110.291 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 71.5 t -99.48 143.83 12.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 O-C-N 120.838 -1.163 . . . . 0.0 109.684 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 79.41 -117.2 4.47 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.4 -84.78 1.0 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -55.73 -43.98 77.09 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-O 122.031 0.919 . . . . 0.0 109.671 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 36.6 m -59.92 -39.27 84.9 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-O 121.947 0.879 . . . . 0.0 109.376 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.564 ' CB ' HG21 ' A' ' 22' ' ' VAL . . . -72.55 -50.22 27.15 Favored 'General case' 0 C--N 1.286 -2.159 0 O-C-N 121.096 -1.003 . . . . 0.0 108.882 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . 0.595 ' NE1' ' O ' ' A' ' 50' ' ' CYS . 1.0 OUTLIER -53.92 -39.25 65.68 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.332 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.63 -25.81 68.39 Favored 'General case' 0 C--N 1.292 -1.924 0 O-C-N 120.834 -1.166 . . . . 0.0 108.838 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.578 ' CB ' ' HZ2' ' A' ' 122' ' ' LYS . 2.4 ttmp? -56.97 -42.66 80.6 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -90.76 -67.68 0.84 Allowed 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.624 -1.298 . . . . 0.0 108.358 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 113.18 48.09 0.62 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.463 ' O ' ' CB ' ' A' ' 50' ' ' CYS . 14.3 mt -126.55 78.67 72.14 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 120.834 -1.392 . . . . 0.0 109.314 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.463 ' HA ' ' H ' ' A' ' 50' ' ' CYS . 31.7 Cg_endo . . . . . 0 C--N 1.302 -1.897 0 C-N-CA 122.274 1.983 . . . . 0.0 113.212 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 . . . . . 0 N--CA 1.5 2.074 0 CA-C-O 122.132 0.967 . . . . 0.0 109.715 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.512 HG12 ' HD2' ' A' ' 17' ' ' PRO . 3.5 t -143.11 149.0 47.28 Favored Pre-proline 0 C--N 1.29 -1.98 0 O-C-N 121.287 -0.883 . . . . 0.0 108.911 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.921 ' CB ' HD21 ' A' ' 103' ' ' LEU . 39.9 Cg_endo -90.78 161.91 4.13 Favored 'Trans proline' 0 C--N 1.298 -2.104 0 C-N-CA 121.885 1.723 . . . . 0.0 111.399 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.0 t -161.23 152.55 18.88 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 122.107 0.956 . . . . 0.0 109.721 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 89.0 p -108.5 144.47 36.11 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 122.694 1.235 . . . . 0.0 109.65 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.687 HG23 ' N ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -144.76 177.76 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 O-C-N 120.993 -1.067 . . . . 0.0 109.4 -178.495 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.687 ' N ' HG23 ' A' ' 20' ' ' VAL . 71.7 m -119.55 151.82 38.0 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.47 -1.394 . . . . 0.0 109.435 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.758 ' CG2' ' HB2' ' A' ' 119' ' ' ALA . 6.5 p -47.53 -33.21 2.99 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.793 0 CA-C-O 122.126 0.965 . . . . 0.0 108.695 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.51 ' OG1' ' N ' ' A' ' 24' ' ' VAL . 0.1 OUTLIER -56.26 -56.77 16.87 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 120.728 -1.233 . . . . 0.0 109.12 179.225 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.51 ' N ' ' OG1' ' A' ' 23' ' ' THR . 0.1 OUTLIER -65.42 -34.74 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.131 -1.605 . . . . 0.0 109.377 179.101 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.947 ' HB2' HD13 ' A' ' 113' ' ' ILE . . . -50.92 -37.43 44.0 Favored 'General case' 0 C--N 1.287 -2.132 0 O-C-N 120.825 -1.172 . . . . 0.0 108.39 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -59.55 -47.83 84.03 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -60.25 -44.45 95.25 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 120.885 -1.134 . . . . 0.0 108.675 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.6 mt -68.7 -53.16 23.86 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.465 ' CD2' ' C ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -58.71 -43.1 89.98 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.016 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.707 HD13 ' C ' ' A' ' 30' ' ' LEU . 1.4 tm? -58.41 -34.71 71.05 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.466 ' HB3' ' CE1' ' A' ' 33' ' ' HIS . . . -71.09 -19.87 62.41 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.712 -1.243 . . . . 0.0 108.391 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.07 49.6 1.88 Allowed Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.466 ' CE1' ' HB3' ' A' ' 31' ' ' ALA . 39.3 m80 -107.4 139.39 41.96 Favored 'General case' 0 C--N 1.291 -1.969 0 O-C-N 121.234 -1.156 . . . . 0.0 109.592 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 36.9 mtt-85 -61.82 141.11 58.13 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 122.331 1.062 . . . . 0.0 109.846 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -125.62 118.06 24.87 Favored 'General case' 0 C--N 1.291 -1.96 0 O-C-N 121.38 -0.825 . . . . 0.0 108.968 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.815 ' HB2' HG22 ' A' ' 87' ' ' VAL . 17.6 mt -92.62 108.2 19.8 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 120.616 -1.303 . . . . 0.0 108.604 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.545 ' OD2' ' NE2' ' A' ' 48' ' ' HIS . 41.0 t0 -90.81 122.97 33.99 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -178.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.756 HG12 ' O ' ' A' ' 55' ' ' VAL . 20.2 m -134.17 87.81 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 CA-C-O 122.502 1.144 . . . . 0.0 108.125 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.744 ' O ' HG23 ' A' ' 40' ' ' THR . 24.5 mtp180 -83.59 -46.08 12.79 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.744 HG23 ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER 172.92 165.64 0.27 Allowed Pre-proline 0 N--CA 1.49 1.564 0 C-N-CA 119.296 -0.962 . . . . 0.0 109.925 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -53.33 -35.43 74.7 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.04 1.827 . . . . 0.0 111.085 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -61.0 -30.43 70.28 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.894 -1.128 . . . . 0.0 108.48 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.593 ' O ' ' N ' ' A' ' 47' ' ' GLY . 83.5 tt0 -55.79 -30.63 61.65 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.755 -1.216 . . . . 0.0 108.968 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -72.6 -38.32 67.85 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 122.176 0.989 . . . . 0.0 108.933 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.6 t -51.49 -48.36 62.92 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.175 -0.953 . . . . 0.0 109.167 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -103.73 -20.75 13.85 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.147 -0.97 . . . . 0.0 108.621 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 43' ' ' GLU . . . 82.37 -172.53 52.47 Favored Glycine 0 N--CA 1.5 2.915 0 CA-C-O 122.289 0.938 . . . . 0.0 110.985 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.545 ' NE2' ' OD2' ' A' ' 37' ' ' ASP . 2.1 t60 176.13 101.71 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.034 0 CA-C-O 122.645 1.212 . . . . 0.0 109.395 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -160.45 147.7 15.94 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 122.26 1.029 . . . . 0.0 109.388 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.4 t -176.32 44.72 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.264 0 CA-C-O 122.548 1.166 . . . . 0.0 107.869 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 117.85 23.81 3.53 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.984 ' HB2' ' CZ2' ' A' ' 120' ' ' TRP . . . -154.11 179.16 9.19 Favored 'General case' 0 C--N 1.289 -2.045 0 O-C-N 120.861 -1.376 . . . . 0.0 109.639 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 77.1 mt -123.47 147.97 27.62 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 O-C-N 120.832 -1.168 . . . . 0.0 110.3 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -131.55 143.57 50.46 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.954 0.883 . . . . 0.0 109.499 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.765 ' O ' HG12 ' A' ' 55' ' ' VAL . 1.1 t -140.62 91.89 9.25 Favored Pre-proline 0 C--N 1.274 -2.717 0 CA-C-O 122.205 1.002 . . . . 0.0 109.089 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -78.77 66.26 8.66 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.524 2.149 . . . . 0.0 111.806 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 . . . . . 0 C--N 1.299 -1.6 0 CA-C-O 122.375 1.083 . . . . 0.0 109.826 -179.549 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 . . . . . 0 N--CA 1.499 2.019 0 CA-C-O 122.193 0.997 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.66 ' H ' ' HB3' ' A' ' 83' ' ' ASP . . . -114.19 134.78 11.98 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.423 HE21 HG11 ' A' ' 55' ' ' VAL . 7.5 pt20 -48.03 -21.19 0.42 Allowed 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.454 -1.027 . . . . 0.0 109.173 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.812 ' HA ' HD12 ' A' ' 85' ' ' ILE . 54.4 m -123.73 15.54 9.44 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.847 -1.158 . . . . 0.0 107.914 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.66 ' HB3' ' H ' ' A' ' 80' ' ' GLY . 12.6 p30 -45.78 109.91 0.22 Allowed 'General case' 0 N--CA 1.507 2.396 0 O-C-N 121.406 -0.809 . . . . 0.0 109.123 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 58.61 64.07 1.54 Allowed 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.973 0.892 . . . . 0.0 109.4 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.812 HD12 ' HA ' ' A' ' 82' ' ' SER . 24.1 mt -142.25 176.32 3.95 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 O-C-N 121.025 -1.047 . . . . 0.0 109.408 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.889 HG23 ' HB2' ' A' ' 111' ' ' LYS . 6.7 mt -121.78 112.57 35.61 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 O-C-N 121.106 -0.997 . . . . 0.0 109.403 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.815 HG22 ' HB2' ' A' ' 36' ' ' LEU . 92.6 t -100.56 -179.68 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 O-C-N 121.281 -0.887 . . . . 0.0 108.919 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.67 ' H ' HG12 ' A' ' 87' ' ' VAL . . . -175.09 140.13 5.13 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 46.3 t -110.61 146.69 35.69 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-O 122.07 0.938 . . . . 0.0 109.283 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.45 ' CD ' HH21 ' A' ' 39' ' ' ARG . 7.8 tt0 -42.57 -70.69 0.1 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.022 0.915 . . . . 0.0 110.464 -178.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.1 t -72.13 160.22 32.82 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 122.238 1.018 . . . . 0.0 109.453 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 94' ' ' ARG . . . -132.25 174.72 20.19 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.415 ' O ' HG22 ' A' ' 96' ' ' ILE . . . 61.67 -76.32 0.02 OUTLIER Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.53 ' N ' ' O ' ' A' ' 92' ' ' GLY . 1.1 ttt-85 -65.93 -37.19 85.42 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.216 -1.167 . . . . 0.0 108.778 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.2 t -87.65 -27.6 22.36 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 121.188 -0.945 . . . . 0.0 109.254 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.585 ' CG2' ' N ' ' A' ' 97' ' ' LYS . 2.6 tt -59.07 -48.82 85.47 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 O-C-N 121.084 -1.01 . . . . 0.0 108.879 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.585 ' N ' ' CG2' ' A' ' 96' ' ' ILE . 17.1 pttp -63.99 -35.67 81.47 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.697 -1.252 . . . . 0.0 108.449 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.97 -43.05 79.91 Favored 'General case' 0 C--N 1.288 -2.074 0 O-C-N 120.534 -1.354 . . . . 0.0 109.206 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 103' ' ' LEU . 30.5 p -77.95 -50.58 11.9 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-O 122.573 1.177 . . . . 0.0 108.697 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.535 ' O ' ' N ' ' A' ' 104' ' ' HIS . 60.3 m -53.91 -49.4 68.7 Favored 'General case' 0 C--N 1.288 -2.102 0 O-C-N 121.012 -1.055 . . . . 0.0 109.033 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -61.94 -46.14 90.63 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.627 -1.296 . . . . 0.0 108.17 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.776 ' O ' HD13 ' A' ' 102' ' ' LEU . 2.5 tm? -64.63 -40.79 96.09 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.305 -0.872 . . . . 0.0 108.808 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.921 HD21 ' CB ' ' A' ' 17' ' ' PRO . 0.3 OUTLIER -75.19 -30.55 60.69 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.122 -0.986 . . . . 0.0 108.966 178.358 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.535 ' N ' ' O ' ' A' ' 100' ' ' THR . 84.0 t60 -53.39 -34.71 58.77 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.597 -1.315 . . . . 0.0 108.606 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -131.23 35.56 3.89 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 120.573 -1.329 . . . . 0.0 108.301 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -148.13 -37.23 0.04 OUTLIER Glycine 0 N--CA 1.495 2.586 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.478 ' O ' ' O ' ' A' ' 103' ' ' LEU . 66.5 m-85 -134.83 164.18 28.13 Favored 'General case' 0 C--N 1.288 -2.078 0 O-C-N 121.235 -1.156 . . . . 0.0 109.414 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.3 t -176.27 151.03 0.97 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.538 -1.351 . . . . 0.0 110.126 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.65 21.97 38.39 Favored Glycine 0 N--CA 1.498 2.814 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.412 HG11 ' CB ' ' A' ' 82' ' ' SER . 1.9 m -148.03 155.86 9.59 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 O-C-N 121.064 -1.257 . . . . 0.0 109.932 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.889 ' HB2' HG23 ' A' ' 86' ' ' ILE . 52.8 mttp -98.87 158.81 15.39 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 122.252 1.025 . . . . 0.0 108.726 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.609 ' O ' HG13 ' A' ' 20' ' ' VAL . 85.2 m-20 -114.92 125.57 53.79 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.947 HD13 ' HB2' ' A' ' 25' ' ' ALA . 3.7 mt -102.7 152.72 5.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.401 0 O-C-N 121.301 -0.874 . . . . 0.0 110.261 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 44.0 t -97.74 135.83 30.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 O-C-N 120.821 -1.174 . . . . 0.0 109.664 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.13 -145.2 17.55 Favored Glycine 0 C--N 1.285 -2.302 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 160.6 -95.26 0.14 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -52.85 -38.33 61.36 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-O 122.084 0.945 . . . . 0.0 109.711 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 29.3 t -57.27 -33.07 67.25 Favored 'General case' 0 C--N 1.291 -1.939 0 O-C-N 121.286 -0.883 . . . . 0.0 109.301 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.758 ' HB2' ' CG2' ' A' ' 22' ' ' VAL . . . -69.81 -52.4 25.45 Favored 'General case' 0 C--N 1.286 -2.171 0 O-C-N 121.103 -0.998 . . . . 0.0 108.873 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . 0.984 ' CZ2' ' HB2' ' A' ' 52' ' ' ALA . 0.6 OUTLIER -61.57 -37.35 83.52 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.25 -27.86 64.78 Favored 'General case' 0 C--N 1.292 -1.92 0 O-C-N 120.848 -1.157 . . . . 0.0 108.789 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.8 ttmm -56.06 -42.78 77.16 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -85.52 -64.59 1.13 Allowed 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.643 -1.286 . . . . 0.0 108.375 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 137.4 39.1 0.13 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.662 ' O ' ' O ' ' A' ' 126' ' ' PRO . 2.7 mt -102.74 127.95 29.01 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 120.848 -1.383 . . . . 0.0 109.362 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.662 ' O ' ' O ' ' A' ' 125' ' ' LEU . 51.3 Cg_exo . . . . . 0 C--N 1.302 -1.89 0 C-N-CA 122.269 1.979 . . . . 0.0 113.2 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.712 ' HE ' ' ND2' ' A' ' 84' ' ' ASN . 4.5 mpt_? . . . . . 0 N--CA 1.5 2.042 0 CA-C-O 122.211 1.005 . . . . 0.0 109.754 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -131.44 173.96 5.26 Favored Pre-proline 0 C--N 1.291 -1.949 0 O-C-N 121.277 -0.89 . . . . 0.0 108.872 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.406 ' N ' ' HG1' ' A' ' 108' ' ' THR . 20.8 Cg_endo -88.91 78.64 1.09 Allowed 'Trans proline' 0 C--N 1.297 -2.16 0 C-N-CA 121.831 1.687 . . . . 0.0 111.42 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 112' ' ' ASP . 33.0 t -75.19 144.52 42.65 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 122.029 0.918 . . . . 0.0 109.705 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 82.7 p -100.36 151.51 21.42 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 122.703 1.239 . . . . 0.0 109.63 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.663 ' CG2' ' N ' ' A' ' 21' ' ' SER . 0.1 OUTLIER -150.6 173.92 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 O-C-N 121.002 -1.061 . . . . 0.0 109.431 -178.653 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.663 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 1.5 m -108.82 166.12 11.05 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.516 -1.365 . . . . 0.0 109.46 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 1.052 HG11 ' HB1' ' A' ' 119' ' ' ALA . 37.1 t -62.86 -29.98 48.42 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.808 0 CA-C-O 122.106 0.955 . . . . 0.0 108.707 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.608 HG23 ' N ' ' A' ' 24' ' ' VAL . 6.5 t -55.38 -47.78 75.3 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 120.82 -1.175 . . . . 0.0 109.106 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.608 ' N ' HG23 ' A' ' 23' ' ' THR . 1.4 t -69.68 -39.74 78.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.157 -1.589 . . . . 0.0 109.42 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.996 ' HB2' HD13 ' A' ' 113' ' ' ILE . . . -51.3 -36.27 41.72 Favored 'General case' 0 C--N 1.288 -2.103 0 O-C-N 120.804 -1.185 . . . . 0.0 108.39 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -60.29 -48.63 80.93 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -59.81 -36.15 76.18 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 120.878 -1.139 . . . . 0.0 108.699 178.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.539 HD13 HD13 ' A' ' 86' ' ' ILE . 51.2 mt -80.86 -25.03 37.96 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 25' ' ' ALA . 8.9 tt -62.22 -43.38 98.95 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.8 HD12 ' N ' ' A' ' 31' ' ' ALA . 3.4 pp -80.21 -14.39 58.48 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.509 -1.369 . . . . 0.0 107.477 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.8 ' N ' HD12 ' A' ' 30' ' ' LEU . . . -67.27 -27.67 67.39 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.736 -1.228 . . . . 0.0 108.398 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.24 47.68 6.0 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.526 ' O ' ' CZ ' ' A' ' 35' ' ' TYR . 14.1 m-70 -115.37 163.61 15.47 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.204 -1.174 . . . . 0.0 109.589 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.636 HH12 HD13 ' A' ' 53' ' ' ILE . 20.0 mmm180 -59.8 132.04 52.75 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 122.359 1.076 . . . . 0.0 109.793 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.526 ' CZ ' ' O ' ' A' ' 33' ' ' HIS . 21.6 m-85 -118.2 108.14 14.8 Favored 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.314 -0.866 . . . . 0.0 108.95 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.788 ' HB3' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -102.35 133.16 47.73 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 120.582 -1.324 . . . . 0.0 108.587 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.62 ' H ' HD13 ' A' ' 36' ' ' LEU . 22.1 t70 -147.75 111.39 5.01 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 -178.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.427 ' O ' HG22 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -83.1 103.97 11.09 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 O-C-N 120.959 -1.088 . . . . 0.0 108.093 177.44 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.705 HH22 ' NE2' ' A' ' 46' ' ' GLN . 25.7 ttp180 -84.34 -43.45 14.74 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -179.01 170.39 0.73 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.182 -0.949 . . . . 0.0 109.95 -179.026 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 40' ' ' THR . 24.7 Cg_exo -55.47 -145.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 121.92 1.746 . . . . 0.0 111.125 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -58.28 -23.44 56.24 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.85 -1.156 . . . . 0.0 108.543 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.473 ' O ' ' OE1' ' A' ' 46' ' ' GLN . 96.7 mt-10 -50.66 -30.0 12.52 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.802 -1.186 . . . . 0.0 108.997 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.662 ' CD1' ' N ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -78.06 -32.22 50.73 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 122.217 1.008 . . . . 0.0 108.91 177.446 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.662 ' N ' ' CD1' ' A' ' 44' ' ' PHE . 16.0 t -49.01 -19.1 0.36 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.153 -0.967 . . . . 0.0 109.052 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.705 ' NE2' HH22 ' A' ' 39' ' ' ARG . 0.4 OUTLIER -69.8 -9.57 55.14 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.089 -1.007 . . . . 0.0 108.619 179.46 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.515 ' O ' ' O ' ' A' ' 44' ' ' PHE . . . 161.78 -164.76 35.41 Favored Glycine 0 N--CA 1.499 2.875 0 CA-C-O 122.245 0.914 . . . . 0.0 111.051 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.635 ' O ' ' O ' ' A' ' 49' ' ' ALA . 3.9 p80 -176.0 106.01 0.08 Allowed 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 122.732 1.254 . . . . 0.0 109.38 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.635 ' O ' ' O ' ' A' ' 48' ' ' HIS . . . -30.87 157.44 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 122.159 0.981 . . . . 0.0 109.421 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.694 ' SG ' ' N ' ' A' ' 51' ' ' GLY . 0.5 OUTLIER -93.53 162.17 14.07 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.694 ' N ' ' SG ' ' A' ' 50' ' ' CYS . . . 105.79 -8.13 42.66 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.771 ' HB3' ' CZ2' ' A' ' 120' ' ' TRP . . . -170.46 157.78 6.13 Favored 'General case' 0 C--N 1.29 -2.009 0 O-C-N 120.784 -1.421 . . . . 0.0 109.615 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.636 HD13 HH12 ' A' ' 34' ' ' ARG . 38.6 mt -99.6 134.83 37.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 O-C-N 120.762 -1.211 . . . . 0.0 110.262 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.477 ' ND2' ' OD2' ' A' ' 37' ' ' ASP . 6.7 m120 -113.3 134.2 54.73 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 121.937 0.875 . . . . 0.0 109.472 -178.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.734 ' O ' HG12 ' A' ' 55' ' ' VAL . 1.1 t -142.6 95.77 6.37 Favored Pre-proline 0 C--N 1.273 -2.754 0 CA-C-O 122.221 1.01 . . . . 0.0 109.133 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.433 ' HG3' ' CD1' ' A' ' 44' ' ' PHE . 28.3 Cg_endo -77.94 54.37 4.83 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.5 2.134 . . . . 0.0 111.693 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.518 ' CE1' ' NE2' ' A' ' 81' ' ' GLN . 61.8 m-85 . . . . . 0 C--N 1.298 -1.661 0 CA-C-O 122.31 1.052 . . . . 0.0 109.848 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 . . . . . 0 N--CA 1.499 2.01 0 CA-C-O 122.211 1.005 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.548 ' H ' ' HB2' ' A' ' 83' ' ' ASP . . . -112.26 137.79 14.51 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.518 ' NE2' ' CE1' ' A' ' 57' ' ' TYR . 10.5 pt20 -45.71 -19.56 0.06 Allowed 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.491 -1.005 . . . . 0.0 109.17 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.819 ' HA ' HD12 ' A' ' 85' ' ' ILE . 16.3 m -122.84 20.92 10.04 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.793 -1.192 . . . . 0.0 107.969 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.548 ' HB2' ' H ' ' A' ' 80' ' ' GLY . 42.2 t0 -42.42 113.8 0.49 Allowed 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.408 -0.808 . . . . 0.0 109.11 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.712 ' ND2' ' HE ' ' A' ' 15' ' ' ARG . 5.4 m120 59.6 63.36 1.53 Allowed 'General case' 0 C--N 1.291 -1.936 0 O-C-N 121.308 -0.87 . . . . 0.0 109.451 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.819 HD12 ' HA ' ' A' ' 82' ' ' SER . 17.8 mt -145.93 176.66 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 O-C-N 121.076 -1.015 . . . . 0.0 109.421 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.66 ' N ' HG22 ' A' ' 85' ' ' ILE . 64.1 mt -111.01 112.43 40.55 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 O-C-N 121.078 -1.014 . . . . 0.0 109.422 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.926 ' CG2' HG21 ' A' ' 110' ' ' VAL . 60.4 t -110.94 175.0 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 O-C-N 121.261 -0.899 . . . . 0.0 108.887 -176.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.561 ' N ' HG12 ' A' ' 87' ' ' VAL . . . -172.02 175.63 45.28 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 19.7 t -128.46 120.31 26.61 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 122.029 0.919 . . . . 0.0 109.319 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.439 ' O ' ' OE1' ' A' ' 90' ' ' GLN . 1.0 OUTLIER -65.63 -38.63 89.95 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.039 0.923 . . . . 0.0 110.422 -178.492 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 92' ' ' GLY . 4.1 m -61.52 160.98 10.26 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 122.171 0.986 . . . . 0.0 109.473 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 91' ' ' SER . . . -43.17 161.95 0.05 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.668 ' O ' HG22 ' A' ' 96' ' ' ILE . . . -54.83 -28.06 46.02 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -55.05 -28.32 51.38 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.221 -1.164 . . . . 0.0 108.72 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 43.7 t -85.24 -32.44 22.6 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.15 -0.969 . . . . 0.0 109.237 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.748 HG13 HG22 ' A' ' 114' ' ' VAL . 0.3 OUTLIER -60.3 -30.56 46.42 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 O-C-N 121.03 -1.044 . . . . 0.0 108.881 -179.289 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.413 ' HB3' ' HZ2' ' A' ' 97' ' ' LYS . 16.1 mtpp -62.56 -47.68 82.78 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.707 -1.246 . . . . 0.0 108.402 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.34 -50.09 72.49 Favored 'General case' 0 C--N 1.289 -2.029 0 O-C-N 120.557 -1.339 . . . . 0.0 109.266 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.733 ' O ' HD13 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -57.86 -47.84 81.55 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-O 122.525 1.155 . . . . 0.0 108.705 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 57.9 m -56.39 -48.81 76.13 Favored 'General case' 0 C--N 1.287 -2.134 0 O-C-N 120.943 -1.098 . . . . 0.0 108.989 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -65.43 -40.34 93.2 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.654 -1.279 . . . . 0.0 108.153 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 102' ' ' LEU . 3.7 tt -68.48 -40.54 80.94 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.968 0.89 . . . . 0.0 108.818 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.733 HD13 ' O ' ' A' ' 99' ' ' THR . 10.8 mp -69.86 -28.93 66.07 Favored 'General case' 0 C--N 1.292 -1.914 0 O-C-N 121.088 -1.007 . . . . 0.0 109.017 178.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -64.02 -32.54 74.12 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.519 -1.363 . . . . 0.0 108.527 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -130.93 37.2 3.8 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.623 -1.298 . . . . 0.0 108.393 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -151.34 -67.64 0.01 OUTLIER Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.666 ' H ' ' HA ' ' A' ' 103' ' ' LEU . 96.7 m-85 -138.48 156.24 47.71 Favored 'General case' 0 C--N 1.289 -2.048 0 O-C-N 121.175 -1.191 . . . . 0.0 109.38 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.426 ' OG1' ' N ' ' A' ' 109' ' ' GLY . 11.0 t -166.42 -161.93 0.49 Allowed 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.667 -1.271 . . . . 0.0 110.104 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.426 ' N ' ' OG1' ' A' ' 108' ' ' THR . . . 79.05 21.13 68.6 Favored Glycine 0 N--CA 1.499 2.836 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.926 HG21 ' CG2' ' A' ' 87' ' ' VAL . 1.7 m -142.29 167.93 14.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 O-C-N 121.07 -1.253 . . . . 0.0 109.874 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.607 ' O ' ' N ' ' A' ' 87' ' ' VAL . 85.6 mttt -97.88 148.94 22.92 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 122.198 0.999 . . . . 0.0 108.739 -179.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -111.74 108.08 17.38 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -178.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.996 HD13 ' HB2' ' A' ' 25' ' ' ALA . 69.7 mt -83.08 125.1 40.04 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 O-C-N 121.265 -0.897 . . . . 0.0 110.261 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.748 HG22 HG13 ' A' ' 96' ' ' ILE . 67.2 t -100.78 138.22 25.75 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 O-C-N 120.825 -1.172 . . . . 0.0 109.63 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 167.67 -147.48 11.72 Favored Glycine 0 C--N 1.285 -2.268 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -154.22 -176.99 27.17 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -59.06 -33.02 70.3 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-O 122.011 0.91 . . . . 0.0 109.647 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.499 ' O ' ' HB3' ' A' ' 121' ' ' ALA . 32.1 t -56.47 -32.26 64.8 Favored 'General case' 0 C--N 1.292 -1.905 0 O-C-N 121.332 -0.855 . . . . 0.0 109.331 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 1.052 ' HB1' HG11 ' A' ' 22' ' ' VAL . . . -62.21 -40.91 97.66 Favored 'General case' 0 C--N 1.286 -2.159 0 O-C-N 121.185 -0.947 . . . . 0.0 108.892 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . 0.771 ' CZ2' ' HB3' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -60.34 -33.77 72.88 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 179.294 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 118' ' ' SER . . . -56.84 -37.63 71.53 Favored 'General case' 0 C--N 1.292 -1.911 0 O-C-N 120.795 -1.19 . . . . 0.0 108.812 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -56.44 -39.19 72.71 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -63.36 -65.29 0.71 Allowed 'General case' 0 N--CA 1.503 2.184 0 O-C-N 120.649 -1.282 . . . . 0.0 108.371 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.06 16.53 35.19 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 50' ' ' CYS . 12.6 mt -126.83 71.98 74.9 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 120.827 -1.396 . . . . 0.0 109.369 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.49 ' HA ' ' H ' ' A' ' 50' ' ' CYS . 32.9 Cg_endo . . . . . 0 C--N 1.302 -1.911 0 C-N-CA 122.29 1.993 . . . . 0.0 113.16 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 122.16 0.981 . . . . 0.0 109.225 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -105.6 145.29 31.18 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-O 122.018 0.913 . . . . 0.0 109.233 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -147.26 25.01 1.12 Allowed 'General case' 0 C--N 1.29 -1.989 0 CA-C-O 122.219 1.009 . . . . 0.0 109.657 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.2 p -83.57 0.58 46.02 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -139.39 99.34 3.71 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 122.16 0.981 . . . . 0.0 109.735 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.625 ' H ' ' N ' ' A' ' 109' ' ' GLY . 9.0 t -146.85 101.75 3.92 Favored Pre-proline 0 C--N 1.291 -1.958 0 O-C-N 121.267 -0.896 . . . . 0.0 108.942 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -88.69 124.72 1.61 Allowed 'Trans proline' 0 C--N 1.297 -2.14 0 C-N-CA 121.875 1.716 . . . . 0.0 111.431 177.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.5 p -138.17 152.2 48.45 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 122.021 0.915 . . . . 0.0 109.681 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.534 ' C ' HG12 ' A' ' 20' ' ' VAL . 39.6 m -115.96 144.55 43.92 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 122.675 1.226 . . . . 0.0 109.627 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.761 HG23 ' N ' ' A' ' 21' ' ' SER . 0.7 OUTLIER -158.81 -179.04 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.196 0 O-C-N 121.025 -1.047 . . . . 0.0 109.402 -178.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.761 ' N ' HG23 ' A' ' 20' ' ' VAL . 14.3 p -115.58 148.19 39.87 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.48 -1.387 . . . . 0.0 109.395 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.6 p -47.32 -21.24 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.768 0 CA-C-O 122.102 0.953 . . . . 0.0 108.648 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.597 HG23 ' HB2' ' A' ' 21' ' ' SER . 0.1 OUTLIER -64.39 -55.7 19.32 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 120.736 -1.227 . . . . 0.0 109.177 179.169 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.494 ' N ' ' OG1' ' A' ' 23' ' ' THR . 0.9 OUTLIER -71.15 -40.5 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.175 -1.578 . . . . 0.0 109.4 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.634 ' HB2' HD12 ' A' ' 113' ' ' ILE . . . -57.98 -35.04 70.64 Favored 'General case' 0 C--N 1.286 -2.159 0 O-C-N 120.829 -1.17 . . . . 0.0 108.361 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.612 ' O ' HD13 ' A' ' 30' ' ' LEU . 86.4 t60 -52.99 -46.66 68.42 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -55.33 -43.42 74.94 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 120.907 -1.12 . . . . 0.0 108.666 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.505 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 10.4 mp -70.72 -36.8 73.38 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 19.2 tp -56.91 -39.69 74.92 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.612 HD13 ' O ' ' A' ' 26' ' ' HIS . 11.0 mp -63.43 -25.8 68.44 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 28' ' ' LEU . . . -66.34 -22.42 66.27 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.77 -1.207 . . . . 0.0 108.385 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.95 48.82 3.5 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -107.41 149.58 27.73 Favored 'General case' 0 C--N 1.292 -1.898 0 O-C-N 121.204 -1.174 . . . . 0.0 109.593 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.429 ' NH2' HD11 ' A' ' 85' ' ' ILE . 75.5 mtm180 -58.66 133.68 56.11 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 122.428 1.109 . . . . 0.0 109.827 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.402 ' O ' ' O ' ' A' ' 53' ' ' ILE . 47.3 t80 -112.6 113.61 25.83 Favored 'General case' 0 C--N 1.292 -1.93 0 O-C-N 121.285 -0.884 . . . . 0.0 108.937 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.756 ' HB3' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -98.84 130.57 45.27 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.594 -1.317 . . . . 0.0 108.554 179.213 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.621 ' N ' ' CD1' ' A' ' 36' ' ' LEU . 48.2 t0 -138.61 142.5 39.13 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.988 HG21 ' CZ ' ' A' ' 57' ' ' TYR . 4.5 m -131.04 96.11 2.59 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 CA-C-O 122.433 1.111 . . . . 0.0 108.158 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.754 ' O ' ' OG1' ' A' ' 40' ' ' THR . 0.1 OUTLIER -89.65 -45.32 9.43 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.754 ' OG1' ' O ' ' A' ' 39' ' ' ARG . 3.6 m 177.45 142.32 0.25 Allowed Pre-proline 0 N--CA 1.49 1.573 0 C-N-CA 119.312 -0.955 . . . . 0.0 109.921 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.559 ' HD2' HG23 ' A' ' 40' ' ' THR . 50.8 Cg_exo -40.21 -39.96 2.73 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 121.983 1.788 . . . . 0.0 111.074 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.663 ' H ' HG22 ' A' ' 40' ' ' THR . 96.6 mt-10 -61.0 -30.34 70.23 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.951 -1.093 . . . . 0.0 108.567 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 40' ' ' THR . 66.1 tt0 -55.48 -32.01 62.47 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.75 -1.219 . . . . 0.0 109.014 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -67.99 -44.21 77.15 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 122.174 0.988 . . . . 0.0 108.978 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.1 t -56.13 -29.72 61.1 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.191 -0.943 . . . . 0.0 109.048 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -70.16 -36.92 75.04 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.124 -0.985 . . . . 0.0 108.631 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.06 -148.38 17.11 Favored Glycine 0 N--CA 1.499 2.84 0 CA-C-O 122.267 0.926 . . . . 0.0 110.977 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.742 ' H ' ' CB ' ' A' ' 128' ' ' LYS . 96.6 m-70 -100.42 -160.2 0.78 Allowed 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 122.684 1.23 . . . . 0.0 109.411 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.69 ' C ' ' H ' ' A' ' 127' ' ' THR . . . -144.62 166.72 24.38 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 122.178 0.99 . . . . 0.0 109.396 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.902 ' N ' ' H ' ' A' ' 127' ' ' THR . 4.7 t -83.63 105.33 14.47 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-O 122.541 1.162 . . . . 0.0 107.89 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.56 26.5 65.27 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.609 ' C ' HD12 ' A' ' 53' ' ' ILE . . . -156.0 123.15 5.37 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 120.784 -1.421 . . . . 0.0 109.595 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.777 ' N ' HD12 ' A' ' 53' ' ' ILE . 2.7 mp -105.14 104.27 16.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 O-C-N 120.709 -1.245 . . . . 0.0 110.247 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -107.94 118.33 36.46 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-O 121.971 0.891 . . . . 0.0 109.449 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.904 ' O ' HG12 ' A' ' 38' ' ' VAL . 2.0 m -142.13 163.34 40.49 Favored Pre-proline 0 C--N 1.274 -2.71 0 CA-C-O 122.171 0.986 . . . . 0.0 109.09 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.638 ' O ' ' N ' ' A' ' 58' ' ' MET . 36.8 Cg_endo -84.08 68.2 6.71 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.451 2.101 . . . . 0.0 111.72 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.988 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 66.4 m-85 54.83 -78.64 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 122.229 1.014 . . . . 0.0 109.789 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.83 ' HB2' ' H ' ' A' ' 68' ' ' ASN . 28.8 mmm -109.45 142.86 39.84 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-O 122.123 0.964 . . . . 0.0 110.071 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -148.26 133.27 18.19 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.2 ttt-85 -78.12 132.73 37.8 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.138 -0.976 . . . . 0.0 108.629 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 63' ' ' SER . . . -175.83 -171.8 40.03 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.06 -1.5 0.98 Allowed 'General case' 0 C--N 1.28 -2.44 0 O-C-N 121.166 -1.196 . . . . 0.0 108.315 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.51 ' H ' ' C ' ' A' ' 61' ' ' GLY . 26.4 t -63.21 -8.59 8.55 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 65' ' ' MET . . . 106.95 29.81 4.47 Favored Glycine 0 N--CA 1.5 2.933 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.438 ' O ' ' O ' ' A' ' 64' ' ' GLY . 72.2 mtm 55.66 115.61 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 122.284 1.04 . . . . 0.0 110.316 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.0 t -161.47 97.63 1.1 Allowed 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 69' ' ' THR . 16.5 tptm -127.54 121.29 30.26 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.03 -1.044 . . . . 0.0 108.544 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.922 ' OD1' HD11 ' A' ' 72' ' ' LEU . 19.5 t30 -40.14 94.14 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 122.208 1.004 . . . . 0.0 110.041 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.505 ' N ' ' O ' ' A' ' 67' ' ' LYS . 4.9 m -159.35 -48.54 0.06 Allowed 'General case' 0 C--N 1.281 -2.396 0 O-C-N 121.465 -0.772 . . . . 0.0 109.915 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' A' ' 71' ' ' PHE . 44.1 p30 -154.06 -27.9 0.13 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.323 -1.486 . . . . 0.0 108.332 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.558 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 97.5 m-85 -51.03 -24.23 3.63 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 122.126 0.965 . . . . 0.0 108.849 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.922 HD11 ' OD1' ' A' ' 68' ' ' ASN . 3.0 mt -52.51 -42.47 64.34 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.973 0.892 . . . . 0.0 108.656 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.47 ' CG ' ' N ' ' A' ' 74' ' ' GLN . 13.5 pt-20 -60.88 -40.85 94.54 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.907 -1.121 . . . . 0.0 108.933 177.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.47 ' N ' ' CG ' ' A' ' 73' ' ' GLU . 84.7 mt-30 -75.53 -45.12 39.93 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.795 -1.191 . . . . 0.0 108.682 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.611 HG12 ' O ' ' A' ' 79' ' ' PHE . 24.3 t -70.88 -54.0 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.781 -1.2 . . . . 0.0 108.752 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 72' ' ' LEU . 9.0 t -58.24 -14.49 7.3 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.598 ' O ' ' CG ' ' A' ' 78' ' ' HIS . 54.8 p -51.21 -37.56 47.45 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.91 -1.119 . . . . 0.0 109.229 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.598 ' CG ' ' O ' ' A' ' 77' ' ' SER . 5.1 m80 -174.41 14.02 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.611 ' O ' HG12 ' A' ' 75' ' ' VAL . 22.7 t80 -142.42 151.24 41.6 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.91 -1.119 . . . . 0.0 110.018 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.568 ' H ' ' HB3' ' A' ' 83' ' ' ASP . . . -116.55 136.24 12.65 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -46.56 -25.92 0.79 Allowed 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.487 -1.007 . . . . 0.0 109.198 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.796 ' HA ' HD12 ' A' ' 85' ' ' ILE . 0.3 OUTLIER -125.09 23.01 7.83 Favored 'General case' 0 C--N 1.292 -1.906 0 O-C-N 120.809 -1.182 . . . . 0.0 107.97 178.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.568 ' HB3' ' H ' ' A' ' 80' ' ' GLY . 9.8 p-10 -35.56 116.33 0.36 Allowed 'General case' 0 N--CA 1.507 2.419 0 CA-C-O 121.762 0.792 . . . . 0.0 109.076 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.576 ' N ' ' O ' ' A' ' 109' ' ' GLY . 28.8 t30 63.0 60.88 1.17 Allowed 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.898 0.856 . . . . 0.0 109.426 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.796 HD12 ' HA ' ' A' ' 82' ' ' SER . 21.5 mt -145.94 175.24 2.28 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 O-C-N 121.063 -1.023 . . . . 0.0 109.41 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.637 ' N ' HG22 ' A' ' 85' ' ' ILE . 28.3 mt -111.26 107.48 23.06 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.294 0 CA-C-O 122.181 0.991 . . . . 0.0 109.407 178.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.756 HG22 ' HB3' ' A' ' 36' ' ' LEU . 38.2 t -109.68 155.11 10.96 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 CA-C-O 121.946 0.879 . . . . 0.0 108.906 -175.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -162.41 138.24 5.27 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 34.7 t -94.58 144.12 25.86 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 122.059 0.933 . . . . 0.0 109.268 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 9.9 tm0? -44.2 -35.9 2.44 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.985 0.897 . . . . 0.0 110.444 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 69.5 m -102.78 158.25 16.39 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 122.141 0.972 . . . . 0.0 109.51 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' A' ' 94' ' ' ARG . . . -123.16 168.26 15.38 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 65.22 -70.74 0.09 OUTLIER Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 92' ' ' GLY . 89.9 mtt180 -62.59 -36.05 81.48 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.214 -1.168 . . . . 0.0 108.766 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.404 ' O ' ' OG1' ' A' ' 99' ' ' THR . 7.0 t -85.5 -24.49 27.32 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.183 -0.948 . . . . 0.0 109.25 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.533 HG22 ' N ' ' A' ' 97' ' ' LYS . 1.0 OUTLIER -58.8 -47.45 89.21 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 O-C-N 121.044 -1.035 . . . . 0.0 108.895 179.871 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.533 ' N ' HG22 ' A' ' 96' ' ' ILE . 49.9 pttt -71.38 -30.87 66.64 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.675 -1.266 . . . . 0.0 108.423 177.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.89 -38.11 89.89 Favored 'General case' 0 C--N 1.289 -2.028 0 O-C-N 120.521 -1.362 . . . . 0.0 109.193 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 95' ' ' SER . 0.0 OUTLIER -63.01 -35.37 79.99 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-O 122.539 1.161 . . . . 0.0 108.679 179.65 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.7 m -57.44 -38.25 74.13 Favored 'General case' 0 C--N 1.288 -2.094 0 O-C-N 120.998 -1.064 . . . . 0.0 109.005 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -61.33 -43.32 99.07 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.644 -1.285 . . . . 0.0 108.087 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.2 mt -70.07 -35.03 73.93 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 122.01 0.91 . . . . 0.0 108.848 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 52.0 tp -56.31 -39.77 73.29 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.062 -1.024 . . . . 0.0 108.966 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 30.0 m170 -61.98 -36.48 81.6 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.551 -1.343 . . . . 0.0 108.57 177.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -76.22 -19.22 58.58 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 120.612 -1.305 . . . . 0.0 108.359 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 120.23 83.39 0.78 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -144.55 62.14 1.33 Allowed 'General case' 0 C--N 1.289 -2.032 0 O-C-N 121.09 -1.241 . . . . 0.0 109.35 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.564 ' OG1' ' N ' ' A' ' 109' ' ' GLY . 0.0 OUTLIER -126.47 179.1 5.47 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.642 -1.287 . . . . 0.0 110.136 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.625 ' N ' ' H ' ' A' ' 16' ' ' VAL . . . 85.76 17.76 61.12 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.563 HG21 ' CG2' ' A' ' 87' ' ' VAL . 1.4 m -147.18 163.06 7.72 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 O-C-N 121.081 -1.247 . . . . 0.0 109.858 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.508 ' N ' HG23 ' A' ' 110' ' ' VAL . 61.1 mttp -98.57 141.98 30.73 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 122.218 1.009 . . . . 0.0 108.694 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.463 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 74.4 m-20 -99.44 108.19 20.59 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.634 HD12 ' HB2' ' A' ' 25' ' ' ALA . 7.4 mm -97.64 155.35 3.67 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 O-C-N 121.241 -0.912 . . . . 0.0 110.218 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.439 HG13 ' HA3' ' A' ' 92' ' ' GLY . 38.0 t -99.12 124.18 52.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 O-C-N 120.783 -1.198 . . . . 0.0 109.638 178.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.17 -145.67 23.39 Favored Glycine 0 C--N 1.286 -2.235 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 135.59 -90.26 0.23 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.503 ' O ' ' N ' ' A' ' 121' ' ' ALA . 79.6 t80 -51.77 -41.63 61.77 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 121.989 0.899 . . . . 0.0 109.659 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 18.5 t -57.57 -45.03 85.67 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-O 121.923 0.868 . . . . 0.0 109.39 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.22 -52.57 12.0 Favored 'General case' 0 C--N 1.287 -2.152 0 O-C-N 121.134 -0.979 . . . . 0.0 108.901 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . 0.584 ' NE1' ' O ' ' A' ' 50' ' ' CYS . 4.9 t-105 -57.93 -35.54 71.23 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.165 -1.421 . . . . 0.0 107.165 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 117' ' ' TYR . . . -63.69 -30.93 71.97 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 120.912 -1.118 . . . . 0.0 108.79 178.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.446 ' HB3' ' HZ2' ' A' ' 122' ' ' LYS . 14.4 ttpp -57.45 -36.39 71.36 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -65.86 -65.19 0.71 Allowed 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.645 -1.284 . . . . 0.0 108.354 178.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 105.87 32.89 3.68 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.482 ' O ' ' CB ' ' A' ' 50' ' ' CYS . 18.6 mt -126.43 79.75 70.32 Favored Pre-proline 0 C--N 1.296 -1.736 0 O-C-N 120.933 -1.334 . . . . 0.0 109.376 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.404 ' HA ' ' H ' ' A' ' 50' ' ' CYS . 30.9 Cg_endo -95.65 115.79 0.17 Allowed 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 122.255 1.97 . . . . 0.0 113.229 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.902 ' H ' ' N ' ' A' ' 50' ' ' CYS . 93.8 m -93.08 132.42 37.21 Favored 'General case' 0 C--N 1.285 -2.212 0 O-C-N 120.733 -1.229 . . . . 0.0 108.996 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.742 ' CB ' ' H ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -175.69 167.21 3.18 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-O 122.178 0.99 . . . . 0.0 108.914 -178.224 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.28 -2.424 0 O-C-N 120.79 -1.193 . . . . 0.0 110.04 -178.424 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 122.188 0.994 . . . . 0.0 109.282 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -94.85 21.35 7.64 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-O 122.002 0.906 . . . . 0.0 109.238 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -52.72 142.33 18.9 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 122.323 1.059 . . . . 0.0 109.63 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.9 m -150.42 83.66 1.36 Allowed 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -164.24 61.95 0.15 Allowed 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.142 0.972 . . . . 0.0 109.781 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.541 HG12 ' HD3' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -142.74 177.3 1.9 Allowed Pre-proline 0 C--N 1.291 -1.976 0 O-C-N 121.347 -0.845 . . . . 0.0 108.92 -179.161 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.541 ' HD3' HG12 ' A' ' 16' ' ' VAL . 29.6 Cg_endo -86.69 135.35 4.13 Favored 'Trans proline' 0 C--N 1.296 -2.194 0 C-N-CA 121.849 1.699 . . . . 0.0 111.426 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 112' ' ' ASP . 32.8 t -140.56 138.99 34.9 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.111 0.958 . . . . 0.0 109.704 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.42 ' OG ' HD11 ' A' ' 96' ' ' ILE . 18.1 t -99.02 143.91 28.77 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-O 122.742 1.258 . . . . 0.0 109.566 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.831 HG13 ' O ' ' A' ' 112' ' ' ASP . 0.2 OUTLIER -148.7 178.9 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 O-C-N 121.013 -1.055 . . . . 0.0 109.41 -178.733 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.713 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 62.6 m -119.14 151.34 38.48 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.499 -1.376 . . . . 0.0 109.415 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.458 HG21 ' HA2' ' A' ' 116' ' ' GLY . 12.5 p -48.62 -27.1 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.273 -2.738 0 CA-C-O 122.159 0.981 . . . . 0.0 108.739 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.509 ' OG1' ' N ' ' A' ' 24' ' ' VAL . 0.1 OUTLIER -65.1 -58.2 6.66 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 120.725 -1.234 . . . . 0.0 109.112 179.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.509 ' N ' ' OG1' ' A' ' 23' ' ' THR . 0.0 OUTLIER -60.31 -35.1 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.158 -1.589 . . . . 0.0 109.436 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.54 ' HB2' HD12 ' A' ' 113' ' ' ILE . . . -51.11 -37.3 45.13 Favored 'General case' 0 C--N 1.287 -2.144 0 O-C-N 120.799 -1.188 . . . . 0.0 108.394 178.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -57.66 -44.09 85.43 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -59.9 -43.61 94.72 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 120.904 -1.122 . . . . 0.0 108.697 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.5 ' N ' HD12 ' A' ' 28' ' ' LEU . 9.1 mp -66.46 -33.55 75.94 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.504 ' O ' HD13 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -53.54 -40.44 65.52 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.733 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.429 ' N ' HD12 ' A' ' 30' ' ' LEU . 9.4 mp -63.99 -31.11 72.19 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 120.568 -1.333 . . . . 0.0 107.421 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 28' ' ' LEU . . . -66.9 -28.77 68.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.634 -1.292 . . . . 0.0 108.362 179.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.31 47.28 8.32 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -96.53 156.45 16.34 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 121.148 -1.207 . . . . 0.0 109.621 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -59.17 144.69 45.13 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 122.365 1.079 . . . . 0.0 109.768 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.707 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 1.4 t80 -123.85 112.16 16.95 Favored 'General case' 0 C--N 1.291 -1.964 0 O-C-N 121.381 -0.824 . . . . 0.0 108.973 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.657 ' O ' HG13 ' A' ' 87' ' ' VAL . 8.0 tt -122.16 101.22 7.4 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.649 -1.282 . . . . 0.0 108.529 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.501 ' OD2' ' NH2' ' A' ' 39' ' ' ARG . 80.6 m-20 -98.89 157.3 16.4 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -176.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 38' ' ' VAL . 6.0 m -133.76 89.05 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 CA-C-O 122.396 1.093 . . . . 0.0 108.064 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.779 ' O ' HG23 ' A' ' 40' ' ' THR . 0.0 OUTLIER -81.71 -45.3 15.89 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -179.394 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.779 HG23 ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER 171.58 163.8 0.24 Allowed Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.138 -0.976 . . . . 0.0 109.965 -179.41 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -66.09 -12.97 37.74 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 121.993 1.795 . . . . 0.0 111.125 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -72.81 -37.75 67.42 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.979 -1.076 . . . . 0.0 108.478 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.444 ' OE2' ' O ' ' A' ' 54' ' ' ASN . 2.0 pp20? -58.49 -28.68 65.61 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.726 -1.233 . . . . 0.0 109.04 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -74.08 -42.39 60.22 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 122.148 0.975 . . . . 0.0 108.977 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.9 t -54.83 -37.87 66.7 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.265 -0.897 . . . . 0.0 109.117 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -82.58 -37.27 25.3 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.158 -0.964 . . . . 0.0 108.714 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 43' ' ' GLU . . . 137.93 -139.57 10.49 Favored Glycine 0 N--CA 1.499 2.879 0 CA-C-O 122.298 0.943 . . . . 0.0 110.988 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.791 ' H ' ' CB ' ' A' ' 128' ' ' LYS . 94.7 m-70 -101.58 -161.73 0.88 Allowed 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 122.683 1.23 . . . . 0.0 109.396 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.944 ' HB1' ' CZ2' ' A' ' 120' ' ' TRP . . . -146.79 159.94 42.88 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 122.234 1.016 . . . . 0.0 109.374 -178.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.916 ' N ' ' H ' ' A' ' 127' ' ' THR . 4.6 t -82.53 162.55 21.96 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-O 122.559 1.171 . . . . 0.0 107.863 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.57 -51.39 4.14 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.707 ' HB1' ' HB3' ' A' ' 35' ' ' TYR . . . -157.23 175.37 14.13 Favored 'General case' 0 C--N 1.29 -1.999 0 O-C-N 120.798 -1.413 . . . . 0.0 109.63 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 73.2 mt -101.41 139.11 23.44 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 O-C-N 120.786 -1.196 . . . . 0.0 110.266 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.444 ' O ' ' OE2' ' A' ' 43' ' ' GLU . 43.5 p-10 -131.44 130.79 42.96 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.982 0.896 . . . . 0.0 109.444 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.557 HG12 ' HD2' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -142.99 165.37 26.54 Favored Pre-proline 0 C--N 1.273 -2.719 0 CA-C-O 122.191 0.996 . . . . 0.0 109.146 179.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.557 ' HD2' HG12 ' A' ' 55' ' ' VAL . 35.7 Cg_endo -76.88 26.45 0.44 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.468 2.112 . . . . 0.0 111.736 -177.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.625 ' CD1' ' NE2' ' A' ' 81' ' ' GLN . 90.7 t80 48.0 -91.21 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 122.266 1.032 . . . . 0.0 109.887 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.53 ' N ' ' O ' ' A' ' 56' ' ' PRO . 24.2 ttt -154.18 127.67 8.6 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-O 122.123 0.963 . . . . 0.0 110.023 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.942 ' OD1' ' HB3' ' A' ' 62' ' ' ALA . 50.3 t-20 -154.83 123.98 6.32 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.456 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 0.2 OUTLIER -120.56 122.16 39.97 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.094 -1.004 . . . . 0.0 108.598 179.376 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.476 ' CA ' ' H ' ' A' ' 65' ' ' MET . . . 76.42 -55.22 3.27 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.942 ' HB3' ' OD1' ' A' ' 59' ' ' ASN . . . -54.06 -29.8 45.52 Favored 'General case' 0 C--N 1.28 -2.448 0 O-C-N 121.16 -1.2 . . . . 0.0 108.227 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.9 t -96.11 16.12 18.93 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 61' ' ' GLY . . . 80.49 42.47 10.24 Favored Glycine 0 N--CA 1.501 3.003 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.476 ' H ' ' CA ' ' A' ' 61' ' ' GLY . 72.2 mtm 57.98 59.81 2.98 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 122.305 1.05 . . . . 0.0 110.337 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.7 t -151.5 91.96 1.72 Allowed 'General case' 0 C--N 1.289 -2.037 0 O-C-N 121.14 -0.975 . . . . 0.0 108.431 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.569 ' O ' ' N ' ' A' ' 69' ' ' THR . 1.1 ttmp? -102.61 147.26 27.01 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 122.244 1.021 . . . . 0.0 108.523 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.81 ' H ' HD22 ' A' ' 68' ' ' ASN . 1.3 m-80 -39.08 90.8 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 122.176 0.988 . . . . 0.0 110.043 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.866 HG22 ' N ' ' A' ' 70' ' ' ASP . 3.0 m 44.64 -101.9 0.05 Allowed 'General case' 0 C--N 1.281 -2.397 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.888 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.866 ' N ' HG22 ' A' ' 69' ' ' THR . 58.7 t0 -173.68 8.23 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.278 -1.514 . . . . 0.0 108.35 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.549 ' O ' HG13 ' A' ' 75' ' ' VAL . 69.2 m-85 -52.21 -23.63 5.9 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 122.128 0.966 . . . . 0.0 108.858 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.571 ' O ' ' N ' ' A' ' 76' ' ' SER . 3.2 mm? -48.9 -52.34 25.03 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -56.84 -34.93 68.25 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.988 -1.07 . . . . 0.0 108.881 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -73.62 -51.66 16.06 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.812 -1.18 . . . . 0.0 108.661 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.621 ' CG2' ' N ' ' A' ' 76' ' ' SER . 1.0 OUTLIER -76.83 -48.57 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.738 -1.226 . . . . 0.0 108.779 -179.315 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.621 ' N ' ' CG2' ' A' ' 75' ' ' VAL . 63.0 p -52.42 -19.96 2.52 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 t -53.58 -32.31 50.39 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.834 -1.166 . . . . 0.0 109.251 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.413 ' H ' ' H ' ' A' ' 79' ' ' PHE . 81.8 t60 -162.55 -19.09 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.572 ' N ' ' O ' ' A' ' 75' ' ' VAL . 99.1 m-85 -117.19 169.77 9.2 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.003 -1.061 . . . . 0.0 110.014 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.589 ' H ' ' HB2' ' A' ' 83' ' ' ASP . . . -109.58 138.14 14.64 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.625 ' NE2' ' CD1' ' A' ' 57' ' ' TYR . 10.0 pt20 -45.6 -18.27 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.425 -1.044 . . . . 0.0 109.242 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.845 ' HA ' HD12 ' A' ' 85' ' ' ILE . 19.2 t -123.16 17.57 9.94 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 120.838 -1.164 . . . . 0.0 107.992 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.589 ' HB2' ' H ' ' A' ' 80' ' ' GLY . 11.9 t70 -40.46 107.46 0.07 Allowed 'General case' 0 N--CA 1.508 2.441 0 O-C-N 121.421 -0.799 . . . . 0.0 109.077 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 53.78 70.03 0.65 Allowed 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 121.97 0.89 . . . . 0.0 109.47 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.845 HD12 ' HA ' ' A' ' 82' ' ' SER . 17.7 mt -143.1 168.84 12.71 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 O-C-N 121.021 -1.05 . . . . 0.0 109.402 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.706 HG22 HG13 ' A' ' 113' ' ' ILE . 49.0 mt -110.44 109.66 29.3 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.231 0 CA-C-O 122.188 0.994 . . . . 0.0 109.473 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.657 HG13 ' O ' ' A' ' 36' ' ' LEU . 18.6 t -112.44 166.75 6.26 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 O-C-N 121.219 -0.926 . . . . 0.0 108.898 -177.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.407 ' HA2' ' H ' ' A' ' 113' ' ' ILE . . . -148.97 141.72 9.22 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.502 ' O ' ' C ' ' A' ' 90' ' ' GLN . 0.4 OUTLIER -90.46 140.43 29.73 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 122.127 0.965 . . . . 0.0 109.23 -179.345 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.537 ' H ' ' CD ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -33.46 -89.88 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.992 0.901 . . . . 0.0 110.486 -178.691 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.7 p -149.64 160.36 43.57 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 122.197 0.998 . . . . 0.0 109.521 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.94 119.36 4.31 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.998 ' O ' HG22 ' A' ' 96' ' ' ILE . . . -57.43 -37.81 83.81 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.101 -1.599 . . . . 0.0 109.101 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 34.4 mtp180 -62.7 -28.1 69.71 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.317 -1.108 . . . . 0.0 108.807 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.8 m -62.3 -39.48 93.12 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.189 -0.944 . . . . 0.0 109.325 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.998 HG22 ' O ' ' A' ' 93' ' ' GLY . 15.7 tt -63.73 -30.9 51.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 O-C-N 121.023 -1.048 . . . . 0.0 108.917 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.0 mtpt -70.85 -45.31 64.7 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.706 -1.246 . . . . 0.0 108.411 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.0 -33.24 68.71 Favored 'General case' 0 C--N 1.289 -2.041 0 O-C-N 120.578 -1.326 . . . . 0.0 109.207 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.88 -57.84 2.88 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-O 122.546 1.165 . . . . 0.0 108.737 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 56.4 m -50.42 -43.44 54.88 Favored 'General case' 0 C--N 1.288 -2.093 0 O-C-N 121.039 -1.038 . . . . 0.0 108.984 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -68.41 -45.91 71.37 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.674 -1.266 . . . . 0.0 108.06 178.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.678 HD13 ' C ' ' A' ' 102' ' ' LEU . 3.0 tm? -65.6 -42.87 91.14 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.944 0.878 . . . . 0.0 108.859 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.3 mp -62.96 -36.84 84.8 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 121.088 -1.007 . . . . 0.0 108.915 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -66.62 -17.76 65.01 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.55 -1.344 . . . . 0.0 108.576 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 102' ' ' LEU . . . -62.06 -19.56 63.05 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 120.643 -1.285 . . . . 0.0 108.361 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 135.46 42.18 0.12 Allowed Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -153.35 32.47 0.47 Allowed 'General case' 0 C--N 1.289 -2.063 0 O-C-N 121.079 -1.248 . . . . 0.0 109.391 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.576 ' OG1' ' N ' ' A' ' 109' ' ' GLY . 4.8 t -87.01 -136.73 0.09 Allowed 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.647 -1.283 . . . . 0.0 110.085 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.576 ' N ' ' OG1' ' A' ' 108' ' ' THR . . . 80.08 23.06 62.08 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.61 HG11 ' HB3' ' A' ' 82' ' ' SER . 1.8 m -143.63 165.67 14.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 O-C-N 121.021 -1.282 . . . . 0.0 109.901 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.519 ' N ' HG23 ' A' ' 110' ' ' VAL . 63.0 mttm -99.27 153.29 19.06 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-O 122.212 1.006 . . . . 0.0 108.729 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.831 ' O ' HG13 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -108.31 115.72 30.63 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.706 HG13 HG22 ' A' ' 86' ' ' ILE . 1.2 mm -100.88 127.99 53.48 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 O-C-N 121.291 -0.881 . . . . 0.0 110.279 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 71.8 t -99.5 137.09 28.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 O-C-N 120.766 -1.209 . . . . 0.0 109.701 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.6 -154.21 30.87 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.458 ' HA2' HG21 ' A' ' 22' ' ' VAL . . . 89.73 -47.33 3.2 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.496 ' O ' ' HB2' ' A' ' 121' ' ' ALA . 46.4 t80 -52.15 -53.64 40.45 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 121.97 0.89 . . . . 0.0 109.637 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 67.8 p -71.52 -34.54 70.17 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.886 0.851 . . . . 0.0 109.33 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.23 -54.72 8.76 Favored 'General case' 0 C--N 1.286 -2.162 0 O-C-N 121.18 -0.95 . . . . 0.0 108.936 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . 0.944 ' CZ2' ' HB1' ' A' ' 49' ' ' ALA . 28.0 t90 -60.07 -34.87 74.03 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' A' ' 117' ' ' TYR . . . -52.45 -36.74 55.36 Favored 'General case' 0 C--N 1.291 -1.942 0 O-C-N 120.88 -1.138 . . . . 0.0 108.763 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -60.7 -26.87 67.45 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.776 ' ND2' ' H ' ' A' ' 125' ' ' LEU . 6.1 p-10 -54.02 -49.26 69.31 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 120.685 -1.259 . . . . 0.0 108.373 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.681 ' N ' ' OD1' ' A' ' 123' ' ' ASN . . . 71.22 18.8 76.93 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.776 ' H ' ' ND2' ' A' ' 123' ' ' ASN . 15.0 mt -124.34 98.14 38.76 Favored Pre-proline 0 C--N 1.298 -1.667 0 O-C-N 120.859 -1.377 . . . . 0.0 109.405 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.48 ' O ' ' NZ ' ' A' ' 128' ' ' LYS . 45.9 Cg_endo -93.29 117.96 0.34 Allowed 'Trans proline' 0 C--N 1.301 -1.946 0 C-N-CA 122.339 2.026 . . . . 0.0 113.28 178.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.916 ' H ' ' N ' ' A' ' 50' ' ' CYS . 53.2 m -92.96 126.19 37.92 Favored 'General case' 0 C--N 1.286 -2.186 0 O-C-N 120.713 -1.242 . . . . 0.0 108.964 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.791 ' CB ' ' H ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -175.46 148.38 0.92 Allowed 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 122.204 1.002 . . . . 0.0 108.933 -178.224 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.281 -2.399 0 O-C-N 120.762 -1.211 . . . . 0.0 109.992 -178.633 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.206 -1.19 0 CA-C-O 122.147 0.975 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -140.93 65.64 1.39 Allowed 'General case' 0 C--N 1.283 -2.292 0 CA-C-O 121.996 0.903 . . . . 0.0 109.198 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -142.09 142.52 32.82 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-O 122.245 1.021 . . . . 0.0 109.69 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 60.1 p -84.42 160.82 20.53 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.65 105.21 3.27 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 122.239 1.019 . . . . 0.0 109.741 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.559 HG12 ' HD3' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -144.87 177.46 1.77 Allowed Pre-proline 0 C--N 1.291 -1.951 0 O-C-N 121.193 -0.942 . . . . 0.0 108.965 -179.624 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.559 ' HD3' HG12 ' A' ' 16' ' ' VAL . 27.4 Cg_endo -86.61 140.76 6.29 Favored 'Trans proline' 0 C--N 1.296 -2.186 0 C-N-CA 121.917 1.744 . . . . 0.0 111.344 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.9 t -144.53 150.1 36.99 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 122.035 0.922 . . . . 0.0 109.779 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.713 ' HB3' HD11 ' A' ' 96' ' ' ILE . 95.2 p -101.02 139.55 36.56 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-O 122.632 1.206 . . . . 0.0 109.661 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.596 HG13 ' O ' ' A' ' 112' ' ' ASP . 0.6 OUTLIER -150.17 158.61 5.42 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.185 0 O-C-N 121.023 -1.048 . . . . 0.0 109.318 -178.641 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.645 ' HB3' HG22 ' A' ' 23' ' ' THR . 1.2 m -117.12 160.09 21.56 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.484 -1.385 . . . . 0.0 109.448 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.564 HG21 ' CB ' ' A' ' 119' ' ' ALA . 9.0 p -49.44 -31.61 5.68 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.81 0 CA-C-O 122.132 0.968 . . . . 0.0 108.669 -178.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.645 HG22 ' HB3' ' A' ' 21' ' ' SER . 0.0 OUTLIER -59.7 -56.16 25.38 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 120.718 -1.239 . . . . 0.0 109.144 179.484 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.614 ' H ' HG23 ' A' ' 23' ' ' THR . 0.1 OUTLIER -65.51 -35.66 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.106 -1.622 . . . . 0.0 109.461 178.864 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.57 ' HB2' HD12 ' A' ' 113' ' ' ILE . . . -55.54 -36.16 66.47 Favored 'General case' 0 C--N 1.286 -2.157 0 O-C-N 120.85 -1.156 . . . . 0.0 108.354 178.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -56.18 -47.03 79.09 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -60.9 -42.19 97.54 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.961 -1.087 . . . . 0.0 108.769 178.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.444 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 69.5 mt -67.58 -31.69 71.92 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.0 tt -56.86 -39.19 73.83 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.3 mp -62.91 -29.85 71.09 Favored 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 28' ' ' LEU . . . -66.19 -28.87 69.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.705 -1.247 . . . . 0.0 108.448 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.19 49.3 27.45 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.8 t60 -102.56 170.21 8.17 Favored 'General case' 0 C--N 1.292 -1.923 0 O-C-N 121.055 -1.262 . . . . 0.0 109.571 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -59.96 128.05 34.91 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.377 1.084 . . . . 0.0 109.773 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.444 ' CE2' ' OD1' ' A' ' 37' ' ' ASP . 16.0 t80 -109.92 106.64 16.27 Favored 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.307 -0.871 . . . . 0.0 108.945 -178.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.813 ' HB3' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -99.92 135.44 41.35 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.541 -1.349 . . . . 0.0 108.611 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.734 ' H ' HD13 ' A' ' 36' ' ' LEU . 14.2 m-20 -138.45 138.19 37.91 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 38' ' ' VAL . 11.9 m -132.55 75.31 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 CA-C-O 122.358 1.075 . . . . 0.0 108.1 177.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.719 ' H ' HD21 ' A' ' 54' ' ' ASN . 0.4 OUTLIER -82.93 -41.94 18.26 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -179.604 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.655 HG23 ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER 176.37 144.42 0.24 Allowed Pre-proline 0 C--N 1.3 -1.577 0 O-C-N 121.131 -0.981 . . . . 0.0 109.981 -179.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -43.14 -27.96 1.22 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.02 1.813 . . . . 0.0 111.102 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -70.02 -30.9 68.31 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.865 -1.147 . . . . 0.0 108.498 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.563 ' CD ' ' HE ' ' A' ' 39' ' ' ARG . 42.1 tp10 -54.42 -33.95 60.43 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.687 -1.258 . . . . 0.0 109.014 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -79.06 -37.12 39.73 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 122.116 0.96 . . . . 0.0 108.854 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.413 ' C ' ' H ' ' A' ' 47' ' ' GLY . 11.2 t -65.95 -40.97 91.82 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.224 -0.922 . . . . 0.0 109.031 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.495 ' NE2' ' O ' ' A' ' 47' ' ' GLY . 5.4 pp0? -75.69 9.5 2.26 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.104 -0.997 . . . . 0.0 108.627 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.495 ' O ' ' NE2' ' A' ' 46' ' ' GLN . . . 89.97 -160.41 28.53 Favored Glycine 0 N--CA 1.5 2.936 0 CA-C-O 122.299 0.944 . . . . 0.0 110.966 178.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.68 ' H ' ' CB ' ' A' ' 128' ' ' LYS . 34.5 m170 -103.05 -159.32 0.72 Allowed 'General case' 0 C--N 1.289 -2.032 0 CA-C-O 122.752 1.263 . . . . 0.0 109.372 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 1.049 ' HB3' ' HB3' ' A' ' 52' ' ' ALA . . . -141.91 169.58 17.32 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 122.207 1.003 . . . . 0.0 109.352 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.942 ' N ' ' H ' ' A' ' 127' ' ' THR . 5.2 t -82.67 106.62 14.67 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.79 25.75 55.39 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 1.049 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . . . -149.29 124.26 9.99 Favored 'General case' 0 C--N 1.29 -1.984 0 O-C-N 120.897 -1.355 . . . . 0.0 109.631 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 29.3 mt -116.99 113.19 42.15 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 O-C-N 120.722 -1.236 . . . . 0.0 110.216 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.719 HD21 ' H ' ' A' ' 39' ' ' ARG . 24.1 t-20 -98.03 135.0 40.36 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 122.01 0.909 . . . . 0.0 109.383 -177.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.42 ' O ' HG12 ' A' ' 55' ' ' VAL . 8.9 t -140.24 92.19 9.59 Favored Pre-proline 0 C--N 1.274 -2.706 0 CA-C-O 122.152 0.977 . . . . 0.0 109.093 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -74.12 86.07 1.32 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.473 2.115 . . . . 0.0 111.769 -178.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.52 ' O ' ' SD ' ' A' ' 58' ' ' MET . 11.3 t80 -64.14 -61.27 2.37 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 122.291 1.043 . . . . 0.0 109.818 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.52 ' SD ' ' O ' ' A' ' 57' ' ' TYR . 16.2 mmt -143.02 149.71 38.64 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-O 122.105 0.955 . . . . 0.0 110.082 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -149.69 120.51 7.6 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.434 ' O ' ' CG ' ' A' ' 60' ' ' ARG . 22.2 ptt180 -94.89 124.11 38.75 Favored 'General case' 0 N--CA 1.504 2.272 0 CA-C-O 122.244 1.021 . . . . 0.0 108.567 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 63' ' ' SER . . . 75.97 -52.47 2.89 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.62 -7.58 0.69 Allowed 'General case' 0 C--N 1.28 -2.417 0 O-C-N 121.068 -1.254 . . . . 0.0 108.246 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.496 ' H ' ' C ' ' A' ' 61' ' ' GLY . 4.8 t -127.35 14.46 7.17 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 107.545 -1.279 . . . . 0.0 107.545 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.41 46.25 9.11 Favored Glycine 0 N--CA 1.503 3.101 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 71.6 mtm 55.95 87.61 0.05 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 122.34 1.067 . . . . 0.0 110.306 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.9 m -168.51 92.48 0.31 Allowed 'General case' 0 C--N 1.29 -1.991 0 O-C-N 121.136 -0.977 . . . . 0.0 108.459 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -128.39 121.91 30.18 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.094 -1.004 . . . . 0.0 108.545 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.467 ' CB ' ' SD ' ' A' ' 58' ' ' MET . 8.5 t-20 -61.03 168.5 2.42 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 122.234 1.016 . . . . 0.0 109.997 -178.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -160.63 51.4 0.28 Allowed 'General case' 0 C--N 1.28 -2.415 0 O-C-N 121.493 -0.754 . . . . 0.0 109.873 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -127.3 -44.81 1.55 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.381 -1.45 . . . . 0.0 108.272 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.487 ' O ' ' N ' ' A' ' 74' ' ' GLN . 97.6 m-85 -57.77 -22.02 44.74 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 122.073 0.94 . . . . 0.0 108.837 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.655 HD23 ' N ' ' A' ' 72' ' ' LEU . 2.2 mt -46.66 -45.47 19.3 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 122.03 0.919 . . . . 0.0 108.679 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -58.27 -36.61 73.53 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.89 -1.131 . . . . 0.0 108.88 176.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 71' ' ' PHE . 43.3 mt-30 -81.76 -49.26 10.62 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.832 -1.168 . . . . 0.0 108.67 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.403 ' N ' ' O ' ' A' ' 71' ' ' PHE . 50.8 t -64.76 -43.85 96.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.758 -1.213 . . . . 0.0 108.735 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 72' ' ' LEU . 18.4 t -66.21 -19.93 65.97 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.572 ' O ' ' CG ' ' A' ' 78' ' ' HIS . 8.0 t -52.9 -49.77 65.24 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.858 -1.151 . . . . 0.0 109.252 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.572 ' CG ' ' O ' ' A' ' 77' ' ' SER . 0.3 OUTLIER 168.7 -10.81 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.014 -1.054 . . . . 0.0 108.223 179.613 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -101.2 150.11 23.3 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.921 -1.112 . . . . 0.0 110.026 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.552 ' H ' ' HB2' ' A' ' 83' ' ' ASP . . . -114.26 142.89 17.8 Favored Glycine 0 N--CA 1.498 2.768 0 N-CA-C 110.476 -1.049 . . . . 0.0 110.476 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' A' ' 80' ' ' GLY . 0.2 OUTLIER -44.38 -43.48 7.65 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.451 -1.029 . . . . 0.0 109.166 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.563 ' HA ' HD12 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -122.22 24.15 9.54 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 120.837 -1.164 . . . . 0.0 107.972 179.324 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.552 ' HB2' ' H ' ' A' ' 80' ' ' GLY . 19.4 t0 -34.97 118.07 0.42 Allowed 'General case' 0 N--CA 1.506 2.364 0 CA-C-O 121.715 0.769 . . . . 0.0 109.108 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.612 ' N ' ' O ' ' A' ' 109' ' ' GLY . 6.8 t-20 65.56 60.7 0.72 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.891 0.853 . . . . 0.0 109.418 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.669 HG22 ' N ' ' A' ' 86' ' ' ILE . 12.0 mt -150.14 177.67 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 O-C-N 121.064 -1.023 . . . . 0.0 109.496 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.669 ' N ' HG22 ' A' ' 85' ' ' ILE . 63.7 mt -111.14 108.33 25.21 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.257 0 CA-C-O 122.195 0.997 . . . . 0.0 109.323 178.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.813 HG22 ' HB3' ' A' ' 36' ' ' LEU . 14.1 t -114.98 166.47 8.74 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-O 121.943 0.878 . . . . 0.0 108.892 -176.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -148.66 142.03 9.57 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 49.7 t -92.64 148.3 22.18 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 122.079 0.942 . . . . 0.0 109.303 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -41.74 -36.3 0.97 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 122.003 0.906 . . . . 0.0 110.402 -178.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 96.3 p -132.71 159.02 40.88 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 122.257 1.027 . . . . 0.0 109.444 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 94' ' ' ARG . . . -110.58 -178.58 20.65 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 68.39 -72.33 0.33 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 92' ' ' GLY . 0.0 OUTLIER -67.57 -29.59 68.99 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.182 -1.187 . . . . 0.0 108.824 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.755 ' O ' HG23 ' A' ' 99' ' ' THR . 54.4 p -84.51 -29.12 26.22 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.187 -0.946 . . . . 0.0 109.27 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.713 HD11 ' HB3' ' A' ' 19' ' ' SER . 0.4 OUTLIER -55.53 -48.71 77.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 O-C-N 121.092 -1.005 . . . . 0.0 108.836 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.557 ' N ' ' CG2' ' A' ' 96' ' ' ILE . 4.6 ptmm? -70.67 -40.84 72.74 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.63 -1.294 . . . . 0.0 108.39 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.05 -40.96 95.5 Favored 'General case' 0 C--N 1.289 -2.026 0 O-C-N 120.544 -1.347 . . . . 0.0 109.294 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.755 HG23 ' O ' ' A' ' 95' ' ' SER . 35.7 p -64.46 -54.57 30.52 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-O 122.553 1.168 . . . . 0.0 108.683 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.543 ' O ' ' CG ' ' A' ' 104' ' ' HIS . 35.5 m -46.22 -37.35 7.04 Favored 'General case' 0 C--N 1.287 -2.14 0 O-C-N 121.06 -1.025 . . . . 0.0 108.992 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -87.11 -50.65 6.49 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.62 -1.3 . . . . 0.0 108.077 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.714 HD13 ' C ' ' A' ' 102' ' ' LEU . 1.9 tm? -61.36 -44.45 97.15 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.982 0.896 . . . . 0.0 108.889 -178.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 99' ' ' THR . 70.5 mt -63.14 -38.58 91.76 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.113 -0.992 . . . . 0.0 108.975 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.543 ' CG ' ' O ' ' A' ' 100' ' ' THR . 24.7 m170 -59.88 -18.58 45.69 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.641 -1.287 . . . . 0.0 108.574 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 102' ' ' LEU . . . -62.01 -19.38 62.77 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 120.629 -1.295 . . . . 0.0 108.326 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 128.78 7.88 4.04 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -103.0 17.65 23.55 Favored 'General case' 0 C--N 1.289 -2.032 0 O-C-N 121.082 -1.246 . . . . 0.0 109.395 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.543 ' OG1' ' N ' ' A' ' 17' ' ' PRO . 8.7 t -78.98 -150.73 0.05 Allowed 'General case' 0 C--N 1.297 -1.698 0 O-C-N 120.669 -1.269 . . . . 0.0 110.074 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.612 ' O ' ' N ' ' A' ' 84' ' ' ASN . . . 77.45 19.43 76.37 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.48 HG23 ' N ' ' A' ' 111' ' ' LYS . 1.6 m -146.62 166.7 7.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 O-C-N 120.999 -1.295 . . . . 0.0 109.898 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.48 ' N ' HG23 ' A' ' 110' ' ' VAL . 84.9 mttt -97.88 145.48 26.39 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 122.211 1.005 . . . . 0.0 108.71 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.596 ' O ' HG13 ' A' ' 20' ' ' VAL . 51.4 t0 -99.95 109.78 22.13 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.639 HD11 ' CG2' ' A' ' 86' ' ' ILE . 1.2 mm -94.88 138.85 19.83 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.39 0 O-C-N 121.229 -0.919 . . . . 0.0 110.291 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 71.5 t -99.48 143.83 12.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 O-C-N 120.838 -1.163 . . . . 0.0 109.684 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 79.41 -117.2 4.47 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.4 -84.78 1.0 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -55.73 -43.98 77.09 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-O 122.031 0.919 . . . . 0.0 109.671 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 36.6 m -59.92 -39.27 84.9 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-O 121.947 0.879 . . . . 0.0 109.376 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.564 ' CB ' HG21 ' A' ' 22' ' ' VAL . . . -72.55 -50.22 27.15 Favored 'General case' 0 C--N 1.286 -2.159 0 O-C-N 121.096 -1.003 . . . . 0.0 108.882 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . 0.595 ' NE1' ' O ' ' A' ' 50' ' ' CYS . 1.0 OUTLIER -53.92 -39.25 65.68 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.332 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.63 -25.81 68.39 Favored 'General case' 0 C--N 1.292 -1.924 0 O-C-N 120.834 -1.166 . . . . 0.0 108.838 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.578 ' CB ' ' HZ2' ' A' ' 122' ' ' LYS . 2.4 ttmp? -56.97 -42.66 80.6 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -90.76 -67.68 0.84 Allowed 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.624 -1.298 . . . . 0.0 108.358 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 113.18 48.09 0.62 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.463 ' O ' ' CB ' ' A' ' 50' ' ' CYS . 14.3 mt -126.55 78.67 72.14 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 120.834 -1.392 . . . . 0.0 109.314 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.564 ' HB2' ' HZ3' ' A' ' 128' ' ' LYS . 31.7 Cg_endo -95.09 118.17 0.23 Allowed 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 122.274 1.983 . . . . 0.0 113.212 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.942 ' H ' ' N ' ' A' ' 50' ' ' CYS . 93.7 m -93.8 136.07 34.46 Favored 'General case' 0 C--N 1.286 -2.174 0 O-C-N 120.668 -1.27 . . . . 0.0 109.039 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.68 ' CB ' ' H ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -175.48 146.78 0.81 Allowed 'General case' 0 C--N 1.289 -2.038 0 CA-C-O 122.213 1.006 . . . . 0.0 108.943 -178.202 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.28 -2.414 0 O-C-N 120.794 -1.191 . . . . 0.0 110.019 -178.399 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 122.158 0.98 . . . . 0.0 109.175 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -82.14 9.6 8.31 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-O 121.97 0.89 . . . . 0.0 109.172 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.539 ' O ' ' CB ' ' A' ' 14' ' ' SER . 71.5 mm-40 -62.71 -147.99 0.0 OUTLIER 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 122.247 1.022 . . . . 0.0 109.696 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.539 ' CB ' ' O ' ' A' ' 13' ' ' GLU . 1.8 p 81.39 142.79 0.07 Allowed 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 -125.05 125.65 44.15 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.132 0.967 . . . . 0.0 109.715 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.512 HG12 ' HD2' ' A' ' 17' ' ' PRO . 3.5 t -143.11 149.0 47.28 Favored Pre-proline 0 C--N 1.29 -1.98 0 O-C-N 121.287 -0.883 . . . . 0.0 108.911 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.921 ' CB ' HD21 ' A' ' 103' ' ' LEU . 39.9 Cg_endo -90.78 161.91 4.13 Favored 'Trans proline' 0 C--N 1.298 -2.104 0 C-N-CA 121.885 1.723 . . . . 0.0 111.399 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.0 t -161.23 152.55 18.88 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 122.107 0.956 . . . . 0.0 109.721 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 89.0 p -108.5 144.47 36.11 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 122.694 1.235 . . . . 0.0 109.65 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.687 HG23 ' N ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -144.76 177.76 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 O-C-N 120.993 -1.067 . . . . 0.0 109.4 -178.495 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.687 ' N ' HG23 ' A' ' 20' ' ' VAL . 71.7 m -119.55 151.82 38.0 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.47 -1.394 . . . . 0.0 109.435 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.758 ' CG2' ' HB2' ' A' ' 119' ' ' ALA . 6.5 p -47.53 -33.21 2.99 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.793 0 CA-C-O 122.126 0.965 . . . . 0.0 108.695 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.51 ' OG1' ' N ' ' A' ' 24' ' ' VAL . 0.1 OUTLIER -56.26 -56.77 16.87 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 120.728 -1.233 . . . . 0.0 109.12 179.225 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.51 ' N ' ' OG1' ' A' ' 23' ' ' THR . 0.1 OUTLIER -65.42 -34.74 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.131 -1.605 . . . . 0.0 109.377 179.101 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.947 ' HB2' HD13 ' A' ' 113' ' ' ILE . . . -50.92 -37.43 44.0 Favored 'General case' 0 C--N 1.287 -2.132 0 O-C-N 120.825 -1.172 . . . . 0.0 108.39 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -59.55 -47.83 84.03 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -60.25 -44.45 95.25 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 120.885 -1.134 . . . . 0.0 108.675 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.6 mt -68.7 -53.16 23.86 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.465 ' CD2' ' C ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -58.71 -43.1 89.98 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.016 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.707 HD13 ' C ' ' A' ' 30' ' ' LEU . 1.4 tm? -58.41 -34.71 71.05 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.466 ' HB3' ' CE1' ' A' ' 33' ' ' HIS . . . -71.09 -19.87 62.41 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.712 -1.243 . . . . 0.0 108.391 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.07 49.6 1.88 Allowed Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.466 ' CE1' ' HB3' ' A' ' 31' ' ' ALA . 39.3 m80 -107.4 139.39 41.96 Favored 'General case' 0 C--N 1.291 -1.969 0 O-C-N 121.234 -1.156 . . . . 0.0 109.592 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 36.9 mtt-85 -61.82 141.11 58.13 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 122.331 1.062 . . . . 0.0 109.846 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -125.62 118.06 24.87 Favored 'General case' 0 C--N 1.291 -1.96 0 O-C-N 121.38 -0.825 . . . . 0.0 108.968 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.815 ' HB2' HG22 ' A' ' 87' ' ' VAL . 17.6 mt -92.62 108.2 19.8 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 120.616 -1.303 . . . . 0.0 108.604 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.545 ' OD2' ' NE2' ' A' ' 48' ' ' HIS . 41.0 t0 -90.81 122.97 33.99 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -178.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.756 HG12 ' O ' ' A' ' 55' ' ' VAL . 20.2 m -134.17 87.81 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 CA-C-O 122.502 1.144 . . . . 0.0 108.125 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.744 ' O ' HG23 ' A' ' 40' ' ' THR . 24.5 mtp180 -83.59 -46.08 12.79 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.744 HG23 ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER 172.92 165.64 0.27 Allowed Pre-proline 0 N--CA 1.49 1.564 0 C-N-CA 119.296 -0.962 . . . . 0.0 109.925 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -53.33 -35.43 74.7 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.04 1.827 . . . . 0.0 111.085 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -61.0 -30.43 70.28 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.894 -1.128 . . . . 0.0 108.48 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.593 ' O ' ' N ' ' A' ' 47' ' ' GLY . 83.5 tt0 -55.79 -30.63 61.65 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.755 -1.216 . . . . 0.0 108.968 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -72.6 -38.32 67.85 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 122.176 0.989 . . . . 0.0 108.933 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.6 t -51.49 -48.36 62.92 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.175 -0.953 . . . . 0.0 109.167 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -103.73 -20.75 13.85 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.147 -0.97 . . . . 0.0 108.621 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 43' ' ' GLU . . . 82.37 -172.53 52.47 Favored Glycine 0 N--CA 1.5 2.915 0 CA-C-O 122.289 0.938 . . . . 0.0 110.985 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.674 ' H ' ' C ' ' A' ' 129' ' ' ALA . 2.1 t60 176.13 101.71 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.034 0 CA-C-O 122.645 1.212 . . . . 0.0 109.395 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 1.059 ' H ' ' N ' ' A' ' 128' ' ' LYS . . . -160.45 147.7 15.94 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 122.26 1.029 . . . . 0.0 109.388 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.4 t -176.32 44.72 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.264 0 CA-C-O 122.548 1.166 . . . . 0.0 107.869 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 117.85 23.81 3.53 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.984 ' HB2' ' CZ2' ' A' ' 120' ' ' TRP . . . -154.11 179.16 9.19 Favored 'General case' 0 C--N 1.289 -2.045 0 O-C-N 120.861 -1.376 . . . . 0.0 109.639 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 77.1 mt -123.47 147.97 27.62 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 O-C-N 120.832 -1.168 . . . . 0.0 110.3 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -131.55 143.57 50.46 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.954 0.883 . . . . 0.0 109.499 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.765 ' O ' HG12 ' A' ' 55' ' ' VAL . 1.1 t -140.62 91.89 9.25 Favored Pre-proline 0 C--N 1.274 -2.717 0 CA-C-O 122.205 1.002 . . . . 0.0 109.089 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.566 ' O ' ' N ' ' A' ' 58' ' ' MET . 36.9 Cg_endo -78.77 66.26 8.66 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.524 2.149 . . . . 0.0 111.806 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 52.39 -85.85 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 122.375 1.083 . . . . 0.0 109.826 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.566 ' N ' ' O ' ' A' ' 56' ' ' PRO . 73.9 mtm -86.79 131.17 34.2 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-O 122.158 0.98 . . . . 0.0 110.051 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.747 ' OD1' ' HB3' ' A' ' 62' ' ' ALA . 47.3 t-20 -142.43 116.83 9.61 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.424 ' O ' ' CG ' ' A' ' 60' ' ' ARG . 22.1 ptt180 -111.48 124.75 52.91 Favored 'General case' 0 N--CA 1.504 2.25 0 CA-C-O 122.255 1.026 . . . . 0.0 108.627 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.405 ' HA2' ' H ' ' A' ' 65' ' ' MET . . . 77.52 -58.36 3.75 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 178.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.747 ' HB3' ' OD1' ' A' ' 59' ' ' ASN . . . -53.43 -28.97 32.83 Favored 'General case' 0 C--N 1.281 -2.41 0 O-C-N 121.161 -1.199 . . . . 0.0 108.254 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.445 ' OG ' ' ND2' ' A' ' 59' ' ' ASN . 2.1 m -97.56 6.35 48.2 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 61' ' ' GLY . . . 85.66 47.47 5.09 Favored Glycine 0 N--CA 1.501 3.0 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.405 ' H ' ' HA2' ' A' ' 61' ' ' GLY . 72.7 mtm 56.64 61.19 2.74 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 122.332 1.063 . . . . 0.0 110.31 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.5 m -165.92 94.08 0.56 Allowed 'General case' 0 C--N 1.29 -2.012 0 O-C-N 121.17 -0.956 . . . . 0.0 108.422 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.7 ptpp? -98.13 142.98 29.14 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 122.24 1.019 . . . . 0.0 108.535 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.417 ' O ' ' OG1' ' A' ' 69' ' ' THR . 3.2 m120 -50.64 128.91 21.61 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 122.219 1.009 . . . . 0.0 109.999 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 68' ' ' ASN . 4.7 m -167.01 -29.17 0.02 OUTLIER 'General case' 0 C--N 1.282 -2.363 0 O-C-N 121.507 -0.746 . . . . 0.0 109.943 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.428 ' OD2' ' OE1' ' A' ' 73' ' ' GLU . 16.0 p30 -150.74 68.07 0.95 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.37 -1.456 . . . . 0.0 108.32 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.485 ' O ' HG23 ' A' ' 75' ' ' VAL . 34.2 m-85 -48.34 -26.56 2.09 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 122.106 0.955 . . . . 0.0 108.85 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 76' ' ' SER . 3.0 mt -54.44 -46.7 73.3 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.916 0.865 . . . . 0.0 108.712 -178.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.432 ' CG ' ' N ' ' A' ' 74' ' ' GLN . 10.9 pt-20 -54.86 -37.75 66.63 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.911 -1.118 . . . . 0.0 108.941 177.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.432 ' N ' ' CG ' ' A' ' 73' ' ' GLU . 23.7 mt-30 -82.52 -48.25 11.24 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.761 -1.212 . . . . 0.0 108.682 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 71' ' ' PHE . 19.8 t -66.84 -44.18 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.783 -1.198 . . . . 0.0 108.74 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.583 ' N ' ' O ' ' A' ' 72' ' ' LEU . 44.6 t -51.68 -36.99 48.67 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.544 ' O ' ' CB ' ' A' ' 78' ' ' HIS . 53.0 p -71.35 1.39 6.3 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.896 -1.127 . . . . 0.0 109.168 178.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.544 ' CB ' ' O ' ' A' ' 77' ' ' SER . 5.1 t-80 78.44 45.14 0.06 Allowed 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.05 -1.032 . . . . 0.0 108.252 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.536 ' CG ' ' O ' ' A' ' 78' ' ' HIS . 65.8 m-85 -162.08 133.06 5.08 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.015 -1.053 . . . . 0.0 109.969 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.66 ' H ' ' HB3' ' A' ' 83' ' ' ASP . . . -114.19 134.78 11.98 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.423 HE21 HG11 ' A' ' 55' ' ' VAL . 7.5 pt20 -48.03 -21.19 0.42 Allowed 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.454 -1.027 . . . . 0.0 109.173 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.812 ' HA ' HD12 ' A' ' 85' ' ' ILE . 54.4 m -123.73 15.54 9.44 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.847 -1.158 . . . . 0.0 107.914 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.66 ' HB3' ' H ' ' A' ' 80' ' ' GLY . 12.6 p30 -45.78 109.91 0.22 Allowed 'General case' 0 N--CA 1.507 2.396 0 O-C-N 121.406 -0.809 . . . . 0.0 109.123 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 58.61 64.07 1.54 Allowed 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.973 0.892 . . . . 0.0 109.4 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.812 HD12 ' HA ' ' A' ' 82' ' ' SER . 24.1 mt -142.25 176.32 3.95 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 O-C-N 121.025 -1.047 . . . . 0.0 109.408 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.889 HG23 ' HB2' ' A' ' 111' ' ' LYS . 6.7 mt -121.78 112.57 35.61 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 O-C-N 121.106 -0.997 . . . . 0.0 109.403 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.815 HG22 ' HB2' ' A' ' 36' ' ' LEU . 92.6 t -100.56 -179.68 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 O-C-N 121.281 -0.887 . . . . 0.0 108.919 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.67 ' H ' HG12 ' A' ' 87' ' ' VAL . . . -175.09 140.13 5.13 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 46.3 t -110.61 146.69 35.69 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-O 122.07 0.938 . . . . 0.0 109.283 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.45 ' CD ' HH21 ' A' ' 39' ' ' ARG . 7.8 tt0 -42.57 -70.69 0.1 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.022 0.915 . . . . 0.0 110.464 -178.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.1 t -72.13 160.22 32.82 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 122.238 1.018 . . . . 0.0 109.453 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 94' ' ' ARG . . . -132.25 174.72 20.19 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.415 ' O ' HG22 ' A' ' 96' ' ' ILE . . . 61.67 -76.32 0.02 OUTLIER Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.53 ' N ' ' O ' ' A' ' 92' ' ' GLY . 1.1 ttt-85 -65.93 -37.19 85.42 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.216 -1.167 . . . . 0.0 108.778 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.2 t -87.65 -27.6 22.36 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 121.188 -0.945 . . . . 0.0 109.254 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.585 ' CG2' ' N ' ' A' ' 97' ' ' LYS . 2.6 tt -59.07 -48.82 85.47 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 O-C-N 121.084 -1.01 . . . . 0.0 108.879 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.585 ' N ' ' CG2' ' A' ' 96' ' ' ILE . 17.1 pttp -63.99 -35.67 81.47 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.697 -1.252 . . . . 0.0 108.449 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.97 -43.05 79.91 Favored 'General case' 0 C--N 1.288 -2.074 0 O-C-N 120.534 -1.354 . . . . 0.0 109.206 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 103' ' ' LEU . 30.5 p -77.95 -50.58 11.9 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-O 122.573 1.177 . . . . 0.0 108.697 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.535 ' O ' ' N ' ' A' ' 104' ' ' HIS . 60.3 m -53.91 -49.4 68.7 Favored 'General case' 0 C--N 1.288 -2.102 0 O-C-N 121.012 -1.055 . . . . 0.0 109.033 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -61.94 -46.14 90.63 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.627 -1.296 . . . . 0.0 108.17 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.776 ' O ' HD13 ' A' ' 102' ' ' LEU . 2.5 tm? -64.63 -40.79 96.09 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.305 -0.872 . . . . 0.0 108.808 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.921 HD21 ' CB ' ' A' ' 17' ' ' PRO . 0.3 OUTLIER -75.19 -30.55 60.69 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.122 -0.986 . . . . 0.0 108.966 178.358 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.535 ' N ' ' O ' ' A' ' 100' ' ' THR . 84.0 t60 -53.39 -34.71 58.77 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.597 -1.315 . . . . 0.0 108.606 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -131.23 35.56 3.89 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 120.573 -1.329 . . . . 0.0 108.301 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -148.13 -37.23 0.04 OUTLIER Glycine 0 N--CA 1.495 2.586 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.478 ' O ' ' O ' ' A' ' 103' ' ' LEU . 66.5 m-85 -134.83 164.18 28.13 Favored 'General case' 0 C--N 1.288 -2.078 0 O-C-N 121.235 -1.156 . . . . 0.0 109.414 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.3 t -176.27 151.03 0.97 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.538 -1.351 . . . . 0.0 110.126 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.65 21.97 38.39 Favored Glycine 0 N--CA 1.498 2.814 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.412 HG11 ' CB ' ' A' ' 82' ' ' SER . 1.9 m -148.03 155.86 9.59 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 O-C-N 121.064 -1.257 . . . . 0.0 109.932 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.889 ' HB2' HG23 ' A' ' 86' ' ' ILE . 52.8 mttp -98.87 158.81 15.39 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 122.252 1.025 . . . . 0.0 108.726 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.609 ' O ' HG13 ' A' ' 20' ' ' VAL . 85.2 m-20 -114.92 125.57 53.79 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.947 HD13 ' HB2' ' A' ' 25' ' ' ALA . 3.7 mt -102.7 152.72 5.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.401 0 O-C-N 121.301 -0.874 . . . . 0.0 110.261 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 44.0 t -97.74 135.83 30.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 O-C-N 120.821 -1.174 . . . . 0.0 109.664 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.13 -145.2 17.55 Favored Glycine 0 C--N 1.285 -2.302 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 160.6 -95.26 0.14 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -52.85 -38.33 61.36 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-O 122.084 0.945 . . . . 0.0 109.711 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 29.3 t -57.27 -33.07 67.25 Favored 'General case' 0 C--N 1.291 -1.939 0 O-C-N 121.286 -0.883 . . . . 0.0 109.301 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.758 ' HB2' ' CG2' ' A' ' 22' ' ' VAL . . . -69.81 -52.4 25.45 Favored 'General case' 0 C--N 1.286 -2.171 0 O-C-N 121.103 -0.998 . . . . 0.0 108.873 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . 0.984 ' CZ2' ' HB2' ' A' ' 52' ' ' ALA . 0.6 OUTLIER -61.57 -37.35 83.52 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.25 -27.86 64.78 Favored 'General case' 0 C--N 1.292 -1.92 0 O-C-N 120.848 -1.157 . . . . 0.0 108.789 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.8 ttmm -56.06 -42.78 77.16 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -85.52 -64.59 1.13 Allowed 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.643 -1.286 . . . . 0.0 108.375 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 137.4 39.1 0.13 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.662 ' O ' ' O ' ' A' ' 126' ' ' PRO . 2.7 mt -102.74 127.95 29.01 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 120.848 -1.383 . . . . 0.0 109.362 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.775 ' O ' HG23 ' A' ' 127' ' ' THR . 51.3 Cg_exo -43.57 -154.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 122.269 1.979 . . . . 0.0 113.2 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.775 HG23 ' O ' ' A' ' 126' ' ' PRO . 0.0 OUTLIER 178.14 109.45 0.03 OUTLIER 'General case' 0 C--N 1.286 -2.163 0 O-C-N 120.778 -1.201 . . . . 0.0 109.001 -178.386 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 1.059 ' N ' ' H ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -138.16 168.41 19.79 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-O 122.204 1.002 . . . . 0.0 108.966 -178.417 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.674 ' C ' ' H ' ' A' ' 48' ' ' HIS . . . . . . . . 0 C--N 1.281 -2.395 0 O-C-N 120.789 -1.194 . . . . 0.0 110.073 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 122.112 0.958 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 61.07 24.58 14.67 Favored 'General case' 0 C--N 1.282 -2.362 0 CA-C-O 122.054 0.931 . . . . 0.0 109.222 178.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.564 ' O ' ' CB ' ' A' ' 14' ' ' SER . 0.7 OUTLIER -84.12 25.79 0.8 Allowed 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 122.299 1.047 . . . . 0.0 109.714 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.564 ' CB ' ' O ' ' A' ' 13' ' ' GLU . 0.9 OUTLIER 83.1 172.69 0.09 Allowed 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.712 ' HE ' ' ND2' ' A' ' 84' ' ' ASN . 4.5 mpt_? -111.68 102.59 10.89 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 122.211 1.005 . . . . 0.0 109.754 -179.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -131.44 173.96 5.26 Favored Pre-proline 0 C--N 1.291 -1.949 0 O-C-N 121.277 -0.89 . . . . 0.0 108.872 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.406 ' N ' ' HG1' ' A' ' 108' ' ' THR . 20.8 Cg_endo -88.91 78.64 1.09 Allowed 'Trans proline' 0 C--N 1.297 -2.16 0 C-N-CA 121.831 1.687 . . . . 0.0 111.42 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 112' ' ' ASP . 33.0 t -75.19 144.52 42.65 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 122.029 0.918 . . . . 0.0 109.705 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 82.7 p -100.36 151.51 21.42 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 122.703 1.239 . . . . 0.0 109.63 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.663 ' CG2' ' N ' ' A' ' 21' ' ' SER . 0.1 OUTLIER -150.6 173.92 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 O-C-N 121.002 -1.061 . . . . 0.0 109.431 -178.653 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.663 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 1.5 m -108.82 166.12 11.05 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.516 -1.365 . . . . 0.0 109.46 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 1.052 HG11 ' HB1' ' A' ' 119' ' ' ALA . 37.1 t -62.86 -29.98 48.42 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.808 0 CA-C-O 122.106 0.955 . . . . 0.0 108.707 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.608 HG23 ' N ' ' A' ' 24' ' ' VAL . 6.5 t -55.38 -47.78 75.3 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 120.82 -1.175 . . . . 0.0 109.106 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.608 ' N ' HG23 ' A' ' 23' ' ' THR . 1.4 t -69.68 -39.74 78.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.157 -1.589 . . . . 0.0 109.42 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.996 ' HB2' HD13 ' A' ' 113' ' ' ILE . . . -51.3 -36.27 41.72 Favored 'General case' 0 C--N 1.288 -2.103 0 O-C-N 120.804 -1.185 . . . . 0.0 108.39 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -60.29 -48.63 80.93 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -59.81 -36.15 76.18 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 120.878 -1.139 . . . . 0.0 108.699 178.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.539 HD13 HD13 ' A' ' 86' ' ' ILE . 51.2 mt -80.86 -25.03 37.96 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 25' ' ' ALA . 8.9 tt -62.22 -43.38 98.95 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.8 HD12 ' N ' ' A' ' 31' ' ' ALA . 3.4 pp -80.21 -14.39 58.48 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.509 -1.369 . . . . 0.0 107.477 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.8 ' N ' HD12 ' A' ' 30' ' ' LEU . . . -67.27 -27.67 67.39 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.736 -1.228 . . . . 0.0 108.398 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.24 47.68 6.0 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.526 ' O ' ' CZ ' ' A' ' 35' ' ' TYR . 14.1 m-70 -115.37 163.61 15.47 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.204 -1.174 . . . . 0.0 109.589 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.636 HH12 HD13 ' A' ' 53' ' ' ILE . 20.0 mmm180 -59.8 132.04 52.75 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 122.359 1.076 . . . . 0.0 109.793 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.526 ' CZ ' ' O ' ' A' ' 33' ' ' HIS . 21.6 m-85 -118.2 108.14 14.8 Favored 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.314 -0.866 . . . . 0.0 108.95 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.788 ' HB3' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -102.35 133.16 47.73 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 120.582 -1.324 . . . . 0.0 108.587 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.62 ' H ' HD13 ' A' ' 36' ' ' LEU . 22.1 t70 -147.75 111.39 5.01 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 -178.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.427 ' O ' HG22 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -83.1 103.97 11.09 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 O-C-N 120.959 -1.088 . . . . 0.0 108.093 177.44 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.705 HH22 ' NE2' ' A' ' 46' ' ' GLN . 25.7 ttp180 -84.34 -43.45 14.74 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -179.01 170.39 0.73 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.182 -0.949 . . . . 0.0 109.95 -179.026 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 40' ' ' THR . 24.7 Cg_exo -55.47 -145.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 121.92 1.746 . . . . 0.0 111.125 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.527 ' OE1' ' NH2' ' A' ' 60' ' ' ARG . 22.2 pt-20 -58.28 -23.44 56.24 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.85 -1.156 . . . . 0.0 108.543 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.473 ' O ' ' OE1' ' A' ' 46' ' ' GLN . 96.7 mt-10 -50.66 -30.0 12.52 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.802 -1.186 . . . . 0.0 108.997 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.662 ' CD1' ' N ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -78.06 -32.22 50.73 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 122.217 1.008 . . . . 0.0 108.91 177.446 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.662 ' N ' ' CD1' ' A' ' 44' ' ' PHE . 16.0 t -49.01 -19.1 0.36 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.153 -0.967 . . . . 0.0 109.052 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.705 ' NE2' HH22 ' A' ' 39' ' ' ARG . 0.4 OUTLIER -69.8 -9.57 55.14 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.089 -1.007 . . . . 0.0 108.619 179.46 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.515 ' O ' ' O ' ' A' ' 44' ' ' PHE . . . 161.78 -164.76 35.41 Favored Glycine 0 N--CA 1.499 2.875 0 CA-C-O 122.245 0.914 . . . . 0.0 111.051 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.635 ' O ' ' O ' ' A' ' 49' ' ' ALA . 3.9 p80 -176.0 106.01 0.08 Allowed 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 122.732 1.254 . . . . 0.0 109.38 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.635 ' O ' ' O ' ' A' ' 48' ' ' HIS . . . -30.87 157.44 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 122.159 0.981 . . . . 0.0 109.421 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.797 ' N ' ' H ' ' A' ' 127' ' ' THR . 0.5 OUTLIER -93.53 162.17 14.07 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.694 ' N ' ' SG ' ' A' ' 50' ' ' CYS . . . 105.79 -8.13 42.66 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.771 ' HB3' ' CZ2' ' A' ' 120' ' ' TRP . . . -170.46 157.78 6.13 Favored 'General case' 0 C--N 1.29 -2.009 0 O-C-N 120.784 -1.421 . . . . 0.0 109.615 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.636 HD13 HH12 ' A' ' 34' ' ' ARG . 38.6 mt -99.6 134.83 37.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 O-C-N 120.762 -1.211 . . . . 0.0 110.262 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.477 ' ND2' ' OD2' ' A' ' 37' ' ' ASP . 6.7 m120 -113.3 134.2 54.73 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 121.937 0.875 . . . . 0.0 109.472 -178.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.734 ' O ' HG12 ' A' ' 55' ' ' VAL . 1.1 t -142.6 95.77 6.37 Favored Pre-proline 0 C--N 1.273 -2.754 0 CA-C-O 122.221 1.01 . . . . 0.0 109.133 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.476 ' C ' ' H ' ' A' ' 58' ' ' MET . 28.3 Cg_endo -77.94 54.37 4.83 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.5 2.134 . . . . 0.0 111.693 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.518 ' CE1' ' NE2' ' A' ' 81' ' ' GLN . 61.8 m-85 50.37 12.08 0.09 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 122.31 1.052 . . . . 0.0 109.848 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.476 ' H ' ' C ' ' A' ' 56' ' ' PRO . 77.8 mtm -151.09 147.16 26.74 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-O 122.137 0.97 . . . . 0.0 110.072 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.416 ' OD1' ' O ' ' A' ' 58' ' ' MET . 79.5 m-20 -146.52 98.58 3.09 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.527 ' NH2' ' OE1' ' A' ' 42' ' ' GLU . 28.4 ttp180 -116.62 137.31 52.28 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.034 -1.042 . . . . 0.0 108.594 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 63' ' ' SER . . . -174.33 -165.88 31.52 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.23 1.89 1.89 Allowed 'General case' 0 C--N 1.28 -2.419 0 O-C-N 121.191 -1.182 . . . . 0.0 108.338 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.483 ' H ' ' C ' ' A' ' 61' ' ' GLY . 48.3 t -62.45 -11.4 15.77 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 111.15 25.67 4.95 Favored Glycine 0 N--CA 1.5 2.956 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 92.8 mtp 50.84 101.1 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 122.337 1.065 . . . . 0.0 110.326 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.7 m -165.83 93.06 0.54 Allowed 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.4 ptpp? -103.58 144.94 30.77 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.077 -1.014 . . . . 0.0 108.572 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -45.08 132.97 6.85 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 122.244 1.021 . . . . 0.0 110.037 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.0 m -146.57 155.62 42.63 Favored 'General case' 0 C--N 1.282 -2.367 0 O-C-N 121.437 -0.79 . . . . 0.0 109.869 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 52.34 47.76 24.04 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.309 -1.494 . . . . 0.0 108.306 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -48.24 -25.49 1.55 Allowed 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 122.127 0.965 . . . . 0.0 108.8 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 76' ' ' SER . 0.5 OUTLIER -50.79 -45.96 59.43 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.026 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -55.81 -35.99 66.93 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.94 -1.1 . . . . 0.0 108.889 176.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -83.03 -47.91 11.19 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.83 -1.169 . . . . 0.0 108.703 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.8 t -67.45 -47.06 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.835 -1.165 . . . . 0.0 108.717 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 72' ' ' LEU . 30.7 t -52.78 -33.12 47.29 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.546 ' O ' ' CB ' ' A' ' 78' ' ' HIS . 43.9 p -72.35 -0.05 11.34 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.956 -1.09 . . . . 0.0 109.116 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.546 ' CB ' ' O ' ' A' ' 77' ' ' SER . 4.0 t-80 77.18 57.26 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.526 ' CG ' ' O ' ' A' ' 78' ' ' HIS . 47.2 m-85 -163.53 139.05 6.5 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.921 -1.112 . . . . 0.0 110.035 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.548 ' H ' ' HB2' ' A' ' 83' ' ' ASP . . . -112.26 137.79 14.51 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.518 ' NE2' ' CE1' ' A' ' 57' ' ' TYR . 10.5 pt20 -45.71 -19.56 0.06 Allowed 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.491 -1.005 . . . . 0.0 109.17 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.819 ' HA ' HD12 ' A' ' 85' ' ' ILE . 16.3 m -122.84 20.92 10.04 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.793 -1.192 . . . . 0.0 107.969 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.548 ' HB2' ' H ' ' A' ' 80' ' ' GLY . 42.2 t0 -42.42 113.8 0.49 Allowed 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.408 -0.808 . . . . 0.0 109.11 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.712 ' ND2' ' HE ' ' A' ' 15' ' ' ARG . 5.4 m120 59.6 63.36 1.53 Allowed 'General case' 0 C--N 1.291 -1.936 0 O-C-N 121.308 -0.87 . . . . 0.0 109.451 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.819 HD12 ' HA ' ' A' ' 82' ' ' SER . 17.8 mt -145.93 176.66 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 O-C-N 121.076 -1.015 . . . . 0.0 109.421 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.66 ' N ' HG22 ' A' ' 85' ' ' ILE . 64.1 mt -111.01 112.43 40.55 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 O-C-N 121.078 -1.014 . . . . 0.0 109.422 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.926 ' CG2' HG21 ' A' ' 110' ' ' VAL . 60.4 t -110.94 175.0 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 O-C-N 121.261 -0.899 . . . . 0.0 108.887 -176.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.561 ' N ' HG12 ' A' ' 87' ' ' VAL . . . -172.02 175.63 45.28 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 19.7 t -128.46 120.31 26.61 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 122.029 0.919 . . . . 0.0 109.319 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.439 ' O ' ' OE1' ' A' ' 90' ' ' GLN . 1.0 OUTLIER -65.63 -38.63 89.95 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.039 0.923 . . . . 0.0 110.422 -178.492 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 92' ' ' GLY . 4.1 m -61.52 160.98 10.26 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 122.171 0.986 . . . . 0.0 109.473 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 91' ' ' SER . . . -43.17 161.95 0.05 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.668 ' O ' HG22 ' A' ' 96' ' ' ILE . . . -54.83 -28.06 46.02 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -55.05 -28.32 51.38 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.221 -1.164 . . . . 0.0 108.72 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 43.7 t -85.24 -32.44 22.6 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.15 -0.969 . . . . 0.0 109.237 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.748 HG13 HG22 ' A' ' 114' ' ' VAL . 0.3 OUTLIER -60.3 -30.56 46.42 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 O-C-N 121.03 -1.044 . . . . 0.0 108.881 -179.289 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.413 ' HB3' ' HZ2' ' A' ' 97' ' ' LYS . 16.1 mtpp -62.56 -47.68 82.78 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.707 -1.246 . . . . 0.0 108.402 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.34 -50.09 72.49 Favored 'General case' 0 C--N 1.289 -2.029 0 O-C-N 120.557 -1.339 . . . . 0.0 109.266 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.733 ' O ' HD13 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -57.86 -47.84 81.55 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-O 122.525 1.155 . . . . 0.0 108.705 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 57.9 m -56.39 -48.81 76.13 Favored 'General case' 0 C--N 1.287 -2.134 0 O-C-N 120.943 -1.098 . . . . 0.0 108.989 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -65.43 -40.34 93.2 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.654 -1.279 . . . . 0.0 108.153 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 102' ' ' LEU . 3.7 tt -68.48 -40.54 80.94 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.968 0.89 . . . . 0.0 108.818 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.733 HD13 ' O ' ' A' ' 99' ' ' THR . 10.8 mp -69.86 -28.93 66.07 Favored 'General case' 0 C--N 1.292 -1.914 0 O-C-N 121.088 -1.007 . . . . 0.0 109.017 178.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -64.02 -32.54 74.12 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.519 -1.363 . . . . 0.0 108.527 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -130.93 37.2 3.8 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 120.623 -1.298 . . . . 0.0 108.393 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -151.34 -67.64 0.01 OUTLIER Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.666 ' H ' ' HA ' ' A' ' 103' ' ' LEU . 96.7 m-85 -138.48 156.24 47.71 Favored 'General case' 0 C--N 1.289 -2.048 0 O-C-N 121.175 -1.191 . . . . 0.0 109.38 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.426 ' OG1' ' N ' ' A' ' 109' ' ' GLY . 11.0 t -166.42 -161.93 0.49 Allowed 'General case' 0 C--N 1.297 -1.689 0 O-C-N 120.667 -1.271 . . . . 0.0 110.104 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.426 ' N ' ' OG1' ' A' ' 108' ' ' THR . . . 79.05 21.13 68.6 Favored Glycine 0 N--CA 1.499 2.836 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.926 HG21 ' CG2' ' A' ' 87' ' ' VAL . 1.7 m -142.29 167.93 14.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 O-C-N 121.07 -1.253 . . . . 0.0 109.874 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.607 ' O ' ' N ' ' A' ' 87' ' ' VAL . 85.6 mttt -97.88 148.94 22.92 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 122.198 0.999 . . . . 0.0 108.739 -179.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -111.74 108.08 17.38 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -178.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.996 HD13 ' HB2' ' A' ' 25' ' ' ALA . 69.7 mt -83.08 125.1 40.04 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 O-C-N 121.265 -0.897 . . . . 0.0 110.261 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.748 HG22 HG13 ' A' ' 96' ' ' ILE . 67.2 t -100.78 138.22 25.75 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 O-C-N 120.825 -1.172 . . . . 0.0 109.63 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 167.67 -147.48 11.72 Favored Glycine 0 C--N 1.285 -2.268 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -154.22 -176.99 27.17 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -59.06 -33.02 70.3 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-O 122.011 0.91 . . . . 0.0 109.647 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.499 ' O ' ' HB3' ' A' ' 121' ' ' ALA . 32.1 t -56.47 -32.26 64.8 Favored 'General case' 0 C--N 1.292 -1.905 0 O-C-N 121.332 -0.855 . . . . 0.0 109.331 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 1.052 ' HB1' HG11 ' A' ' 22' ' ' VAL . . . -62.21 -40.91 97.66 Favored 'General case' 0 C--N 1.286 -2.159 0 O-C-N 121.185 -0.947 . . . . 0.0 108.892 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . 0.771 ' CZ2' ' HB3' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -60.34 -33.77 72.88 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 179.294 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 118' ' ' SER . . . -56.84 -37.63 71.53 Favored 'General case' 0 C--N 1.292 -1.911 0 O-C-N 120.795 -1.19 . . . . 0.0 108.812 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -56.44 -39.19 72.71 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -63.36 -65.29 0.71 Allowed 'General case' 0 N--CA 1.503 2.184 0 O-C-N 120.649 -1.282 . . . . 0.0 108.371 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.06 16.53 35.19 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 50' ' ' CYS . 12.6 mt -126.83 71.98 74.9 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 120.827 -1.396 . . . . 0.0 109.369 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.49 ' HA ' ' H ' ' A' ' 50' ' ' CYS . 32.9 Cg_endo -96.54 115.86 0.14 Allowed 'Trans proline' 0 C--N 1.302 -1.911 0 C-N-CA 122.29 1.993 . . . . 0.0 113.16 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.797 ' H ' ' N ' ' A' ' 50' ' ' CYS . 82.0 p -125.08 130.39 52.16 Favored 'General case' 0 C--N 1.287 -2.151 0 O-C-N 120.743 -1.223 . . . . 0.0 109.027 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.524 ' O ' ' HB3' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -179.63 141.02 0.15 Allowed 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 122.126 0.965 . . . . 0.0 108.953 -179.121 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 128' ' ' LYS . . . . . . . . 0 C--N 1.281 -2.401 0 O-C-N 120.859 -1.151 . . . . 0.0 110.086 -178.502 . . . . . . . . 1 1 . 1 stop_ save_